data_2d9b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2d9b _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.843 0.354 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.61 -63.29 1.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.0 tt -49.64 -31.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.211 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -76.48 -40.1 51.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 m -67.11 -35.33 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.452 HD12 ' CD1' ' A' ' 73' ' ' LEU . 28.3 mt -64.72 -45.24 87.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.927 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -58.08 -34.81 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -67.15 -50.83 59.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.439 ' CG2' HD21 ' A' ' 80' ' ' LEU . 6.9 m -51.22 -48.2 62.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.559 HG11 ' CE2' ' A' ' 26' ' ' PHE . 11.7 t -65.77 -36.12 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.107 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.03 -42.65 94.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.99 -49.61 49.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.574 ' CE1' ' CE ' ' A' ' 83' ' ' LYS . 6.8 t80 -41.93 -64.25 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.559 ' CE2' HG11 ' A' ' 22' ' ' VAL . 22.6 m-85 -42.01 -34.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.4 m -72.69 -36.73 67.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.453 ' N ' ' O ' ' A' ' 25' ' ' TYR . 1.2 t80 -67.39 -48.68 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.0 m -63.58 -39.81 95.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.485 ' CD1' HD13 ' A' ' 90' ' ' ILE . 13.1 t80 -67.62 -52.57 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.64 -29.02 72.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -44.87 72.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.72 -27.61 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.38 -33.16 75.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.67 20.48 19.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' CE ' HG21 ' A' ' 40' ' ' VAL . 11.6 mtmt -92.71 179.12 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.1 p -108.53 20.05 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -151.8 164.16 37.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.72 142.07 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.429 ' CG1' ' HD2' ' A' ' 41' ' ' PRO . 40.2 t -115.63 135.96 22.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.429 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.77 117.91 5.37 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.24 112.07 14.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 80.49 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.686 2.257 . . . . 0.0 112.289 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -53.04 -47.51 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -50.34 -44.83 54.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.947 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -74.32 -59.27 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.566 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 59.3 mtp -45.7 -33.59 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.1 mt -60.46 -48.32 82.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -73.39 -36.29 66.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -128.33 97.93 4.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.797 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -95.13 47.14 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 p -124.52 -41.51 2.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.812 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.89 25.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.064 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.5 t -149.87 126.0 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.108 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 46.6 t -98.42 158.4 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.564 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 44.5 t -128.13 126.51 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -120.49 165.32 15.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.16 10.82 68.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mt -84.22 155.76 63.41 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.95 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.2 Cg_endo -69.76 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 0.0 112.376 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.57 158.03 15.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.2 17.26 23.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.4 p -108.61 175.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.136 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -157.01 120.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.566 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 84.6 t80 -34.79 119.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ptpp? -166.56 170.5 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -45.45 141.65 3.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.528 0.68 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.523 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.9 Cg_endo -69.75 -1.06 7.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 0.0 112.366 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.19 -17.48 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.2 -14.89 57.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -88.33 135.39 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 149.2 47.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.452 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.8 tp -40.47 -39.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.22 23.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.4 m -59.17 -45.6 90.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.9 mt -46.27 -49.59 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -55.68 -43.79 76.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 60.1 t90 -53.28 -60.15 3.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.2 mt -41.62 -53.63 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.439 HD21 ' CG2' ' A' ' 21' ' ' THR . 23.8 mt -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.99 -53.85 43.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.446 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -100.49 35.13 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.574 ' CE ' ' CE1' ' A' ' 25' ' ' TYR . 21.1 ptmt -74.19 -52.59 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -36.93 -30.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.066 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -84.96 -37.85 9.79 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 19.4 mt -45.52 124.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 0.0 111.058 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -124.71 168.75 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.564 ' CZ ' HG23 ' A' ' 56' ' ' VAL . 5.9 m-85 -135.72 129.46 32.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.01 112.0 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.0 113.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.46 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.1 mmtt -91.0 -29.73 17.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.475 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.93 135.29 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.402 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.294 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.865 0.364 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.09 -65.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 tt -50.4 -32.15 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -76.27 -36.91 58.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -70.96 -34.52 71.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.443 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 17.1 mt -62.79 -47.45 83.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.949 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -54.99 -41.33 71.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -67.16 -51.58 52.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.445 ' CG2' HD22 ' A' ' 80' ' ' LEU . 91.6 m -49.03 -48.4 43.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.109 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.505 HG12 ' CE2' ' A' ' 26' ' ' PHE . 86.3 t -67.69 -37.02 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 13.8 mt-10 -56.05 -43.05 77.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -65.68 -49.51 68.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.566 ' CD1' ' HE3' ' A' ' 83' ' ' LYS . 8.7 t80 -44.12 -64.19 0.72 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.505 ' CE2' HG12 ' A' ' 22' ' ' VAL . 26.5 m-85 -42.8 -39.83 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 25' ' ' TYR . 21.2 t80 -65.28 -56.64 11.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.1 m -54.05 -40.47 67.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -65.78 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.19 -25.02 61.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.541 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.13 -42.16 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.68 67.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.091 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -62.69 -34.83 77.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.47 24.03 9.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.545 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.517 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 8.7 mtmt -92.35 -179.97 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 t -109.87 19.3 19.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -154.09 161.87 41.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -74.77 144.35 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 40.5 t -119.46 136.08 24.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.598 0.713 . . . . 0.0 111.135 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 54.3 Cg_endo -69.71 118.5 5.72 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.662 2.242 . . . . 0.0 112.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -70.42 111.99 11.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . 53.5 Cg_endo -69.81 79.97 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -55.88 -47.16 77.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -51.27 -46.4 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HD2' ' CB ' ' A' ' 43' ' ' PRO . 44.6 mttt -71.7 -55.56 7.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.525 ' HE2' ' CE2' ' A' ' 65' ' ' PHE . 80.1 mtp -50.33 -31.97 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.48 -30.43 71.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -86.03 -38.49 17.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -133.18 94.65 3.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.2 40.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' VAL . 22.1 p -113.36 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.95 -35.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' SER . 19.0 t -148.78 143.32 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 58.7 t -118.04 139.9 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.572 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 22.9 t -109.17 125.71 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -120.03 158.85 25.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.12 15.35 45.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.504 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.421 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 11.6 mt -87.12 154.34 54.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.936 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.9 Cg_endo -69.68 -168.68 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -86.99 164.42 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.79 29.1 0.75 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.437 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG13 ' CD ' ' A' ' 60' ' ' PRO . 4.0 p -117.84 156.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -139.15 118.26 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' HG22 ' A' ' 56' ' ' VAL . 83.3 t80 -34.11 117.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.7 ptpt -164.33 174.41 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.516 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -44.86 140.75 3.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.721 . . . . 0.0 110.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.6 Cg_endo -69.75 2.28 3.66 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -97.18 -22.04 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -81.17 -12.45 59.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.415 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.7 m-85 -88.2 117.7 27.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' LEU . 2.0 m-20 -49.02 144.03 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.443 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.2 tp -35.72 -50.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.29 -51.14 63.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -60.98 -46.65 89.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.1 mt -47.53 -54.96 10.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.938 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -48.56 -47.93 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.569 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.2 t90 -48.64 -61.62 1.94 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.2 mt -41.14 -52.42 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.445 HD22 ' CG2' ' A' ' 21' ' ' THR . 29.4 mt -59.49 -37.82 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.56 -55.27 25.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.73 37.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.566 ' HE3' ' CD1' ' A' ' 25' ' ' TYR . 16.6 ptmt -72.85 -53.92 10.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.17 -33.4 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.055 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.65 -33.28 38.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 25.0 mt -53.19 126.05 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.5 m -123.91 169.06 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.828 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.572 ' CZ ' HG23 ' A' ' 56' ' ' VAL . 7.1 m-85 -136.42 126.41 26.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.04 109.61 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.519 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.17 112.98 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.4 mmtp -92.05 -31.28 15.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.48 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.72 129.96 0.28 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.875 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.461 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 0.0 112.323 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.789 0.328 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.49 -63.62 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 9.6 tt -51.13 -38.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.7 mm-40 -68.78 -46.03 69.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 m -61.56 -33.44 73.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 19.1 mt -59.25 -47.48 85.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.459 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -58.85 -47.68 84.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -54.53 -52.62 61.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 m -51.46 -48.38 62.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.523 HG11 ' CE2' ' A' ' 26' ' ' PHE . 23.7 t -67.72 -37.41 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.42 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -56.41 -36.92 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.94 -47.9 27.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.3 t80 -44.34 -63.06 0.96 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.523 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.3 m-85 -41.92 -34.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.1 m -71.83 -38.91 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' TYR . 1.7 t80 -64.8 -47.52 77.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 65.3 m -65.56 -41.75 92.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.4 ' CE1' HD13 ' A' ' 90' ' ' ILE . 14.7 t80 -66.7 -47.91 70.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.98 -32.67 63.21 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -42.31 93.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.42 -31.3 70.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -61.71 -36.1 79.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.41 10.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -94.28 179.31 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.0 p -108.65 21.01 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.0 p -155.76 162.27 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -76.12 155.41 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.87 135.0 25.21 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.663 0.744 . . . . 0.0 111.077 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 118.55 5.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 0.0 112.286 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 81.3 t -67.0 117.81 49.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 111.122 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 80.01 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -50.57 -53.11 32.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -43.16 -56.21 3.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -65.79 -56.1 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.416 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 41.0 mmm -50.06 -23.52 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.826 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.24 -30.41 57.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.955 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -42.12 15.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.33 94.54 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -81.69 47.63 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.915 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -125.18 -56.07 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.72 -36.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 52' ' ' SER . 16.1 t -149.69 119.77 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.448 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 19.9 t -95.86 154.85 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 5.0 t -125.69 119.53 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -112.04 158.93 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.41 13.24 42.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.401 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.1 mt -85.89 156.97 57.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.667 0.746 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.57 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.4 Cg_endo -69.8 -172.16 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -86.53 158.87 19.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.39 28.7 9.8 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.401 ' CG1' ' HB3' ' A' ' 59' ' ' LEU . 4.2 p -118.69 171.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -154.66 120.31 5.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 64' ' ' ALA . 82.4 t80 -35.15 121.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -167.31 170.58 11.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.518 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.3 t-80 -39.75 141.01 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.65 0.738 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.7 Cg_endo -69.71 -9.54 26.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -91.19 -16.81 27.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -82.82 -13.88 55.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.489 ' CD2' HD13 ' A' ' 79' ' ' ILE . 21.9 m-85 -87.39 121.06 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.03 147.67 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 7.0 tp -40.01 -48.8 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.41 -44.73 84.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -63.42 -57.79 9.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.496 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 16.0 mt -39.44 -47.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -55.05 -46.55 75.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.57 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.5 t90 -54.5 -58.81 6.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.489 HD13 ' CD2' ' A' ' 71' ' ' TYR . 49.4 mt -41.52 -53.76 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.2 mt -61.1 -40.5 93.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -55.61 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -97.93 35.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 51.8 pttt -77.63 -49.77 13.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.82 -26.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -91.24 -39.1 5.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' LYS . 28.4 mt -43.22 122.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 111.149 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -120.49 162.73 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 6.3 m-85 -128.25 126.48 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.5 110.35 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.516 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.41 113.17 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.448 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 19.5 mmtt -91.45 -28.12 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.474 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 134.5 0.31 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.632 0.73 . . . . 0.0 110.842 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.418 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.2 0 C-N-CA 122.612 2.208 . . . . 0.0 112.392 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.752 0.311 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.47 -65.05 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tt -49.66 -31.01 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -76.6 -40.15 50.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -66.8 -34.44 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.488 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 20.6 mt -63.54 -41.39 98.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -64.44 -39.09 93.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -41.6 77.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.0 m -59.78 -49.03 79.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.555 HG13 ' CE2' ' A' ' 26' ' ' PHE . 96.1 t -65.36 -37.34 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.084 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -54.85 -39.14 68.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.92 -52.16 32.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.558 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 10.0 t80 -42.34 -62.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.555 ' CE2' HG13 ' A' ' 22' ' ' VAL . 21.4 m-85 -43.78 -40.74 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 m -68.32 -37.83 80.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -66.47 -47.0 74.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.5 m -64.1 -40.94 97.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.97 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE1' HD13 ' A' ' 90' ' ' ILE . 14.9 t80 -66.61 -56.71 9.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.23 -29.84 74.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.464 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -42.25 75.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.745 0.307 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -26.52 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.092 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.5 mt -67.6 -30.9 70.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 23.09 13.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.555 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 14.6 mtmt -95.77 178.85 5.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.347 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -107.7 6.06 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.2 p -136.95 160.96 37.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -79.35 136.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.555 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 55.0 t -112.76 137.8 21.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 0.0 111.137 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.74 125.76 12.53 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.672 2.248 . . . . 0.0 112.383 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.48 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 61.7 t -71.13 111.93 11.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.619 0.723 . . . . 0.0 111.169 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 80.44 0.89 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.674 2.249 . . . . 0.0 112.326 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -53.02 -53.21 53.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -47.42 -52.03 18.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -65.86 -61.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.543 ' HE1' ' CE2' ' A' ' 65' ' ' PHE . 79.4 mtp -43.54 -37.95 2.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.5 mt -55.31 -40.26 70.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -82.26 -39.52 22.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -126.16 80.24 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -68.19 -20.63 64.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.2 t -62.25 -57.14 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -31.79 -36.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' SER . 15.0 t -151.53 121.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.41 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 20.8 t -100.02 157.78 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 23.7 t -125.53 123.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -117.36 153.24 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.46 39.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.3 mt -84.85 155.73 61.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.623 0.725 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.565 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 52.8 Cg_endo -69.86 178.86 4.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.297 . . . . 0.0 112.311 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.18 154.61 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.08 23.21 51.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.543 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.2 p -116.61 164.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.161 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -144.59 117.95 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.543 ' CE2' ' HE1' ' A' ' 47' ' ' MET . 64.1 t80 -34.65 120.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -167.11 171.48 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.518 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -42.96 141.89 1.57 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.3 Cg_endo -69.77 -4.88 14.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.319 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.92 -14.27 26.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -85.21 -12.38 52.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.54 128.38 36.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 73' ' ' LEU . 4.5 m-20 -56.63 145.81 27.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.488 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.9 tp -36.19 -48.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.74 62.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -58.89 -46.38 87.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.2 mt -47.61 -47.99 28.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.985 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -55.1 -48.58 73.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.841 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.565 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.3 t90 -49.21 -60.56 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.6 mt -40.74 -53.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.73 -38.78 79.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -62.98 -55.42 25.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.464 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.48 38.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.9 pttp -77.39 -45.42 25.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.463 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -44.06 -35.89 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.07 -35.27 31.05 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 mt -49.51 123.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -126.09 167.6 15.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 7.6 m-85 -132.83 128.43 36.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.69 111.06 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.536 HD13 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.88 112.52 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 22.3 mmtt -89.94 -33.3 16.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.17 129.6 0.26 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 110.835 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.436 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.201 0 C-N-CA 122.732 2.288 . . . . 0.0 112.371 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.824 0.345 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.5 -57.33 3.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 5.5 tt -54.48 -46.11 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.082 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.549 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.3 mt-10 -63.48 -48.61 76.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 m -57.2 -30.89 64.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 28.6 mt -64.54 -48.64 74.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.474 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -58.18 -42.07 85.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -39.02 92.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.46 ' CG2' HD23 ' A' ' 80' ' ' LEU . 48.5 m -64.33 -49.4 71.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.537 HG13 ' CE2' ' A' ' 26' ' ' PHE . 94.5 t -66.69 -39.49 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -53.36 -43.22 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.11 -49.68 69.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.565 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 12.5 t80 -45.99 -63.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.537 ' CE2' HG13 ' A' ' 22' ' ' VAL . 22.0 m-85 -44.18 -40.4 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.7 m -65.25 -38.3 89.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -66.64 -59.6 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -51.49 -37.57 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE1' HD12 ' A' ' 90' ' ' ILE . 17.0 t80 -69.71 -64.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.18 57.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.87 -45.95 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.43 67.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mt -62.71 -33.17 74.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.86 23.43 11.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.585 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 10.2 mtmt -94.35 179.11 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -109.54 20.21 18.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.8 p -154.16 159.67 41.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -76.58 138.71 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.585 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 51.0 t -114.58 137.67 22.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.664 0.745 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.8 120.82 7.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.611 2.207 . . . . 0.0 112.349 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 58.7 t -73.72 111.96 14.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.738 . . . . 0.0 111.148 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 79.83 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.715 2.277 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -51.43 -45.2 62.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -54.36 -40.25 67.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -74.38 -59.62 2.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.618 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 92.5 mtp -47.38 -46.19 25.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -43.92 -46.96 8.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -80.77 -39.81 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -127.48 81.64 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -72.28 -30.96 65.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' ALA . 24.0 p -45.01 -50.07 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -36.14 -45.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 t -144.7 128.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.467 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 35.0 t -99.64 142.98 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.558 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 39.6 t -116.56 112.66 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -102.49 162.63 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.6 0.78 64.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.406 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 9.6 mt -75.55 149.35 83.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.603 0.716 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.3 Cg_endo -69.81 178.47 4.57 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.685 2.257 . . . . 0.0 112.339 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.86 160.21 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.74 19.77 10.97 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.446 HG12 ' CD ' ' A' ' 60' ' ' PRO . 3.2 p -112.94 169.82 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.455 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.618 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 72.8 t80 -34.31 113.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -159.78 171.06 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.512 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.2 t-80 -42.15 141.24 1.42 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.512 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.7 Cg_endo -69.8 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 0.0 112.378 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.59 -15.11 31.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -89.07 -7.15 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -91.29 121.25 32.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.82 147.16 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.82 -47.35 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.11 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.5 m -66.77 -57.51 6.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.474 ' CD1' ' HD2' ' A' ' 19' ' ' ARG . 14.9 mt -39.41 -48.32 1.91 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -55.99 -48.23 76.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.558 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.8 t90 -49.16 -57.71 6.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -43.1 -52.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.46 HD23 ' CG2' ' A' ' 21' ' ' THR . 21.6 mt -59.77 -38.28 81.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.23 -55.78 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.432 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -97.8 40.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.852 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.565 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 16.7 ptmt -80.05 -53.57 6.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.929 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -36.27 -33.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -83.29 -37.54 12.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 14.4 mt -44.14 125.83 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 t -124.34 162.99 22.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.558 ' CZ ' HG22 ' A' ' 56' ' ' VAL . 6.9 m-85 -131.77 126.2 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.2 111.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -81.23 113.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.185 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.467 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.0 mmtt -93.18 -31.24 14.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.483 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.89 125.71 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 0.0 110.872 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.823 0.344 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.9 -57.94 3.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 8.2 tt -50.83 -42.65 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.115 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.7 mt-10 -66.31 -43.23 86.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 m -63.28 -32.94 74.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 27.3 mt -61.41 -45.92 92.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.46 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -59.42 -50.14 75.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -47.78 70.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.3 m -55.25 -49.03 73.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.181 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.517 HG12 ' CE2' ' A' ' 26' ' ' PHE . 59.6 t -67.78 -36.1 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 15.3 mt-10 -57.75 -45.26 86.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -65.95 -47.98 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.421 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.4 t80 -44.87 -59.4 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' A' ' 22' ' ' VAL . 20.1 m-85 -46.71 -39.3 11.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.1 m -65.52 -39.9 92.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -64.49 -54.12 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.821 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.48 ' CB ' ' CD1' ' A' ' 88' ' ' PHE . 35.5 m -58.13 -43.86 87.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -63.15 -58.66 6.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.38 -27.86 72.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.31 -41.27 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.15 -32.65 69.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.129 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.52 -26.26 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.91 24.1 21.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.435 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 15.1 mtmt -96.86 177.21 5.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.6 p -109.24 22.68 15.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.0 p -153.26 165.59 35.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -84.54 140.46 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.47 ' CG1' ' HD2' ' A' ' 41' ' ' PRO . 43.6 t -117.82 137.39 24.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.79 114.0 3.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.496 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 82.7 t -71.52 113.6 21.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.649 0.738 . . . . 0.0 111.076 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.427 ' CB ' ' CE ' ' A' ' 46' ' ' LYS . 54.3 Cg_endo -69.74 80.73 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 0.0 112.352 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -52.15 -45.21 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -49.46 -46.55 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' CE ' ' CB ' ' A' ' 43' ' ' PRO . 43.7 mtmt -75.69 -52.83 9.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.619 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 38.5 mtp -51.81 -21.44 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -76.67 -33.27 58.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -34.68 57.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -136.92 109.82 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -97.58 40.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 p -117.61 -41.93 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.93 -43.74 39.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.142 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 t -146.32 124.93 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 40.0 t -97.76 149.38 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.158 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 65' ' ' PHE . 98.9 t -118.67 116.56 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.516 ' CD ' ' CD1' ' A' ' 89' ' ' ILE . 2.2 mp0 -100.74 -179.6 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.33 4.32 73.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.442 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 mt -78.11 154.02 79.9 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.67 0.748 . . . . 0.0 110.854 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.552 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.8 Cg_endo -69.71 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.715 2.277 . . . . 0.0 112.341 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 33.9 tp10 -87.26 160.16 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.415 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 47.45 29.07 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 p -119.18 167.65 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -150.59 126.78 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.063 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.619 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 78.4 t80 -35.95 130.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -174.44 172.77 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.518 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.5 t-80 -47.18 140.99 6.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.558 0.694 . . . . 0.0 110.883 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.4 Cg_endo -69.73 -7.26 20.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' OE2' ' ND1' ' A' ' 67' ' ' HIS . 5.2 pt-20 -93.09 -17.28 24.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -81.69 -15.72 53.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -85.05 131.8 34.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.0 OUTLIER -56.44 147.21 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.43 -49.12 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.19 79.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 26.6 m -71.15 -51.54 24.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.493 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 12.2 mt -45.29 -54.17 7.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -49.67 -47.44 50.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.0 t90 -49.12 -55.87 10.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.9 mt -45.37 -54.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.3 mt -59.45 -34.27 72.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.948 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.26 -52.31 55.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.508 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.92 33.82 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 86' ' ' ILE . 55.8 pttt -76.47 -45.29 31.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.58 -25.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.72 -30.24 9.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 83' ' ' LYS . 20.0 mt -49.57 122.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.8 m -121.82 170.26 9.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 29' ' ' CYS . 6.1 m-85 -128.89 116.13 18.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.516 ' CD1' ' CD ' ' A' ' 57' ' ' GLN . 9.2 mt -103.83 93.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.166 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.503 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -71.39 114.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.2 mmtp -93.68 -30.07 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.456 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 128.45 0.27 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.611 0.72 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.453 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.383 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -62.2 -68.85 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.9 tt -48.52 -34.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.51 -40.41 64.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -66.05 -38.04 87.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.451 HD12 ' CD1' ' A' ' 73' ' ' LEU . 27.6 mt -59.61 -45.8 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -58.27 -40.67 82.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.842 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -45.74 73.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -52.15 -49.69 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.089 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 26' ' ' PHE . 42.3 t -65.92 -39.59 85.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -51.1 -48.31 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -63.97 -48.85 74.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.554 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.8 t80 -44.21 -62.69 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' A' ' 22' ' ' VAL . 24.6 m-85 -44.63 -35.14 2.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.0 m -67.59 -39.72 84.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.11 -58.04 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.8 m -54.78 -39.75 68.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -65.78 -64.8 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.78 -24.22 62.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.6 -46.64 63.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.58 -31.03 71.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.99 -34.07 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.36 22.83 11.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.41 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.524 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 15.0 mtmt -91.55 179.46 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.9 p -107.98 18.98 20.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -152.12 172.72 15.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -90.05 140.44 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.18 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.524 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 42.9 t -116.76 136.31 23.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.654 0.74 . . . . 0.0 111.114 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.418 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.78 122.52 9.2 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.12 112.04 14.01 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.659 0.743 . . . . 0.0 111.11 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 80.54 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.761 2.307 . . . . 0.0 112.323 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -48.84 -52.01 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.02 -52.65 14.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -65.86 -57.84 6.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.542 ' HE2' ' CE2' ' A' ' 65' ' ' PHE . 32.1 mmm -48.25 -33.65 9.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.7 mt -59.97 -32.6 70.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -87.02 -40.32 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -129.18 90.88 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -80.74 -19.89 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p -58.52 -46.72 86.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.53 -42.96 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.4 t -146.52 132.03 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 51.1 t -102.91 148.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 65' ' ' PHE . 12.4 t -121.86 116.9 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -104.73 170.02 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.96 9.6 73.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.7 mt -83.45 150.15 59.49 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.636 0.732 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.6 Cg_endo -69.78 -171.98 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -83.4 163.69 20.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.37 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.438 HG13 ' CD ' ' A' ' 60' ' ' PRO . 3.2 p -119.8 157.86 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.166 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.12 123.83 16.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 56' ' ' VAL . 91.5 t80 -34.62 119.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -167.37 169.89 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.514 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.6 t-80 -41.86 140.99 1.36 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.514 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.7 Cg_endo -69.71 -6.59 18.93 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.657 2.238 . . . . 0.0 112.365 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.66 -21.4 21.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -78.86 -9.65 59.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.44 129.28 39.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.93 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' THR . 4.2 m-20 -57.77 143.46 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.451 ' CD1' HD12 ' A' ' 18' ' ' LEU . 9.8 tp -36.32 -48.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -42.69 79.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 72' ' ' ASP . 60.7 m -70.09 -45.77 66.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.427 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 14.0 mt -47.78 -52.75 17.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -51.34 -46.68 62.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.559 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.1 t90 -50.05 -56.85 9.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -44.63 -55.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.0 mt -57.97 -36.67 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.02 -53.33 55.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.493 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.38 34.86 2.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.554 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 60.7 pttt -77.2 -48.8 16.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -42.87 -27.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.94 -32.26 11.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.1 mt -47.66 121.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 111.154 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -118.03 162.55 18.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 56' ' ' VAL . 6.1 m-85 -131.1 123.33 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.5 110.84 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.499 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.22 113.23 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.138 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.452 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 4.9 mmtp -93.17 -32.46 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.477 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.12 127.73 0.25 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.42 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.189 0 C-N-CA 122.669 2.246 . . . . 0.0 112.298 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.816 0.341 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.96 -62.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.8 tt -47.36 -36.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.14 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -70.09 -40.67 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -66.43 -38.7 88.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.491 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 20.0 mt -59.36 -46.33 88.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -64.44 -37.45 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -68.18 -46.45 70.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.7 m -56.69 -45.9 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.087 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 26' ' ' PHE . 41.0 t -68.18 -31.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.62 -47.38 63.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -45.33 -61.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.569 ' CE2' HG13 ' A' ' 22' ' ' VAL . 21.9 m-85 -46.71 -39.98 12.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m -67.46 -40.44 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -62.85 -56.53 16.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.0 m -52.61 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.549 ' CE1' HD12 ' A' ' 90' ' ' ILE . 15.1 t80 -66.87 -64.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -23.16 58.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -39.2 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.906 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.17 -27.25 60.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -66.09 -32.66 74.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 25.93 9.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.517 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 13.6 mtmt -95.56 179.73 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 t -110.93 21.39 16.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.3 p -154.3 163.94 39.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -79.04 143.04 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 57.5 t -118.92 137.84 25.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.684 0.754 . . . . 0.0 111.09 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.75 120.94 7.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.61 112.66 14.81 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 111.137 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 80.63 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.716 2.277 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -60.32 -39.61 87.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.9 -38.5 70.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -80.3 -55.02 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.549 ' HE1' ' CZ ' ' A' ' 65' ' ' PHE . 84.2 mtp -49.41 -35.98 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -85.69 -38.38 18.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.07 91.5 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -81.15 41.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 14.3 p -116.41 -55.86 2.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.795 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.94 -37.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 52' ' ' SER . 29.7 t -148.02 135.95 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.476 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 46.7 t -109.32 146.07 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.545 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 15.3 t -117.57 124.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.2 165.27 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.92 62.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.44 151.2 55.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.536 0.684 . . . . 0.0 110.9 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.545 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.1 Cg_endo -69.77 -169.07 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 63' ' ' VAL . 7.7 tt0 -87.52 167.5 13.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.21 24.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 61' ' ' GLU . 3.5 p -115.27 159.81 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.63 117.38 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CZ ' ' HE1' ' A' ' 47' ' ' MET . 42.0 t80 -34.21 114.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -159.02 173.76 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.517 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 6.9 t-80 -42.92 140.62 1.85 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 110.875 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.3 Cg_endo -69.78 0.75 5.21 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.643 2.229 . . . . 0.0 112.335 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.42 -17.79 18.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.93 -11.35 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -88.17 121.39 30.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 73' ' ' LEU . 1.8 m-20 -51.45 144.84 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.818 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.491 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.2 tp -36.91 -48.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.89 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -57.18 -48.93 77.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.161 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -43.48 -57.2 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -48.14 -44.0 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.93 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.545 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.8 t90 -53.14 -59.73 4.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.7 mt -41.87 -54.65 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.149 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.8 mt -59.85 -36.86 77.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -63.03 -53.45 53.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.484 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -100.84 35.0 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -76.38 -45.54 31.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -42.0 -29.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.8 -35.84 8.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.9 mt -46.01 120.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -120.52 163.13 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.545 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 6.2 m-85 -129.74 126.65 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.65 111.39 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -81.97 113.06 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.476 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 22.8 mmtt -91.54 -31.66 15.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.468 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.02 132.46 0.28 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo . . . . . 0 N--CA 1.465 -0.206 0 C-N-CA 122.75 2.3 . . . . 0.0 112.384 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.774 0.321 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -57.96 -69.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 tt -45.84 -32.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.54 -37.74 59.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 15.7 mt -61.31 -40.96 96.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -63.44 -45.91 88.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -44.83 83.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.9 m -53.74 -47.38 70.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.509 HG11 ' CE2' ' A' ' 26' ' ' PHE . 59.5 t -68.73 -36.54 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.93 -47.65 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.558 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.2 t80 -45.28 -58.3 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.509 ' CE2' HG11 ' A' ' 22' ' ' VAL . 22.5 m-85 -50.13 -40.71 47.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.4 m -65.42 -40.13 92.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.16 -58.48 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.0 m -52.0 -40.65 61.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -66.66 -64.72 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -21.89 56.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -41.01 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.2 -27.24 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.83 -31.46 72.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.949 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.6 24.68 10.69 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.514 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.539 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 17.6 mtmt -94.66 179.9 5.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 t -109.65 21.3 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.9 p -155.39 174.88 14.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 m -88.31 148.35 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 98.6 t -123.12 137.1 27.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.664 0.745 . . . . 0.0 111.153 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 54.2 Cg_endo -69.74 111.92 2.94 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.405 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 39.6 t -69.96 111.9 10.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.573 0.701 . . . . 0.0 111.111 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 79.97 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.624 2.216 . . . . 0.0 112.355 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -52.05 -48.45 64.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -50.34 -43.23 53.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -74.17 -58.37 3.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.555 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 56.9 mtp -46.59 -35.39 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.2 mt -54.24 -42.2 69.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 6.7 ptt85 -84.23 -32.89 24.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.878 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.439 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 8.3 p-10 -130.62 86.87 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -80.09 -7.39 58.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 53' ' ' ALA . 2.5 p -68.61 -57.26 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.83 -37.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.079 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' SER . 3.4 t -154.33 125.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 40.2 t -96.3 165.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.507 HG23 ' CD1' ' A' ' 65' ' ' PHE . 39.4 t -136.2 123.1 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -116.21 166.44 12.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.33 5.49 67.31 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 mt -79.68 152.29 74.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.2 Cg_endo -69.8 -174.63 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.306 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -83.61 162.69 20.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.1 23.43 2.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.413 HG12 ' CD ' ' A' ' 60' ' ' PRO . 3.2 p -115.93 166.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -150.12 128.76 12.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' HE3' ' A' ' 47' ' ' MET . 86.9 t80 -37.87 128.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -174.07 174.49 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.6 t-80 -50.61 141.87 16.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.569 0.699 . . . . 0.0 110.839 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.3 Cg_endo -69.7 -1.98 9.34 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.457 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 4.3 pt-20 -95.81 -20.09 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -78.12 -17.45 56.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -83.19 145.05 29.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.36 150.09 38.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 7.3 tp -38.77 -51.77 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.28 -56.76 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -55.0 -50.11 69.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.7 mt -43.19 -57.03 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -47.14 -46.56 23.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.568 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 67.4 t90 -51.01 -61.87 1.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mt -40.14 -54.63 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -58.88 -40.14 83.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.36 -53.76 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.487 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -100.97 35.67 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 53.7 pttt -76.79 -45.06 30.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -43.11 -28.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.32 -35.01 9.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.455 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.4 mt -47.61 120.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.356 . . . . 0.0 111.084 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -120.76 164.79 16.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.464 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 6.5 m-85 -131.22 122.16 26.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.05 110.48 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.515 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.66 112.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.474 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 21.0 mmtt -91.48 -28.79 17.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.49 140.43 0.34 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.672 2.248 . . . . 0.0 112.278 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.812 0.339 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -82.01 -55.47 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 16' ' ' GLU . 11.2 tt -52.49 -36.46 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' N ' HG22 ' A' ' 15' ' ' ILE . 7.4 mt-10 -72.69 -45.42 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.9 m -59.5 -36.25 75.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 29.8 mt -60.64 -44.8 95.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -58.88 -36.07 74.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -45.79 75.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.423 ' CG2' HD21 ' A' ' 80' ' ' LEU . 33.0 m -55.83 -50.23 71.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.172 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.07 -40.64 87.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -51.9 -49.54 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.59 -47.39 85.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -44.95 -62.11 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -45.24 -41.73 8.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 m -62.41 -42.46 99.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.401 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 22.9 t80 -63.35 -55.24 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 64.9 m -57.53 -40.41 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.477 ' CE1' HD11 ' A' ' 90' ' ' ILE . 20.3 t80 -67.14 -62.83 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.53 -23.46 60.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.54 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -72.17 -46.61 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.57 -28.67 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.62 -34.81 77.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 22.85 12.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.451 ' CE ' HG22 ' A' ' 40' ' ' VAL . 19.4 mtmt -93.39 -179.91 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 p -109.34 20.52 18.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.3 p -156.39 159.44 38.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.88 155.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG22 ' CE ' ' A' ' 36' ' ' LYS . 70.5 t -130.82 131.75 23.47 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.626 0.726 . . . . 0.0 111.082 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.348 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.68 115.51 15.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.72 0.771 . . . . 0.0 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.92 0.97 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -48.78 -52.85 21.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -45.86 -54.2 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -61.19 2.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.799 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.549 ' HE2' ' CE2' ' A' ' 65' ' ' PHE . 31.5 mmm -42.25 -39.2 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -49.34 71.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.937 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -80.53 -25.53 38.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.54 87.87 2.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 54' ' ' VAL . 52.2 mt-30 -83.36 -28.31 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 31.0 p -49.84 -56.39 10.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.21 -43.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 51' ' ' GLN . 2.5 t -143.99 122.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.097 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.22 142.01 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.524 HG21 ' CE1' ' A' ' 65' ' ' PHE . 19.0 t -111.19 125.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -116.74 162.94 16.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.38 44.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.446 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 18.3 mt -92.14 155.96 42.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.668 0.746 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.564 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.8 Cg_endo -69.71 -165.59 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' GLY . 10.3 tt0 -88.16 166.73 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.66 33.09 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 59' ' ' LEU . 3.2 p -120.28 149.82 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -133.86 123.17 24.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CE2' ' HE2' ' A' ' 47' ' ' MET . 82.6 t80 -33.98 121.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.0 ptpt -170.88 166.15 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.528 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.1 t-80 -39.92 141.52 0.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.841 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.528 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.4 Cg_endo -69.71 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.674 2.249 . . . . 0.0 112.356 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -20.54 25.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -81.76 -15.44 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.426 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 24.5 m-85 -84.04 123.15 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.7 145.07 7.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -37.99 -49.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.62 76.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.8 m -60.51 -47.84 84.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 26.7 mt -47.97 -54.55 12.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -48.59 -43.41 36.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.6 t90 -56.87 -57.21 13.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.0 mt -44.19 -52.42 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.423 HD21 ' CG2' ' A' ' 21' ' ' THR . 21.4 mt -60.62 -36.15 77.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.02 -53.09 55.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -101.47 35.31 2.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.856 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 52.3 pttt -75.54 -49.3 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -41.0 -30.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.39 8.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.8 mt -40.47 124.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -121.51 170.2 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -132.47 115.42 15.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.2 mt -101.03 93.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.081 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -72.0 112.91 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -87.82 -31.97 19.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.55 137.34 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.562 0.696 . . . . 0.0 110.886 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.338 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.784 0.326 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.29 -49.92 65.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 16' ' ' GLU . 3.8 tt -57.19 -33.49 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' N ' HG22 ' A' ' 15' ' ' ILE . 5.1 mt-10 -75.47 -40.82 56.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 m -64.67 -37.71 88.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' CD1' ' A' ' 73' ' ' LEU . 31.0 mt -64.2 -37.05 86.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.468 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 31.1 mtm105 -66.41 -36.82 83.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -62.79 -48.89 77.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.447 ' CG2' HD21 ' A' ' 80' ' ' LEU . 28.3 m -56.29 -46.2 79.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.553 HG12 ' CE2' ' A' ' 26' ' ' PHE . 23.4 t -67.01 -35.57 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.01 -44.66 97.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.72 -46.35 72.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.9 t80 -46.52 -62.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.553 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.0 m-85 -42.31 -36.45 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.83 -42.98 76.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -59.59 -49.66 76.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -62.97 -43.79 97.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -62.37 -58.7 6.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.34 82.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -44.55 86.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.6 71.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.0 mt -64.01 -34.4 77.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.95 11.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.481 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 14.3 mtmt -93.25 179.59 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.945 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.87 20.27 18.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.3 p -154.55 164.56 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.79 145.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 59.1 t -124.22 132.94 24.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 0.0 111.158 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 122.17 8.87 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.626 2.218 . . . . 0.0 112.336 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 79.5 t -68.08 111.54 8.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.707 0.765 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 79.61 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 0.0 112.364 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' MET . 38.3 m-85 -45.23 -73.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.4 tp10 -30.91 -54.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -62.09 -43.11 99.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.546 ' N ' ' O ' ' A' ' 44' ' ' TYR . 47.3 mtp -65.78 -58.68 5.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.5 mt -42.45 -35.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -91.86 -29.34 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.45 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 25.3 t0 -134.12 75.09 1.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -63.83 -43.76 95.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -40.16 -61.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -31.43 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' SER . 12.1 t -155.19 119.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.17 157.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.571 HG21 ' CE2' ' A' ' 88' ' ' PHE . 19.9 t -126.68 121.79 59.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -114.28 153.31 29.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.67 15.12 27.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.407 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 17.3 mt -89.64 157.69 46.39 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.648 0.737 . . . . 0.0 110.863 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.566 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 52.9 Cg_endo -69.84 -168.01 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 0.0 112.248 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.84 164.86 15.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.2 29.31 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.424 ' CG1' ' HB3' ' A' ' 59' ' ' LEU . 3.1 p -118.66 152.59 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.179 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.97 123.25 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.009 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.496 ' CZ ' ' SD ' ' A' ' 47' ' ' MET . 86.9 t80 -33.81 126.29 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.83 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.49 166.83 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.944 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.525 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.4 t-80 -43.01 141.73 1.63 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.676 0.75 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.525 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.9 Cg_endo -69.76 -7.59 21.45 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.709 2.272 . . . . 0.0 112.325 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.468 ' HA ' ' CD ' ' A' ' 19' ' ' ARG . 1.5 pp20? -89.23 -16.95 30.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -85.62 -13.73 47.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.79 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -85.79 128.5 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.7 m-20 -56.41 141.96 40.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 72' ' ' ASP . 7.5 tp -36.05 -46.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.33 84.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 92.4 m -64.53 -48.13 76.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.1 mt -45.04 -51.72 9.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -52.99 -46.28 68.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.566 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 56.5 t90 -52.08 -61.81 2.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.993 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.3 mt -39.61 -52.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.447 HD21 ' CG2' ' A' ' 21' ' ' THR . 19.6 mt -61.22 -37.34 82.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -63.12 -53.84 47.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.531 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.2 m-80 -99.78 37.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.529 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 44.8 pttt -79.93 -50.04 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.451 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.48 -31.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.083 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -86.9 -37.16 8.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.6 mt -42.47 127.37 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.751 0.31 . . . . 0.0 111.146 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -127.61 166.16 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CE2' HG21 ' A' ' 56' ' ' VAL . 7.9 m-85 -131.77 121.85 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.48 110.42 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.81 112.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -91.85 -25.35 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.13 139.41 0.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.655 0.741 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.216 0 C-N-CA 122.695 2.264 . . . . 0.0 112.365 -179.987 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.806 0.336 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.62 -60.85 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 16' ' ' GLU . 6.1 tt -49.55 -37.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 15' ' ' ILE . 7.4 mt-10 -72.38 -41.79 65.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 m -64.61 -38.36 90.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.467 HD13 ' CD1' ' A' ' 73' ' ' LEU . 26.9 mt -60.92 -35.52 76.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -71.88 -41.33 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -58.18 -39.61 79.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -63.87 -43.97 94.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.531 HG13 ' CE2' ' A' ' 26' ' ' PHE . 47.4 t -70.58 -32.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.223 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -62.41 -40.15 95.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.73 -46.86 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.571 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 11.1 t80 -47.98 -62.85 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.531 ' CE2' HG13 ' A' ' 22' ' ' VAL . 28.9 m-85 -42.13 -37.73 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.1 m -68.6 -43.51 76.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -60.18 -52.55 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -57.83 -43.4 85.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.437 ' CE1' HD12 ' A' ' 90' ' ' ILE . 15.7 t80 -64.06 -61.1 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.952 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.21 -27.37 67.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -42.57 68.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.706 0.288 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 -24.27 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.35 -28.63 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.06 23.47 24.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.572 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.542 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 16.5 mtmt -91.92 -179.98 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.889 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 m -109.48 19.11 19.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -150.54 172.13 15.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.196 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.58 139.52 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 74.4 t -117.93 133.08 23.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 0.0 111.124 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 124.7 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.331 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.469 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 90.7 t -72.54 111.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.635 0.731 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 79.9 0.92 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 0.0 112.368 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -52.41 -51.12 60.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -46.0 -51.5 13.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -69.66 -60.5 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.601 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 40.2 mtp -42.2 -39.35 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.943 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.5 mt -53.78 -46.19 70.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -79.39 -31.94 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.32 88.94 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -78.44 -38.38 41.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 53' ' ' ALA . 37.0 p -39.52 -55.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -34.28 -40.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 t -153.06 128.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.447 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 35.2 t -102.25 165.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 88' ' ' PHE . 14.5 t -134.48 124.22 44.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -116.02 163.47 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.03 11.98 58.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.41 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 13.2 mt -86.29 154.04 56.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.565 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.5 Cg_endo -69.7 172.76 11.99 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.356 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -78.69 147.52 33.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.47 18.83 72.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.453 HG12 ' CD ' ' A' ' 60' ' ' PRO . 3.3 p -115.41 168.59 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 111.143 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -146.65 117.85 7.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.601 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 68.3 t80 -35.94 122.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.419 ' N ' ' OH ' ' A' ' 71' ' ' TYR . 11.2 ptpt -170.8 169.99 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.519 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.4 t-80 -42.19 140.82 1.52 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 110.938 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.2 Cg_endo -69.85 3.34 2.87 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -95.32 -21.7 18.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -83.41 -7.06 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.954 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.419 ' OH ' ' N ' ' A' ' 66' ' ' LYS . 22.9 m-85 -92.72 133.82 35.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.91 154.87 36.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.467 ' CD1' HD13 ' A' ' 18' ' ' LEU . 6.3 tp -44.59 -47.53 10.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.54 -54.63 44.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.2 m -55.99 -47.1 78.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.8 mt -45.29 -59.69 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -46.1 -46.36 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.565 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.0 t90 -51.04 -62.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.5 mt -40.21 -51.44 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.12 -36.08 80.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' TRP . 12.0 mm-40 -64.56 -54.07 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.486 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.65 36.77 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.571 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -76.75 -45.51 28.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.53 -33.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.17 -31.47 28.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.41 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 mt -50.25 118.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.4 m -121.55 156.64 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 56' ' ' VAL . 7.1 m-85 -121.66 126.56 49.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.71 109.53 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.51 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.55 113.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.447 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.3 mmtp -93.84 -26.88 16.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.8 137.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.216 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 2.1 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.79 0.329 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.69 -54.87 5.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.458 HG21 ' N ' ' A' ' 16' ' ' GLU . 10.4 tt -52.27 -30.37 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.458 ' N ' HG21 ' A' ' 15' ' ' ILE . 3.4 mt-10 -77.37 -43.48 32.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -61.67 -34.44 75.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 73' ' ' LEU . 24.0 mt -64.62 -44.45 90.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -61.55 -22.87 65.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -76.26 -56.0 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.442 ' CG2' HD21 ' A' ' 80' ' ' LEU . 4.1 m -44.47 -44.81 8.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.57 HG13 ' CE2' ' A' ' 26' ' ' PHE . 21.9 t -71.51 -34.74 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.464 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 14.7 mt-10 -62.75 -39.05 92.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -72.99 -38.05 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.528 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 7.0 t80 -58.41 -60.15 4.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' HG13 ' A' ' 22' ' ' VAL . 20.9 m-85 -44.03 -40.8 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.22 -58.0 7.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.7 m -53.24 -40.12 64.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -66.72 -63.7 1.01 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.959 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.56 60.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -41.23 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.732 0.301 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.85 67.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.051 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -62.06 -35.3 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.35 25.61 8.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.501 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.58 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 13.1 mtmt -95.93 179.6 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -111.35 20.51 17.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.9 p -152.5 159.94 43.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -73.49 141.56 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.58 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 98.4 t -120.22 138.91 27.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 0.0 111.178 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.474 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.83 122.82 9.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.748 2.299 . . . . 0.0 112.265 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.457 ' O ' ' CD1' ' A' ' 44' ' ' TYR . 55.2 t -67.98 116.79 42.27 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.628 0.727 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 80.03 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.736 2.291 . . . . 0.0 112.349 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.517 ' O ' ' C ' ' A' ' 45' ' ' GLU . 67.9 m-85 -55.69 -72.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.921 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 44' ' ' TYR . 37.0 tt0 -28.79 -56.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -48.07 83.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.568 ' HE3' ' CZ ' ' A' ' 65' ' ' PHE . 74.2 mtp -59.26 -56.92 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.1 mt -43.83 -46.51 7.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -77.81 -31.28 51.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 51.8 m-20 -134.96 95.26 3.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -92.25 51.92 1.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 p -130.27 -38.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.97 -35.73 59.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 t -149.29 123.35 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 33.4 t -95.95 155.06 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.557 HG23 ' CD1' ' A' ' 65' ' ' PHE . 19.8 t -126.25 121.55 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.114 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -111.68 168.18 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.033 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.98 4.24 78.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.93 158.11 75.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 0.0 110.925 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.6 Cg_endo -69.81 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.653 2.235 . . . . 0.0 112.3 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -98.3 157.41 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.09 17.53 10.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 60' ' ' PRO . 8.0 p -107.78 168.08 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -145.94 115.08 7.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.098 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.568 ' CZ ' ' HE3' ' A' ' 47' ' ' MET . 55.5 t80 -35.01 125.19 0.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.839 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.496 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 14.7 ptpt -169.35 172.78 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.513 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.0 t-80 -43.84 140.66 2.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.599 0.714 . . . . 0.0 110.818 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.513 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.6 Cg_endo -69.77 2.59 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.1 -16.99 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.04 -11.06 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.496 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.6 m-85 -86.81 116.99 25.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.41 143.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.46 ' CD1' HD13 ' A' ' 18' ' ' LEU . 8.9 tp -39.44 -41.56 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.976 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.63 70.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -58.13 -46.25 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.7 mt -47.0 -52.5 14.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -50.45 -46.23 56.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.568 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -54.32 -60.95 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.9 mt -41.14 -50.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.442 HD21 ' CG2' ' A' ' 21' ' ' THR . 31.7 mt -62.68 -35.6 80.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.1 -55.17 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.465 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.5 m-80 -98.19 39.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.837 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.528 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 19.7 ptmt -78.27 -51.91 9.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.56 -31.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -85.05 -37.51 9.97 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.1 mt -43.18 118.4 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 111.169 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.0 m -118.91 160.17 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -126.59 125.98 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.11 112.0 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.61 113.31 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.462 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.6 mmtt -93.36 -28.38 16.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.481 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.91 129.5 0.27 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.655 0.74 . . . . 0.0 110.833 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.451 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.221 0 C-N-CA 122.707 2.271 . . . . 0.0 112.385 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.863 0.363 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.25 -59.31 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.82 -34.5 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -40.81 74.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -67.18 -32.14 73.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 15.6 mt -64.27 -46.54 83.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -63.96 -29.08 70.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -67.54 -54.57 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -51.32 -47.9 62.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG13 ' CE2' ' A' ' 26' ' ' PHE . 20.0 t -64.72 -37.35 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.04 -43.19 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.36 -44.29 68.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 6.4 t80 -48.92 -61.18 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.563 ' CE2' HG13 ' A' ' 22' ' ' VAL . 19.7 m-85 -44.45 -35.06 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.2 m -68.05 -40.17 82.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -62.49 -55.04 31.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.68 -35.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -68.03 -58.48 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -26.83 70.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -43.07 77.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.793 0.33 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.91 -27.65 62.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -72.6 -21.1 61.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.16 32.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -90.71 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -98.68 -4.3 34.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.4 p -137.94 166.53 23.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.84 129.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.145 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.0 t -105.67 132.38 20.93 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.585 0.707 . . . . 0.0 111.157 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 124.46 11.14 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.388 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 81.0 t -64.91 111.17 5.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.693 0.759 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 79.18 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.261 . . . . 0.0 112.327 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 47' ' ' MET . 72.7 m-85 -47.3 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 44' ' ' TYR . 9.4 pt-20 -30.04 -42.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' TYR . 23.7 mttp -73.13 -47.09 47.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' TYR . 70.4 mtp -62.51 -50.98 69.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 11.7 mt -50.4 -37.49 37.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -88.73 -27.63 21.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.41 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 3.8 t70 -134.11 69.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -59.0 -40.99 86.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 53' ' ' ALA . 3.4 t -48.37 -58.45 4.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -31.94 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 53' ' ' ALA . 59.1 t -138.94 119.74 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.151 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.438 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 39.2 t -98.94 160.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 88' ' ' PHE . 18.1 t -129.61 129.1 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.179 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -118.51 163.96 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.3 6.87 62.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.6 mt -82.13 157.27 68.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.614 0.721 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.56 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.3 Cg_endo -69.79 -168.17 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.309 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -90.11 162.37 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 46.61 26.69 2.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 p -116.33 163.22 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.91 0.386 . . . . 0.0 111.078 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -145.0 118.77 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.57 ' CD1' HG22 ' A' ' 56' ' ' VAL . 91.5 t80 -34.39 126.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 13.0 ptpt -170.67 165.71 8.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.516 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -38.29 140.82 0.57 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.0 Cg_endo -69.82 2.23 3.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.668 2.245 . . . . 0.0 112.302 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.22 -20.87 16.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -84.79 -12.61 53.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.492 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 20.4 m-85 -84.16 117.04 23.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.4 OUTLIER -45.46 139.12 3.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -35.79 -46.9 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.03 87.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' ASP . 51.8 m -65.49 -45.25 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.8 mt -46.59 -54.7 8.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -48.94 -50.44 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.56 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 51.8 t90 -50.61 -60.71 2.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.0 mt -39.87 -52.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.95 -40.19 96.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.98 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -55.45 34.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -97.16 37.76 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.56 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 58.7 pttt -82.96 -45.64 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -38.43 -27.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.54 -40.07 4.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 85' ' ' GLY . 13.9 mt -34.16 127.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.1 m -127.92 169.6 13.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CE2' HG23 ' A' ' 56' ' ' VAL . 8.4 m-85 -134.96 127.92 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.23 109.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.133 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.504 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.75 113.38 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.215 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.438 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.3 mmtp -92.89 -31.74 14.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.85 127.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.594 0.711 . . . . 0.0 110.859 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo . . . . . 0 C--N 1.342 0.206 0 C-N-CA 122.727 2.284 . . . . 0.0 112.343 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.87 -61.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 tt -50.79 -33.55 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.68 -43.9 62.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.6 m -62.96 -33.26 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.1 mt -63.32 -44.84 93.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -62.23 -40.2 95.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -64.55 -46.0 84.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 m -57.12 -48.98 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.536 HG12 ' CE2' ' A' ' 26' ' ' PHE . 46.4 t -65.97 -39.01 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.91 -43.69 69.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.1 -49.51 56.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 9.0 t80 -42.72 -61.92 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.536 ' CE2' HG12 ' A' ' 22' ' ' VAL . 25.7 m-85 -45.13 -38.03 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 m -66.82 -47.37 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -55.6 -52.57 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.3 m -56.49 -46.21 80.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.56 ' CE2' HG11 ' A' ' 40' ' ' VAL . 12.9 t80 -61.95 -62.41 1.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -27.83 64.48 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.519 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -41.81 74.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.24 66.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -64.89 -34.33 78.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.78 6.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.568 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 11.4 mtmt -99.86 177.61 5.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.756 0.313 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.9 p -105.84 -0.54 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.4 p -128.78 165.82 20.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.5 146.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.568 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 78.3 t -125.31 128.12 24.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.703 0.763 . . . . 0.0 111.157 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 124.33 10.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.254 . . . . 0.0 112.306 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -71.16 113.1 16.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.682 0.753 . . . . 0.0 111.151 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 80.89 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.245 . . . . 0.0 112.344 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.574 ' O ' ' N ' ' A' ' 47' ' ' MET . 53.1 m-85 -47.85 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.498 ' C ' ' O ' ' A' ' 44' ' ' TYR . 35.0 tt0 -29.92 -46.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -70.11 -44.17 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 44' ' ' TYR . 37.2 mmm -63.34 -53.01 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.82 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 12.1 mt -40.29 -35.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 mtp85 -93.73 -39.83 10.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -122.99 80.11 1.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.0 -28.0 57.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -52.54 -57.65 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.43 -36.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.3 t -152.69 119.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.455 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 20.0 t -96.28 153.41 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG23 ' CE2' ' A' ' 88' ' ' PHE . 11.9 t -125.36 123.58 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -112.15 163.82 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.39 61.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.444 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 11.3 mt -81.66 151.01 67.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.971 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.7 Cg_endo -69.74 -179.95 3.26 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.7 2.266 . . . . 0.0 112.4 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.62 161.24 27.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.83 24.04 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.473 HG12 ' CD ' ' A' ' 60' ' ' PRO . 3.7 p -115.65 171.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -154.52 119.97 5.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.56 ' CE2' ' HE3' ' A' ' 47' ' ' MET . 85.6 t80 -34.75 121.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.437 ' CG ' ' CE1' ' A' ' 71' ' ' TYR . 8.4 ptpp? -166.6 179.08 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.511 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -51.24 140.74 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.4 Cg_endo -69.78 2.99 3.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 8.1 pt-20 -98.29 -22.54 16.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -79.12 -15.38 58.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 66' ' ' LYS . 20.9 m-85 -83.42 129.55 34.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.9 m-20 -61.67 143.24 56.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -34.78 -45.56 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.096 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' ASP . 87.5 m -60.58 -52.03 66.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.8 mt -43.04 -56.74 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -46.57 -44.97 18.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.546 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.9 t90 -54.43 -57.9 9.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.7 mt -43.84 -55.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.15 -35.81 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.97 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -64.06 -52.8 57.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.504 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.74 33.64 2.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.519 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 59.0 pttt -74.87 -44.12 50.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.53 -22.07 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.4 -27.74 10.41 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.469 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mt -53.67 120.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.121 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 p -117.9 165.24 13.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.567 ' CE2' HG23 ' A' ' 56' ' ' VAL . 7.4 m-85 -133.09 122.86 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.43 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -80.7 113.24 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 32.2 mmtt -93.07 -25.97 17.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.53 140.0 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.673 0.749 . . . . 0.0 110.842 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.342 0.201 0 C-N-CA 122.635 2.224 . . . . 0.0 112.36 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.793 0.33 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.22 -44.95 82.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 16' ' ' GLU . 6.7 tt -64.27 -31.64 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 15' ' ' ILE . 4.2 mt-10 -77.0 -34.08 57.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -74.89 -35.26 62.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.431 HD13 ' CD1' ' A' ' 73' ' ' LEU . 29.3 mt -63.59 -46.27 86.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.946 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.53 -38.25 74.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -64.34 -61.35 2.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 m -43.83 -46.92 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 26' ' ' PHE . 96.4 t -65.13 -36.3 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 12.3 mt-10 -64.59 -39.24 93.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.87 -51.78 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -40.58 -60.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.574 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.5 m-85 -45.69 -34.69 3.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.886 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m -63.88 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 1.2 t80 -66.37 -64.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.3 m -51.14 -45.12 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.546 ' CE2' HD12 ' A' ' 34' ' ' LEU . 17.7 t80 -59.65 -55.79 30.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.03 -41.17 92.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.43 -38.16 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -18.09 49.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.069 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.546 HD12 ' CE2' ' A' ' 30' ' ' TYR . 30.1 mt -75.18 -26.91 59.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.15 4.33 9.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 153.2 41.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.318 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -88.7 11.61 17.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.3 p -105.87 170.07 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.198 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.5 115.4 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.407 ' CG1' ' HD2' ' A' ' 41' ' ' PRO . 96.9 t -100.05 137.37 20.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.623 0.725 . . . . 0.0 111.134 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.8 109.24 2.27 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.707 2.271 . . . . 0.0 112.254 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.1 111.24 6.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.075 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 79.52 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.293 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -48.9 -48.48 42.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -44.55 -57.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.541 ' CG ' ' N ' ' A' ' 47' ' ' MET . 0.0 OUTLIER -69.08 -50.94 43.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.558 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 25.4 mmm -51.12 -24.76 4.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.8 mt -71.21 -32.96 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -87.52 -33.12 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -130.81 88.94 2.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -78.47 -39.86 37.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.2 t -43.56 -58.36 2.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -30.76 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' SER . 12.3 t -148.85 119.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 21.9 t -97.04 149.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.571 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 11.2 t -123.16 115.15 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -100.31 -178.02 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.37 -2.23 85.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 8.8 mt -77.87 154.09 80.54 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.671 0.748 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.557 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.7 Cg_endo -69.76 -175.42 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.344 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -83.19 164.44 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.84 20.45 1.22 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.424 HG11 ' CD ' ' A' ' 60' ' ' PRO . 3.2 p -113.27 169.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 111.065 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -150.31 120.85 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.072 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.558 ' CE2' ' HE3' ' A' ' 47' ' ' MET . 61.3 t80 -34.56 123.31 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.1 ptpt -166.7 175.32 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.946 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.495 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -47.81 140.39 8.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.0 Cg_endo -69.65 2.08 3.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.674 2.25 . . . . 0.0 112.352 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -98.16 -17.89 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.28 -11.61 49.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 23.0 m-85 -87.72 112.01 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -40.23 144.5 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.431 ' CD1' HD13 ' A' ' 18' ' ' LEU . 7.5 tp -39.99 -47.29 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -44.67 95.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.4 m -62.99 -47.98 80.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt -46.45 -59.27 3.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -45.18 -42.11 8.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.557 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.4 t90 -56.61 -59.32 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.0 mt -41.65 -55.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.162 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.47 -37.35 77.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -62.5 -54.56 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.563 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.1 m-80 -98.87 39.85 1.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' GLY . 27.4 pttt -85.86 -37.77 18.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -40.29 -24.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -97.61 -31.8 6.57 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.5 mt -42.25 110.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 111.058 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 m -121.93 138.56 54.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 5.7 m-85 -98.01 124.31 42.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.67 110.06 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.96 113.06 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.152 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 18.8 mmtt -91.08 -32.58 15.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.06 130.13 0.26 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.652 0.739 . . . . 0.0 110.866 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.437 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.231 0 C-N-CA 122.669 2.246 . . . . 0.0 112.349 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.853 0.358 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.97 -65.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.951 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 10.1 tt -47.03 -41.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.4 mm-40 -64.54 -45.94 84.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -62.37 -33.06 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.145 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 21.1 mt -61.06 -48.2 82.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' CG ' ' HA ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -60.66 -43.47 97.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mtmm -60.88 -52.03 66.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.0 m -51.79 -48.3 63.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.09 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.46 HG11 ' CE2' ' A' ' 26' ' ' PHE . 18.9 t -67.12 -36.47 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -54.69 -43.54 72.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.88 -50.99 60.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.571 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.7 t80 -42.71 -64.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.5 m-85 -43.7 -35.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 -36.87 66.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.79 -46.9 73.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.2 m -64.28 -40.01 95.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.471 ' CD1' HD13 ' A' ' 90' ' ' ILE . 16.2 t80 -69.71 -47.53 62.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.972 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 -28.98 64.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.434 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -47.64 68.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.863 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.08 73.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.0 -36.3 81.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 23.38 9.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.498 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 17.4 mtmt -92.37 178.36 5.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 m -107.42 17.63 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 p -152.82 163.5 39.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.213 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.46 146.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.497 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 64.4 t -118.29 133.81 23.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.82 112.06 11.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.577 0.703 . . . . 0.0 111.133 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.2 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -49.49 -49.9 43.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -45.51 -50.66 12.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -71.56 -55.56 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.454 ' HE1' ' CE2' ' A' ' 65' ' ' PHE . 40.1 mmm -49.84 -19.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.826 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 -35.37 42.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -78.95 -40.11 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.28 99.16 4.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.56 43.42 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 53' ' ' ALA . 12.2 p -118.45 -56.61 2.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.883 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.42 -36.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 52' ' ' SER . 6.2 t -152.48 123.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 46.4 t -94.15 161.3 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.422 ' N ' HG12 ' A' ' 55' ' ' VAL . 14.2 t -134.07 121.76 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.94 166.98 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.35 3.33 69.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 9.6 mt -76.09 152.68 84.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.7 Cg_endo -69.75 -172.77 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.626 2.217 . . . . 0.0 112.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.33 160.93 21.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.78 31.7 2.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 59' ' ' LEU . 3.2 p -121.79 155.46 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.79 123.17 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CE2' ' HE1' ' A' ' 47' ' ' MET . 78.8 t80 -35.55 119.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 11.8 ptpt -164.65 171.01 14.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 5.7 t-80 -41.76 140.94 1.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.553 0.692 . . . . 0.0 110.855 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.526 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.9 Cg_endo -69.67 -2.95 10.99 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.385 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.404 ' HA ' ' CG ' ' A' ' 19' ' ' ARG . 7.5 pt-20 -95.87 -21.83 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -78.13 -14.76 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.407 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.0 m-85 -84.77 119.02 24.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' THR . 2.8 m-20 -45.04 142.45 1.88 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 5.9 tp -36.49 -53.87 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.85 72.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 72' ' ' ASP . 65.0 m -64.93 -49.7 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.505 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 13.7 mt -48.04 -50.49 27.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -51.13 -42.79 60.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.568 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.9 t90 -56.02 -56.11 24.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -46.04 -52.09 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.4 mt -60.28 -33.0 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -67.85 -54.37 19.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.449 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.5 m-80 -99.86 37.39 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.571 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -77.53 -45.23 26.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.457 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.69 -31.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' ILE . . . -83.97 -44.93 6.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLY . 23.9 mt -37.28 119.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 0.0 111.08 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -116.75 166.1 12.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -133.92 123.8 25.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.71 111.18 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.515 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.09 113.26 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.474 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.9 mmtt -92.61 -29.59 16.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.85 139.66 0.36 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.578 0.704 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.465 -0.171 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.836 0.35 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.75 -66.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.7 tt -49.15 -36.04 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.24 -42.64 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 m -65.22 -39.66 93.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.196 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.0 mt -58.24 -45.94 86.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -56.49 -33.36 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.461 ' N ' ' HE2' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -70.44 -57.96 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.455 ' CG2' HD22 ' A' ' 80' ' ' LEU . 9.9 m -40.37 -46.01 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.561 HG12 ' CE2' ' A' ' 26' ' ' PHE . 40.1 t -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 28.1 mt-10 -57.94 -41.91 83.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.45 -42.37 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.477 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 5.9 t80 -50.36 -60.57 2.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.561 ' CE2' HG12 ' A' ' 22' ' ' VAL . 19.0 m-85 -46.87 -37.45 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.0 m -69.56 -42.89 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -58.7 -56.79 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -53.73 -47.08 70.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.465 ' CD1' HD12 ' A' ' 90' ' ' ILE . 13.2 t80 -58.83 -68.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.69 -31.23 53.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.489 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.76 -42.23 82.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -28.04 65.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.87 -31.81 72.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.16 24.51 11.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.515 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 13.9 mtmt -93.86 179.96 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -109.47 20.93 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.7 p -155.42 159.58 39.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.28 144.65 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.515 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 93.4 t -122.39 138.36 29.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.733 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.75 128.38 15.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.29 111.87 12.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.612 0.72 . . . . 0.0 111.133 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 80.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.52 ' O ' ' C ' ' A' ' 45' ' ' GLU . 74.0 m-85 -54.96 -72.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.0 tp10 -28.03 -61.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -55.07 -49.13 72.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.957 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.561 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 56.9 mtp -57.32 -56.76 17.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 8.6 mt -40.41 -34.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -78.55 -42.33 29.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' MET . 2.4 m-20 -134.16 95.44 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -79.99 42.93 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.4 t -118.76 -57.85 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.58 -38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' SER . 56.9 t -147.33 119.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.01 146.94 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.563 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 23.1 t -115.36 131.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -121.93 166.19 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.0 63.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 mt -92.45 158.06 39.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.606 0.717 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.564 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.8 Cg_endo -69.77 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -96.22 164.33 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.93 13.99 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.526 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.414 ' CG2' ' H ' ' A' ' 64' ' ' ALA . 3.8 p -106.25 175.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.334 . . . . 0.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -156.55 117.89 3.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.03 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 84.4 t80 -33.67 124.87 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.451 ' CD ' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -169.33 179.48 3.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.519 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.8 t-80 -51.8 141.48 26.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 110.879 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.1 Cg_endo -69.8 -6.23 18.13 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.705 2.27 . . . . 0.0 112.362 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -93.23 -18.88 21.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.451 ' HB3' ' CD ' ' A' ' 66' ' ' LYS . 34.4 t-20 -79.92 -17.25 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.13 133.92 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' LEU . 0.6 OUTLIER -64.91 146.19 55.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.871 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 8.5 tp -37.66 -40.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.18 -53.98 51.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -59.67 -52.76 64.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.4 mt -39.29 -52.31 2.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -52.9 -48.93 66.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.2 t90 -50.22 -59.83 3.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.2 mt -41.02 -52.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.086 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.455 HD22 ' CG2' ' A' ' 21' ' ' THR . 20.4 mt -61.09 -37.1 81.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -62.64 -53.12 59.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.51 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -100.52 36.67 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' GLY . 56.8 pttt -80.41 -48.72 12.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.455 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.28 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.42 -33.71 7.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 15.1 mt -42.91 122.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.375 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -124.22 163.39 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.563 ' CZ ' HG22 ' A' ' 56' ' ' VAL . 7.2 m-85 -131.48 124.56 30.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.81 110.66 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.51 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.67 113.44 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -91.32 -28.69 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.479 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.89 136.53 0.32 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.653 0.739 . . . . 0.0 110.844 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.342 0.204 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 -179.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.843 0.354 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.51 -64.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.824 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -48.64 -34.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -72.3 -45.26 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -60.78 -35.39 76.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 25.0 mt -62.2 -42.7 99.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -62.07 -41.97 98.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.78 -54.04 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.404 ' CG2' HD21 ' A' ' 80' ' ' LEU . 87.3 m -44.87 -49.81 10.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG12 ' CE2' ' A' ' 26' ' ' PHE . 53.4 t -67.8 -40.54 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 14.7 mt-10 -50.76 -47.47 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.47 -51.46 65.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.545 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.2 t80 -42.44 -63.92 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.928 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.563 ' CE2' HG12 ' A' ' 22' ' ' VAL . 28.0 m-85 -41.89 -38.89 1.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.2 m -66.78 -44.89 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -58.28 -50.9 71.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.2 m -59.3 -43.44 92.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.437 ' CE2' HG11 ' A' ' 40' ' ' VAL . 12.9 t80 -62.1 -63.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.41 -29.28 66.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 -43.13 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.352 . . . . 0.0 110.975 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -33.53 74.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.04 -34.23 75.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 28.35 8.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.594 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 13.3 mtmt -95.66 179.62 5.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 m -109.23 22.11 16.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.9 p -154.49 175.1 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.74 141.53 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.594 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 91.9 t -116.7 132.7 23.25 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.657 0.742 . . . . 0.0 111.163 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 116.72 4.69 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.636 2.224 . . . . 0.0 112.37 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.481 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 46.3 t -67.25 112.28 9.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 79.5 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.709 2.272 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -51.3 -49.19 61.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -49.48 -48.99 47.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -68.34 -60.37 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.692 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 69.7 mtp -45.56 -35.45 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -58.8 -42.2 88.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.974 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -46.32 83.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -134.98 100.02 4.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -84.7 46.22 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.1 p -121.51 -44.61 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.12 -43.7 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.6 t -140.26 128.4 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.156 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 88.4 t -100.94 158.58 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.084 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 21.6 t -131.76 119.1 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -103.16 178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.78 -0.33 88.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.422 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.405 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.4 mt -77.07 153.84 82.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.723 . . . . 0.0 110.937 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.0 Cg_endo -69.82 -171.81 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.339 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -84.6 162.51 19.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.64 31.74 1.84 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.455 HG12 ' CD ' ' A' ' 60' ' ' PRO . 6.0 p -119.15 161.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.098 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -140.9 119.29 12.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.149 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 48.6 t80 -34.48 131.17 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 11.4 ptpt -175.09 163.14 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.519 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.7 t-80 -36.73 141.31 0.39 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.863 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.7 Cg_endo -69.77 -4.06 13.28 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.308 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -89.18 -27.03 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.72 -18.64 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.49 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-85 -80.97 111.34 17.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -42.69 145.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 11.0 tp -38.85 -46.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.32 82.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 50.2 m -63.16 -45.2 92.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.7 mt -48.64 -53.05 20.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -49.2 -45.55 44.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.571 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.6 t90 -54.55 -63.77 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -40.05 -50.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.404 HD21 ' CG2' ' A' ' 21' ' ' THR . 18.0 mt -62.11 -35.65 79.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' TRP . 10.3 mt-10 -65.32 -54.98 21.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.464 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -98.21 40.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.545 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 18.4 ptmt -82.68 -50.57 8.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 83' ' ' LYS . . . -35.07 -37.95 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.72 13.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.54 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 16.2 mt -37.9 124.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -126.47 169.98 12.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 5.6 m-85 -132.54 125.72 31.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.09 112.5 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -84.52 112.46 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.1 mmtp -91.51 -28.87 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.465 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.57 130.74 0.26 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.757 . . . . 0.0 110.898 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.411 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.742 2.295 . . . . 0.0 112.391 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.82 0.343 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -71.2 -47.88 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.414 HG21 ' N ' ' A' ' 16' ' ' GLU . 6.1 tt -62.88 -32.76 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' N ' HG21 ' A' ' 15' ' ' ILE . 6.2 mt-10 -76.39 -39.26 54.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 m -65.91 -35.82 81.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 73' ' ' LEU . 19.4 mt -63.52 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.98 -39.25 81.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -66.01 -52.42 49.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.8 m -52.01 -48.36 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.422 HG12 ' CE2' ' A' ' 26' ' ' PHE . 58.8 t -66.5 -38.51 81.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.162 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -56.75 -41.18 77.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.38 -47.91 62.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 7.2 t80 -44.59 -63.1 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.9 m-85 -43.31 -38.83 2.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.5 m -65.45 -46.02 81.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.61 -58.28 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 92.9 m -54.06 -40.75 67.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -64.61 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.65 -27.54 58.91 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.531 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -41.66 73.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.03 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.08 -33.99 77.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 25.77 8.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.485 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.59 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 12.4 mtmt -96.29 179.24 5.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.93 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.4 7.75 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.5 p -140.31 167.79 21.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -80.35 148.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.59 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 87.2 t -127.1 135.51 27.49 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.642 0.734 . . . . 0.0 111.1 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' N ' HG11 ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.79 121.02 7.71 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.74 2.293 . . . . 0.0 112.32 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.69 112.09 8.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 79.68 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.698 2.265 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' MET . 95.1 m-85 -47.43 -71.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 44' ' ' TYR . 7.7 tp10 -29.42 -59.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -60.13 -40.22 89.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 44' ' ' TYR . 28.0 mmm -64.08 -50.06 69.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 15.5 mt -51.22 -37.2 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -90.29 -26.89 19.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -135.0 77.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -72.52 -40.61 66.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -43.2 -57.28 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.02 -39.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.088 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' SER . 13.6 t -148.93 119.92 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.93 152.95 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 65' ' ' PHE . 31.4 t -121.68 124.56 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -116.52 160.75 20.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.81 10.05 59.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.449 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 mt -85.02 157.83 59.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 110.94 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.4 Cg_endo -69.82 -167.51 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 9.0 tp10 -96.06 156.25 16.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 56.68 18.17 23.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.558 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.7 p -109.12 166.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.072 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -144.37 113.04 6.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CD1' HG21 ' A' ' 56' ' ' VAL . 29.1 t80 -34.24 111.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.4 ptpt -156.69 -178.87 7.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.522 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.3 t-80 -48.81 141.43 10.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.629 0.728 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.522 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.1 Cg_endo -69.67 -7.31 20.69 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.756 2.304 . . . . 0.0 112.379 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -91.95 -19.92 21.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -81.48 -16.58 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.469 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.9 m-85 -84.44 120.13 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.5 OUTLIER -49.66 143.68 6.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.469 ' CD1' HD11 ' A' ' 18' ' ' LEU . 7.9 tp -37.48 -46.06 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.19 80.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 72' ' ' ASP . 61.8 m -67.08 -50.66 60.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.073 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 19.5 mt -42.88 -51.82 5.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -52.22 -47.09 65.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.568 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -52.0 -62.25 1.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.5 mt -39.25 -53.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.8 mt -59.61 -39.78 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.66 -54.4 45.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.468 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.87 38.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.821 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' GLY . 55.4 pttt -80.67 -51.22 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -37.76 -27.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.127 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -90.17 -35.62 7.49 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.54 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.3 mt -43.27 123.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 111.067 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.1 m -121.83 168.75 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CE2' HG22 ' A' ' 56' ' ' VAL . 9.4 m-85 -136.01 121.34 19.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.07 111.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.64 112.84 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -92.04 -29.77 16.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.466 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.91 134.2 0.29 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.571 0.7 . . . . 0.0 110.846 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.414 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 52.9 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 122.61 2.206 . . . . 0.0 112.349 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t -88.95 153.09 21.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.916 0.388 . . . . 0.0 110.804 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -108.14 -59.37 1.86 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.53 52.02 0.66 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.4 m -45.69 121.07 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.934 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 m -109.93 108.42 18.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.41 -139.35 1.48 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 30.6 ttp -123.37 153.7 39.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -53.51 149.62 7.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.4 p -73.5 -34.84 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.141 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.85 -16.43 59.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.52 -46.23 73.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 p -54.07 -17.51 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.177 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.61 -63.29 1.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.0 tt -49.64 -31.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.211 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -76.48 -40.1 51.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 m -67.11 -35.33 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.452 HD12 ' CD1' ' A' ' 73' ' ' LEU . 28.3 mt -64.72 -45.24 87.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.927 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -58.08 -34.81 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -67.15 -50.83 59.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.439 ' CG2' HD21 ' A' ' 80' ' ' LEU . 6.9 m -51.22 -48.2 62.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.559 HG11 ' CE2' ' A' ' 26' ' ' PHE . 11.7 t -65.77 -36.12 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.107 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.03 -42.65 94.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.99 -49.61 49.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.574 ' CE1' ' CE ' ' A' ' 83' ' ' LYS . 6.8 t80 -41.93 -64.25 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.559 ' CE2' HG11 ' A' ' 22' ' ' VAL . 22.6 m-85 -42.01 -34.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.4 m -72.69 -36.73 67.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.453 ' N ' ' O ' ' A' ' 25' ' ' TYR . 1.2 t80 -67.39 -48.68 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.0 m -63.58 -39.81 95.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.485 ' CD1' HD13 ' A' ' 90' ' ' ILE . 13.1 t80 -67.62 -52.57 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.64 -29.02 72.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -44.87 72.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.72 -27.61 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.38 -33.16 75.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.67 20.48 19.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' CE ' HG21 ' A' ' 40' ' ' VAL . 11.6 mtmt -92.71 179.12 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.1 p -108.53 20.05 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -151.8 164.16 37.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.72 142.07 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.429 ' CG1' ' HD2' ' A' ' 41' ' ' PRO . 40.2 t -115.63 135.96 22.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.429 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.77 117.91 5.37 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.24 112.07 14.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 80.49 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.686 2.257 . . . . 0.0 112.289 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -53.04 -47.51 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -50.34 -44.83 54.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.947 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -74.32 -59.27 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.566 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 59.3 mtp -45.7 -33.59 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.1 mt -60.46 -48.32 82.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -73.39 -36.29 66.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -128.33 97.93 4.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.797 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -95.13 47.14 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 p -124.52 -41.51 2.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.812 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.89 25.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.064 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.5 t -149.87 126.0 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.108 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 46.6 t -98.42 158.4 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.564 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 44.5 t -128.13 126.51 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -120.49 165.32 15.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.16 10.82 68.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mt -84.22 155.76 63.41 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.95 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.2 Cg_endo -69.76 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 0.0 112.376 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.57 158.03 15.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.2 17.26 23.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.4 p -108.61 175.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.136 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -157.01 120.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.566 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 84.6 t80 -34.79 119.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ptpp? -166.56 170.5 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -45.45 141.65 3.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.528 0.68 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.523 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.9 Cg_endo -69.75 -1.06 7.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 0.0 112.366 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.19 -17.48 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.2 -14.89 57.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -88.33 135.39 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 149.2 47.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.452 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.8 tp -40.47 -39.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.22 23.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.4 m -59.17 -45.6 90.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.9 mt -46.27 -49.59 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -55.68 -43.79 76.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 60.1 t90 -53.28 -60.15 3.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.2 mt -41.62 -53.63 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.439 HD21 ' CG2' ' A' ' 21' ' ' THR . 23.8 mt -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.99 -53.85 43.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.446 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -100.49 35.13 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.574 ' CE ' ' CE1' ' A' ' 25' ' ' TYR . 21.1 ptmt -74.19 -52.59 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -36.93 -30.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.066 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -84.96 -37.85 9.79 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 19.4 mt -45.52 124.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 0.0 111.058 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -124.71 168.75 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.564 ' CZ ' HG23 ' A' ' 56' ' ' VAL . 5.9 m-85 -135.72 129.46 32.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.01 112.0 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.0 113.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.46 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.1 mmtt -91.0 -29.73 17.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.475 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.93 135.29 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.6 Cg_endo -69.86 129.75 18.04 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.294 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -48.82 160.09 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.8 mt -86.17 117.68 25.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -165.02 142.54 5.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.676 0.751 . . . . 0.0 110.881 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 137.27 35.06 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.716 2.277 . . . . 0.0 112.403 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -65.48 169.78 5.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -108.64 139.48 43.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -70.14 150.4 46.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.71 128.81 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.114 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.75 -96.79 1.14 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.42 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.44 125.16 5.16 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.56 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.8 t -92.76 157.94 16.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 110.849 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.35 68.39 0.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.447 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 118.69 5.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.411 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.6 m -135.94 170.8 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 85.6 p -113.47 154.99 26.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.859 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.477 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -43.35 -58.24 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.937 0.399 . . . . 0.0 110.885 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 t -95.29 152.5 18.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.955 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.64 -161.32 31.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.2 m -78.51 127.19 31.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.972 0.415 . . . . 0.0 110.844 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 m -108.3 168.1 9.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.61 -46.15 2.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 8.8 ttt -103.73 169.93 8.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.37 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 m -101.82 163.83 12.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.7 p -70.95 -40.09 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.94 -11.28 59.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.03 -43.02 86.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.09 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.53 -30.66 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.175 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.09 -65.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 tt -50.4 -32.15 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -76.27 -36.91 58.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -70.96 -34.52 71.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.443 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 17.1 mt -62.79 -47.45 83.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.949 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -54.99 -41.33 71.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -67.16 -51.58 52.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.445 ' CG2' HD22 ' A' ' 80' ' ' LEU . 91.6 m -49.03 -48.4 43.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.109 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.505 HG12 ' CE2' ' A' ' 26' ' ' PHE . 86.3 t -67.69 -37.02 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 13.8 mt-10 -56.05 -43.05 77.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -65.68 -49.51 68.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.566 ' CD1' ' HE3' ' A' ' 83' ' ' LYS . 8.7 t80 -44.12 -64.19 0.72 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.505 ' CE2' HG12 ' A' ' 22' ' ' VAL . 26.5 m-85 -42.8 -39.83 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 25' ' ' TYR . 21.2 t80 -65.28 -56.64 11.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.1 m -54.05 -40.47 67.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -65.78 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.19 -25.02 61.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.541 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.13 -42.16 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.68 67.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.091 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -62.69 -34.83 77.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.47 24.03 9.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.545 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.517 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 8.7 mtmt -92.35 -179.97 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 t -109.87 19.3 19.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -154.09 161.87 41.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -74.77 144.35 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.517 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 40.5 t -119.46 136.08 24.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.598 0.713 . . . . 0.0 111.135 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 54.3 Cg_endo -69.71 118.5 5.72 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.662 2.242 . . . . 0.0 112.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -70.42 111.99 11.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . 53.5 Cg_endo -69.81 79.97 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -55.88 -47.16 77.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -51.27 -46.4 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HD2' ' CB ' ' A' ' 43' ' ' PRO . 44.6 mttt -71.7 -55.56 7.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.525 ' HE2' ' CE2' ' A' ' 65' ' ' PHE . 80.1 mtp -50.33 -31.97 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.48 -30.43 71.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -86.03 -38.49 17.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -133.18 94.65 3.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.2 40.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' VAL . 22.1 p -113.36 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.95 -35.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' SER . 19.0 t -148.78 143.32 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 58.7 t -118.04 139.9 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.572 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 22.9 t -109.17 125.71 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -120.03 158.85 25.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.12 15.35 45.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.504 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.421 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 11.6 mt -87.12 154.34 54.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.936 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.9 Cg_endo -69.68 -168.68 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -86.99 164.42 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.79 29.1 0.75 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.437 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG13 ' CD ' ' A' ' 60' ' ' PRO . 4.0 p -117.84 156.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -139.15 118.26 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' HG22 ' A' ' 56' ' ' VAL . 83.3 t80 -34.11 117.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.7 ptpt -164.33 174.41 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.516 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -44.86 140.75 3.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.721 . . . . 0.0 110.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.6 Cg_endo -69.75 2.28 3.66 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -97.18 -22.04 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -81.17 -12.45 59.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.415 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.7 m-85 -88.2 117.7 27.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' LEU . 2.0 m-20 -49.02 144.03 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.443 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.2 tp -35.72 -50.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.29 -51.14 63.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -60.98 -46.65 89.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.1 mt -47.53 -54.96 10.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.938 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -48.56 -47.93 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.569 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.2 t90 -48.64 -61.62 1.94 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.2 mt -41.14 -52.42 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.445 HD22 ' CG2' ' A' ' 21' ' ' THR . 29.4 mt -59.49 -37.82 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.56 -55.27 25.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.73 37.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.566 ' HE3' ' CD1' ' A' ' 25' ' ' TYR . 16.6 ptmt -72.85 -53.92 10.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.17 -33.4 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.055 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.65 -33.28 38.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 25.0 mt -53.19 126.05 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.5 m -123.91 169.06 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.828 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.572 ' CZ ' HG23 ' A' ' 56' ' ' VAL . 7.1 m-85 -136.42 126.41 26.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.04 109.61 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.519 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.17 112.98 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.4 mmtp -92.05 -31.28 15.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.48 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.72 129.96 0.28 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.875 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.461 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.74 119.44 6.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 0.0 112.323 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' PRO . 32.0 m-85 -35.02 148.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 94' ' ' PHE . 15.3 mt -36.17 136.91 0.28 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' CG ' ' HD2' ' A' ' 97' ' ' PRO . 30.0 tt0 -102.48 139.94 20.67 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.579 0.705 . . . . 0.0 110.919 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 96' ' ' GLU . 54.1 Cg_endo -69.72 165.55 30.53 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.79 2.327 . . . . 0.0 112.327 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -45.24 -44.75 11.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -110.67 105.53 14.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.957 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.446 ' CD2' ' H ' ' A' ' 101' ' ' VAL . 1.1 p80 -48.74 -41.68 32.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.446 ' H ' ' CD2' ' A' ' 100' ' ' HIS . 29.5 m -130.56 90.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.52 141.85 22.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.05 148.68 23.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.0 p -130.22 -46.88 1.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.001 0.429 . . . . 0.0 110.898 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 121.49 84.32 0.75 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.464 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 2.83 3.18 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.648 2.232 . . . . 0.0 112.389 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.7 t -110.74 112.17 23.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.808 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.0 m -112.54 128.91 56.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.505 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p -91.75 108.79 20.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.88 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -72.36 96.82 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.91 -136.61 9.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -106.46 -46.09 4.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 0.0 110.862 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.5 t -47.46 97.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.849 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.92 -42.34 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 4.4 ttt -119.87 108.61 14.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.1 p -76.56 152.64 35.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.86 -38.23 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -86.58 7.84 24.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.98 -42.46 76.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.1 p -63.02 -29.21 46.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.129 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.49 -63.62 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 9.6 tt -51.13 -38.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.7 mm-40 -68.78 -46.03 69.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 m -61.56 -33.44 73.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 19.1 mt -59.25 -47.48 85.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.459 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -58.85 -47.68 84.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -54.53 -52.62 61.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 m -51.46 -48.38 62.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.523 HG11 ' CE2' ' A' ' 26' ' ' PHE . 23.7 t -67.72 -37.41 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.42 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -56.41 -36.92 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.94 -47.9 27.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.3 t80 -44.34 -63.06 0.96 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.523 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.3 m-85 -41.92 -34.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.1 m -71.83 -38.91 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' TYR . 1.7 t80 -64.8 -47.52 77.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 65.3 m -65.56 -41.75 92.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.4 ' CE1' HD13 ' A' ' 90' ' ' ILE . 14.7 t80 -66.7 -47.91 70.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.98 -32.67 63.21 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -42.31 93.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.42 -31.3 70.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -61.71 -36.1 79.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.41 10.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -94.28 179.31 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.0 p -108.65 21.01 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.0 p -155.76 162.27 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -76.12 155.41 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.87 135.0 25.21 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.663 0.744 . . . . 0.0 111.077 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 118.55 5.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 0.0 112.286 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 81.3 t -67.0 117.81 49.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 111.122 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 80.01 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -50.57 -53.11 32.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -43.16 -56.21 3.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.539 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 10.3 mptt -65.79 -56.1 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.416 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 41.0 mmm -50.06 -23.52 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.826 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.24 -30.41 57.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.955 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -42.12 15.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.33 94.54 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -81.69 47.63 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.915 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -125.18 -56.07 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.72 -36.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 52' ' ' SER . 16.1 t -149.69 119.77 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.448 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 19.9 t -95.86 154.85 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 5.0 t -125.69 119.53 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -112.04 158.93 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.41 13.24 42.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.401 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.1 mt -85.89 156.97 57.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.667 0.746 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.57 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.4 Cg_endo -69.8 -172.16 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -86.53 158.87 19.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.39 28.7 9.8 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.401 ' CG1' ' HB3' ' A' ' 59' ' ' LEU . 4.2 p -118.69 171.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -154.66 120.31 5.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 64' ' ' ALA . 82.4 t80 -35.15 121.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -167.31 170.58 11.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.518 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.3 t-80 -39.75 141.01 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.65 0.738 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.7 Cg_endo -69.71 -9.54 26.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -91.19 -16.81 27.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -82.82 -13.88 55.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.489 ' CD2' HD13 ' A' ' 79' ' ' ILE . 21.9 m-85 -87.39 121.06 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.03 147.67 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 7.0 tp -40.01 -48.8 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.41 -44.73 84.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -63.42 -57.79 9.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.496 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 16.0 mt -39.44 -47.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -55.05 -46.55 75.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.57 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.5 t90 -54.5 -58.81 6.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.489 HD13 ' CD2' ' A' ' 71' ' ' TYR . 49.4 mt -41.52 -53.76 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.2 mt -61.1 -40.5 93.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -55.61 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -97.93 35.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 51.8 pttt -77.63 -49.77 13.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.82 -26.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -91.24 -39.1 5.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' LYS . 28.4 mt -43.22 122.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 111.149 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -120.49 162.73 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 6.3 m-85 -128.25 126.48 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.5 110.35 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.516 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.41 113.17 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.448 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 19.5 mmtt -91.45 -28.12 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.474 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 134.5 0.31 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.632 0.73 . . . . 0.0 110.842 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.418 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.8 128.9 16.65 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.612 2.208 . . . . 0.0 112.392 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 46' ' ' LYS . 72.6 m-85 -50.79 149.4 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.09 120.54 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -106.08 125.89 31.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 0.0 110.931 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 176.63 6.52 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.734 2.289 . . . . 0.0 112.314 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -66.04 154.62 39.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -86.93 152.09 22.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.884 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -138.69 148.91 44.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.2 m -62.93 139.38 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.84 -159.08 18.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.515 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.59 62.29 1.4 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.442 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 t -121.12 128.13 52.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.82 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -75.45 -159.65 8.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.428 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 134.91 29.09 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.687 2.258 . . . . 0.0 112.351 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.7 p -136.66 174.97 10.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.1 t -172.05 108.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.51 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -126.84 101.21 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.845 0.355 . . . . 0.0 110.866 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -143.57 128.03 17.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.899 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.56 -166.52 12.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 m -125.79 146.18 49.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 110.778 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -124.79 97.29 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.11 -179.42 39.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.517 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 148.87 37.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.801 0.334 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.6 m -149.44 175.96 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.34 -43.02 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.106 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -81.72 -10.86 59.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.42 73.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.096 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 p -52.78 -21.73 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.47 -65.05 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tt -49.66 -31.01 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -76.6 -40.15 50.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -66.8 -34.44 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 20.6 mt -63.54 -41.39 98.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -64.44 -39.09 93.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -41.6 77.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.0 m -59.78 -49.03 79.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.555 HG13 ' CE2' ' A' ' 26' ' ' PHE . 96.1 t -65.36 -37.34 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.084 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -54.85 -39.14 68.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.92 -52.16 32.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.558 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 10.0 t80 -42.34 -62.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.555 ' CE2' HG13 ' A' ' 22' ' ' VAL . 21.4 m-85 -43.78 -40.74 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 m -68.32 -37.83 80.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -66.47 -47.0 74.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.5 m -64.1 -40.94 97.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.97 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE1' HD13 ' A' ' 90' ' ' ILE . 14.9 t80 -66.61 -56.71 9.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.23 -29.84 74.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.464 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -42.25 75.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.745 0.307 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -26.52 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.092 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.5 mt -67.6 -30.9 70.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 23.09 13.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 14.6 mtmt -95.77 178.85 5.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.347 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -107.7 6.06 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.2 p -136.95 160.96 37.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -79.35 136.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.555 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 55.0 t -112.76 137.8 21.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 0.0 111.137 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.74 125.76 12.53 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.672 2.248 . . . . 0.0 112.383 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 61.7 t -71.13 111.93 11.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.619 0.723 . . . . 0.0 111.169 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 80.44 0.89 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.674 2.249 . . . . 0.0 112.326 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -53.02 -53.21 53.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -47.42 -52.03 18.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -65.86 -61.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.543 ' HE1' ' CE2' ' A' ' 65' ' ' PHE . 79.4 mtp -43.54 -37.95 2.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.5 mt -55.31 -40.26 70.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -82.26 -39.52 22.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -126.16 80.24 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -68.19 -20.63 64.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.2 t -62.25 -57.14 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -31.79 -36.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' SER . 15.0 t -151.53 121.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.41 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 20.8 t -100.02 157.78 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 23.7 t -125.53 123.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -117.36 153.24 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.46 39.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.3 mt -84.85 155.73 61.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.623 0.725 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.565 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 52.8 Cg_endo -69.86 178.86 4.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.297 . . . . 0.0 112.311 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.18 154.61 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.08 23.21 51.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.543 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.2 p -116.61 164.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.161 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -144.59 117.95 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.543 ' CE2' ' HE1' ' A' ' 47' ' ' MET . 64.1 t80 -34.65 120.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -167.11 171.48 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.518 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -42.96 141.89 1.57 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.3 Cg_endo -69.77 -4.88 14.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.319 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.92 -14.27 26.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -85.21 -12.38 52.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.54 128.38 36.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 73' ' ' LEU . 4.5 m-20 -56.63 145.81 27.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.488 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.9 tp -36.19 -48.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.74 62.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -58.89 -46.38 87.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.2 mt -47.61 -47.99 28.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.985 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -55.1 -48.58 73.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.841 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.565 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.3 t90 -49.21 -60.56 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.6 mt -40.74 -53.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.73 -38.78 79.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -62.98 -55.42 25.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.464 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.48 38.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.9 pttp -77.39 -45.42 25.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.463 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -44.06 -35.89 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.07 -35.27 31.05 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 mt -49.51 123.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -126.09 167.6 15.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 7.6 m-85 -132.83 128.43 36.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.69 111.06 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.536 HD13 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.88 112.52 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 22.3 mmtt -89.94 -33.3 16.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.17 129.6 0.26 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 110.835 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.436 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.7 Cg_endo -69.65 122.33 9.04 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.732 2.288 . . . . 0.0 112.371 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 93' ' ' PRO . 37.2 m-85 -37.41 153.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.8 mt -64.33 145.06 56.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -159.16 149.95 15.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.729 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 167.59 24.07 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.673 2.249 . . . . 0.0 112.331 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.438 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 1.3 ptpp? -108.3 27.51 9.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -129.33 148.6 51.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.826 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -105.71 -61.34 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.7 m -99.04 152.27 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.05 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -176.45 -59.67 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.528 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.94 158.67 22.98 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.519 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.9 p -112.68 -46.97 3.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 110.879 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.27 145.29 12.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.529 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 -50.83 0.44 Allowed 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 122.7 2.267 . . . . 0.0 112.32 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.2 p -48.72 -55.75 10.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t -82.84 85.16 7.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -133.17 -47.56 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.846 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -60.67 140.7 57.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.834 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.33 63.7 0.43 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.545 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.2 p -74.64 172.02 12.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 110.864 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 p -73.28 82.08 1.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.48 -144.67 16.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.4 mmt -80.16 128.38 33.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.6 t -75.71 165.74 24.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 11' ' ' ASP . 6.1 p -67.64 -40.85 84.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.445 ' N ' HG13 ' A' ' 10' ' ' VAL . 98.4 m-20 -82.09 -7.03 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.8 -46.37 78.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p -57.94 -16.6 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.5 -57.33 3.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 5.5 tt -54.48 -46.11 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.082 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.549 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.3 mt-10 -63.48 -48.61 76.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 m -57.2 -30.89 64.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 28.6 mt -64.54 -48.64 74.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.474 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -58.18 -42.07 85.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -39.02 92.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.46 ' CG2' HD23 ' A' ' 80' ' ' LEU . 48.5 m -64.33 -49.4 71.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.537 HG13 ' CE2' ' A' ' 26' ' ' PHE . 94.5 t -66.69 -39.49 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -53.36 -43.22 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.11 -49.68 69.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.565 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 12.5 t80 -45.99 -63.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.537 ' CE2' HG13 ' A' ' 22' ' ' VAL . 22.0 m-85 -44.18 -40.4 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.7 m -65.25 -38.3 89.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -66.64 -59.6 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -51.49 -37.57 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE1' HD12 ' A' ' 90' ' ' ILE . 17.0 t80 -69.71 -64.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.18 57.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.87 -45.95 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.43 67.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mt -62.71 -33.17 74.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.86 23.43 11.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.585 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 10.2 mtmt -94.35 179.11 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -109.54 20.21 18.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.8 p -154.16 159.67 41.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -76.58 138.71 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.585 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 51.0 t -114.58 137.67 22.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.664 0.745 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.8 120.82 7.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.611 2.207 . . . . 0.0 112.349 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 58.7 t -73.72 111.96 14.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.738 . . . . 0.0 111.148 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 79.83 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.715 2.277 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -51.43 -45.2 62.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -54.36 -40.25 67.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -74.38 -59.62 2.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.618 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 92.5 mtp -47.38 -46.19 25.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -43.92 -46.96 8.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -80.77 -39.81 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -127.48 81.64 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -72.28 -30.96 65.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' ALA . 24.0 p -45.01 -50.07 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -36.14 -45.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 t -144.7 128.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 35.0 t -99.64 142.98 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.558 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 39.6 t -116.56 112.66 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -102.49 162.63 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.6 0.78 64.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.406 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 9.6 mt -75.55 149.35 83.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.603 0.716 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.3 Cg_endo -69.81 178.47 4.57 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.685 2.257 . . . . 0.0 112.339 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.86 160.21 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.74 19.77 10.97 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.446 HG12 ' CD ' ' A' ' 60' ' ' PRO . 3.2 p -112.94 169.82 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.455 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.618 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 72.8 t80 -34.31 113.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -159.78 171.06 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.512 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.2 t-80 -42.15 141.24 1.42 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.512 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.7 Cg_endo -69.8 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 0.0 112.378 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.59 -15.11 31.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -89.07 -7.15 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -91.29 121.25 32.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.82 147.16 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.82 -47.35 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.11 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.5 m -66.77 -57.51 6.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.474 ' CD1' ' HD2' ' A' ' 19' ' ' ARG . 14.9 mt -39.41 -48.32 1.91 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -55.99 -48.23 76.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.558 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.8 t90 -49.16 -57.71 6.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -43.1 -52.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.46 HD23 ' CG2' ' A' ' 21' ' ' THR . 21.6 mt -59.77 -38.28 81.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.23 -55.78 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.432 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -97.8 40.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.852 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.565 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 16.7 ptmt -80.05 -53.57 6.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.929 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -36.27 -33.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -83.29 -37.54 12.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 14.4 mt -44.14 125.83 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 t -124.34 162.99 22.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.558 ' CZ ' HG22 ' A' ' 56' ' ' VAL . 6.9 m-85 -131.77 126.2 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.2 111.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -81.23 113.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.185 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.467 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.0 mmtt -93.18 -31.24 14.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.483 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.89 125.71 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 0.0 110.872 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.1 Cg_endo -69.73 119.33 6.29 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -37.83 157.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.97 121.11 9.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -146.78 149.41 36.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.66 0.743 . . . . 0.0 110.815 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -173.69 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.691 2.26 . . . . 0.0 112.372 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -91.78 161.76 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -123.05 157.08 33.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -146.17 170.6 16.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.6 t -93.9 118.66 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.158 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.56 153.29 20.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.34 -162.63 36.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.576 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.4 t -122.93 -61.16 1.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.14 141.05 15.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.457 ' O ' ' C ' ' A' ' 107' ' ' SER . 54.3 Cg_endo -69.73 -20.72 34.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 106' ' ' PRO . 24.9 p -33.9 131.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.832 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.1 t -118.43 -178.98 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.853 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.546 -179.905 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.3 p -168.54 150.16 4.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.35 . . . . 0.0 110.852 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -158.03 174.88 14.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 5' ' ' SER . . . -162.8 76.64 0.17 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.496 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 4' ' ' GLY . 3.3 m -35.65 -62.37 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.822 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.7 p -66.49 88.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.95 -118.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.476 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.01 146.06 31.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.937 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -65.02 171.54 3.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.6 p -73.1 -35.79 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.54 -5.14 59.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.58 -43.67 89.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.174 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 p -61.07 -12.84 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.9 -57.94 3.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 8.2 tt -50.83 -42.65 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.115 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.7 mt-10 -66.31 -43.23 86.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 m -63.28 -32.94 74.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 27.3 mt -61.41 -45.92 92.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.46 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -59.42 -50.14 75.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -47.78 70.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.3 m -55.25 -49.03 73.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.181 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.517 HG12 ' CE2' ' A' ' 26' ' ' PHE . 59.6 t -67.78 -36.1 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 15.3 mt-10 -57.75 -45.26 86.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -65.95 -47.98 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.421 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.4 t80 -44.87 -59.4 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' A' ' 22' ' ' VAL . 20.1 m-85 -46.71 -39.3 11.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.1 m -65.52 -39.9 92.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -64.49 -54.12 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.821 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.48 ' CB ' ' CD1' ' A' ' 88' ' ' PHE . 35.5 m -58.13 -43.86 87.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -63.15 -58.66 6.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.38 -27.86 72.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.31 -41.27 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.15 -32.65 69.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.129 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.52 -26.26 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.91 24.1 21.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 15.1 mtmt -96.86 177.21 5.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.6 p -109.24 22.68 15.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.0 p -153.26 165.59 35.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -84.54 140.46 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.47 ' CG1' ' HD2' ' A' ' 41' ' ' PRO . 43.6 t -117.82 137.39 24.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.79 114.0 3.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.496 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 82.7 t -71.52 113.6 21.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.649 0.738 . . . . 0.0 111.076 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.427 ' CB ' ' CE ' ' A' ' 46' ' ' LYS . 54.3 Cg_endo -69.74 80.73 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 0.0 112.352 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -52.15 -45.21 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -49.46 -46.55 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' CE ' ' CB ' ' A' ' 43' ' ' PRO . 43.7 mtmt -75.69 -52.83 9.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.619 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 38.5 mtp -51.81 -21.44 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -76.67 -33.27 58.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -34.68 57.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -136.92 109.82 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -97.58 40.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 p -117.61 -41.93 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.93 -43.74 39.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.142 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 t -146.32 124.93 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 40.0 t -97.76 149.38 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.158 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 65' ' ' PHE . 98.9 t -118.67 116.56 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.516 ' CD ' ' CD1' ' A' ' 89' ' ' ILE . 2.2 mp0 -100.74 -179.6 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.33 4.32 73.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.442 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 mt -78.11 154.02 79.9 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.67 0.748 . . . . 0.0 110.854 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.552 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.8 Cg_endo -69.71 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.715 2.277 . . . . 0.0 112.341 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 33.9 tp10 -87.26 160.16 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.415 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 47.45 29.07 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 p -119.18 167.65 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -150.59 126.78 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.063 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.619 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 78.4 t80 -35.95 130.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -174.44 172.77 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.518 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.5 t-80 -47.18 140.99 6.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.558 0.694 . . . . 0.0 110.883 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.4 Cg_endo -69.73 -7.26 20.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' OE2' ' ND1' ' A' ' 67' ' ' HIS . 5.2 pt-20 -93.09 -17.28 24.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -81.69 -15.72 53.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -85.05 131.8 34.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.0 OUTLIER -56.44 147.21 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.43 -49.12 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.19 79.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 26.6 m -71.15 -51.54 24.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.493 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 12.2 mt -45.29 -54.17 7.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -49.67 -47.44 50.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.0 t90 -49.12 -55.87 10.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.9 mt -45.37 -54.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.3 mt -59.45 -34.27 72.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.948 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.26 -52.31 55.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.508 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.92 33.82 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 86' ' ' ILE . 55.8 pttt -76.47 -45.29 31.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.58 -25.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.72 -30.24 9.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 83' ' ' LYS . 20.0 mt -49.57 122.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.8 m -121.82 170.26 9.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 29' ' ' CYS . 6.1 m-85 -128.89 116.13 18.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.516 ' CD1' ' CD ' ' A' ' 57' ' ' GLN . 9.2 mt -103.83 93.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.166 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.503 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -71.39 114.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.2 mmtp -93.68 -30.07 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.456 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 128.45 0.27 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.611 0.72 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.453 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 54.1 Cg_endo -69.83 124.82 11.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.383 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.415 ' C ' ' O ' ' A' ' 93' ' ' PRO . 26.5 m-85 -37.24 156.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.4 mt -50.27 156.81 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -118.53 143.38 33.22 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.627 0.727 . . . . 0.0 110.914 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 177.33 5.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.305 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -74.3 -62.38 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -124.8 179.18 5.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -174.98 128.36 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.5 t -135.85 110.75 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.34 170.54 16.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.451 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.33 165.28 24.45 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.464 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.1 p -123.3 -57.97 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.815 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.73 175.7 14.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.482 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 88.14 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.694 2.262 . . . . 0.0 112.347 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.9 t -41.68 117.83 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.3 m -144.17 126.26 15.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.824 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.531 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 p -106.56 112.49 25.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.379 . . . . 0.0 110.826 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 t -145.83 137.92 25.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.04 39.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.47 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.4 t -130.85 170.69 14.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -42.78 144.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.8 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.89 -54.56 0.21 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 14.6 mmt -81.69 137.71 35.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.347 . . . . 0.0 110.828 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.8 m -69.84 168.83 14.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 11' ' ' ASP . 7.5 p -61.35 -44.52 98.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.124 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -80.36 -9.12 59.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.63 88.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.071 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -57.31 -36.37 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -62.2 -68.85 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.9 tt -48.52 -34.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.51 -40.41 64.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -66.05 -38.04 87.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.451 HD12 ' CD1' ' A' ' 73' ' ' LEU . 27.6 mt -59.61 -45.8 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -58.27 -40.67 82.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.842 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -45.74 73.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -52.15 -49.69 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.089 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 26' ' ' PHE . 42.3 t -65.92 -39.59 85.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -51.1 -48.31 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -63.97 -48.85 74.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.554 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.8 t80 -44.21 -62.69 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' A' ' 22' ' ' VAL . 24.6 m-85 -44.63 -35.14 2.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.0 m -67.59 -39.72 84.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.11 -58.04 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.8 m -54.78 -39.75 68.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -65.78 -64.8 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.78 -24.22 62.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.6 -46.64 63.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.58 -31.03 71.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.99 -34.07 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.36 22.83 11.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.41 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.524 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 15.0 mtmt -91.55 179.46 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.9 p -107.98 18.98 20.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -152.12 172.72 15.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -90.05 140.44 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.18 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.524 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 42.9 t -116.76 136.31 23.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.654 0.74 . . . . 0.0 111.114 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.418 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.78 122.52 9.2 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.12 112.04 14.01 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.659 0.743 . . . . 0.0 111.11 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 80.54 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.761 2.307 . . . . 0.0 112.323 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -48.84 -52.01 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.02 -52.65 14.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -65.86 -57.84 6.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.542 ' HE2' ' CE2' ' A' ' 65' ' ' PHE . 32.1 mmm -48.25 -33.65 9.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.7 mt -59.97 -32.6 70.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -87.02 -40.32 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -129.18 90.88 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -80.74 -19.89 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p -58.52 -46.72 86.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.53 -42.96 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.4 t -146.52 132.03 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 51.1 t -102.91 148.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 65' ' ' PHE . 12.4 t -121.86 116.9 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -104.73 170.02 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.96 9.6 73.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.7 mt -83.45 150.15 59.49 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.636 0.732 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.6 Cg_endo -69.78 -171.98 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -83.4 163.69 20.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.37 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.438 HG13 ' CD ' ' A' ' 60' ' ' PRO . 3.2 p -119.8 157.86 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.166 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.12 123.83 16.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 56' ' ' VAL . 91.5 t80 -34.62 119.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -167.37 169.89 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.514 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.6 t-80 -41.86 140.99 1.36 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.514 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.7 Cg_endo -69.71 -6.59 18.93 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.657 2.238 . . . . 0.0 112.365 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.66 -21.4 21.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -78.86 -9.65 59.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.44 129.28 39.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.93 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' THR . 4.2 m-20 -57.77 143.46 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.451 ' CD1' HD12 ' A' ' 18' ' ' LEU . 9.8 tp -36.32 -48.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -42.69 79.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 72' ' ' ASP . 60.7 m -70.09 -45.77 66.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.427 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 14.0 mt -47.78 -52.75 17.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -51.34 -46.68 62.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.559 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.1 t90 -50.05 -56.85 9.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -44.63 -55.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.0 mt -57.97 -36.67 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.02 -53.33 55.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.493 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.38 34.86 2.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.554 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 60.7 pttt -77.2 -48.8 16.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -42.87 -27.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.94 -32.26 11.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.1 mt -47.66 121.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 111.154 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -118.03 162.55 18.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 56' ' ' VAL . 6.1 m-85 -131.1 123.33 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.5 110.84 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.499 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.22 113.23 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.138 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.452 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 4.9 mmtp -93.17 -32.46 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.477 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.12 127.73 0.25 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.42 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.4 Cg_endo -69.87 124.34 10.95 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.669 2.246 . . . . 0.0 112.298 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.408 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 0.3 OUTLIER -42.73 166.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.3 mt -82.08 117.13 22.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.955 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.76 125.85 49.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.634 0.73 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -164.63 0.13 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.729 2.286 . . . . 0.0 112.351 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -53.28 168.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -74.49 -61.96 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -70.18 109.05 4.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.84 38.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.096 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.68 -96.49 1.97 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 147.07 57.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.502 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.7 p -145.79 138.95 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.883 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.67 145.16 4.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.508 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 84.8 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.361 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 t 58.27 53.35 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.4 p -99.37 152.15 20.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.844 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 66.25 44.65 2.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -81.28 -42.76 20.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.27 106.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.465 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 t -96.41 150.56 20.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.851 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 t -42.23 160.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.841 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.47 -92.59 0.78 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.466 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.37 156.46 18.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.7 m -98.54 178.59 4.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.853 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p -79.56 -36.07 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.2 -10.73 51.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.68 91.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.13 -26.02 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.178 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.96 -62.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.8 tt -47.36 -36.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.14 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -70.09 -40.67 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -66.43 -38.7 88.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.491 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 20.0 mt -59.36 -46.33 88.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -64.44 -37.45 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -68.18 -46.45 70.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.7 m -56.69 -45.9 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.087 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 26' ' ' PHE . 41.0 t -68.18 -31.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.62 -47.38 63.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -45.33 -61.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.569 ' CE2' HG13 ' A' ' 22' ' ' VAL . 21.9 m-85 -46.71 -39.98 12.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m -67.46 -40.44 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -62.85 -56.53 16.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.0 m -52.61 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.549 ' CE1' HD12 ' A' ' 90' ' ' ILE . 15.1 t80 -66.87 -64.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -23.16 58.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -39.2 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.906 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.17 -27.25 60.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -66.09 -32.66 74.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 25.93 9.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.517 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 13.6 mtmt -95.56 179.73 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 t -110.93 21.39 16.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.3 p -154.3 163.94 39.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -79.04 143.04 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.517 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 57.5 t -118.92 137.84 25.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.684 0.754 . . . . 0.0 111.09 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.75 120.94 7.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.61 112.66 14.81 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 111.137 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 80.63 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.716 2.277 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -60.32 -39.61 87.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.9 -38.5 70.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -80.3 -55.02 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.549 ' HE1' ' CZ ' ' A' ' 65' ' ' PHE . 84.2 mtp -49.41 -35.98 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -85.69 -38.38 18.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.07 91.5 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -81.15 41.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 14.3 p -116.41 -55.86 2.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.795 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.94 -37.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 52' ' ' SER . 29.7 t -148.02 135.95 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.476 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 46.7 t -109.32 146.07 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.545 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 15.3 t -117.57 124.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.2 165.27 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.92 62.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.44 151.2 55.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.536 0.684 . . . . 0.0 110.9 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.545 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.1 Cg_endo -69.77 -169.07 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 63' ' ' VAL . 7.7 tt0 -87.52 167.5 13.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.21 24.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 61' ' ' GLU . 3.5 p -115.27 159.81 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.63 117.38 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CZ ' ' HE1' ' A' ' 47' ' ' MET . 42.0 t80 -34.21 114.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -159.02 173.76 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.517 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 6.9 t-80 -42.92 140.62 1.85 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 110.875 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.3 Cg_endo -69.78 0.75 5.21 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.643 2.229 . . . . 0.0 112.335 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.42 -17.79 18.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.93 -11.35 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -88.17 121.39 30.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 73' ' ' LEU . 1.8 m-20 -51.45 144.84 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.818 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.491 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.2 tp -36.91 -48.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.89 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -57.18 -48.93 77.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.161 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -43.48 -57.2 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -48.14 -44.0 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.93 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.545 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.8 t90 -53.14 -59.73 4.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.7 mt -41.87 -54.65 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.149 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.8 mt -59.85 -36.86 77.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -63.03 -53.45 53.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.484 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -100.84 35.0 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -76.38 -45.54 31.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -42.0 -29.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.8 -35.84 8.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.9 mt -46.01 120.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -120.52 163.13 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.545 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 6.2 m-85 -129.74 126.65 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.65 111.39 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -81.97 113.06 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.476 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 22.8 mmtt -91.54 -31.66 15.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.468 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.02 132.46 0.28 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo -69.71 124.66 11.33 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.75 2.3 . . . . 0.0 112.384 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.43 ' CE2' ' HB1' ' A' ' 53' ' ' ALA . 21.5 m-85 -49.07 179.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.9 mt -104.67 113.63 27.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.979 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.65 145.5 0.96 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.67 0.747 . . . . 0.0 110.837 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -172.86 0.62 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.623 2.215 . . . . 0.0 112.366 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -22.83 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.784 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -95.47 162.96 13.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.93 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -170.4 137.36 1.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.9 t -123.73 93.36 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 39.15 74.25 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.437 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.83 -110.81 3.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.478 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.6 p -49.72 108.51 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 0.0 110.849 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.15 -164.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.534 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 172.27 13.01 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.665 2.243 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 t -162.44 131.38 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.848 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.6 t -51.22 126.14 15.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.543 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.4 p -127.46 173.14 10.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.831 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p -86.45 108.77 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.46 -96.01 2.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.496 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.8 m -69.32 119.24 13.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.9 p -79.23 -52.27 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 12' ' ' ALA . . . -131.72 -123.49 2.47 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.461 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.01 51.85 4.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.877 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 m -166.31 175.99 7.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.69 -44.49 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.73 -16.22 54.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.82 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.452 ' HB3' ' CA ' ' A' ' 7' ' ' GLY . . . -54.59 -35.98 63.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.83 -38.89 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -57.96 -69.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 tt -45.84 -32.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.54 -37.74 59.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 15.7 mt -61.31 -40.96 96.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -63.44 -45.91 88.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -44.83 83.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.9 m -53.74 -47.38 70.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.509 HG11 ' CE2' ' A' ' 26' ' ' PHE . 59.5 t -68.73 -36.54 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.93 -47.65 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.558 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.2 t80 -45.28 -58.3 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.509 ' CE2' HG11 ' A' ' 22' ' ' VAL . 22.5 m-85 -50.13 -40.71 47.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.4 m -65.42 -40.13 92.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.16 -58.48 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.0 m -52.0 -40.65 61.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -66.66 -64.72 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -21.89 56.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -41.01 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.2 -27.24 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.83 -31.46 72.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.949 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.6 24.68 10.69 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.514 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.539 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 17.6 mtmt -94.66 179.9 5.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 t -109.65 21.3 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.9 p -155.39 174.88 14.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 m -88.31 148.35 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 98.6 t -123.12 137.1 27.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.664 0.745 . . . . 0.0 111.153 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 54.2 Cg_endo -69.74 111.92 2.94 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.405 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 39.6 t -69.96 111.9 10.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.573 0.701 . . . . 0.0 111.111 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 79.97 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.624 2.216 . . . . 0.0 112.355 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -52.05 -48.45 64.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -50.34 -43.23 53.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -74.17 -58.37 3.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.555 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 56.9 mtp -46.59 -35.39 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.2 mt -54.24 -42.2 69.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 6.7 ptt85 -84.23 -32.89 24.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.878 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.571 ' OD2' ' CE2' ' A' ' 94' ' ' PHE . 8.3 p-10 -130.62 86.87 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -80.09 -7.39 58.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 53' ' ' ALA . 2.5 p -68.61 -57.26 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.83 -37.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.079 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' SER . 3.4 t -154.33 125.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 40.2 t -96.3 165.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.507 HG23 ' CD1' ' A' ' 65' ' ' PHE . 39.4 t -136.2 123.1 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -116.21 166.44 12.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.33 5.49 67.31 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 mt -79.68 152.29 74.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.2 Cg_endo -69.8 -174.63 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.306 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -83.61 162.69 20.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.1 23.43 2.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.413 HG12 ' CD ' ' A' ' 60' ' ' PRO . 3.2 p -115.93 166.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -150.12 128.76 12.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' HE3' ' A' ' 47' ' ' MET . 86.9 t80 -37.87 128.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -174.07 174.49 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.6 t-80 -50.61 141.87 16.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.569 0.699 . . . . 0.0 110.839 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.3 Cg_endo -69.7 -1.98 9.34 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 4.3 pt-20 -95.81 -20.09 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -78.12 -17.45 56.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -83.19 145.05 29.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.36 150.09 38.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 7.3 tp -38.77 -51.77 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.28 -56.76 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -55.0 -50.11 69.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.7 mt -43.19 -57.03 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -47.14 -46.56 23.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.568 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 67.4 t90 -51.01 -61.87 1.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mt -40.14 -54.63 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -58.88 -40.14 83.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.36 -53.76 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.487 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -100.97 35.67 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 53.7 pttt -76.79 -45.06 30.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -43.11 -28.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.32 -35.01 9.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.455 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.4 mt -47.61 120.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.356 . . . . 0.0 111.084 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -120.76 164.79 16.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.464 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 6.5 m-85 -131.22 122.16 26.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.05 110.48 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.515 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.66 112.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.474 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 21.0 mmtt -91.48 -28.79 17.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.49 140.43 0.34 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.86 151.57 68.54 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.672 2.248 . . . . 0.0 112.278 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.571 ' CE2' ' OD2' ' A' ' 50' ' ' ASP . 32.0 m-85 -71.26 118.07 13.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.0 mt -45.9 113.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.961 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.56 153.21 54.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.647 0.737 . . . . 0.0 110.884 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 156.55 63.28 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.399 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -55.33 164.74 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -55.63 165.53 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -169.58 146.98 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.2 t -80.53 125.63 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.173 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.93 101.03 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -172.74 49.98 0.17 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.3 p -171.04 152.82 3.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 110.872 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 99.84 69.45 0.9 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 145.61 57.94 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.644 2.23 . . . . 0.0 112.342 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.8 m -94.33 102.42 14.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.8 t -49.04 113.28 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.533 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -75.05 103.08 5.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 t 60.03 42.17 16.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.63 105.2 0.2 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.409 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.0 p -44.7 144.81 1.02 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.4 p -99.3 41.99 1.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.65 174.97 47.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.89 143.13 26.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.74 0.305 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m -100.78 165.15 11.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.71 -35.61 25.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -93.29 14.54 17.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.781 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.05 -41.72 34.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p -66.44 -11.39 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.193 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -82.01 -55.47 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 16' ' ' GLU . 11.2 tt -52.49 -36.46 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' N ' HG22 ' A' ' 15' ' ' ILE . 7.4 mt-10 -72.69 -45.42 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.9 m -59.5 -36.25 75.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 29.8 mt -60.64 -44.8 95.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -58.88 -36.07 74.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -45.79 75.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.423 ' CG2' HD21 ' A' ' 80' ' ' LEU . 33.0 m -55.83 -50.23 71.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.172 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.07 -40.64 87.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -51.9 -49.54 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.59 -47.39 85.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -44.95 -62.11 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -45.24 -41.73 8.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 m -62.41 -42.46 99.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.401 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 22.9 t80 -63.35 -55.24 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 64.9 m -57.53 -40.41 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.477 ' CE1' HD11 ' A' ' 90' ' ' ILE . 20.3 t80 -67.14 -62.83 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.53 -23.46 60.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.54 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -72.17 -46.61 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.57 -28.67 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.62 -34.81 77.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 22.85 12.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.451 ' CE ' HG22 ' A' ' 40' ' ' VAL . 19.4 mtmt -93.39 -179.91 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 p -109.34 20.52 18.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.3 p -156.39 159.44 38.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.88 155.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG22 ' CE ' ' A' ' 36' ' ' LYS . 70.5 t -130.82 131.75 23.47 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.626 0.726 . . . . 0.0 111.082 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.348 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.68 115.51 15.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.72 0.771 . . . . 0.0 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.92 0.97 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -48.78 -52.85 21.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -45.86 -54.2 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -61.19 2.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.799 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.549 ' HE2' ' CE2' ' A' ' 65' ' ' PHE . 31.5 mmm -42.25 -39.2 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -49.34 71.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.937 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -80.53 -25.53 38.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.54 87.87 2.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 54' ' ' VAL . 52.2 mt-30 -83.36 -28.31 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 31.0 p -49.84 -56.39 10.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.21 -43.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 51' ' ' GLN . 2.5 t -143.99 122.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.097 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.22 142.01 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.524 HG21 ' CE1' ' A' ' 65' ' ' PHE . 19.0 t -111.19 125.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -116.74 162.94 16.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.38 44.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.446 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 18.3 mt -92.14 155.96 42.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.668 0.746 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.564 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.8 Cg_endo -69.71 -165.59 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' GLY . 10.3 tt0 -88.16 166.73 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.66 33.09 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 59' ' ' LEU . 3.2 p -120.28 149.82 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -133.86 123.17 24.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CE2' ' HE2' ' A' ' 47' ' ' MET . 82.6 t80 -33.98 121.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.0 ptpt -170.88 166.15 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.528 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.1 t-80 -39.92 141.52 0.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.841 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.528 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.4 Cg_endo -69.71 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.674 2.249 . . . . 0.0 112.356 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -20.54 25.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -81.76 -15.44 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.426 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 24.5 m-85 -84.04 123.15 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.7 145.07 7.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -37.99 -49.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.62 76.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.8 m -60.51 -47.84 84.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 26.7 mt -47.97 -54.55 12.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -48.59 -43.41 36.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.6 t90 -56.87 -57.21 13.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.0 mt -44.19 -52.42 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.423 HD21 ' CG2' ' A' ' 21' ' ' THR . 21.4 mt -60.62 -36.15 77.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.02 -53.09 55.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -101.47 35.31 2.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.856 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 52.3 pttt -75.54 -49.3 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -41.0 -30.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.39 8.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.8 mt -40.47 124.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -121.51 170.2 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -132.47 115.42 15.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.2 mt -101.03 93.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.081 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -72.0 112.91 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -87.82 -31.97 19.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.55 137.34 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.562 0.696 . . . . 0.0 110.886 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 133.73 26.14 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.338 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -51.45 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.419 ' CD2' ' H ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -93.28 15.1 16.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -82.92 115.82 60.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.712 0.768 . . . . 0.0 110.819 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 166.38 27.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.52 13.55 17.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 100' ' ' HIS . 2.0 pptp? -85.36 -179.0 6.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.467 ' N ' ' HD2' ' A' ' 99' ' ' LYS . 24.0 p80 -175.13 176.13 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.6 p -161.58 121.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.151 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.76 172.69 12.63 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.87 140.06 15.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.467 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.1 t -80.76 -57.89 3.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.958 0.408 . . . . 0.0 110.865 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.39 147.95 5.27 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 0.87 5.09 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.677 2.251 . . . . 0.0 112.314 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 p -117.66 144.64 45.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.1 p -165.39 163.21 19.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 -179.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 t -142.82 142.87 31.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 110.842 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 p -98.54 42.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.84 116.14 5.45 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.43 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 96.7 p -137.7 153.61 49.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.815 0.341 . . . . 0.0 110.889 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.7 t -68.18 135.15 51.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.47 148.96 19.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.526 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.2 tpp -76.24 158.66 31.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 m -151.46 175.46 12.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.68 -39.05 79.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -85.84 -5.08 59.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.98 -50.91 71.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p -61.49 -24.66 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.29 -49.92 65.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 16' ' ' GLU . 3.8 tt -57.19 -33.49 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' N ' HG22 ' A' ' 15' ' ' ILE . 5.1 mt-10 -75.47 -40.82 56.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 m -64.67 -37.71 88.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' CD1' ' A' ' 73' ' ' LEU . 31.0 mt -64.2 -37.05 86.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.468 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 31.1 mtm105 -66.41 -36.82 83.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -62.79 -48.89 77.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.447 ' CG2' HD21 ' A' ' 80' ' ' LEU . 28.3 m -56.29 -46.2 79.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.553 HG12 ' CE2' ' A' ' 26' ' ' PHE . 23.4 t -67.01 -35.57 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.01 -44.66 97.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.72 -46.35 72.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.9 t80 -46.52 -62.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.553 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.0 m-85 -42.31 -36.45 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.83 -42.98 76.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -59.59 -49.66 76.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -62.97 -43.79 97.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -62.37 -58.7 6.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.34 82.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -44.55 86.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.6 71.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.0 mt -64.01 -34.4 77.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.95 11.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.481 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 14.3 mtmt -93.25 179.59 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.945 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.87 20.27 18.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.3 p -154.55 164.56 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.79 145.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 59.1 t -124.22 132.94 24.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 0.0 111.158 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 122.17 8.87 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.626 2.218 . . . . 0.0 112.336 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 79.5 t -68.08 111.54 8.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.707 0.765 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 79.61 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 0.0 112.364 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' MET . 38.3 m-85 -45.23 -73.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.4 tp10 -30.91 -54.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.555 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 27.2 mttm -62.09 -43.11 99.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.546 ' N ' ' O ' ' A' ' 44' ' ' TYR . 47.3 mtp -65.78 -58.68 5.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.5 mt -42.45 -35.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -91.86 -29.34 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.45 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 25.3 t0 -134.12 75.09 1.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -63.83 -43.76 95.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -40.16 -61.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -31.43 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' SER . 12.1 t -155.19 119.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.17 157.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.571 HG21 ' CE2' ' A' ' 88' ' ' PHE . 19.9 t -126.68 121.79 59.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -114.28 153.31 29.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.67 15.12 27.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.407 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 17.3 mt -89.64 157.69 46.39 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.648 0.737 . . . . 0.0 110.863 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.566 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 52.9 Cg_endo -69.84 -168.01 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 0.0 112.248 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.84 164.86 15.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.2 29.31 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.424 ' CG1' ' HB3' ' A' ' 59' ' ' LEU . 3.1 p -118.66 152.59 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.179 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.97 123.25 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.009 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.496 ' CZ ' ' SD ' ' A' ' 47' ' ' MET . 86.9 t80 -33.81 126.29 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.83 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.49 166.83 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.944 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.525 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.4 t-80 -43.01 141.73 1.63 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.676 0.75 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.525 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.9 Cg_endo -69.76 -7.59 21.45 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.709 2.272 . . . . 0.0 112.325 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.468 ' HA ' ' CD ' ' A' ' 19' ' ' ARG . 1.5 pp20? -89.23 -16.95 30.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -85.62 -13.73 47.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.79 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -85.79 128.5 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.7 m-20 -56.41 141.96 40.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 72' ' ' ASP . 7.5 tp -36.05 -46.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.33 84.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 92.4 m -64.53 -48.13 76.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.1 mt -45.04 -51.72 9.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -52.99 -46.28 68.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.566 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 56.5 t90 -52.08 -61.81 2.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.993 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.3 mt -39.61 -52.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.447 HD21 ' CG2' ' A' ' 21' ' ' THR . 19.6 mt -61.22 -37.34 82.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -63.12 -53.84 47.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.531 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.2 m-80 -99.78 37.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.529 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 44.8 pttt -79.93 -50.04 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.451 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.48 -31.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.083 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -86.9 -37.16 8.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.6 mt -42.47 127.37 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.751 0.31 . . . . 0.0 111.146 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -127.61 166.16 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CE2' HG21 ' A' ' 56' ' ' VAL . 7.9 m-85 -131.77 121.85 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.48 110.42 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.81 112.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -91.85 -25.35 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.13 139.41 0.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.655 0.741 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 132.58 23.55 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.695 2.264 . . . . 0.0 112.365 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.555 ' CD2' ' HB3' ' A' ' 46' ' ' LYS . 66.2 m-85 -51.38 131.94 28.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 mt -100.14 123.71 44.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -146.77 148.94 34.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.5 60.57 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -83.78 164.15 19.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -124.98 167.67 14.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.415 ' O ' ' CD2' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -110.53 138.26 47.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.8 t -109.29 95.66 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -120.69 67.99 0.41 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 162.38 150.78 6.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.469 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.7 m -106.63 173.49 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.4 . . . . 0.0 110.913 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 158.82 86.4 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 134.81 28.78 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.9 t -56.12 99.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 t -145.05 147.42 32.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.854 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 m -120.81 153.94 36.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -92.89 111.23 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.67 97.55 1.0 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.9 m -97.86 114.18 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 p -65.94 152.73 43.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 9' ' ' SER . . . 98.09 62.96 0.88 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.552 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 7' ' ' GLY . 3.8 ppp? 32.6 37.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 110.854 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 7' ' ' GLY . 9.8 t -55.08 169.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.6 -39.9 86.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.86 -1.0 55.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.84 68.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.057 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -52.21 -28.14 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.62 -60.85 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 16' ' ' GLU . 6.1 tt -49.55 -37.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 15' ' ' ILE . 7.4 mt-10 -72.38 -41.79 65.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 m -64.61 -38.36 90.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.467 HD13 ' CD1' ' A' ' 73' ' ' LEU . 26.9 mt -60.92 -35.52 76.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -71.88 -41.33 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -58.18 -39.61 79.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -63.87 -43.97 94.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.531 HG13 ' CE2' ' A' ' 26' ' ' PHE . 47.4 t -70.58 -32.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.223 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -62.41 -40.15 95.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.73 -46.86 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.571 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 11.1 t80 -47.98 -62.85 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.531 ' CE2' HG13 ' A' ' 22' ' ' VAL . 28.9 m-85 -42.13 -37.73 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.1 m -68.6 -43.51 76.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -60.18 -52.55 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -57.83 -43.4 85.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.437 ' CE1' HD12 ' A' ' 90' ' ' ILE . 15.7 t80 -64.06 -61.1 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.952 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.21 -27.37 67.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -42.57 68.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.706 0.288 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 -24.27 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.35 -28.63 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.06 23.47 24.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.572 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 16.5 mtmt -91.92 -179.98 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.889 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 m -109.48 19.11 19.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -150.54 172.13 15.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.196 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.58 139.52 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 74.4 t -117.93 133.08 23.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 0.0 111.124 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 124.7 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.331 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.469 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 90.7 t -72.54 111.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.635 0.731 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 79.9 0.92 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 0.0 112.368 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -52.41 -51.12 60.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -46.0 -51.5 13.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -69.66 -60.5 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.601 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 40.2 mtp -42.2 -39.35 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.943 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.5 mt -53.78 -46.19 70.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -79.39 -31.94 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.32 88.94 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -78.44 -38.38 41.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 53' ' ' ALA . 37.0 p -39.52 -55.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -34.28 -40.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 t -153.06 128.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.447 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 35.2 t -102.25 165.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 88' ' ' PHE . 14.5 t -134.48 124.22 44.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -116.02 163.47 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.03 11.98 58.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.41 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 13.2 mt -86.29 154.04 56.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.565 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.5 Cg_endo -69.7 172.76 11.99 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.356 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -78.69 147.52 33.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.47 18.83 72.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.453 HG12 ' CD ' ' A' ' 60' ' ' PRO . 3.3 p -115.41 168.59 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 111.143 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -146.65 117.85 7.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.601 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 68.3 t80 -35.94 122.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' N ' ' OH ' ' A' ' 71' ' ' TYR . 11.2 ptpt -170.8 169.99 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.519 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.4 t-80 -42.19 140.82 1.52 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 110.938 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.2 Cg_endo -69.85 3.34 2.87 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -95.32 -21.7 18.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -83.41 -7.06 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.954 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.419 ' OH ' ' N ' ' A' ' 66' ' ' LYS . 22.9 m-85 -92.72 133.82 35.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.91 154.87 36.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.467 ' CD1' HD13 ' A' ' 18' ' ' LEU . 6.3 tp -44.59 -47.53 10.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.54 -54.63 44.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.2 m -55.99 -47.1 78.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.8 mt -45.29 -59.69 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -46.1 -46.36 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.565 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.0 t90 -51.04 -62.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.5 mt -40.21 -51.44 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.12 -36.08 80.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' TRP . 12.0 mm-40 -64.56 -54.07 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.486 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.65 36.77 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.571 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -76.75 -45.51 28.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.53 -33.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.17 -31.47 28.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.41 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 mt -50.25 118.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.4 m -121.55 156.64 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 56' ' ' VAL . 7.1 m-85 -121.66 126.56 49.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.71 109.53 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.51 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.55 113.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.447 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.3 mmtp -93.84 -26.88 16.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.8 137.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 151.67 68.53 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -72.35 149.29 44.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -120.33 27.52 8.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -85.32 118.49 70.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 0.0 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 106.97 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.751 2.301 . . . . 0.0 112.305 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -95.36 152.27 18.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -115.59 144.08 44.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.509 ' CG ' ' N ' ' A' ' 101' ' ' VAL . 33.4 p-80 -54.6 -49.24 70.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.84 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.509 ' N ' ' CG ' ' A' ' 100' ' ' HIS . 13.4 p -73.49 140.59 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -123.88 -62.08 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.533 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.51 106.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.527 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.1 t -72.92 -57.43 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.937 0.398 . . . . 0.0 110.818 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.64 85.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.528 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 107' ' ' SER . 54.4 Cg_endo -69.58 -176.3 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 106' ' ' PRO . 52.5 p -34.67 136.11 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.7 m -104.26 135.96 44.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.549 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 t -123.44 -47.2 2.0 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.933 0.397 . . . . 0.0 110.856 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m 55.26 44.62 27.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.843 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.59 104.65 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.526 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 t -79.96 165.18 22.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.92 0.391 . . . . 0.0 110.81 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.0 m -126.58 -43.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.861 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.26 111.19 0.25 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.9 ttm 51.16 35.0 12.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.949 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.424 ' N ' ' HB2' ' A' ' 12' ' ' ALA . 2.3 m -60.93 -177.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.53 -43.3 90.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.24 -6.49 59.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.424 ' HB2' ' N ' ' A' ' 9' ' ' SER . . . -63.08 -45.55 91.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.155 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 2.1 p -64.96 -11.37 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.69 -54.87 5.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.458 HG21 ' N ' ' A' ' 16' ' ' GLU . 10.4 tt -52.27 -30.37 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.458 ' N ' HG21 ' A' ' 15' ' ' ILE . 3.4 mt-10 -77.37 -43.48 32.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -61.67 -34.44 75.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 73' ' ' LEU . 24.0 mt -64.62 -44.45 90.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -61.55 -22.87 65.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -76.26 -56.0 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.442 ' CG2' HD21 ' A' ' 80' ' ' LEU . 4.1 m -44.47 -44.81 8.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.57 HG13 ' CE2' ' A' ' 26' ' ' PHE . 21.9 t -71.51 -34.74 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.464 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 14.7 mt-10 -62.75 -39.05 92.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -72.99 -38.05 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.528 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 7.0 t80 -58.41 -60.15 4.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' HG13 ' A' ' 22' ' ' VAL . 20.9 m-85 -44.03 -40.8 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.22 -58.0 7.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.7 m -53.24 -40.12 64.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -66.72 -63.7 1.01 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.959 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.56 60.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -41.23 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.732 0.301 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.85 67.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.051 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -62.06 -35.3 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.35 25.61 8.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.501 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.58 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 13.1 mtmt -95.93 179.6 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -111.35 20.51 17.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.9 p -152.5 159.94 43.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -73.49 141.56 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.58 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 98.4 t -120.22 138.91 27.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 0.0 111.178 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.474 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.83 122.82 9.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.748 2.299 . . . . 0.0 112.265 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.457 ' O ' ' CD1' ' A' ' 44' ' ' TYR . 55.2 t -67.98 116.79 42.27 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.628 0.727 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.595 ' CG ' ' CE1' ' A' ' 94' ' ' PHE . 54.0 Cg_endo -69.71 80.03 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.736 2.291 . . . . 0.0 112.349 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.517 ' O ' ' C ' ' A' ' 45' ' ' GLU . 67.9 m-85 -55.69 -72.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.921 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 44' ' ' TYR . 37.0 tt0 -28.79 -56.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.574 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -60.74 -48.07 83.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.568 ' HE3' ' CZ ' ' A' ' 65' ' ' PHE . 74.2 mtp -59.26 -56.92 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.1 mt -43.83 -46.51 7.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -77.81 -31.28 51.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 51.8 m-20 -134.96 95.26 3.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -92.25 51.92 1.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 p -130.27 -38.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.97 -35.73 59.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 t -149.29 123.35 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 33.4 t -95.95 155.06 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.557 HG23 ' CD1' ' A' ' 65' ' ' PHE . 19.8 t -126.25 121.55 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.114 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -111.68 168.18 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.033 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.98 4.24 78.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.93 158.11 75.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 0.0 110.925 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.6 Cg_endo -69.81 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.653 2.235 . . . . 0.0 112.3 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -98.3 157.41 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.09 17.53 10.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 60' ' ' PRO . 8.0 p -107.78 168.08 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -145.94 115.08 7.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.098 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.568 ' CZ ' ' HE3' ' A' ' 47' ' ' MET . 55.5 t80 -35.01 125.19 0.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.839 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.496 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 14.7 ptpt -169.35 172.78 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.513 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.0 t-80 -43.84 140.66 2.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.599 0.714 . . . . 0.0 110.818 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.513 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.6 Cg_endo -69.77 2.59 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.1 -16.99 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.04 -11.06 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.6 m-85 -86.81 116.99 25.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.41 143.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.46 ' CD1' HD13 ' A' ' 18' ' ' LEU . 8.9 tp -39.44 -41.56 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.976 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.63 70.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -58.13 -46.25 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.7 mt -47.0 -52.5 14.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -50.45 -46.23 56.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.568 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -54.32 -60.95 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.9 mt -41.14 -50.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.442 HD21 ' CG2' ' A' ' 21' ' ' THR . 31.7 mt -62.68 -35.6 80.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.1 -55.17 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.465 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.5 m-80 -98.19 39.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.837 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.528 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 19.7 ptmt -78.27 -51.91 9.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.56 -31.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -85.05 -37.51 9.97 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.1 mt -43.18 118.4 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 111.169 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.0 m -118.91 160.17 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -126.59 125.98 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.11 112.0 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.61 113.31 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.462 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.6 mmtt -93.36 -28.38 16.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.481 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.91 129.5 0.27 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.655 0.74 . . . . 0.0 110.833 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.451 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.3 Cg_endo -69.67 127.26 14.4 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.707 2.271 . . . . 0.0 112.385 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.595 ' CE1' ' CG ' ' A' ' 43' ' ' PRO . 33.0 m-85 -46.57 174.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.93 109.0 20.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.992 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.55 143.01 0.98 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.723 0.773 . . . . 0.0 110.851 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -177.34 1.82 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -61.8 149.77 39.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 31.4 mtmm -91.8 -55.0 3.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 99' ' ' LYS . 94.1 m-70 -161.38 148.65 14.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.7 p -155.72 119.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.18 152.12 28.39 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.441 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.42 95.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.498 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 105' ' ' GLY . 21.0 t -57.31 92.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.931 0.396 . . . . 0.0 110.806 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 104' ' ' SER . . . 35.35 -97.33 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.422 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 104' ' ' SER . 53.7 Cg_endo -69.7 118.49 5.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.74 2.293 . . . . 0.0 112.37 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 m -88.0 -51.65 5.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.0 t -53.76 148.96 9.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.83 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 179.998 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m -62.16 101.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.818 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.5 m -106.92 151.58 25.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.27 48.97 0.79 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.399 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -46.79 132.98 11.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.3 t -167.87 163.43 13.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.42 -105.95 2.67 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.503 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 42.7 mtt -111.75 106.68 15.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.6 m -82.08 -176.22 6.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -79.71 -41.82 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -83.86 -8.3 59.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.03 88.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.86 -29.65 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.128 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.25 -59.31 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.82 -34.5 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -40.81 74.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -67.18 -32.14 73.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 15.6 mt -64.27 -46.54 83.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -63.96 -29.08 70.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -67.54 -54.57 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -51.32 -47.9 62.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.563 HG13 ' CE2' ' A' ' 26' ' ' PHE . 20.0 t -64.72 -37.35 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.04 -43.19 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.36 -44.29 68.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 6.4 t80 -48.92 -61.18 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.563 ' CE2' HG13 ' A' ' 22' ' ' VAL . 19.7 m-85 -44.45 -35.06 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.2 m -68.05 -40.17 82.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -62.49 -55.04 31.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.68 -35.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -68.03 -58.48 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -26.83 70.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -43.07 77.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.793 0.33 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.91 -27.65 62.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -72.6 -21.1 61.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.16 32.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -90.71 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -98.68 -4.3 34.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.4 p -137.94 166.53 23.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.84 129.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.145 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.0 t -105.67 132.38 20.93 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.585 0.707 . . . . 0.0 111.157 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 124.46 11.14 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.388 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 81.0 t -64.91 111.17 5.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.693 0.759 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 79.18 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.261 . . . . 0.0 112.327 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 47' ' ' MET . 72.7 m-85 -47.3 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 44' ' ' TYR . 9.4 pt-20 -30.04 -42.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' TYR . 23.7 mttp -73.13 -47.09 47.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' TYR . 70.4 mtp -62.51 -50.98 69.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 11.7 mt -50.4 -37.49 37.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -88.73 -27.63 21.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 3.8 t70 -134.11 69.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -59.0 -40.99 86.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 53' ' ' ALA . 3.4 t -48.37 -58.45 4.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -31.94 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 53' ' ' ALA . 59.1 t -138.94 119.74 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.151 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.438 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 39.2 t -98.94 160.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 88' ' ' PHE . 18.1 t -129.61 129.1 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.179 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -118.51 163.96 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.3 6.87 62.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.6 mt -82.13 157.27 68.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.614 0.721 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.56 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.3 Cg_endo -69.79 -168.17 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.309 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -90.11 162.37 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 46.61 26.69 2.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 p -116.33 163.22 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.91 0.386 . . . . 0.0 111.078 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -145.0 118.77 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.57 ' CD1' HG22 ' A' ' 56' ' ' VAL . 91.5 t80 -34.39 126.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 13.0 ptpt -170.67 165.71 8.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.516 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -38.29 140.82 0.57 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.0 Cg_endo -69.82 2.23 3.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.668 2.245 . . . . 0.0 112.302 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.22 -20.87 16.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -84.79 -12.61 53.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.492 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 20.4 m-85 -84.16 117.04 23.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.4 OUTLIER -45.46 139.12 3.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -35.79 -46.9 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.03 87.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' ASP . 51.8 m -65.49 -45.25 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.8 mt -46.59 -54.7 8.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -48.94 -50.44 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.56 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 51.8 t90 -50.61 -60.71 2.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.0 mt -39.87 -52.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.95 -40.19 96.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.98 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -55.45 34.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -97.16 37.76 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.56 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 58.7 pttt -82.96 -45.64 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -38.43 -27.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.54 -40.07 4.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 85' ' ' GLY . 13.9 mt -34.16 127.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.1 m -127.92 169.6 13.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CE2' HG23 ' A' ' 56' ' ' VAL . 8.4 m-85 -134.96 127.92 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.23 109.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.133 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.504 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.75 113.38 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.215 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.438 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.3 mmtp -92.89 -31.74 14.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.85 127.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.594 0.711 . . . . 0.0 110.859 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 94' ' ' PHE . 54.4 Cg_endo -69.75 116.76 4.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.727 2.284 . . . . 0.0 112.343 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -35.52 153.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.825 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.3 mt -75.9 143.81 41.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -100.19 101.58 15.06 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.656 0.741 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 119.37 6.32 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.347 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 99' ' ' LYS . 18.2 tttm -169.72 149.89 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' N ' ' HG2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -132.05 -70.61 0.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.99 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -81.36 -67.83 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.4 p -168.32 128.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.25 175.4 29.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.52 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -174.64 66.53 0.1 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.483 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.3 t -52.27 -51.01 60.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.817 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.31 89.85 1.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 166.09 28.72 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.748 2.299 . . . . 0.0 112.328 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -100.16 118.48 36.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.8 m -125.81 102.74 7.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.4 p -91.13 122.13 33.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.92 0.39 . . . . 0.0 110.838 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.7 p -40.38 -46.5 2.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.0 87.33 0.56 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 6' ' ' SER . 13.5 m -63.31 113.78 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.847 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' SER . 5.3 t -35.92 -47.15 0.51 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.64 -129.1 4.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.428 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 66.0 mtt -77.45 117.07 18.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.742 0.306 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -96.06 177.38 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.63 -36.26 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.71 -3.75 58.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.65 92.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p -68.81 -24.12 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.87 -61.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 tt -50.79 -33.55 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.68 -43.9 62.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.6 m -62.96 -33.26 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.1 mt -63.32 -44.84 93.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -62.23 -40.2 95.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -64.55 -46.0 84.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 m -57.12 -48.98 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.536 HG12 ' CE2' ' A' ' 26' ' ' PHE . 46.4 t -65.97 -39.01 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.91 -43.69 69.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.1 -49.51 56.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 9.0 t80 -42.72 -61.92 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.536 ' CE2' HG12 ' A' ' 22' ' ' VAL . 25.7 m-85 -45.13 -38.03 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 m -66.82 -47.37 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -55.6 -52.57 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.3 m -56.49 -46.21 80.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.56 ' CE2' HG11 ' A' ' 40' ' ' VAL . 12.9 t80 -61.95 -62.41 1.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -27.83 64.48 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.519 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -41.81 74.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.24 66.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -64.89 -34.33 78.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.78 6.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.568 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 11.4 mtmt -99.86 177.61 5.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.756 0.313 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.9 p -105.84 -0.54 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.4 p -128.78 165.82 20.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.5 146.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.568 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 78.3 t -125.31 128.12 24.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.703 0.763 . . . . 0.0 111.157 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 124.33 10.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.254 . . . . 0.0 112.306 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -71.16 113.1 16.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.682 0.753 . . . . 0.0 111.151 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 80.89 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.245 . . . . 0.0 112.344 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.574 ' O ' ' N ' ' A' ' 47' ' ' MET . 53.1 m-85 -47.85 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' C ' ' O ' ' A' ' 44' ' ' TYR . 35.0 tt0 -29.92 -46.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -70.11 -44.17 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 44' ' ' TYR . 37.2 mmm -63.34 -53.01 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.82 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 12.1 mt -40.29 -35.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 mtp85 -93.73 -39.83 10.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -122.99 80.11 1.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.0 -28.0 57.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -52.54 -57.65 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.43 -36.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.3 t -152.69 119.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 20.0 t -96.28 153.41 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG23 ' CE2' ' A' ' 88' ' ' PHE . 11.9 t -125.36 123.58 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -112.15 163.82 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.39 61.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.444 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 11.3 mt -81.66 151.01 67.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.971 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.7 Cg_endo -69.74 -179.95 3.26 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.7 2.266 . . . . 0.0 112.4 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.62 161.24 27.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.83 24.04 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.473 HG12 ' CD ' ' A' ' 60' ' ' PRO . 3.7 p -115.65 171.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -154.52 119.97 5.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.56 ' CE2' ' HE3' ' A' ' 47' ' ' MET . 85.6 t80 -34.75 121.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' CG ' ' CE1' ' A' ' 71' ' ' TYR . 8.4 ptpp? -166.6 179.08 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.511 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -51.24 140.74 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.4 Cg_endo -69.78 2.99 3.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 8.1 pt-20 -98.29 -22.54 16.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -79.12 -15.38 58.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 66' ' ' LYS . 20.9 m-85 -83.42 129.55 34.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.9 m-20 -61.67 143.24 56.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -34.78 -45.56 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.096 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' ASP . 87.5 m -60.58 -52.03 66.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.8 mt -43.04 -56.74 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -46.57 -44.97 18.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.546 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.9 t90 -54.43 -57.9 9.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.7 mt -43.84 -55.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.15 -35.81 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.97 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -64.06 -52.8 57.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.504 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.74 33.64 2.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.519 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 59.0 pttt -74.87 -44.12 50.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.53 -22.07 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.4 -27.74 10.41 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.469 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mt -53.67 120.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.121 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 p -117.9 165.24 13.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.567 ' CE2' HG23 ' A' ' 56' ' ' VAL . 7.4 m-85 -133.09 122.86 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.43 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -80.7 113.24 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 32.2 mmtt -93.07 -25.97 17.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.53 140.0 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.673 0.749 . . . . 0.0 110.842 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 145.4 57.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.635 2.224 . . . . 0.0 112.36 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -69.02 141.22 54.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.3 108.81 4.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 97' ' ' PRO . 4.0 mm-40 -144.06 106.03 4.85 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.648 0.737 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 96' ' ' GLU . 53.9 Cg_endo -69.79 101.28 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.721 2.281 . . . . 0.0 112.408 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.449 ' HG2' ' N ' ' A' ' 99' ' ' LYS . 22.2 ttmt -167.71 151.51 6.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.449 ' N ' ' HG2' ' A' ' 98' ' ' LYS . 26.2 mtmt -108.31 108.75 19.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -93.72 137.87 32.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.41 137.01 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 44.5 -151.48 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.52 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.2 161.82 28.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.535 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.9 m -173.95 165.66 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.398 . . . . 0.0 110.853 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.45 148.84 10.54 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.518 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 107' ' ' SER . 54.3 Cg_endo -69.66 -9.42 26.1 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.722 2.281 . . . . 0.0 112.36 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 106' ' ' PRO . 1.6 t -34.8 111.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t -129.17 -49.17 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.835 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.523 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 p -132.84 -49.91 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.2 t -58.94 107.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.11 -133.18 1.47 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.476 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' SER . 39.3 m -148.24 132.76 17.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' SER . 54.6 m -35.23 -57.34 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.5 -45.8 0.41 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.419 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 7.1 mmt -118.51 167.12 11.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -50.21 144.07 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 p -58.15 -30.47 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.075 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.42 -9.68 58.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.18 -44.89 53.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.145 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p -66.72 -22.86 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.22 -44.95 82.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 16' ' ' GLU . 6.7 tt -64.27 -31.64 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 15' ' ' ILE . 4.2 mt-10 -77.0 -34.08 57.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -74.89 -35.26 62.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.431 HD13 ' CD1' ' A' ' 73' ' ' LEU . 29.3 mt -63.59 -46.27 86.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.946 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.53 -38.25 74.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -64.34 -61.35 2.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 m -43.83 -46.92 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 26' ' ' PHE . 96.4 t -65.13 -36.3 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 12.3 mt-10 -64.59 -39.24 93.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.87 -51.78 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -40.58 -60.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.574 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.5 m-85 -45.69 -34.69 3.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.886 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m -63.88 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 1.2 t80 -66.37 -64.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.3 m -51.14 -45.12 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.546 ' CE2' HD12 ' A' ' 34' ' ' LEU . 17.7 t80 -59.65 -55.79 30.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.03 -41.17 92.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.43 -38.16 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -18.09 49.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.069 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.546 HD12 ' CE2' ' A' ' 30' ' ' TYR . 30.1 mt -75.18 -26.91 59.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.15 4.33 9.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 153.2 41.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.318 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -88.7 11.61 17.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.3 p -105.87 170.07 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.198 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.5 115.4 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.407 ' CG1' ' HD2' ' A' ' 41' ' ' PRO . 96.9 t -100.05 137.37 20.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.623 0.725 . . . . 0.0 111.134 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.8 109.24 2.27 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.707 2.271 . . . . 0.0 112.254 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.1 111.24 6.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.075 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 79.52 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.293 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -48.9 -48.48 42.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -44.55 -57.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.566 ' HD3' ' CD2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -69.08 -50.94 43.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.558 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 25.4 mmm -51.12 -24.76 4.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.8 mt -71.21 -32.96 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -87.52 -33.12 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -130.81 88.94 2.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -78.47 -39.86 37.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.2 t -43.56 -58.36 2.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -30.76 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' SER . 12.3 t -148.85 119.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 21.9 t -97.04 149.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.571 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 11.2 t -123.16 115.15 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -100.31 -178.02 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.37 -2.23 85.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 8.8 mt -77.87 154.09 80.54 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.671 0.748 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.557 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.7 Cg_endo -69.76 -175.42 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.344 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -83.19 164.44 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.84 20.45 1.22 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.424 HG11 ' CD ' ' A' ' 60' ' ' PRO . 3.2 p -113.27 169.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 111.065 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -150.31 120.85 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.072 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.558 ' CE2' ' HE3' ' A' ' 47' ' ' MET . 61.3 t80 -34.56 123.31 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.1 ptpt -166.7 175.32 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.946 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.495 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -47.81 140.39 8.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.0 Cg_endo -69.65 2.08 3.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.674 2.25 . . . . 0.0 112.352 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -98.16 -17.89 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.28 -11.61 49.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 23.0 m-85 -87.72 112.01 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -40.23 144.5 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' CD1' HD13 ' A' ' 18' ' ' LEU . 7.5 tp -39.99 -47.29 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -44.67 95.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.4 m -62.99 -47.98 80.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt -46.45 -59.27 3.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -45.18 -42.11 8.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.557 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.4 t90 -56.61 -59.32 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.0 mt -41.65 -55.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.162 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.47 -37.35 77.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -62.5 -54.56 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.563 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.1 m-80 -98.87 39.85 1.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' GLY . 27.4 pttt -85.86 -37.77 18.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -40.29 -24.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -97.61 -31.8 6.57 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.5 mt -42.25 110.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 111.058 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 m -121.93 138.56 54.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 5.7 m-85 -98.01 124.31 42.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.67 110.06 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.96 113.06 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.152 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 18.8 mmtt -91.08 -32.58 15.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.06 130.13 0.26 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.652 0.739 . . . . 0.0 110.866 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.437 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.76 122.96 9.64 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.669 2.246 . . . . 0.0 112.349 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.566 ' CD2' ' HD3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -37.59 156.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.0 mt -52.78 127.19 22.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.903 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -134.06 83.63 45.09 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.641 0.734 . . . . 0.0 110.89 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -179.26 2.77 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.713 2.275 . . . . 0.0 112.353 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -156.69 151.64 26.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.39 -179.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -175.08 121.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.96 133.73 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.03 156.96 7.38 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.02 135.13 1.79 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.542 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.1 t -47.95 165.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.897 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -124.36 -159.78 10.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.456 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 106.97 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.74 2.293 . . . . 0.0 112.369 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.5 p -119.45 121.54 39.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.7 m -76.77 -61.18 2.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.821 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.492 -179.965 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -130.47 119.78 23.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 t -125.72 124.69 41.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.23 -176.7 33.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.466 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -44.31 116.48 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.866 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.1 p -105.43 134.12 49.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.54 -137.12 12.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.481 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 23.7 mtt -95.59 146.88 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 m -81.16 176.86 9.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.865 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.45 -38.86 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.139 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.14 -9.31 59.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.14 87.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.35 -28.77 45.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.16 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.97 -65.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.951 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 10.1 tt -47.03 -41.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.4 mm-40 -64.54 -45.94 84.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -62.37 -33.06 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.145 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 21.1 mt -61.06 -48.2 82.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' CG ' ' HA ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -60.66 -43.47 97.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mtmm -60.88 -52.03 66.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.0 m -51.79 -48.3 63.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.09 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.46 HG11 ' CE2' ' A' ' 26' ' ' PHE . 18.9 t -67.12 -36.47 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -54.69 -43.54 72.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.88 -50.99 60.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.571 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.7 t80 -42.71 -64.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.5 m-85 -43.7 -35.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 -36.87 66.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.79 -46.9 73.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.2 m -64.28 -40.01 95.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.471 ' CD1' HD13 ' A' ' 90' ' ' ILE . 16.2 t80 -69.71 -47.53 62.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.972 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 -28.98 64.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.434 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -47.64 68.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.863 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.08 73.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.0 -36.3 81.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 23.38 9.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.498 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 17.4 mtmt -92.37 178.36 5.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 m -107.42 17.63 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 p -152.82 163.5 39.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.213 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.46 146.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.497 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 64.4 t -118.29 133.81 23.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.82 112.06 11.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.577 0.703 . . . . 0.0 111.133 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.2 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -49.49 -49.9 43.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -45.51 -50.66 12.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -71.56 -55.56 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.454 ' HE1' ' CE2' ' A' ' 65' ' ' PHE . 40.1 mmm -49.84 -19.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.826 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 -35.37 42.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -78.95 -40.11 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.28 99.16 4.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.56 43.42 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 53' ' ' ALA . 12.2 p -118.45 -56.61 2.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.883 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.42 -36.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 52' ' ' SER . 6.2 t -152.48 123.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 46.4 t -94.15 161.3 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.422 ' N ' HG12 ' A' ' 55' ' ' VAL . 14.2 t -134.07 121.76 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.94 166.98 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.35 3.33 69.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 9.6 mt -76.09 152.68 84.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.7 Cg_endo -69.75 -172.77 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.626 2.217 . . . . 0.0 112.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.33 160.93 21.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.78 31.7 2.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 59' ' ' LEU . 3.2 p -121.79 155.46 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.79 123.17 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CE2' ' HE1' ' A' ' 47' ' ' MET . 78.8 t80 -35.55 119.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 11.8 ptpt -164.65 171.01 14.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 5.7 t-80 -41.76 140.94 1.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.553 0.692 . . . . 0.0 110.855 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.526 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.9 Cg_endo -69.67 -2.95 10.99 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.385 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.404 ' HA ' ' CG ' ' A' ' 19' ' ' ARG . 7.5 pt-20 -95.87 -21.83 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -78.13 -14.76 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.407 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.0 m-85 -84.77 119.02 24.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' THR . 2.8 m-20 -45.04 142.45 1.88 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 5.9 tp -36.49 -53.87 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.85 72.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 72' ' ' ASP . 65.0 m -64.93 -49.7 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.505 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 13.7 mt -48.04 -50.49 27.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -51.13 -42.79 60.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.568 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.9 t90 -56.02 -56.11 24.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -46.04 -52.09 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.4 mt -60.28 -33.0 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -67.85 -54.37 19.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.449 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.5 m-80 -99.86 37.39 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.571 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -77.53 -45.23 26.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.457 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.69 -31.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' ILE . . . -83.97 -44.93 6.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLY . 23.9 mt -37.28 119.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 0.0 111.08 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -116.75 166.1 12.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -133.92 123.8 25.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.71 111.18 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.515 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.09 113.26 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.474 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.9 mmtt -92.61 -29.59 16.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.85 139.66 0.36 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.578 0.704 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 148.73 65.76 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -70.4 118.39 13.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.6 mt -115.29 127.95 55.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.9 142.82 1.33 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.617 0.722 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -173.67 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.637 2.225 . . . . 0.0 112.381 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' LYS . 19.6 pttt -167.57 162.34 14.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 98' ' ' LYS . 33.6 mtpt -37.14 -62.75 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.6 t60 43.07 54.74 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.0 m -95.22 50.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 53.19 -105.38 0.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.551 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -163.58 141.29 7.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.498 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.8 m -138.85 117.24 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.3 120.26 21.14 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.498 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 109.72 2.38 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.668 2.245 . . . . 0.0 112.325 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.3 p -94.03 122.01 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.5 m -104.8 123.58 47.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.517 179.991 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -86.54 151.99 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 110.802 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.3 m -56.31 122.08 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.76 -143.05 5.11 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.56 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 m -101.01 156.35 17.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.3 t -125.66 153.81 43.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.52 -144.83 15.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.436 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -110.68 118.14 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.84 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -72.56 165.44 24.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.6 p -64.11 -42.19 94.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.22 -12.69 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.431 ' O ' ' CG ' ' A' ' 16' ' ' GLU . . . -61.09 -42.22 98.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.084 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 p -60.01 -33.35 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.75 -66.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.7 tt -49.15 -36.04 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 12' ' ' ALA . 5.2 mm-40 -71.24 -42.64 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 m -65.22 -39.66 93.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.196 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.0 mt -58.24 -45.94 86.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -56.49 -33.36 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.461 ' N ' ' HE2' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -70.44 -57.96 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.455 ' CG2' HD22 ' A' ' 80' ' ' LEU . 9.9 m -40.37 -46.01 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.561 HG12 ' CE2' ' A' ' 26' ' ' PHE . 40.1 t -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 28.1 mt-10 -57.94 -41.91 83.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.45 -42.37 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.477 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 5.9 t80 -50.36 -60.57 2.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.561 ' CE2' HG12 ' A' ' 22' ' ' VAL . 19.0 m-85 -46.87 -37.45 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.0 m -69.56 -42.89 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -58.7 -56.79 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -53.73 -47.08 70.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.465 ' CD1' HD12 ' A' ' 90' ' ' ILE . 13.2 t80 -58.83 -68.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.69 -31.23 53.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.489 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.76 -42.23 82.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -28.04 65.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.87 -31.81 72.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.16 24.51 11.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.515 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 13.9 mtmt -93.86 179.96 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -109.47 20.93 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.7 p -155.42 159.58 39.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.28 144.65 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.515 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 93.4 t -122.39 138.36 29.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.733 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.75 128.38 15.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.29 111.87 12.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.612 0.72 . . . . 0.0 111.133 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 80.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.52 ' O ' ' C ' ' A' ' 45' ' ' GLU . 74.0 m-85 -54.96 -72.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.0 tp10 -28.03 -61.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.569 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 10.7 mptt -55.07 -49.13 72.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.957 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.561 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 56.9 mtp -57.32 -56.76 17.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 8.6 mt -40.41 -34.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -78.55 -42.33 29.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' MET . 2.4 m-20 -134.16 95.44 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -79.99 42.93 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.4 t -118.76 -57.85 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.58 -38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' SER . 56.9 t -147.33 119.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.01 146.94 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.563 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 23.1 t -115.36 131.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -121.93 166.19 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.0 63.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 mt -92.45 158.06 39.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.606 0.717 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.564 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.8 Cg_endo -69.77 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -96.22 164.33 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.93 13.99 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.526 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.414 ' CG2' ' H ' ' A' ' 64' ' ' ALA . 3.8 p -106.25 175.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.334 . . . . 0.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -156.55 117.89 3.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.03 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 84.4 t80 -33.67 124.87 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.451 ' CD ' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -169.33 179.48 3.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.519 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.8 t-80 -51.8 141.48 26.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 110.879 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.1 Cg_endo -69.8 -6.23 18.13 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.705 2.27 . . . . 0.0 112.362 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -93.23 -18.88 21.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.451 ' HB3' ' CD ' ' A' ' 66' ' ' LYS . 34.4 t-20 -79.92 -17.25 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.13 133.92 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' LEU . 0.6 OUTLIER -64.91 146.19 55.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.871 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 8.5 tp -37.66 -40.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.18 -53.98 51.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -59.67 -52.76 64.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.4 mt -39.29 -52.31 2.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -52.9 -48.93 66.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.2 t90 -50.22 -59.83 3.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.2 mt -41.02 -52.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.086 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.455 HD22 ' CG2' ' A' ' 21' ' ' THR . 20.4 mt -61.09 -37.1 81.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -62.64 -53.12 59.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.51 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -100.52 36.67 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' GLY . 56.8 pttt -80.41 -48.72 12.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.455 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.28 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.42 -33.71 7.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 15.1 mt -42.91 122.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.375 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -124.22 163.39 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.563 ' CZ ' HG22 ' A' ' 56' ' ' VAL . 7.2 m-85 -131.48 124.56 30.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.81 110.66 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.51 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.67 113.44 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -91.32 -28.69 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.479 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.89 136.53 0.32 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.653 0.739 . . . . 0.0 110.844 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.88 131.79 21.8 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 46' ' ' LYS . 63.6 m-85 -52.36 169.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.841 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.464 ' C ' ' CD ' ' A' ' 96' ' ' GLU . 25.7 mt -109.64 119.86 40.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.877 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' CD ' ' C ' ' A' ' 95' ' ' LEU . 24.1 mp0 -143.2 136.39 13.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.684 0.754 . . . . 0.0 110.858 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -169.23 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.654 2.236 . . . . 0.0 112.354 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 40.6 tptt -116.98 152.31 34.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 11.1 ptmt -81.33 176.47 9.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.899 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 99' ' ' LYS . 9.5 m-70 -174.81 126.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.861 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.62 155.57 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.167 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.76 -151.69 5.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.508 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -129.92 64.17 0.61 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.557 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.1 m -118.14 124.96 49.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.963 0.411 . . . . 0.0 110.768 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 161.41 -158.18 29.91 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.4 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 133.41 25.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.746 2.297 . . . . 0.0 112.336 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.5 m -114.42 145.15 42.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.9 t -97.68 -46.09 6.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.513 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t -107.82 158.7 17.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.976 0.417 . . . . 0.0 110.782 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -141.57 110.89 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.854 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.53 -168.29 12.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.6 p -133.65 177.57 7.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.925 0.393 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.7 t -126.19 155.81 41.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 122.08 172.29 14.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.521 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 9.8 mtt -86.24 155.14 20.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -163.72 174.12 12.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.26 -47.6 77.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -77.7 -17.63 57.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 16' ' ' GLU . . . -49.22 -40.34 33.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.43 -38.44 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.184 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.51 -64.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.824 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -48.64 -34.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 12' ' ' ALA . 7.3 mm-40 -72.3 -45.26 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -60.78 -35.39 76.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 25.0 mt -62.2 -42.7 99.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -62.07 -41.97 98.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.78 -54.04 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.404 ' CG2' HD21 ' A' ' 80' ' ' LEU . 87.3 m -44.87 -49.81 10.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.563 HG12 ' CE2' ' A' ' 26' ' ' PHE . 53.4 t -67.8 -40.54 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 14.7 mt-10 -50.76 -47.47 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.47 -51.46 65.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.545 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.2 t80 -42.44 -63.92 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.928 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.563 ' CE2' HG12 ' A' ' 22' ' ' VAL . 28.0 m-85 -41.89 -38.89 1.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.2 m -66.78 -44.89 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -58.28 -50.9 71.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.2 m -59.3 -43.44 92.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.437 ' CE2' HG11 ' A' ' 40' ' ' VAL . 12.9 t80 -62.1 -63.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.41 -29.28 66.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 -43.13 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.352 . . . . 0.0 110.975 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -33.53 74.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.04 -34.23 75.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 28.35 8.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.594 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 13.3 mtmt -95.66 179.62 5.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 m -109.23 22.11 16.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.9 p -154.49 175.1 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.74 141.53 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.594 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 91.9 t -116.7 132.7 23.25 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.657 0.742 . . . . 0.0 111.163 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 116.72 4.69 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.636 2.224 . . . . 0.0 112.37 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.481 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 46.3 t -67.25 112.28 9.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 79.5 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.709 2.272 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -51.3 -49.19 61.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -49.48 -48.99 47.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -68.34 -60.37 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.692 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 69.7 mtp -45.56 -35.45 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -58.8 -42.2 88.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.974 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -46.32 83.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -134.98 100.02 4.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -84.7 46.22 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.1 p -121.51 -44.61 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.12 -43.7 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.6 t -140.26 128.4 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.156 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 88.4 t -100.94 158.58 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.084 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 21.6 t -131.76 119.1 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -103.16 178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.78 -0.33 88.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.422 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 10.4 mt -77.07 153.84 82.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.723 . . . . 0.0 110.937 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.0 Cg_endo -69.82 -171.81 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.339 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -84.6 162.51 19.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.64 31.74 1.84 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.455 HG12 ' CD ' ' A' ' 60' ' ' PRO . 6.0 p -119.15 161.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.098 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -140.9 119.29 12.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.149 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 48.6 t80 -34.48 131.17 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 11.4 ptpt -175.09 163.14 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.519 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.7 t-80 -36.73 141.31 0.39 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.863 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 53.7 Cg_endo -69.77 -4.06 13.28 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.308 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -89.18 -27.03 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.72 -18.64 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.49 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-85 -80.97 111.34 17.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -42.69 145.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 11.0 tp -38.85 -46.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.32 82.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 50.2 m -63.16 -45.2 92.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.7 mt -48.64 -53.05 20.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -49.2 -45.55 44.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.571 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.6 t90 -54.55 -63.77 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -40.05 -50.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.404 HD21 ' CG2' ' A' ' 21' ' ' THR . 18.0 mt -62.11 -35.65 79.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' TRP . 10.3 mt-10 -65.32 -54.98 21.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.464 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -98.21 40.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.545 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 18.4 ptmt -82.68 -50.57 8.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 83' ' ' LYS . . . -35.07 -37.95 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.72 13.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.54 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 16.2 mt -37.9 124.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -126.47 169.98 12.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 56' ' ' VAL . 5.6 m-85 -132.54 125.72 31.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.09 112.5 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -84.52 112.46 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.1 mmtp -91.51 -28.87 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.465 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.57 130.74 0.26 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.757 . . . . 0.0 110.898 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo -69.71 127.61 14.88 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.742 2.295 . . . . 0.0 112.391 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -45.04 168.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.2 mt -110.62 131.43 55.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -149.81 142.08 15.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.655 0.741 . . . . 0.0 110.868 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -171.89 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.658 2.239 . . . . 0.0 112.322 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -64.79 131.34 46.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -44.24 125.0 4.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -141.53 122.82 14.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.87 107.29 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 0.0 111.119 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.03 91.68 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.86 125.83 0.79 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.8 p -168.66 157.35 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.885 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.72 -74.94 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -1.58 8.66 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.7 p -43.55 -52.42 6.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.8 m -90.7 -62.59 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.551 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.4 t -117.99 -50.01 2.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -101.98 171.64 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.97 -45.88 1.13 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.489 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.7 p -62.99 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.837 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.3 p -144.17 135.99 26.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.57 175.12 40.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.26 158.21 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 110.884 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -112.01 172.21 7.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 11' ' ' ASP . 7.1 p -78.92 -42.05 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.165 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 10' ' ' VAL . 13.1 t70 -79.24 -13.87 59.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.93 -51.41 52.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.84 -19.31 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -71.2 -47.88 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.414 HG21 ' N ' ' A' ' 16' ' ' GLU . 6.1 tt -62.88 -32.76 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' N ' HG21 ' A' ' 15' ' ' ILE . 6.2 mt-10 -76.39 -39.26 54.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 m -65.91 -35.82 81.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 73' ' ' LEU . 19.4 mt -63.52 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.98 -39.25 81.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -66.01 -52.42 49.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.8 m -52.01 -48.36 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.422 HG12 ' CE2' ' A' ' 26' ' ' PHE . 58.8 t -66.5 -38.51 81.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.162 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -56.75 -41.18 77.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.38 -47.91 62.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 7.2 t80 -44.59 -63.1 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.9 m-85 -43.31 -38.83 2.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.5 m -65.45 -46.02 81.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -56.61 -58.28 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 92.9 m -54.06 -40.75 67.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -64.61 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.65 -27.54 58.91 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.531 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -41.66 73.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.03 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.08 -33.99 77.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 25.77 8.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.485 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.59 ' CE ' ' CG2' ' A' ' 40' ' ' VAL . 12.4 mtmt -96.29 179.24 5.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.93 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.4 7.75 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.5 p -140.31 167.79 21.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -80.35 148.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.59 ' CG2' ' CE ' ' A' ' 36' ' ' LYS . 87.2 t -127.1 135.51 27.49 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.642 0.734 . . . . 0.0 111.1 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' N ' HG11 ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.79 121.02 7.71 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.74 2.293 . . . . 0.0 112.32 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.69 112.09 8.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 79.68 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.698 2.265 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' MET . 95.1 m-85 -47.43 -71.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 44' ' ' TYR . 7.7 tp10 -29.42 -59.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -60.13 -40.22 89.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 44' ' ' TYR . 28.0 mmm -64.08 -50.06 69.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 15.5 mt -51.22 -37.2 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -90.29 -26.89 19.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -135.0 77.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -72.52 -40.61 66.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -43.2 -57.28 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.02 -39.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.088 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' SER . 13.6 t -148.93 119.92 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.93 152.95 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 65' ' ' PHE . 31.4 t -121.68 124.56 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -116.52 160.75 20.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.81 10.05 59.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.449 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 mt -85.02 157.83 59.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 110.94 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.4 Cg_endo -69.82 -167.51 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 9.0 tp10 -96.06 156.25 16.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 56.68 18.17 23.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.558 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.7 p -109.12 166.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.072 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -144.37 113.04 6.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CD1' HG21 ' A' ' 56' ' ' VAL . 29.1 t80 -34.24 111.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.4 ptpt -156.69 -178.87 7.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.522 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.3 t-80 -48.81 141.43 10.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.629 0.728 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.522 ' HD2' ' CG ' ' A' ' 67' ' ' HIS . 54.1 Cg_endo -69.67 -7.31 20.69 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.756 2.304 . . . . 0.0 112.379 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -91.95 -19.92 21.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -81.48 -16.58 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.469 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.9 m-85 -84.44 120.13 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.5 OUTLIER -49.66 143.68 6.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.469 ' CD1' HD11 ' A' ' 18' ' ' LEU . 7.9 tp -37.48 -46.06 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.19 80.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 72' ' ' ASP . 61.8 m -67.08 -50.66 60.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.073 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 68' ' ' PRO . 19.5 mt -42.88 -51.82 5.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -52.22 -47.09 65.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.568 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -52.0 -62.25 1.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.5 mt -39.25 -53.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.8 mt -59.61 -39.78 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.66 -54.4 45.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.468 HD21 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.87 38.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.821 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' GLY . 55.4 pttt -80.67 -51.22 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -37.76 -27.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.127 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -90.17 -35.62 7.49 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.54 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.3 mt -43.27 123.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 111.067 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.1 m -121.83 168.75 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CE2' HG22 ' A' ' 56' ' ' VAL . 9.4 m-85 -136.01 121.34 19.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.07 111.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.64 112.84 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -92.04 -29.77 16.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.466 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.91 134.2 0.29 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.571 0.7 . . . . 0.0 110.846 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.414 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 52.9 Cg_endo -69.83 127.58 14.73 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.61 2.206 . . . . 0.0 112.349 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -46.2 126.23 7.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.4 mt -116.99 146.69 42.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -138.07 151.59 70.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.693 0.758 . . . . 0.0 110.864 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 170.95 15.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.767 2.311 . . . . 0.0 112.309 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 99' ' ' LYS . 1.7 ttpm? 63.77 41.09 7.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 100' ' ' HIS . 58.1 mttt 37.98 43.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 99' ' ' LYS . 6.9 p-80 -34.93 129.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.5 t -96.0 84.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.175 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.7 -61.45 4.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 154.93 -139.82 6.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.521 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.2 p -158.41 108.49 2.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.867 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.25 164.72 34.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 158.16 58.0 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.704 2.269 . . . . 0.0 112.312 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -81.22 172.67 13.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.6 t -140.27 173.64 11.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.843 0.354 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.61 -63.29 1.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.0 tt -49.64 -31.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.211 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -76.48 -40.1 51.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 m -67.11 -35.33 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 22' ' ' VAL . 28.3 mt -64.72 -45.24 87.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.927 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -58.08 -34.81 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -67.15 -50.83 59.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.401 HG22 HD21 ' A' ' 80' ' ' LEU . 6.9 m -51.22 -48.2 62.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG12 ' CE2' ' A' ' 26' ' ' PHE . 11.7 t -65.77 -36.12 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.107 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.03 -42.65 94.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.99 -49.61 49.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.574 ' CE1' ' CE ' ' A' ' 83' ' ' LYS . 6.8 t80 -41.93 -64.25 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.563 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.6 m-85 -42.01 -34.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.4 m -72.69 -36.73 67.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.717 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.2 t80 -67.39 -48.68 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.0 m -63.58 -39.81 95.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.691 ' CD1' HD11 ' A' ' 90' ' ' ILE . 13.1 t80 -67.62 -52.57 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.64 -29.02 72.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -44.87 72.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.72 -27.61 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.38 -33.16 75.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.67 20.48 19.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -92.71 179.12 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.1 p -108.53 20.05 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -151.8 164.16 37.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.4 m -80.72 142.07 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.5 HG13 ' HD2' ' A' ' 41' ' ' PRO . 40.2 t -115.63 135.96 22.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.77 117.91 5.37 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.409 HG13 ' SD ' ' A' ' 47' ' ' MET . 92.3 t -73.24 112.07 14.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 80.49 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.686 2.257 . . . . 0.0 112.289 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -53.04 -47.51 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -50.34 -44.83 54.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.947 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -74.32 -59.27 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.566 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 59.3 mtp -45.7 -33.59 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.1 mt -60.46 -48.32 82.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -73.39 -36.29 66.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -128.33 97.93 4.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.797 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -95.13 47.14 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 p -124.52 -41.51 2.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.812 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.89 25.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.064 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 90' ' ' ILE . 25.5 t -149.87 126.0 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 56' ' ' VAL . 46.6 t -98.42 158.4 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.75 HG21 ' CD1' ' A' ' 65' ' ' PHE . 44.5 t -128.13 126.51 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -120.49 165.32 15.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.16 10.82 68.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.6 mt -84.22 155.76 63.41 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.542 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.2 Cg_endo -69.76 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 0.0 112.376 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.57 158.03 15.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.2 17.26 23.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 64' ' ' ALA . 3.4 p -108.61 175.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.136 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.719 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -157.01 120.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.75 ' CD1' HG21 ' A' ' 56' ' ' VAL . 84.6 t80 -34.79 119.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HZ3' ' HE1' ' A' ' 71' ' ' TYR . 11.2 ptpp? -166.56 170.5 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -45.45 141.65 3.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.528 0.68 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.84 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.75 -1.06 7.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 0.0 112.366 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.19 -17.48 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.2 -14.89 57.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.423 ' HE1' ' HZ3' ' A' ' 66' ' ' LYS . 23.6 m-85 -88.33 135.39 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 149.2 47.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.45 HD11 ' CD1' ' A' ' 18' ' ' LEU . 6.8 tp -40.47 -39.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.22 23.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.4 m -59.17 -45.6 90.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.9 mt -46.27 -49.59 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -55.68 -43.79 76.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.542 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 60.1 t90 -53.28 -60.15 3.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.2 mt -41.62 -53.63 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 21' ' ' THR . 23.8 mt -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.99 -53.85 43.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -100.49 35.13 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.574 ' CE ' ' CE1' ' A' ' 25' ' ' TYR . 21.1 ptmt -74.19 -52.59 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.93 -30.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.066 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -84.96 -37.85 9.79 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 19.4 mt -45.52 124.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 0.0 111.058 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -124.71 168.75 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 56' ' ' VAL . 5.9 m-85 -135.72 129.46 32.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.01 112.0 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.691 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.0 113.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.1 mmtt -91.0 -29.73 17.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.475 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.93 135.29 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.408 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.294 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.865 0.364 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.09 -65.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 tt -50.4 -32.15 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -76.27 -36.91 58.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -70.96 -34.52 71.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.508 HD12 ' CD1' ' A' ' 73' ' ' LEU . 17.1 mt -62.79 -47.45 83.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.949 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -54.99 -41.33 71.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -67.16 -51.58 52.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.607 HG22 HD21 ' A' ' 80' ' ' LEU . 91.6 m -49.03 -48.4 43.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.109 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 26' ' ' PHE . 86.3 t -67.69 -37.02 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.446 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 13.8 mt-10 -56.05 -43.05 77.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -65.68 -49.51 68.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.586 ' CD1' ' HE3' ' A' ' 83' ' ' LYS . 8.7 t80 -44.12 -64.19 0.72 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.538 ' CE2' HG12 ' A' ' 22' ' ' VAL . 26.5 m-85 -42.8 -39.83 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.537 ' HA ' HG12 ' A' ' 39' ' ' VAL . 21.2 t80 -65.28 -56.64 11.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.1 m -54.05 -40.47 67.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.578 ' CD1' HD11 ' A' ' 90' ' ' ILE . 14.8 t80 -65.78 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.19 -25.02 61.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.541 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.13 -42.16 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.68 67.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.091 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -62.69 -34.83 77.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.47 24.03 9.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.545 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.523 ' HE2' HG21 ' A' ' 40' ' ' VAL . 8.7 mtmt -92.35 -179.97 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 t -109.87 19.3 19.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -154.09 161.87 41.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.3 m -74.77 144.35 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.523 HG21 ' HE2' ' A' ' 36' ' ' LYS . 40.5 t -119.46 136.08 24.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.598 0.713 . . . . 0.0 111.135 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.3 Cg_endo -69.71 118.5 5.72 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.662 2.242 . . . . 0.0 112.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.4 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 94.3 t -70.42 111.99 11.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . 53.5 Cg_endo -69.81 79.97 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -55.88 -47.16 77.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -51.27 -46.4 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HD2' ' CB ' ' A' ' 43' ' ' PRO . 44.6 mttt -71.7 -55.56 7.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.469 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 80.1 mtp -50.33 -31.97 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.48 -30.43 71.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -86.03 -38.49 17.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -133.18 94.65 3.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.2 40.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' VAL . 22.1 p -113.36 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -32.95 -35.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 90' ' ' ILE . 19.0 t -148.78 143.32 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.477 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 58.7 t -118.04 139.9 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 65' ' ' PHE . 22.9 t -109.17 125.71 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -120.03 158.85 25.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.12 15.35 45.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.504 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.6 mt -87.12 154.34 54.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.936 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.621 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.9 Cg_endo -69.68 -168.68 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -86.99 164.42 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.79 29.1 0.75 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.437 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.621 HG11 ' HD2' ' A' ' 60' ' ' PRO . 4.0 p -117.84 156.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -139.15 118.26 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 56' ' ' VAL . 83.3 t80 -34.11 117.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.7 ptpt -164.33 174.41 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.524 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -44.86 140.75 3.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.721 . . . . 0.0 110.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.882 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.6 Cg_endo -69.75 2.28 3.66 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -97.18 -22.04 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -81.17 -12.45 59.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.7 m-85 -88.2 117.7 27.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' LEU . 2.0 m-20 -49.02 144.03 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.508 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.2 tp -35.72 -50.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.29 -51.14 63.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -60.98 -46.65 89.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.882 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.1 mt -47.53 -54.96 10.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.938 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -48.56 -47.93 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.2 t90 -48.64 -61.62 1.94 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.2 mt -41.14 -52.42 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.607 HD21 HG22 ' A' ' 21' ' ' THR . 29.4 mt -59.49 -37.82 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.56 -55.27 25.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -99.73 37.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.586 ' HE3' ' CD1' ' A' ' 25' ' ' TYR . 16.6 ptmt -72.85 -53.92 10.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.17 -33.4 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.055 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.65 -33.28 38.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 25.0 mt -53.19 126.05 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.5 m -123.91 169.06 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.828 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.554 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.1 m-85 -136.42 126.41 26.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.04 109.61 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.17 112.98 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.477 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.4 mmtp -92.05 -31.28 15.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.591 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.72 129.96 0.28 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.875 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.461 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 0.0 112.323 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.789 0.328 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.49 -63.62 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 9.6 tt -51.13 -38.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.7 mm-40 -68.78 -46.03 69.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 m -61.56 -33.44 73.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 19.1 mt -59.25 -47.48 85.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.452 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -58.85 -47.68 84.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -54.53 -52.62 61.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.505 HG22 HD21 ' A' ' 80' ' ' LEU . 24.6 m -51.46 -48.38 62.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.535 HG12 ' CE2' ' A' ' 26' ' ' PHE . 23.7 t -67.72 -37.41 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -56.41 -36.92 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.94 -47.9 27.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.3 t80 -44.34 -63.06 0.96 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.535 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.3 m-85 -41.92 -34.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.1 m -71.83 -38.91 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.746 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.7 t80 -64.8 -47.52 77.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 65.3 m -65.56 -41.75 92.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.744 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.7 t80 -66.7 -47.91 70.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.98 -32.67 63.21 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -42.31 93.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.42 -31.3 70.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -61.71 -36.1 79.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.41 10.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.474 ' HE2' HG21 ' A' ' 40' ' ' VAL . 18.8 mtmt -94.28 179.31 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.0 p -108.65 21.01 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.0 p -155.76 162.27 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.746 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.0 m -76.12 155.41 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.474 HG21 ' HE2' ' A' ' 36' ' ' LYS . 41.5 t -132.87 135.0 25.21 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.663 0.744 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.1 Cg_endo -69.77 118.55 5.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 0.0 112.286 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 81.3 t -67.0 117.81 49.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 111.122 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 80.01 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -50.57 -53.11 32.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 2.6 tp10 -43.16 -56.21 3.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -65.79 -56.1 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 41.0 mmm -50.06 -23.52 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.826 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.24 -30.41 57.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.955 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -84.52 -42.12 15.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.33 94.54 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -81.69 47.63 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.915 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -125.18 -56.07 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.72 -36.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 90' ' ' ILE . 16.1 t -149.69 119.77 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.471 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 19.9 t -95.86 154.85 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.817 HG13 ' CE1' ' A' ' 88' ' ' PHE . 5.0 t -125.69 119.53 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -112.04 158.93 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.41 13.24 42.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.1 mt -85.89 156.97 57.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.667 0.746 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.621 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.4 Cg_endo -69.8 -172.16 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -86.53 158.87 19.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.39 28.7 9.8 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 64' ' ' ALA . 4.2 p -118.69 171.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.635 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -154.66 120.31 5.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 56' ' ' VAL . 82.4 t80 -35.15 121.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -167.31 170.58 11.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.3 t-80 -39.75 141.01 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.65 0.738 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 1.0 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.71 -9.54 26.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -91.19 -16.81 27.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -82.82 -13.88 55.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CD2' HD11 ' A' ' 79' ' ' ILE . 21.9 m-85 -87.39 121.06 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.03 147.67 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 7.0 tp -40.01 -48.8 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.41 -44.73 84.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -63.42 -57.79 9.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.0 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.0 mt -39.44 -47.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -55.05 -46.55 75.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.56 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.5 t90 -54.5 -58.81 6.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.523 HD11 ' CD2' ' A' ' 71' ' ' TYR . 49.4 mt -41.52 -53.76 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 21' ' ' THR . 14.2 mt -61.1 -40.5 93.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -55.61 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -97.93 35.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 51.8 pttt -77.63 -49.77 13.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.82 -26.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -91.24 -39.1 5.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' LYS . 28.4 mt -43.22 122.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 111.149 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -120.49 162.73 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.817 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.3 m-85 -128.25 126.48 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.5 110.35 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.744 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.41 113.17 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 19.5 mmtt -91.45 -28.12 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.474 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 134.5 0.31 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.632 0.73 . . . . 0.0 110.842 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.422 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.2 0 C-N-CA 122.612 2.208 . . . . 0.0 112.392 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.752 0.311 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.47 -65.05 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tt -49.66 -31.01 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -76.6 -40.15 50.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -66.8 -34.44 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.51 HD12 ' CD1' ' A' ' 73' ' ' LEU . 20.6 mt -63.54 -41.39 98.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -64.44 -39.09 93.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -41.6 77.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.511 HG22 HD21 ' A' ' 80' ' ' LEU . 90.0 m -59.78 -49.03 79.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.551 HG12 ' CE2' ' A' ' 26' ' ' PHE . 96.1 t -65.36 -37.34 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.084 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -54.85 -39.14 68.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.92 -52.16 32.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 10.0 t80 -42.34 -62.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.716 ' HB3' HG21 ' A' ' 42' ' ' VAL . 21.4 m-85 -43.78 -40.74 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 m -68.32 -37.83 80.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.75 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -66.47 -47.0 74.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.5 m -64.1 -40.94 97.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.97 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.928 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.9 t80 -66.61 -56.71 9.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.23 -29.84 74.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.464 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -42.25 75.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.745 0.307 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -26.52 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.092 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.5 mt -67.6 -30.9 70.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 23.09 13.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.735 ' HE2' HG21 ' A' ' 40' ' ' VAL . 14.6 mtmt -95.77 178.85 5.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.347 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -107.7 6.06 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.2 p -136.95 160.96 37.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.3 m -79.35 136.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.735 HG21 ' HE2' ' A' ' 36' ' ' LYS . 55.0 t -112.76 137.8 21.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 0.0 111.137 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.584 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.74 125.76 12.53 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.672 2.248 . . . . 0.0 112.383 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 26' ' ' PHE . 61.7 t -71.13 111.93 11.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.619 0.723 . . . . 0.0 111.169 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 80.44 0.89 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.674 2.249 . . . . 0.0 112.326 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -53.02 -53.21 53.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -47.42 -52.03 18.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -65.86 -61.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.551 ' HE1' ' CZ ' ' A' ' 65' ' ' PHE . 79.4 mtp -43.54 -37.95 2.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.5 mt -55.31 -40.26 70.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -82.26 -39.52 22.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -126.16 80.24 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -68.19 -20.63 64.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.2 t -62.25 -57.14 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -31.79 -36.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' SER . 15.0 t -151.53 121.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 91' ' ' LYS . 20.8 t -100.02 157.78 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 65' ' ' PHE . 23.7 t -125.53 123.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -117.36 153.24 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.46 39.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 59' ' ' LEU . 12.3 mt -84.85 155.73 61.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.623 0.725 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.666 ' O ' HG12 ' A' ' 63' ' ' VAL . 52.8 Cg_endo -69.86 178.86 4.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.297 . . . . 0.0 112.311 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.18 154.61 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.08 23.21 51.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.543 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -116.61 164.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.161 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -144.59 117.95 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.746 ' CD1' HG21 ' A' ' 56' ' ' VAL . 64.1 t80 -34.65 120.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -167.11 171.48 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -42.96 141.89 1.57 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.88 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.3 Cg_endo -69.77 -4.88 14.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.319 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.92 -14.27 26.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -85.21 -12.38 52.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.54 128.38 36.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 73' ' ' LEU . 4.5 m-20 -56.63 145.81 27.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.9 tp -36.19 -48.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.74 62.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -58.89 -46.38 87.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.88 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.2 mt -47.61 -47.99 28.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.985 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -55.1 -48.58 73.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.841 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.3 t90 -49.21 -60.56 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.6 mt -40.74 -53.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.511 HD21 HG22 ' A' ' 21' ' ' THR . 23.3 mt -58.73 -38.78 79.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -62.98 -55.42 25.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -99.48 38.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.9 pttp -77.39 -45.42 25.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.476 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -44.06 -35.89 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.07 -35.27 31.05 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 mt -49.51 123.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -126.09 167.6 15.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.54 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.6 m-85 -132.83 128.43 36.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.69 111.06 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.928 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.88 112.52 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HE3' HG21 ' A' ' 55' ' ' VAL . 22.3 mmtt -89.94 -33.3 16.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.17 129.6 0.26 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 110.835 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.44 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.201 0 C-N-CA 122.732 2.288 . . . . 0.0 112.371 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.824 0.345 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.5 -57.33 3.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 5.5 tt -54.48 -46.11 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.082 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.549 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.3 mt-10 -63.48 -48.61 76.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 m -57.2 -30.89 64.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 28.6 mt -64.54 -48.64 74.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.697 ' HD2' HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -58.18 -42.07 85.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -39.02 92.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.6 HG22 HD21 ' A' ' 80' ' ' LEU . 48.5 m -64.33 -49.4 71.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.643 HG12 ' CE2' ' A' ' 26' ' ' PHE . 94.5 t -66.69 -39.49 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.481 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -53.36 -43.22 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.11 -49.68 69.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 12.5 t80 -45.99 -63.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.643 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.0 m-85 -44.18 -40.4 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.7 m -65.25 -38.3 89.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.603 ' HA ' HG12 ' A' ' 39' ' ' VAL . 31.3 t80 -66.64 -59.6 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -51.49 -37.57 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.58 ' CE1' HD11 ' A' ' 90' ' ' ILE . 17.0 t80 -69.71 -64.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.18 57.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.87 -45.95 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.43 67.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mt -62.71 -33.17 74.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.86 23.43 11.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.65 ' HE2' HG21 ' A' ' 40' ' ' VAL . 10.2 mtmt -94.35 179.11 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -109.54 20.21 18.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.8 p -154.16 159.67 41.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.603 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.3 m -76.58 138.71 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.65 HG21 ' HE2' ' A' ' 36' ' ' LYS . 51.0 t -114.58 137.67 22.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.664 0.745 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.569 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.8 120.82 7.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.611 2.207 . . . . 0.0 112.349 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 58.7 t -73.72 111.96 14.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.738 . . . . 0.0 111.148 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 79.83 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.715 2.277 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -51.43 -45.2 62.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -54.36 -40.25 67.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -74.38 -59.62 2.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.625 ' HE2' ' CE2' ' A' ' 65' ' ' PHE . 92.5 mtp -47.38 -46.19 25.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -43.92 -46.96 8.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -80.77 -39.81 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -127.48 81.64 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -72.28 -30.96 65.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' ALA . 24.0 p -45.01 -50.07 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -36.14 -45.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.515 HG22 HG13 ' A' ' 90' ' ' ILE . 14.4 t -144.7 128.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.49 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 35.0 t -99.64 142.98 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 65' ' ' PHE . 39.6 t -116.56 112.66 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -102.49 162.63 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.6 0.78 64.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.6 mt -75.55 149.35 83.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.603 0.716 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.815 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.3 Cg_endo -69.81 178.47 4.57 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.685 2.257 . . . . 0.0 112.339 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.86 160.21 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.74 19.77 10.97 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -112.94 169.82 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.962 ' CD1' HG21 ' A' ' 56' ' ' VAL . 72.8 t80 -34.31 113.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -159.78 171.06 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.2 t-80 -42.15 141.24 1.42 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.92 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.8 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 0.0 112.378 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.59 -15.11 31.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.07 -7.15 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -91.29 121.25 32.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.82 147.16 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.82 -47.35 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.11 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.5 m -66.77 -57.51 6.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.92 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.9 mt -39.41 -48.32 1.91 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -55.99 -48.23 76.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.8 t90 -49.16 -57.71 6.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -43.1 -52.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.6 HD21 HG22 ' A' ' 21' ' ' THR . 21.6 mt -59.77 -38.28 81.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.23 -55.78 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -97.8 40.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.852 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.59 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 16.7 ptmt -80.05 -53.57 6.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.929 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -36.27 -33.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -83.29 -37.54 12.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 14.4 mt -44.14 125.83 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 t -124.34 162.99 22.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.614 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.9 m-85 -131.77 126.2 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.2 111.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.667 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.23 113.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.185 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.49 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.0 mmtt -93.18 -31.24 14.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.51 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.89 125.71 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 0.0 110.872 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' VAL . 4.4 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.823 0.344 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.9 -57.94 3.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 8.2 tt -50.83 -42.65 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.115 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.7 mt-10 -66.31 -43.23 86.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 m -63.28 -32.94 74.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 27.3 mt -61.41 -45.92 92.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.453 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -59.42 -50.14 75.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -47.78 70.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 HD21 ' A' ' 80' ' ' LEU . 24.3 m -55.25 -49.03 73.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.552 HG12 ' CE2' ' A' ' 26' ' ' PHE . 59.6 t -67.78 -36.1 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.438 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 15.3 mt-10 -57.75 -45.26 86.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -65.95 -47.98 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.406 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.4 t80 -44.87 -59.4 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.552 ' CE2' HG12 ' A' ' 22' ' ' VAL . 20.1 m-85 -46.71 -39.3 11.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.1 m -65.52 -39.9 92.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.79 ' HA ' HG12 ' A' ' 39' ' ' VAL . 12.6 t80 -64.49 -54.12 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.821 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.48 ' CB ' ' CD1' ' A' ' 88' ' ' PHE . 35.5 m -58.13 -43.86 87.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -63.15 -58.66 6.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.38 -27.86 72.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.31 -41.27 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.15 -32.65 69.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.129 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.52 -26.26 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.91 24.1 21.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.521 ' CE ' HG21 ' A' ' 40' ' ' VAL . 15.1 mtmt -96.86 177.21 5.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.6 p -109.24 22.68 15.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.0 p -153.26 165.59 35.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.0 m -84.54 140.46 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.127 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 41' ' ' PRO . 43.6 t -117.82 137.39 24.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.79 114.0 3.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.496 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 82.7 t -71.52 113.6 21.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.649 0.738 . . . . 0.0 111.076 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.427 ' CB ' ' CE ' ' A' ' 46' ' ' LYS . 54.3 Cg_endo -69.74 80.73 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 0.0 112.352 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -52.15 -45.21 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -49.46 -46.55 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' CE ' ' CB ' ' A' ' 43' ' ' PRO . 43.7 mtmt -75.69 -52.83 9.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.619 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 38.5 mtp -51.81 -21.44 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -76.67 -33.27 58.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -34.68 57.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -136.92 109.82 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -97.58 40.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 p -117.61 -41.93 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -48.93 -43.74 39.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.142 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG22 HG13 ' A' ' 90' ' ' ILE . 9.0 t -146.32 124.93 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.466 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 40.0 t -97.76 149.38 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.158 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.873 HG21 ' CD1' ' A' ' 65' ' ' PHE . 98.9 t -118.67 116.56 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.682 ' CD ' HD12 ' A' ' 89' ' ' ILE . 2.2 mp0 -100.74 -179.6 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.33 4.32 73.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.442 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.6 mt -78.11 154.02 79.9 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.67 0.748 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.643 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.8 Cg_endo -69.71 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.715 2.277 . . . . 0.0 112.341 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -87.26 160.16 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.45 29.07 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.643 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.8 p -119.18 167.65 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.529 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.59 126.78 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.063 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.873 ' CD1' HG21 ' A' ' 56' ' ' VAL . 78.4 t80 -35.95 130.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HZ2' ' HE1' ' A' ' 71' ' ' TYR . 8.5 ptpp? -174.44 172.77 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.5 t-80 -47.18 140.99 6.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.558 0.694 . . . . 0.0 110.883 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.987 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.4 Cg_endo -69.73 -7.26 20.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' OE2' ' ND1' ' A' ' 67' ' ' HIS . 5.2 pt-20 -93.09 -17.28 24.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.69 -15.72 53.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.426 ' HE1' ' HZ2' ' A' ' 66' ' ' LYS . 26.1 m-85 -85.05 131.8 34.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.0 OUTLIER -56.44 147.21 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.43 -49.12 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.19 79.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 26.6 m -71.15 -51.54 24.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 68' ' ' PRO . 12.2 mt -45.29 -54.17 7.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.417 ' HE2' HD11 ' A' ' 73' ' ' LEU . 17.9 mttm -49.67 -47.44 50.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.536 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.0 t90 -49.12 -55.87 10.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.9 mt -45.37 -54.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.524 HD21 HG22 ' A' ' 21' ' ' THR . 23.3 mt -59.45 -34.27 72.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.948 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.26 -52.31 55.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -101.92 33.82 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 86' ' ' ILE . 55.8 pttt -76.47 -45.29 31.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.58 -25.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.72 -30.24 9.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 83' ' ' LYS . 20.0 mt -49.57 122.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.8 m -121.82 170.26 9.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 29' ' ' CYS . 6.1 m-85 -128.89 116.13 18.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.682 HD12 ' CD ' ' A' ' 57' ' ' GLN . 9.2 mt -103.83 93.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.166 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.641 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -71.39 114.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.466 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.2 mmtp -93.68 -30.07 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.456 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 128.45 0.27 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.611 0.72 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.453 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.383 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -62.2 -68.85 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.9 tt -48.52 -34.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.51 -40.41 64.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -66.05 -38.04 87.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 27.6 mt -59.61 -45.8 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -58.27 -40.67 82.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.842 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -45.74 73.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.479 HG22 HD21 ' A' ' 80' ' ' LEU . 25.7 m -52.15 -49.69 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.089 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.656 HG12 ' CE2' ' A' ' 26' ' ' PHE . 42.3 t -65.92 -39.59 85.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -51.1 -48.31 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -63.97 -48.85 74.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.8 t80 -44.21 -62.69 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' HG12 ' A' ' 22' ' ' VAL . 24.6 m-85 -44.63 -35.14 2.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.0 m -67.59 -39.72 84.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.694 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -62.11 -58.04 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.8 m -54.78 -39.75 68.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -65.78 -64.8 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.78 -24.22 62.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.6 -46.64 63.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.58 -31.03 71.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.99 -34.07 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.36 22.83 11.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.41 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 40' ' ' VAL . 15.0 mtmt -91.55 179.46 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.9 p -107.98 18.98 20.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -152.12 172.72 15.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.694 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.4 m -90.05 140.44 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.18 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 36' ' ' LYS . 42.9 t -116.76 136.31 23.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.654 0.74 . . . . 0.0 111.114 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.78 122.52 9.2 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.604 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 60.2 t -73.12 112.04 14.01 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.659 0.743 . . . . 0.0 111.11 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 80.54 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.761 2.307 . . . . 0.0 112.323 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -48.84 -52.01 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.02 -52.65 14.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -65.86 -57.84 6.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 32.1 mmm -48.25 -33.65 9.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.7 mt -59.97 -32.6 70.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -87.02 -40.32 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -129.18 90.88 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -80.74 -19.89 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p -58.52 -46.72 86.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -40.53 -42.96 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.476 HG22 HG13 ' A' ' 90' ' ' ILE . 5.4 t -146.52 132.03 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 51.1 t -102.91 148.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.918 HG21 ' CD1' ' A' ' 65' ' ' PHE . 12.4 t -121.86 116.9 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -104.73 170.02 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.96 9.6 73.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.7 mt -83.45 150.15 59.49 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.636 0.732 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.664 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.6 Cg_endo -69.78 -171.98 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -83.4 163.69 20.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.37 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.664 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -119.8 157.86 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.166 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.12 123.83 16.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.918 ' CD1' HG21 ' A' ' 56' ' ' VAL . 91.5 t80 -34.62 119.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -167.37 169.89 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.6 t-80 -41.86 140.99 1.36 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.957 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.71 -6.59 18.93 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.657 2.238 . . . . 0.0 112.365 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.66 -21.4 21.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -78.86 -9.65 59.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.44 129.28 39.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.93 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' THR . 4.2 m-20 -57.77 143.46 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 72' ' ' ASP . 9.8 tp -36.32 -48.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -42.69 79.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 72' ' ' ASP . 60.7 m -70.09 -45.77 66.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.0 mt -47.78 -52.75 17.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -51.34 -46.68 62.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.1 t90 -50.05 -56.85 9.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -44.63 -55.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.479 HD21 HG22 ' A' ' 21' ' ' THR . 22.0 mt -57.97 -36.67 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.02 -53.33 55.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -101.38 34.86 2.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 60.7 pttt -77.2 -48.8 16.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -42.87 -27.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.94 -32.26 11.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.1 mt -47.66 121.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 111.154 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -118.03 162.55 18.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.847 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.1 m-85 -131.1 123.33 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.5 110.84 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.22 113.23 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.138 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.462 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 4.9 mmtp -93.17 -32.46 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.567 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -179.12 127.73 0.25 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.428 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.189 0 C-N-CA 122.669 2.246 . . . . 0.0 112.298 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.816 0.341 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.96 -62.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.8 tt -47.36 -36.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.14 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -70.09 -40.67 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -66.43 -38.7 88.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 22' ' ' VAL . 20.0 mt -59.36 -46.33 88.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -64.44 -37.45 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -68.18 -46.45 70.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.588 HG22 HD21 ' A' ' 80' ' ' LEU . 27.7 m -56.69 -45.9 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.087 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.604 HG12 ' CE2' ' A' ' 26' ' ' PHE . 41.0 t -68.18 -31.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.62 -47.38 63.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -45.33 -61.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.604 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.9 m-85 -46.71 -39.98 12.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m -67.46 -40.44 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.47 ' HA ' HG12 ' A' ' 39' ' ' VAL . 9.7 t80 -62.85 -56.53 16.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.0 m -52.61 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.825 ' CE1' HD11 ' A' ' 90' ' ' ILE . 15.1 t80 -66.87 -64.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -23.16 58.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -39.2 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.906 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.17 -27.25 60.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -66.09 -32.66 74.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 25.93 9.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.59 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.6 mtmt -95.56 179.73 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 t -110.93 21.39 16.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.3 p -154.3 163.94 39.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.7 m -79.04 143.04 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.202 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 41' ' ' PRO . 57.5 t -118.92 137.84 25.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.684 0.754 . . . . 0.0 111.09 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.75 120.94 7.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 26' ' ' PHE . 60.6 t -71.61 112.66 14.81 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 80.63 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.716 2.277 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -60.32 -39.61 87.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.9 -38.5 70.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -80.3 -55.02 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.527 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 84.2 mtp -49.41 -35.98 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -85.69 -38.38 18.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.07 91.5 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -81.15 41.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 14.3 p -116.41 -55.86 2.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.795 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -33.94 -37.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 90' ' ' ILE . 29.7 t -148.02 135.95 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.501 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 46.7 t -109.32 146.07 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 65' ' ' PHE . 15.3 t -117.57 124.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.2 165.27 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.92 62.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.9 mt -85.44 151.2 55.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.536 0.684 . . . . 0.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.616 ' HD2' HG11 ' A' ' 63' ' ' VAL . 54.1 Cg_endo -69.77 -169.07 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 63' ' ' VAL . 7.7 tt0 -87.52 167.5 13.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.21 24.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.616 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.5 p -115.27 159.81 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.63 117.38 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.741 ' CD1' HG21 ' A' ' 56' ' ' VAL . 42.0 t80 -34.21 114.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -159.02 173.76 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 6.9 t-80 -42.92 140.62 1.85 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 110.875 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.769 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.3 Cg_endo -69.78 0.75 5.21 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.643 2.229 . . . . 0.0 112.335 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.42 -17.79 18.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.93 -11.35 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -88.17 121.39 30.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 73' ' ' LEU . 1.8 m-20 -51.45 144.84 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.818 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.518 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.2 tp -36.91 -48.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.89 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -57.18 -48.93 77.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.161 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 68' ' ' PRO . 15.5 mt -43.48 -57.2 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -48.14 -44.0 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.93 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.537 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.8 t90 -53.14 -59.73 4.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.7 mt -41.87 -54.65 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.149 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 21' ' ' THR . 20.8 mt -59.85 -36.86 77.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -63.03 -53.45 53.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -100.84 35.0 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -76.38 -45.54 31.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -42.0 -29.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.8 -35.84 8.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.9 mt -46.01 120.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -120.52 163.13 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.63 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.2 m-85 -129.74 126.65 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.65 111.39 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.825 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -81.97 113.06 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.501 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 22.8 mmtt -91.54 -31.66 15.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.518 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -179.02 132.46 0.28 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.439 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo . . . . . 0 N--CA 1.465 -0.206 0 C-N-CA 122.75 2.3 . . . . 0.0 112.384 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.774 0.321 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -57.96 -69.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 tt -45.84 -32.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.54 -37.74 59.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.449 ' HA ' ' HZ2' ' A' ' 20' ' ' LYS . 55.1 m -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD12 ' CD1' ' A' ' 73' ' ' LEU . 15.7 mt -61.31 -40.96 96.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -63.44 -45.91 88.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HZ2' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -66.13 -44.83 83.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.526 HG22 HD21 ' A' ' 80' ' ' LEU . 98.9 m -53.74 -47.38 70.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.593 HG12 ' CE2' ' A' ' 26' ' ' PHE . 59.5 t -68.73 -36.54 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.93 -47.65 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.2 t80 -45.28 -58.3 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.593 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.5 m-85 -50.13 -40.71 47.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.4 m -65.42 -40.13 92.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.69 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.2 t80 -63.16 -58.48 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.0 m -52.0 -40.65 61.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.733 ' CE1' HD11 ' A' ' 90' ' ' ILE . 17.5 t80 -66.66 -64.72 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -21.89 56.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -41.01 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.2 -27.24 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.83 -31.46 72.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.949 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.6 24.68 10.69 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.514 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.63 ' HE2' HG21 ' A' ' 40' ' ' VAL . 17.6 mtmt -94.66 179.9 5.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 t -109.65 21.3 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.9 p -155.39 174.88 14.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.8 m -88.31 148.35 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.63 HG21 ' HE2' ' A' ' 36' ' ' LYS . 98.6 t -123.12 137.1 27.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.664 0.745 . . . . 0.0 111.153 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.2 Cg_endo -69.74 111.92 2.94 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.405 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 39.6 t -69.96 111.9 10.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.573 0.701 . . . . 0.0 111.111 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 79.97 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.624 2.216 . . . . 0.0 112.355 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -52.05 -48.45 64.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 48' ' ' LEU . 20.6 tt0 -50.34 -43.23 53.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -74.17 -58.37 3.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.405 ' SD ' ' CG1' ' A' ' 42' ' ' VAL . 56.9 mtp -46.59 -35.39 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 45' ' ' GLU . 24.2 mt -54.24 -42.2 69.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.985 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 6.7 ptt85 -84.23 -32.89 24.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.878 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.454 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 8.3 p-10 -130.62 86.87 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -80.09 -7.39 58.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 53' ' ' ALA . 2.5 p -68.61 -57.26 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.83 -37.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.079 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' SER . 3.4 t -154.33 125.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 56' ' ' VAL . 40.2 t -96.3 165.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.812 HG21 ' CD1' ' A' ' 65' ' ' PHE . 39.4 t -136.2 123.1 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -116.21 166.44 12.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.33 5.49 67.31 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.8 mt -79.68 152.29 74.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.914 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.682 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.2 Cg_endo -69.8 -174.63 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.306 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -83.61 162.69 20.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.1 23.43 2.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -115.93 166.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.491 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.12 128.76 12.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.812 ' CD1' HG21 ' A' ' 56' ' ' VAL . 86.9 t80 -37.87 128.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -174.07 174.49 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.538 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.6 t-80 -50.61 141.87 16.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.569 0.699 . . . . 0.0 110.839 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.681 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.3 Cg_endo -69.7 -1.98 9.34 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.457 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 4.3 pt-20 -95.81 -20.09 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -78.12 -17.45 56.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -83.19 145.05 29.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.36 150.09 38.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.649 ' CD1' HD12 ' A' ' 18' ' ' LEU . 7.3 tp -38.77 -51.77 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.28 -56.76 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -55.0 -50.11 69.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.681 HD21 ' O ' ' A' ' 68' ' ' PRO . 19.7 mt -43.19 -57.03 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -47.14 -46.56 23.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 67.4 t90 -51.01 -61.87 1.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mt -40.14 -54.63 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.526 HD21 HG22 ' A' ' 21' ' ' THR . 29.2 mt -58.88 -40.14 83.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.36 -53.76 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -100.97 35.67 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 53.7 pttt -76.79 -45.06 30.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -43.11 -28.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.32 -35.01 9.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.455 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.4 mt -47.61 120.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.356 . . . . 0.0 111.084 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -120.76 164.79 16.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.427 ' CE2' HG22 ' A' ' 56' ' ' VAL . 6.5 m-85 -131.22 122.16 26.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.05 110.48 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.733 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.66 112.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 21.0 mmtt -91.48 -28.79 17.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.49 140.43 0.34 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.672 2.248 . . . . 0.0 112.278 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 13' ' ' VAL . 2.8 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.812 0.339 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -82.01 -55.47 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.2 tt -52.49 -36.46 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -72.69 -45.42 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.9 m -59.5 -36.25 75.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 29.8 mt -60.64 -44.8 95.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -58.88 -36.07 74.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -45.79 75.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.665 HG22 HD21 ' A' ' 80' ' ' LEU . 33.0 m -55.83 -50.23 71.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.172 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.511 HG12 ' CE2' ' A' ' 26' ' ' PHE . 39.5 t -66.07 -40.64 87.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -51.9 -49.54 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.59 -47.39 85.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -44.95 -62.11 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.511 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.6 m-85 -45.24 -41.73 8.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 m -62.41 -42.46 99.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.544 ' HA ' HG12 ' A' ' 39' ' ' VAL . 22.9 t80 -63.35 -55.24 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 64.9 m -57.53 -40.41 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CE1' HD11 ' A' ' 90' ' ' ILE . 20.3 t80 -67.14 -62.83 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.53 -23.46 60.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.54 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -72.17 -46.61 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.57 -28.67 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.62 -34.81 77.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 22.85 12.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.534 ' HE2' HG21 ' A' ' 40' ' ' VAL . 19.4 mtmt -93.39 -179.91 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 p -109.34 20.52 18.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.3 p -156.39 159.44 38.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -68.88 155.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG21 ' HE2' ' A' ' 36' ' ' LYS . 70.5 t -130.82 131.75 23.47 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.626 0.726 . . . . 0.0 111.082 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.348 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.68 115.51 15.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.72 0.771 . . . . 0.0 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.92 0.97 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -48.78 -52.85 21.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -45.86 -54.2 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -61.19 2.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.799 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 31.5 mmm -42.25 -39.2 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -49.34 71.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.937 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -80.53 -25.53 38.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.54 87.87 2.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 54' ' ' VAL . 52.2 mt-30 -83.36 -28.31 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 31.0 p -49.84 -56.39 10.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.21 -43.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 51' ' ' GLN . 2.5 t -143.99 122.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.097 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.22 142.01 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.984 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.0 t -111.19 125.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -116.74 162.94 16.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.38 44.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 18.3 mt -92.14 155.96 42.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.668 0.746 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.8 Cg_endo -69.71 -165.59 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' GLY . 10.3 tt0 -88.16 166.73 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.66 33.09 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.654 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -120.28 149.82 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -133.86 123.17 24.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.984 ' CD1' HG21 ' A' ' 56' ' ' VAL . 82.6 t80 -33.98 121.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.452 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.0 ptpt -170.88 166.15 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.531 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.1 t-80 -39.92 141.52 0.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.841 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.954 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.4 Cg_endo -69.71 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.674 2.249 . . . . 0.0 112.356 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -20.54 25.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -81.76 -15.44 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 24.5 m-85 -84.04 123.15 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.7 145.07 7.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -37.99 -49.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.62 76.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.8 m -60.51 -47.84 84.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 68' ' ' PRO . 26.7 mt -47.97 -54.55 12.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -48.59 -43.41 36.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.546 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.6 t90 -56.87 -57.21 13.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.0 mt -44.19 -52.42 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.665 HD21 HG22 ' A' ' 21' ' ' THR . 21.4 mt -60.62 -36.15 77.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.02 -53.09 55.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -101.47 35.31 2.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.856 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 52.3 pttt -75.54 -49.3 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -41.0 -30.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.39 8.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.8 mt -40.47 124.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -121.51 170.2 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -132.47 115.42 15.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.2 mt -101.03 93.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.081 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -72.0 112.91 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -87.82 -31.97 19.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.55 137.34 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.562 0.696 . . . . 0.0 110.886 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.338 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.784 0.326 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.29 -49.92 65.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.8 tt -57.19 -33.49 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.413 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 5.1 mt-10 -75.47 -40.82 56.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 m -64.67 -37.71 88.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' VAL . 31.0 mt -64.2 -37.05 86.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.475 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 31.1 mtm105 -66.41 -36.82 83.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -62.79 -48.89 77.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 HD21 ' A' ' 80' ' ' LEU . 28.3 m -56.29 -46.2 79.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.649 HG12 ' CE2' ' A' ' 26' ' ' PHE . 23.4 t -67.01 -35.57 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.428 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 12.7 mt-10 -61.01 -44.66 97.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.72 -46.35 72.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.52 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.9 t80 -46.52 -62.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.649 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.0 m-85 -42.31 -36.45 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.83 -42.98 76.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.583 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -59.59 -49.66 76.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -62.97 -43.79 97.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.625 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.1 t80 -62.37 -58.7 6.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.34 82.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -44.55 86.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.6 71.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.0 mt -64.01 -34.4 77.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.95 11.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.68 ' HE2' HG21 ' A' ' 40' ' ' VAL . 14.3 mtmt -93.25 179.59 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.945 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.87 20.27 18.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.3 p -154.55 164.56 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -77.79 145.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.68 HG21 ' HE2' ' A' ' 36' ' ' LYS . 59.1 t -124.22 132.94 24.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 0.0 111.158 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.7 122.17 8.87 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.626 2.218 . . . . 0.0 112.336 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 79.5 t -68.08 111.54 8.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.707 0.765 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 79.61 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 0.0 112.364 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' MET . 38.3 m-85 -45.23 -73.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.4 tp10 -30.91 -54.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -62.09 -43.11 99.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.546 ' N ' ' O ' ' A' ' 44' ' ' TYR . 47.3 mtp -65.78 -58.68 5.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.5 mt -42.45 -35.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.463 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -91.86 -29.34 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.564 ' OD2' ' HB2' ' A' ' 53' ' ' ALA . 25.3 t0 -134.12 75.09 1.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -63.83 -43.76 95.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -40.16 -61.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.564 ' HB2' ' OD2' ' A' ' 50' ' ' ASP . . . -31.43 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' SER . 12.1 t -155.19 119.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 91' ' ' LYS . 21.5 t -98.17 157.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.627 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.9 t -126.68 121.79 59.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -114.28 153.31 29.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.67 15.12 27.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.407 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 17.3 mt -89.64 157.69 46.39 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.648 0.737 . . . . 0.0 110.863 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.647 ' HD2' HG11 ' A' ' 63' ' ' VAL . 52.9 Cg_endo -69.84 -168.01 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 0.0 112.248 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.84 164.86 15.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.2 29.31 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.647 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.1 p -118.66 152.59 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.179 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.97 123.25 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.009 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.627 ' CD1' HG21 ' A' ' 56' ' ' VAL . 86.9 t80 -33.81 126.29 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.83 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' HD3' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -172.49 166.83 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.944 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.4 t-80 -43.01 141.73 1.63 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.676 0.75 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.931 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.76 -7.59 21.45 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.709 2.272 . . . . 0.0 112.325 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HA ' ' CD ' ' A' ' 19' ' ' ARG . 1.5 pp20? -89.23 -16.95 30.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.405 ' CB ' ' HD3' ' A' ' 66' ' ' LYS . 52.0 m-20 -85.62 -13.73 47.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.79 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -85.79 128.5 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.7 m-20 -56.41 141.96 40.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 72' ' ' ASP . 7.5 tp -36.05 -46.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.33 84.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 92.4 m -64.53 -48.13 76.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.931 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.1 mt -45.04 -51.72 9.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -52.99 -46.28 68.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.553 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 56.5 t90 -52.08 -61.81 2.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.993 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.3 mt -39.61 -52.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.595 HD21 HG22 ' A' ' 21' ' ' THR . 19.6 mt -61.22 -37.34 82.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -63.12 -53.84 47.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.78 37.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 44.8 pttt -79.93 -50.04 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.466 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.48 -31.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.083 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -86.9 -37.16 8.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.6 mt -42.47 127.37 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.751 0.31 . . . . 0.0 111.146 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -127.61 166.16 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.56 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.9 m-85 -131.77 121.85 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.48 110.42 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.81 112.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HE3' HG21 ' A' ' 55' ' ' VAL . 24.3 mmtt -91.85 -25.35 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.13 139.41 0.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.655 0.741 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.216 0 C-N-CA 122.695 2.264 . . . . 0.0 112.365 -179.987 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.806 0.336 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.62 -60.85 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 6.1 tt -49.55 -37.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.409 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.4 mt-10 -72.38 -41.79 65.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 m -64.61 -38.36 90.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.47 ' CD1' HD11 ' A' ' 73' ' ' LEU . 26.9 mt -60.92 -35.52 76.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.667 ' NH1' HD11 ' A' ' 76' ' ' LEU . 57.6 mtt-85 -71.88 -41.33 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -58.18 -39.61 79.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.562 HG22 HD21 ' A' ' 80' ' ' LEU . 25.0 m -63.87 -43.97 94.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.763 HG12 ' CE2' ' A' ' 26' ' ' PHE . 47.4 t -70.58 -32.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.223 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 20.0 mt-10 -62.41 -40.15 95.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.73 -46.86 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.565 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 11.1 t80 -47.98 -62.85 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.763 ' CE2' HG12 ' A' ' 22' ' ' VAL . 28.9 m-85 -42.13 -37.73 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.1 m -68.6 -43.51 76.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.556 ' HA ' HG12 ' A' ' 39' ' ' VAL . 28.0 t80 -60.18 -52.55 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -57.83 -43.4 85.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.579 ' CE1' HD11 ' A' ' 90' ' ' ILE . 15.7 t80 -64.06 -61.1 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.952 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.21 -27.37 67.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -42.57 68.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.706 0.288 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 -24.27 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.35 -28.63 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.06 23.47 24.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.572 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.624 ' HE2' HG21 ' A' ' 40' ' ' VAL . 16.5 mtmt -91.92 -179.98 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.889 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 m -109.48 19.11 19.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -150.54 172.13 15.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.196 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -88.58 139.52 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.624 HG21 ' HE2' ' A' ' 36' ' ' LYS . 74.4 t -117.93 133.08 23.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 0.0 111.124 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.4 Cg_endo -69.77 124.7 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.331 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 47' ' ' MET . 90.7 t -72.54 111.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.635 0.731 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 79.9 0.92 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 0.0 112.368 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -52.41 -51.12 60.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -46.0 -51.5 13.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -69.66 -60.5 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.601 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 40.2 mtp -42.2 -39.35 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.943 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.5 mt -53.78 -46.19 70.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -79.39 -31.94 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.32 88.94 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -78.44 -38.38 41.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 53' ' ' ALA . 37.0 p -39.52 -55.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -34.28 -40.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 t -153.06 128.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 56' ' ' VAL . 35.2 t -102.25 165.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.763 HG21 ' CD1' ' A' ' 65' ' ' PHE . 14.5 t -134.48 124.22 44.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -116.02 163.47 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.03 11.98 58.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 13.2 mt -86.29 154.04 56.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.751 ' O ' HG12 ' A' ' 63' ' ' VAL . 54.5 Cg_endo -69.7 172.76 11.99 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.356 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -78.69 147.52 33.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.47 18.83 72.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.3 p -115.41 168.59 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 111.143 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.541 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -146.65 117.85 7.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.763 ' CD1' HG21 ' A' ' 56' ' ' VAL . 68.3 t80 -35.94 122.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.419 ' N ' ' OH ' ' A' ' 71' ' ' TYR . 11.2 ptpt -170.8 169.99 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.4 t-80 -42.19 140.82 1.52 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 110.938 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.573 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.2 Cg_endo -69.85 3.34 2.87 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -95.32 -21.7 18.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -83.41 -7.06 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.954 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.419 ' OH ' ' N ' ' A' ' 66' ' ' LYS . 22.9 m-85 -92.72 133.82 35.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.91 154.87 36.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' A' ' 18' ' ' LEU . 6.3 tp -44.59 -47.53 10.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.54 -54.63 44.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.2 m -55.99 -47.1 78.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.667 HD11 ' NH1' ' A' ' 19' ' ' ARG . 22.8 mt -45.29 -59.69 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -46.1 -46.36 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.0 t90 -51.04 -62.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.5 mt -40.21 -51.44 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.562 HD21 HG22 ' A' ' 21' ' ' THR . 28.5 mt -62.12 -36.08 80.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' TRP . 12.0 mm-40 -64.56 -54.07 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -99.65 36.77 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.565 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -76.75 -45.51 28.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.53 -33.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.17 -31.47 28.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.41 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 mt -50.25 118.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.4 m -121.55 156.64 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.56 ' CE1' HG13 ' A' ' 56' ' ' VAL . 7.1 m-85 -121.66 126.56 49.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.71 109.53 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.55 113.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.456 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.3 mmtp -93.84 -26.88 16.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.8 137.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.216 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 13' ' ' VAL . 2.1 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.79 0.329 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.69 -54.87 5.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 tt -52.27 -30.37 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.37 -43.48 32.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -61.67 -34.44 75.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 24.0 mt -64.62 -44.45 90.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -61.55 -22.87 65.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -76.26 -56.0 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 m -44.47 -44.81 8.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.799 HG12 ' CE2' ' A' ' 26' ' ' PHE . 21.9 t -71.51 -34.74 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.487 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 14.7 mt-10 -62.75 -39.05 92.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -72.99 -38.05 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.551 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 7.0 t80 -58.41 -60.15 4.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.799 ' CE2' HG12 ' A' ' 22' ' ' VAL . 20.9 m-85 -44.03 -40.8 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.22 -58.0 7.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.7 m -53.24 -40.12 64.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.636 ' CE1' HD11 ' A' ' 90' ' ' ILE . 18.4 t80 -66.72 -63.7 1.01 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.959 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.56 60.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -41.23 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.732 0.301 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.85 67.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.051 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -62.06 -35.3 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.35 25.61 8.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.501 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.737 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.1 mtmt -95.93 179.6 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -111.35 20.51 17.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.9 p -152.5 159.94 43.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.2 m -73.49 141.56 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.737 HG21 ' HE2' ' A' ' 36' ' ' LYS . 98.4 t -120.22 138.91 27.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 0.0 111.178 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.668 ' HD2' HG13 ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.83 122.82 9.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.748 2.299 . . . . 0.0 112.265 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 26' ' ' PHE . 55.2 t -67.98 116.79 42.27 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.628 0.727 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 80.03 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.736 2.291 . . . . 0.0 112.349 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.517 ' O ' ' C ' ' A' ' 45' ' ' GLU . 67.9 m-85 -55.69 -72.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.921 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 44' ' ' TYR . 37.0 tt0 -28.79 -56.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -48.07 83.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.52 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 74.2 mtp -59.26 -56.92 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.1 mt -43.83 -46.51 7.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -77.81 -31.28 51.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 51.8 m-20 -134.96 95.26 3.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -92.25 51.92 1.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 p -130.27 -38.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -52.97 -35.73 59.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 90' ' ' ILE . 34.5 t -149.29 123.35 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.487 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 33.4 t -95.95 155.06 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.8 t -126.25 121.55 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.114 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -111.68 168.18 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.033 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.98 4.24 78.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.1 mt -78.93 158.11 75.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 0.0 110.925 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.6 Cg_endo -69.81 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.653 2.235 . . . . 0.0 112.3 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -98.3 157.41 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.09 17.53 10.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 64' ' ' ALA . 8.0 p -107.78 168.08 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.577 ' N ' HG22 ' A' ' 63' ' ' VAL . . . -145.94 115.08 7.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.098 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.828 ' CD1' HG21 ' A' ' 56' ' ' VAL . 55.5 t80 -35.01 125.19 0.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.839 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 14.7 ptpt -169.35 172.78 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.0 t-80 -43.84 140.66 2.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.599 0.714 . . . . 0.0 110.818 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.846 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.6 Cg_endo -69.77 2.59 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.1 -16.99 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.04 -11.06 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.521 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.6 m-85 -86.81 116.99 25.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.41 143.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 8.9 tp -39.44 -41.56 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.976 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.63 70.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -58.13 -46.25 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.846 HD21 ' O ' ' A' ' 68' ' ' PRO . 26.7 mt -47.0 -52.5 14.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -50.45 -46.23 56.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.558 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -54.32 -60.95 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.9 mt -41.14 -50.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.7 mt -62.68 -35.6 80.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.1 -55.17 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -98.19 39.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.551 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 19.7 ptmt -78.27 -51.91 9.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.56 -31.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -85.05 -37.51 9.97 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.1 mt -43.18 118.4 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 111.169 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.0 m -118.91 160.17 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.1 m-85 -126.59 125.98 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.11 112.0 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.61 113.31 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.487 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.6 mmtt -93.36 -28.38 16.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.516 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.91 129.5 0.27 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.655 0.74 . . . . 0.0 110.833 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.451 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.221 0 C-N-CA 122.707 2.271 . . . . 0.0 112.385 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.863 0.363 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.25 -59.31 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.82 -34.5 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -40.81 74.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -67.18 -32.14 73.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 15.6 mt -64.27 -46.54 83.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -63.96 -29.08 70.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -67.54 -54.57 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.43 HG22 HD21 ' A' ' 80' ' ' LEU . 6.3 m -51.32 -47.9 62.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.641 HG12 ' CE2' ' A' ' 26' ' ' PHE . 20.0 t -64.72 -37.35 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.04 -43.19 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.36 -44.29 68.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 6.4 t80 -48.92 -61.18 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.675 ' HB3' HG21 ' A' ' 42' ' ' VAL . 19.7 m-85 -44.45 -35.06 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.2 m -68.05 -40.17 82.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 39' ' ' VAL . 4.5 t80 -62.49 -55.04 31.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.68 -35.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -68.03 -58.48 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -26.83 70.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -43.07 77.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.793 0.33 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.91 -27.65 62.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -72.6 -21.1 61.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.16 32.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -90.71 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -98.68 -4.3 34.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.4 p -137.94 166.53 23.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -72.84 129.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.145 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 41' ' ' PRO . 63.0 t -105.67 132.38 20.93 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.585 0.707 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.412 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.1 Cg_endo -69.68 124.46 11.14 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.388 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.675 HG21 ' HB3' ' A' ' 26' ' ' PHE . 81.0 t -64.91 111.17 5.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.693 0.759 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 42' ' ' VAL . 53.5 Cg_endo -69.83 79.18 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.261 . . . . 0.0 112.327 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 47' ' ' MET . 72.7 m-85 -47.3 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 44' ' ' TYR . 9.4 pt-20 -30.04 -42.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' TYR . 23.7 mttp -73.13 -47.09 47.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' TYR . 70.4 mtp -62.51 -50.98 69.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 11.7 mt -50.4 -37.49 37.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -88.73 -27.63 21.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.629 ' OD2' ' HB2' ' A' ' 53' ' ' ALA . 3.8 t70 -134.11 69.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -59.0 -40.99 86.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 53' ' ' ALA . 3.4 t -48.37 -58.45 4.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.629 ' HB2' ' OD2' ' A' ' 50' ' ' ASP . . . -31.94 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.676 HG22 HG13 ' A' ' 90' ' ' ILE . 59.1 t -138.94 119.74 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.151 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 56' ' ' VAL . 39.2 t -98.94 160.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.841 HG21 ' CD1' ' A' ' 65' ' ' PHE . 18.1 t -129.61 129.1 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.179 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -118.51 163.96 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.3 6.87 62.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB3' HG11 ' A' ' 63' ' ' VAL . 11.6 mt -82.13 157.27 68.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.614 0.721 . . . . 0.0 110.902 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.601 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.3 Cg_endo -69.79 -168.17 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.309 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -90.11 162.37 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 46.61 26.69 2.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.7 p -116.33 163.22 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.91 0.386 . . . . 0.0 111.078 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -145.0 118.77 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.841 ' CD1' HG21 ' A' ' 56' ' ' VAL . 91.5 t80 -34.39 126.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 13.0 ptpt -170.67 165.71 8.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.528 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -38.29 140.82 0.57 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.807 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.0 Cg_endo -69.82 2.23 3.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.668 2.245 . . . . 0.0 112.302 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.22 -20.87 16.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -84.79 -12.61 53.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 20.4 m-85 -84.16 117.04 23.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.4 OUTLIER -45.46 139.12 3.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -35.79 -46.9 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.03 87.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' ASP . 51.8 m -65.49 -45.25 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.807 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.8 mt -46.59 -54.7 8.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -48.94 -50.44 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.547 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 51.8 t90 -50.61 -60.71 2.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.0 mt -39.87 -52.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.43 HD21 HG22 ' A' ' 21' ' ' THR . 17.0 mt -62.95 -40.19 96.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.98 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -55.45 34.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -97.16 37.76 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 58.7 pttt -82.96 -45.64 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -38.43 -27.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.54 -40.07 4.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 85' ' ' GLY . 13.9 mt -34.16 127.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.1 m -127.92 169.6 13.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 56' ' ' VAL . 8.4 m-85 -134.96 127.92 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.23 109.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.133 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.676 HG13 HG22 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -81.75 113.38 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.215 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.499 ' HE3' HG21 ' A' ' 55' ' ' VAL . 5.3 mmtp -92.89 -31.74 14.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.618 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.85 127.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.594 0.711 . . . . 0.0 110.859 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.425 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo . . . . . 0 C--N 1.342 0.206 0 C-N-CA 122.727 2.284 . . . . 0.0 112.343 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.87 -61.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 tt -50.79 -33.55 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.68 -43.9 62.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.6 m -62.96 -33.26 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.1 mt -63.32 -44.84 93.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -62.23 -40.2 95.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -64.55 -46.0 84.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.494 HG22 HD21 ' A' ' 80' ' ' LEU . 28.6 m -57.12 -48.98 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.643 HG12 ' CE2' ' A' ' 26' ' ' PHE . 46.4 t -65.97 -39.01 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.91 -43.69 69.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.1 -49.51 56.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 9.0 t80 -42.72 -61.92 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.643 ' CE2' HG12 ' A' ' 22' ' ' VAL . 25.7 m-85 -45.13 -38.03 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 m -66.82 -47.37 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.407 ' HA ' HG12 ' A' ' 39' ' ' VAL . 12.3 t80 -55.6 -52.57 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.3 m -56.49 -46.21 80.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.577 ' CE1' HD11 ' A' ' 90' ' ' ILE . 12.9 t80 -61.95 -62.41 1.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -27.83 64.48 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.519 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -41.81 74.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.24 66.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -64.89 -34.33 78.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.78 6.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.694 ' HE2' HG21 ' A' ' 40' ' ' VAL . 11.4 mtmt -99.86 177.61 5.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.756 0.313 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.9 p -105.84 -0.54 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.4 p -128.78 165.82 20.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.5 146.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.694 HG21 ' HE2' ' A' ' 36' ' ' LYS . 78.3 t -125.31 128.12 24.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.703 0.763 . . . . 0.0 111.157 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 124.33 10.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.254 . . . . 0.0 112.306 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.685 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 73.3 t -71.16 113.1 16.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.682 0.753 . . . . 0.0 111.151 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 80.89 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.245 . . . . 0.0 112.344 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.574 ' O ' ' N ' ' A' ' 47' ' ' MET . 53.1 m-85 -47.85 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.498 ' C ' ' O ' ' A' ' 44' ' ' TYR . 35.0 tt0 -29.92 -46.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -70.11 -44.17 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 44' ' ' TYR . 37.2 mmm -63.34 -53.01 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.82 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 12.1 mt -40.29 -35.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 9.7 mtp85 -93.73 -39.83 10.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -122.99 80.11 1.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.0 -28.0 57.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -52.54 -57.65 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.43 -36.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.3 t -152.69 119.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.543 HG21 ' HE3' ' A' ' 91' ' ' LYS . 20.0 t -96.28 153.41 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.794 HG13 ' CE1' ' A' ' 88' ' ' PHE . 11.9 t -125.36 123.58 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -112.15 163.82 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.39 61.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 11.3 mt -81.66 151.01 67.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.971 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.822 ' O ' HG12 ' A' ' 63' ' ' VAL . 54.7 Cg_endo -69.74 -179.95 3.26 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.7 2.266 . . . . 0.0 112.4 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.62 161.24 27.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.83 24.04 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.7 p -115.65 171.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -154.52 119.97 5.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.759 ' CD1' HG21 ' A' ' 56' ' ' VAL . 85.6 t80 -34.75 121.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 8.4 ptpp? -166.6 179.08 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.52 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -51.24 140.74 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.779 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.4 Cg_endo -69.78 2.99 3.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 8.1 pt-20 -98.29 -22.54 16.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -79.12 -15.38 58.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.449 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 20.9 m-85 -83.42 129.55 34.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.9 m-20 -61.67 143.24 56.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -34.78 -45.56 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.096 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' ASP . 87.5 m -60.58 -52.03 66.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 68' ' ' PRO . 24.8 mt -43.04 -56.74 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -46.57 -44.97 18.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.536 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.9 t90 -54.43 -57.9 9.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.7 mt -43.84 -55.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.494 HD21 HG22 ' A' ' 21' ' ' THR . 22.8 mt -59.15 -35.81 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.97 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -64.06 -52.8 57.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -101.74 33.64 2.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.521 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 59.0 pttt -74.87 -44.12 50.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.53 -22.07 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.4 -27.74 10.41 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.469 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mt -53.67 120.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.121 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 p -117.9 165.24 13.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.794 ' CE1' HG13 ' A' ' 56' ' ' VAL . 7.4 m-85 -133.09 122.86 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.43 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.667 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -80.7 113.24 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.543 ' HE3' HG21 ' A' ' 55' ' ' VAL . 32.2 mmtt -93.07 -25.97 17.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.53 140.0 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.673 0.749 . . . . 0.0 110.842 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.342 0.201 0 C-N-CA 122.635 2.224 . . . . 0.0 112.36 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.793 0.33 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.22 -44.95 82.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 tt -64.27 -31.64 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -77.0 -34.08 57.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -74.89 -35.26 62.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.3 mt -63.59 -46.27 86.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.53 -38.25 74.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -64.34 -61.35 2.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 m -43.83 -46.92 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.588 HG12 ' CE2' ' A' ' 26' ' ' PHE . 96.4 t -65.13 -36.3 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.502 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 12.3 mt-10 -64.59 -39.24 93.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.87 -51.78 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -40.58 -60.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.588 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.5 m-85 -45.69 -34.69 3.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.886 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m -63.88 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 1.2 t80 -66.37 -64.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.3 m -51.14 -45.12 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.942 ' CE2' HD11 ' A' ' 34' ' ' LEU . 17.7 t80 -59.65 -55.79 30.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.501 ' HA2' HD12 ' A' ' 34' ' ' LEU . . . -57.03 -41.17 92.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.43 -38.16 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -18.09 49.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.069 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.942 HD11 ' CE2' ' A' ' 30' ' ' TYR . 30.1 mt -75.18 -26.91 59.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.15 4.33 9.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 153.2 41.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.318 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -88.7 11.61 17.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.3 p -105.87 170.07 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.198 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.5 115.4 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.606 HG13 ' HD2' ' A' ' 41' ' ' PRO . 96.9 t -100.05 137.37 20.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.623 0.725 . . . . 0.0 111.134 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.606 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.8 109.24 2.27 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.707 2.271 . . . . 0.0 112.254 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 30' ' ' TYR . 47.7 t -67.1 111.24 6.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.075 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 53.7 Cg_endo -69.73 79.52 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.293 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -48.9 -48.48 42.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -44.55 -57.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.541 ' CG ' ' N ' ' A' ' 47' ' ' MET . 0.0 OUTLIER -69.08 -50.94 43.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.541 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 25.4 mmm -51.12 -24.76 4.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.8 mt -71.21 -32.96 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -87.52 -33.12 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -130.81 88.94 2.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -78.47 -39.86 37.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.2 t -43.56 -58.36 2.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -30.76 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG22 HG13 ' A' ' 90' ' ' ILE . 12.3 t -148.85 119.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 21.9 t -97.04 149.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.715 HG13 ' CE1' ' A' ' 88' ' ' PHE . 11.2 t -123.16 115.15 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -100.31 -178.02 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.37 -2.23 85.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 65' ' ' PHE . 8.8 mt -77.87 154.09 80.54 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.671 0.748 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.731 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.7 Cg_endo -69.76 -175.42 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.344 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -83.19 164.44 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.84 20.45 1.22 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -113.27 169.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 111.065 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.31 120.85 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.072 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CD1' HG21 ' A' ' 56' ' ' VAL . 61.3 t80 -34.56 123.31 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.536 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.1 ptpt -166.7 175.32 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.946 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.503 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -47.81 140.39 8.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.743 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.0 Cg_endo -69.65 2.08 3.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.674 2.25 . . . . 0.0 112.352 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -98.16 -17.89 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.28 -11.61 49.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.536 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 23.0 m-85 -87.72 112.01 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -40.23 144.5 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tp -39.99 -47.29 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -44.67 95.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.4 m -62.99 -47.98 80.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.743 HD21 ' O ' ' A' ' 68' ' ' PRO . 15.3 mt -46.45 -59.27 3.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -45.18 -42.11 8.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.545 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.4 t90 -56.61 -59.32 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.0 mt -41.65 -55.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.162 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.47 -37.35 77.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -62.5 -54.56 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -98.87 39.85 1.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' GLY . 27.4 pttt -85.86 -37.77 18.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -40.29 -24.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -97.61 -31.8 6.57 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.5 mt -42.25 110.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 111.058 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 m -121.93 138.56 54.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.715 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.7 m-85 -98.01 124.31 42.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.67 110.06 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.676 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.96 113.06 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.152 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 18.8 mmtt -91.08 -32.58 15.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.06 130.13 0.26 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.652 0.739 . . . . 0.0 110.866 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.443 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.231 0 C-N-CA 122.669 2.246 . . . . 0.0 112.349 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.853 0.358 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.97 -65.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.951 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 10.1 tt -47.03 -41.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.4 mm-40 -64.54 -45.94 84.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -62.37 -33.06 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.145 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.1 mt -61.06 -48.2 82.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.408 ' CG ' ' HA ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -60.66 -43.47 97.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mtmm -60.88 -52.03 66.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.603 HG22 HD21 ' A' ' 80' ' ' LEU . 95.0 m -51.79 -48.3 63.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.09 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 18' ' ' LEU . 18.9 t -67.12 -36.47 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -54.69 -43.54 72.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.88 -50.99 60.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.569 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.7 t80 -42.71 -64.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.5 m-85 -43.7 -35.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 -36.87 66.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.711 ' HA ' HG12 ' A' ' 39' ' ' VAL . 13.9 t80 -66.79 -46.9 73.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.2 m -64.28 -40.01 95.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.733 ' CD1' HD11 ' A' ' 90' ' ' ILE . 16.2 t80 -69.71 -47.53 62.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.972 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 -28.98 64.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.434 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -47.64 68.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.863 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.08 73.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.0 -36.3 81.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 23.38 9.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.498 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.579 ' HE2' HG21 ' A' ' 40' ' ' VAL . 17.4 mtmt -92.37 178.36 5.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 m -107.42 17.63 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 p -152.82 163.5 39.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.213 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -77.46 146.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.155 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.579 HG21 ' HE2' ' A' ' 36' ' ' LYS . 64.4 t -118.29 133.81 23.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.448 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 96.2 t -70.82 112.06 11.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.577 0.703 . . . . 0.0 111.133 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.2 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -49.49 -49.9 43.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -45.51 -50.66 12.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -71.56 -55.56 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 40.1 mmm -49.84 -19.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.826 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 -35.37 42.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -78.95 -40.11 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.28 99.16 4.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.56 43.42 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 53' ' ' ALA . 12.2 p -118.45 -56.61 2.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.883 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.42 -36.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 52' ' ' SER . 6.2 t -152.48 123.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 56' ' ' VAL . 46.4 t -94.15 161.3 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.801 HG21 ' CD1' ' A' ' 65' ' ' PHE . 14.2 t -134.07 121.76 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.94 166.98 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.35 3.33 69.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.436 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 9.6 mt -76.09 152.68 84.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.685 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.7 Cg_endo -69.75 -172.77 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.626 2.217 . . . . 0.0 112.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.33 160.93 21.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.78 31.7 2.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.685 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -121.79 155.46 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.79 123.17 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 56' ' ' VAL . 78.8 t80 -35.55 119.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 11.8 ptpt -164.65 171.01 14.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.536 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 5.7 t-80 -41.76 140.94 1.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.553 0.692 . . . . 0.0 110.855 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 1.002 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.67 -2.95 10.99 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.385 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HA ' ' CG ' ' A' ' 19' ' ' ARG . 7.5 pt-20 -95.87 -21.83 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -78.13 -14.76 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.0 m-85 -84.77 119.02 24.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' THR . 2.8 m-20 -45.04 142.45 1.88 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 5.9 tp -36.49 -53.87 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.85 72.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 72' ' ' ASP . 65.0 m -64.93 -49.7 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.002 HD21 ' O ' ' A' ' 68' ' ' PRO . 13.7 mt -48.04 -50.49 27.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -51.13 -42.79 60.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.556 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.9 t90 -56.02 -56.11 24.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -46.04 -52.09 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.603 HD21 HG22 ' A' ' 21' ' ' THR . 27.4 mt -60.28 -33.0 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -67.85 -54.37 19.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -99.86 37.39 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.569 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -77.53 -45.23 26.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.47 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.69 -31.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' ILE . . . -83.97 -44.93 6.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLY . 23.9 mt -37.28 119.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 0.0 111.08 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -116.75 166.1 12.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.671 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.7 m-85 -133.92 123.8 25.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.71 111.18 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.733 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.09 113.26 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.498 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.9 mmtt -92.61 -29.59 16.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.433 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.85 139.66 0.36 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.578 0.704 . . . . 0.0 110.877 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.465 -0.171 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.836 0.35 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.75 -66.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.7 tt -49.15 -36.04 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.24 -42.64 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 m -65.22 -39.66 93.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.196 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.0 mt -58.24 -45.94 86.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -56.49 -33.36 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' N ' ' HE2' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -70.44 -57.96 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.638 HG22 HD21 ' A' ' 80' ' ' LEU . 9.9 m -40.37 -46.01 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.671 HG12 ' CE2' ' A' ' 26' ' ' PHE . 40.1 t -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 28.1 mt-10 -57.94 -41.91 83.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.45 -42.37 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.467 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 5.9 t80 -50.36 -60.57 2.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.671 ' CE2' HG12 ' A' ' 22' ' ' VAL . 19.0 m-85 -46.87 -37.45 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.0 m -69.56 -42.89 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.737 ' HA ' HG12 ' A' ' 39' ' ' VAL . 5.5 t80 -58.7 -56.79 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -53.73 -47.08 70.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.752 ' CD1' HD11 ' A' ' 90' ' ' ILE . 13.2 t80 -58.83 -68.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.69 -31.23 53.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.489 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.76 -42.23 82.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -28.04 65.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.87 -31.81 72.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.16 24.51 11.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.686 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.9 mtmt -93.86 179.96 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -109.47 20.93 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.7 p -155.42 159.58 39.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -73.28 144.65 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.686 HG21 ' HE2' ' A' ' 36' ' ' LYS . 93.4 t -122.39 138.36 29.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.733 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.631 ' HD2' HG13 ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.75 128.38 15.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 26' ' ' PHE . 69.9 t -72.29 111.87 12.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.612 0.72 . . . . 0.0 111.133 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 80.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.52 ' O ' ' C ' ' A' ' 45' ' ' GLU . 74.0 m-85 -54.96 -72.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.0 tp10 -28.03 -61.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -55.07 -49.13 72.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.957 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.561 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 56.9 mtp -57.32 -56.76 17.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 8.6 mt -40.41 -34.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -78.55 -42.33 29.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' MET . 2.4 m-20 -134.16 95.44 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -79.99 42.93 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.4 t -118.76 -57.85 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.58 -38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 90' ' ' ILE . 56.9 t -147.33 119.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.01 146.94 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.74 HG21 ' CD1' ' A' ' 65' ' ' PHE . 23.1 t -115.36 131.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -121.93 166.19 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.0 63.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.8 mt -92.45 158.06 39.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.606 0.717 . . . . 0.0 110.865 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.8 Cg_endo -69.77 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -96.22 164.33 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.93 13.99 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.526 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 64' ' ' ALA . 3.8 p -106.25 175.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.334 . . . . 0.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.731 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -156.55 117.89 3.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.03 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.74 ' CD1' HG21 ' A' ' 56' ' ' VAL . 84.4 t80 -33.67 124.87 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' CD ' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -169.33 179.48 3.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.8 t-80 -51.8 141.48 26.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 110.879 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.724 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.1 Cg_endo -69.8 -6.23 18.13 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.705 2.27 . . . . 0.0 112.362 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -93.23 -18.88 21.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.45 ' HB3' ' CD ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -79.92 -17.25 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.13 133.92 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' LEU . 0.6 OUTLIER -64.91 146.19 55.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.871 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 8.5 tp -37.66 -40.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.18 -53.98 51.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -59.67 -52.76 64.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.4 mt -39.29 -52.31 2.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -52.9 -48.93 66.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.554 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.2 t90 -50.22 -59.83 3.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.2 mt -41.02 -52.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.086 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.638 HD21 HG22 ' A' ' 21' ' ' THR . 20.4 mt -61.09 -37.1 81.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -62.64 -53.12 59.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -100.52 36.67 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' GLY . 56.8 pttt -80.41 -48.72 12.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.455 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.28 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.42 -33.71 7.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 15.1 mt -42.91 122.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.375 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -124.22 163.39 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.552 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.2 m-85 -131.48 124.56 30.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.81 110.66 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.67 113.44 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -91.32 -28.69 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.479 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.89 136.53 0.32 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.653 0.739 . . . . 0.0 110.844 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.342 0.204 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 -179.967 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.843 0.354 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.51 -64.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.824 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -48.64 -34.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -72.3 -45.26 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -60.78 -35.39 76.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 25.0 mt -62.2 -42.7 99.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -62.07 -41.97 98.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.78 -54.04 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.538 HG22 HD21 ' A' ' 80' ' ' LEU . 87.3 m -44.87 -49.81 10.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.799 HG12 ' CE2' ' A' ' 26' ' ' PHE . 53.4 t -67.8 -40.54 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 14.7 mt-10 -50.76 -47.47 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.47 -51.46 65.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.2 t80 -42.44 -63.92 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.928 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.799 ' CE2' HG12 ' A' ' 22' ' ' VAL . 28.0 m-85 -41.89 -38.89 1.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.2 m -66.78 -44.89 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.611 ' HA ' HG12 ' A' ' 39' ' ' VAL . 14.6 t80 -58.28 -50.9 71.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.2 m -59.3 -43.44 92.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.41 ' CE1' HD11 ' A' ' 90' ' ' ILE . 12.9 t80 -62.1 -63.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.41 -29.28 66.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 -43.13 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.352 . . . . 0.0 110.975 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -33.53 74.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.04 -34.23 75.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 28.35 8.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.663 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.3 mtmt -95.66 179.62 5.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 m -109.23 22.11 16.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.9 p -154.49 175.1 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -88.74 141.53 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.663 HG21 ' HE2' ' A' ' 36' ' ' LYS . 91.9 t -116.7 132.7 23.25 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.657 0.742 . . . . 0.0 111.163 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.0 Cg_endo -69.78 116.72 4.69 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.636 2.224 . . . . 0.0 112.37 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.481 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 46.3 t -67.25 112.28 9.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 79.5 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.709 2.272 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -51.3 -49.19 61.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -49.48 -48.99 47.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -68.34 -60.37 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.692 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 69.7 mtp -45.56 -35.45 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -58.8 -42.2 88.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.974 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -46.32 83.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -134.98 100.02 4.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -84.7 46.22 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.1 p -121.51 -44.61 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.12 -43.7 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.646 HG22 HG13 ' A' ' 90' ' ' ILE . 93.6 t -140.26 128.4 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 56' ' ' VAL . 88.4 t -100.94 158.58 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.084 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.718 HG13 ' CE1' ' A' ' 88' ' ' PHE . 21.6 t -131.76 119.1 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -103.16 178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.78 -0.33 88.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.422 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 59' ' ' LEU . 10.4 mt -77.07 153.84 82.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.723 . . . . 0.0 110.937 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.643 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.0 Cg_endo -69.82 -171.81 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.339 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -84.6 162.51 19.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.64 31.74 1.84 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 60' ' ' PRO . 6.0 p -119.15 161.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.098 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -140.9 119.29 12.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.149 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 48.6 t80 -34.48 131.17 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 11.4 ptpt -175.09 163.14 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.7 t-80 -36.73 141.31 0.39 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.863 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.883 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.77 -4.06 13.28 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.308 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -89.18 -27.03 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.72 -18.64 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-85 -80.97 111.34 17.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -42.69 145.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 11.0 tp -38.85 -46.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.32 82.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 50.2 m -63.16 -45.2 92.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.883 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.7 mt -48.64 -53.05 20.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -49.2 -45.55 44.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.56 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.6 t90 -54.55 -63.77 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -40.05 -50.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.538 HD21 HG22 ' A' ' 21' ' ' THR . 18.0 mt -62.11 -35.65 79.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' TRP . 10.3 mt-10 -65.32 -54.98 21.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -98.21 40.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 18.4 ptmt -82.68 -50.57 8.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 83' ' ' LYS . . . -35.07 -37.95 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.72 13.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.54 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 16.2 mt -37.9 124.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -126.47 169.98 12.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.718 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.6 m-85 -132.54 125.72 31.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.09 112.5 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -84.52 112.46 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.466 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.1 mmtp -91.51 -28.87 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.465 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.57 130.74 0.26 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.757 . . . . 0.0 110.898 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.42 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.742 2.295 . . . . 0.0 112.391 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.82 0.343 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -71.2 -47.88 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.1 tt -62.88 -32.76 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -76.39 -39.26 54.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 m -65.91 -35.82 81.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.61 HD12 ' CD1' ' A' ' 73' ' ' LEU . 19.4 mt -63.52 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.98 -39.25 81.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -66.01 -52.42 49.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.498 HG22 HD21 ' A' ' 80' ' ' LEU . 27.8 m -52.01 -48.36 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 26' ' ' PHE . 58.8 t -66.5 -38.51 81.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.162 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 13.3 mt-10 -56.75 -41.18 77.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.38 -47.91 62.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.402 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 7.2 t80 -44.59 -63.1 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.576 ' HB3' HG21 ' A' ' 42' ' ' VAL . 21.9 m-85 -43.31 -38.83 2.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.5 m -65.45 -46.02 81.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.556 ' HA ' HG12 ' A' ' 39' ' ' VAL . 10.3 t80 -56.61 -58.28 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 92.9 m -54.06 -40.75 67.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -64.61 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.65 -27.54 58.91 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.531 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -41.66 73.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.03 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.08 -33.99 77.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 25.77 8.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.485 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.673 ' HE2' HG21 ' A' ' 40' ' ' VAL . 12.4 mtmt -96.29 179.24 5.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.93 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.4 7.75 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.5 p -140.31 167.79 21.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -80.35 148.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 ' HE2' ' A' ' 36' ' ' LYS . 87.2 t -127.1 135.51 27.49 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.642 0.734 . . . . 0.0 111.1 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.541 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.79 121.02 7.71 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.74 2.293 . . . . 0.0 112.32 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 26' ' ' PHE . 57.3 t -66.69 112.09 8.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 79.68 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.698 2.265 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' MET . 95.1 m-85 -47.43 -71.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 44' ' ' TYR . 7.7 tp10 -29.42 -59.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -60.13 -40.22 89.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 44' ' ' TYR . 28.0 mmm -64.08 -50.06 69.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 15.5 mt -51.22 -37.2 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -90.29 -26.89 19.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -135.0 77.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -72.52 -40.61 66.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -43.2 -57.28 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -33.02 -39.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.088 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 HG13 ' A' ' 90' ' ' ILE . 13.6 t -148.93 119.92 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.93 152.95 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.886 HG21 ' CD1' ' A' ' 65' ' ' PHE . 31.4 t -121.68 124.56 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -116.52 160.75 20.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.81 10.05 59.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.449 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 59' ' ' LEU . 13.2 mt -85.02 157.83 59.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.4 Cg_endo -69.82 -167.51 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 9.0 tp10 -96.06 156.25 16.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 56.68 18.17 23.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.558 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.569 HG11 ' HD2' ' A' ' 60' ' ' PRO . 9.7 p -109.12 166.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.072 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.528 ' N ' HG22 ' A' ' 63' ' ' VAL . . . -144.37 113.04 6.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.886 ' CD1' HG21 ' A' ' 56' ' ' VAL . 29.1 t80 -34.24 111.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.4 ptpt -156.69 -178.87 7.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.3 t-80 -48.81 141.43 10.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.629 0.728 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.956 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.1 Cg_endo -69.67 -7.31 20.69 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.756 2.304 . . . . 0.0 112.379 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -91.95 -19.92 21.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -81.48 -16.58 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.9 m-85 -84.44 120.13 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.5 OUTLIER -49.66 143.68 6.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.61 ' CD1' HD12 ' A' ' 18' ' ' LEU . 7.9 tp -37.48 -46.06 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.19 80.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 72' ' ' ASP . 61.8 m -67.08 -50.66 60.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.073 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.956 HD21 ' O ' ' A' ' 68' ' ' PRO . 19.5 mt -42.88 -51.82 5.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -52.22 -47.09 65.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.551 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -52.0 -62.25 1.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.5 mt -39.25 -53.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 21' ' ' THR . 20.8 mt -59.61 -39.78 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.66 -54.4 45.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -99.87 38.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.821 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' GLY . 55.4 pttt -80.67 -51.22 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -37.76 -27.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.127 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -90.17 -35.62 7.49 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.54 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.3 mt -43.27 123.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 111.067 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.1 m -121.83 168.75 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 56' ' ' VAL . 9.4 m-85 -136.01 121.34 19.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.07 111.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.64 112.84 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -92.04 -29.77 16.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.466 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.91 134.2 0.29 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.571 0.7 . . . . 0.0 110.846 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 52.9 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 122.61 2.206 . . . . 0.0 112.349 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t -88.95 153.09 21.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.916 0.388 . . . . 0.0 110.804 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -108.14 -59.37 1.86 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.53 52.02 0.66 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.4 m -45.69 121.07 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.934 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 m -109.93 108.42 18.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.41 -139.35 1.48 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 30.6 ttp -123.37 153.7 39.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -53.51 149.62 7.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.682 ' O ' HG12 ' A' ' 13' ' ' VAL . 5.4 p -73.5 -34.84 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.141 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.85 -16.43 59.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -54.52 -46.23 73.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 10' ' ' VAL . 2.5 p -54.07 -17.51 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.177 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.61 -63.29 1.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 12' ' ' ALA . 8.0 tt -49.64 -31.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.211 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -76.48 -40.1 51.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 m -67.11 -35.33 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 22' ' ' VAL . 28.3 mt -64.72 -45.24 87.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.927 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -58.08 -34.81 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -67.15 -50.83 59.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.401 HG22 HD21 ' A' ' 80' ' ' LEU . 6.9 m -51.22 -48.2 62.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.563 HG12 ' CE2' ' A' ' 26' ' ' PHE . 11.7 t -65.77 -36.12 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.107 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.03 -42.65 94.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.99 -49.61 49.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.574 ' CE1' ' CE ' ' A' ' 83' ' ' LYS . 6.8 t80 -41.93 -64.25 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.563 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.6 m-85 -42.01 -34.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.4 m -72.69 -36.73 67.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.717 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.2 t80 -67.39 -48.68 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.0 m -63.58 -39.81 95.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.691 ' CD1' HD11 ' A' ' 90' ' ' ILE . 13.1 t80 -67.62 -52.57 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.64 -29.02 72.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -44.87 72.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.72 -27.61 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.38 -33.16 75.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.67 20.48 19.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -92.71 179.12 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.1 p -108.53 20.05 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -151.8 164.16 37.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.4 m -80.72 142.07 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.5 HG13 ' HD2' ' A' ' 41' ' ' PRO . 40.2 t -115.63 135.96 22.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.77 117.91 5.37 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.409 HG13 ' SD ' ' A' ' 47' ' ' MET . 92.3 t -73.24 112.07 14.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 80.49 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.686 2.257 . . . . 0.0 112.289 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -53.04 -47.51 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -50.34 -44.83 54.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.947 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -74.32 -59.27 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.566 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 59.3 mtp -45.7 -33.59 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.1 mt -60.46 -48.32 82.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -73.39 -36.29 66.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -128.33 97.93 4.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.797 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -95.13 47.14 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 p -124.52 -41.51 2.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.812 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.89 25.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.064 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 90' ' ' ILE . 25.5 t -149.87 126.0 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 56' ' ' VAL . 46.6 t -98.42 158.4 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.75 HG21 ' CD1' ' A' ' 65' ' ' PHE . 44.5 t -128.13 126.51 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -120.49 165.32 15.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.16 10.82 68.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.6 mt -84.22 155.76 63.41 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.542 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.2 Cg_endo -69.76 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 0.0 112.376 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.57 158.03 15.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.2 17.26 23.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 64' ' ' ALA . 3.4 p -108.61 175.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.136 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.719 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -157.01 120.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.75 ' CD1' HG21 ' A' ' 56' ' ' VAL . 84.6 t80 -34.79 119.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HZ3' ' HE1' ' A' ' 71' ' ' TYR . 11.2 ptpp? -166.56 170.5 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -45.45 141.65 3.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.528 0.68 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.84 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.75 -1.06 7.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 0.0 112.366 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.19 -17.48 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.2 -14.89 57.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.423 ' HE1' ' HZ3' ' A' ' 66' ' ' LYS . 23.6 m-85 -88.33 135.39 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 149.2 47.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.45 HD11 ' CD1' ' A' ' 18' ' ' LEU . 6.8 tp -40.47 -39.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.22 23.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.4 m -59.17 -45.6 90.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.9 mt -46.27 -49.59 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -55.68 -43.79 76.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.542 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 60.1 t90 -53.28 -60.15 3.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.2 mt -41.62 -53.63 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 21' ' ' THR . 23.8 mt -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.99 -53.85 43.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -100.49 35.13 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.574 ' CE ' ' CE1' ' A' ' 25' ' ' TYR . 21.1 ptmt -74.19 -52.59 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.93 -30.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.066 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -84.96 -37.85 9.79 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 19.4 mt -45.52 124.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 0.0 111.058 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -124.71 168.75 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 56' ' ' VAL . 5.9 m-85 -135.72 129.46 32.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.01 112.0 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.691 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.0 113.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.1 mmtt -91.0 -29.73 17.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.475 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.93 135.29 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.6 Cg_endo -69.86 129.75 18.04 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.294 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -48.82 160.09 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.8 mt -86.17 117.68 25.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -165.02 142.54 5.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.676 0.751 . . . . 0.0 110.881 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 137.27 35.06 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.716 2.277 . . . . 0.0 112.403 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -65.48 169.78 5.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -108.64 139.48 43.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -70.14 150.4 46.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.71 128.81 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.114 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.75 -96.79 1.14 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.42 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.44 125.16 5.16 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.56 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.8 t -92.76 157.94 16.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 110.849 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.35 68.39 0.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.447 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 118.69 5.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.411 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.6 m -135.94 170.8 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 85.6 p -113.47 154.99 26.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.859 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.477 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -43.35 -58.24 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.937 0.399 . . . . 0.0 110.885 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 t -95.29 152.5 18.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.955 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.64 -161.32 31.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.2 m -78.51 127.19 31.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.972 0.415 . . . . 0.0 110.844 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 m -108.3 168.1 9.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.61 -46.15 2.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 8.8 ttt -103.73 169.93 8.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.37 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 m -101.82 163.83 12.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 13' ' ' VAL . 8.7 p -70.95 -40.09 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 10' ' ' VAL . 2.2 m-20 -80.94 -11.28 59.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.03 -43.02 86.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.09 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.2 p -58.53 -30.66 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.175 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.09 -65.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 tt -50.4 -32.15 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -76.27 -36.91 58.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -70.96 -34.52 71.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.508 HD12 ' CD1' ' A' ' 73' ' ' LEU . 17.1 mt -62.79 -47.45 83.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.949 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -54.99 -41.33 71.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -67.16 -51.58 52.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.607 HG22 HD21 ' A' ' 80' ' ' LEU . 91.6 m -49.03 -48.4 43.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.109 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 26' ' ' PHE . 86.3 t -67.69 -37.02 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.446 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 13.8 mt-10 -56.05 -43.05 77.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -65.68 -49.51 68.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.586 ' CD1' ' HE3' ' A' ' 83' ' ' LYS . 8.7 t80 -44.12 -64.19 0.72 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.538 ' CE2' HG12 ' A' ' 22' ' ' VAL . 26.5 m-85 -42.8 -39.83 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.537 ' HA ' HG12 ' A' ' 39' ' ' VAL . 21.2 t80 -65.28 -56.64 11.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.1 m -54.05 -40.47 67.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.578 ' CD1' HD11 ' A' ' 90' ' ' ILE . 14.8 t80 -65.78 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.19 -25.02 61.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.541 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.13 -42.16 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.68 67.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.091 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -62.69 -34.83 77.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.47 24.03 9.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.545 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.523 ' HE2' HG21 ' A' ' 40' ' ' VAL . 8.7 mtmt -92.35 -179.97 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 t -109.87 19.3 19.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -154.09 161.87 41.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.3 m -74.77 144.35 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.523 HG21 ' HE2' ' A' ' 36' ' ' LYS . 40.5 t -119.46 136.08 24.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.598 0.713 . . . . 0.0 111.135 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.3 Cg_endo -69.71 118.5 5.72 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.662 2.242 . . . . 0.0 112.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.4 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 94.3 t -70.42 111.99 11.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . 53.5 Cg_endo -69.81 79.97 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -55.88 -47.16 77.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -51.27 -46.4 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HD2' ' CB ' ' A' ' 43' ' ' PRO . 44.6 mttt -71.7 -55.56 7.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.469 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 80.1 mtp -50.33 -31.97 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.48 -30.43 71.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -86.03 -38.49 17.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -133.18 94.65 3.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.2 40.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' VAL . 22.1 p -113.36 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -32.95 -35.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 90' ' ' ILE . 19.0 t -148.78 143.32 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.477 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 58.7 t -118.04 139.9 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 65' ' ' PHE . 22.9 t -109.17 125.71 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -120.03 158.85 25.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.12 15.35 45.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.504 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.6 mt -87.12 154.34 54.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.936 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.621 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.9 Cg_endo -69.68 -168.68 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -86.99 164.42 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.79 29.1 0.75 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.437 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.621 HG11 ' HD2' ' A' ' 60' ' ' PRO . 4.0 p -117.84 156.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -139.15 118.26 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 56' ' ' VAL . 83.3 t80 -34.11 117.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.7 ptpt -164.33 174.41 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.524 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -44.86 140.75 3.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.721 . . . . 0.0 110.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.882 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.6 Cg_endo -69.75 2.28 3.66 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -97.18 -22.04 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -81.17 -12.45 59.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.7 m-85 -88.2 117.7 27.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' LEU . 2.0 m-20 -49.02 144.03 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.508 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.2 tp -35.72 -50.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.29 -51.14 63.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -60.98 -46.65 89.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.882 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.1 mt -47.53 -54.96 10.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.938 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -48.56 -47.93 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.2 t90 -48.64 -61.62 1.94 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.2 mt -41.14 -52.42 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.607 HD21 HG22 ' A' ' 21' ' ' THR . 29.4 mt -59.49 -37.82 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.56 -55.27 25.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -99.73 37.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.586 ' HE3' ' CD1' ' A' ' 25' ' ' TYR . 16.6 ptmt -72.85 -53.92 10.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.17 -33.4 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.055 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.65 -33.28 38.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 25.0 mt -53.19 126.05 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.5 m -123.91 169.06 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.828 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.554 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.1 m-85 -136.42 126.41 26.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.04 109.61 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.17 112.98 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.477 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.4 mmtp -92.05 -31.28 15.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.591 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.72 129.96 0.28 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.875 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.461 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.74 119.44 6.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 0.0 112.323 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' PRO . 32.0 m-85 -35.02 148.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 94' ' ' PHE . 15.3 mt -36.17 136.91 0.28 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.467 ' CG ' ' HD2' ' A' ' 97' ' ' PRO . 30.0 tt0 -102.48 139.94 20.67 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.579 0.705 . . . . 0.0 110.919 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 96' ' ' GLU . 54.1 Cg_endo -69.72 165.55 30.53 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.79 2.327 . . . . 0.0 112.327 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -45.24 -44.75 11.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -110.67 105.53 14.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.957 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.854 ' CE1' HG22 ' A' ' 101' ' ' VAL . 5.1 p-80 -48.74 -41.68 32.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.854 HG22 ' CE1' ' A' ' 100' ' ' HIS . 29.5 m -130.56 90.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.52 141.85 22.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.05 148.68 23.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.0 p -130.22 -46.88 1.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.001 0.429 . . . . 0.0 110.898 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 121.49 84.32 0.75 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.464 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 2.83 3.18 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.648 2.232 . . . . 0.0 112.389 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.7 t -110.74 112.17 23.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.808 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.0 m -112.54 128.91 56.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.505 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p -91.75 108.79 20.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.88 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -72.36 96.82 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.91 -136.61 9.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -106.46 -46.09 4.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 0.0 110.862 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.5 t -47.46 97.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.849 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.92 -42.34 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 4.4 ttt -119.87 108.61 14.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.1 p -76.56 152.64 35.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.86 -38.23 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -86.58 7.84 24.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.98 -42.46 76.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.1 p -63.02 -29.21 46.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.129 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.49 -63.62 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 9.6 tt -51.13 -38.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.7 mm-40 -68.78 -46.03 69.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 m -61.56 -33.44 73.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 19.1 mt -59.25 -47.48 85.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.452 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -58.85 -47.68 84.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -54.53 -52.62 61.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.505 HG22 HD21 ' A' ' 80' ' ' LEU . 24.6 m -51.46 -48.38 62.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.535 HG12 ' CE2' ' A' ' 26' ' ' PHE . 23.7 t -67.72 -37.41 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -56.41 -36.92 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.94 -47.9 27.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.3 t80 -44.34 -63.06 0.96 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.535 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.3 m-85 -41.92 -34.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.1 m -71.83 -38.91 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.746 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.7 t80 -64.8 -47.52 77.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 65.3 m -65.56 -41.75 92.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.744 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.7 t80 -66.7 -47.91 70.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.98 -32.67 63.21 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -42.31 93.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.42 -31.3 70.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -61.71 -36.1 79.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.41 10.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.474 ' HE2' HG21 ' A' ' 40' ' ' VAL . 18.8 mtmt -94.28 179.31 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.0 p -108.65 21.01 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.0 p -155.76 162.27 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.746 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.0 m -76.12 155.41 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.474 HG21 ' HE2' ' A' ' 36' ' ' LYS . 41.5 t -132.87 135.0 25.21 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.663 0.744 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.1 Cg_endo -69.77 118.55 5.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 0.0 112.286 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 81.3 t -67.0 117.81 49.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 111.122 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 80.01 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -50.57 -53.11 32.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 2.6 tp10 -43.16 -56.21 3.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 10.3 mptt -65.79 -56.1 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 41.0 mmm -50.06 -23.52 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.826 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.24 -30.41 57.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.955 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -84.52 -42.12 15.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.33 94.54 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -81.69 47.63 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.915 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -125.18 -56.07 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.72 -36.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 90' ' ' ILE . 16.1 t -149.69 119.77 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.471 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 19.9 t -95.86 154.85 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.817 HG13 ' CE1' ' A' ' 88' ' ' PHE . 5.0 t -125.69 119.53 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -112.04 158.93 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.41 13.24 42.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.1 mt -85.89 156.97 57.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.667 0.746 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.621 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.4 Cg_endo -69.8 -172.16 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -86.53 158.87 19.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.39 28.7 9.8 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 64' ' ' ALA . 4.2 p -118.69 171.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.635 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -154.66 120.31 5.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 56' ' ' VAL . 82.4 t80 -35.15 121.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -167.31 170.58 11.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.3 t-80 -39.75 141.01 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.65 0.738 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 1.0 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.71 -9.54 26.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -91.19 -16.81 27.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -82.82 -13.88 55.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CD2' HD11 ' A' ' 79' ' ' ILE . 21.9 m-85 -87.39 121.06 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.03 147.67 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 7.0 tp -40.01 -48.8 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.41 -44.73 84.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -63.42 -57.79 9.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.0 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.0 mt -39.44 -47.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -55.05 -46.55 75.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.56 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.5 t90 -54.5 -58.81 6.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.523 HD11 ' CD2' ' A' ' 71' ' ' TYR . 49.4 mt -41.52 -53.76 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 21' ' ' THR . 14.2 mt -61.1 -40.5 93.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -55.61 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -97.93 35.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 51.8 pttt -77.63 -49.77 13.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.82 -26.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -91.24 -39.1 5.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' LYS . 28.4 mt -43.22 122.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 111.149 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -120.49 162.73 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.817 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.3 m-85 -128.25 126.48 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.5 110.35 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.744 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.41 113.17 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 19.5 mmtt -91.45 -28.12 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.474 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 134.5 0.31 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.632 0.73 . . . . 0.0 110.842 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.422 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.8 128.9 16.65 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.612 2.208 . . . . 0.0 112.392 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.557 ' CE2' ' HB3' ' A' ' 46' ' ' LYS . 72.6 m-85 -50.79 149.4 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.09 120.54 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -106.08 125.89 31.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 0.0 110.931 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 176.63 6.52 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.734 2.289 . . . . 0.0 112.314 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -66.04 154.62 39.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -86.93 152.09 22.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.884 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -138.69 148.91 44.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.2 m -62.93 139.38 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.84 -159.08 18.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.515 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.59 62.29 1.4 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.442 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 t -121.12 128.13 52.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.82 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -75.45 -159.65 8.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.428 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 134.91 29.09 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.687 2.258 . . . . 0.0 112.351 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.7 p -136.66 174.97 10.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.1 t -172.05 108.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.51 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -126.84 101.21 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.845 0.355 . . . . 0.0 110.866 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -143.57 128.03 17.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.899 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.56 -166.52 12.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 m -125.79 146.18 49.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 110.778 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -124.79 97.29 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.11 -179.42 39.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.517 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 148.87 37.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.801 0.334 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.6 m -149.44 175.96 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 11' ' ' ASP . 7.1 p -74.34 -43.02 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.106 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' N ' HG13 ' A' ' 10' ' ' VAL . 14.4 m-20 -81.72 -10.86 59.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.42 73.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.096 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 10' ' ' VAL . 2.7 p -52.78 -21.73 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.47 -65.05 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tt -49.66 -31.01 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -76.6 -40.15 50.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -66.8 -34.44 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.51 HD12 ' CD1' ' A' ' 73' ' ' LEU . 20.6 mt -63.54 -41.39 98.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -64.44 -39.09 93.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -41.6 77.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.511 HG22 HD21 ' A' ' 80' ' ' LEU . 90.0 m -59.78 -49.03 79.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.551 HG12 ' CE2' ' A' ' 26' ' ' PHE . 96.1 t -65.36 -37.34 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.084 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -54.85 -39.14 68.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.92 -52.16 32.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 10.0 t80 -42.34 -62.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.716 ' HB3' HG21 ' A' ' 42' ' ' VAL . 21.4 m-85 -43.78 -40.74 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 m -68.32 -37.83 80.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.75 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -66.47 -47.0 74.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.5 m -64.1 -40.94 97.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.97 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.928 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.9 t80 -66.61 -56.71 9.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.23 -29.84 74.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.464 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -42.25 75.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.745 0.307 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -26.52 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.092 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.5 mt -67.6 -30.9 70.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 23.09 13.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.735 ' HE2' HG21 ' A' ' 40' ' ' VAL . 14.6 mtmt -95.77 178.85 5.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.347 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -107.7 6.06 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.2 p -136.95 160.96 37.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.3 m -79.35 136.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.735 HG21 ' HE2' ' A' ' 36' ' ' LYS . 55.0 t -112.76 137.8 21.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 0.0 111.137 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.584 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.74 125.76 12.53 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.672 2.248 . . . . 0.0 112.383 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 26' ' ' PHE . 61.7 t -71.13 111.93 11.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.619 0.723 . . . . 0.0 111.169 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 80.44 0.89 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.674 2.249 . . . . 0.0 112.326 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -53.02 -53.21 53.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -47.42 -52.03 18.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -65.86 -61.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.551 ' HE1' ' CZ ' ' A' ' 65' ' ' PHE . 79.4 mtp -43.54 -37.95 2.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.5 mt -55.31 -40.26 70.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -82.26 -39.52 22.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -126.16 80.24 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -68.19 -20.63 64.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.2 t -62.25 -57.14 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -31.79 -36.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' SER . 15.0 t -151.53 121.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 91' ' ' LYS . 20.8 t -100.02 157.78 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 65' ' ' PHE . 23.7 t -125.53 123.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -117.36 153.24 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.46 39.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 59' ' ' LEU . 12.3 mt -84.85 155.73 61.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.623 0.725 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.666 ' O ' HG12 ' A' ' 63' ' ' VAL . 52.8 Cg_endo -69.86 178.86 4.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.297 . . . . 0.0 112.311 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.18 154.61 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.08 23.21 51.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.543 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -116.61 164.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.161 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -144.59 117.95 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.746 ' CD1' HG21 ' A' ' 56' ' ' VAL . 64.1 t80 -34.65 120.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -167.11 171.48 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -42.96 141.89 1.57 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.88 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.3 Cg_endo -69.77 -4.88 14.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.319 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.92 -14.27 26.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -85.21 -12.38 52.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.54 128.38 36.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 73' ' ' LEU . 4.5 m-20 -56.63 145.81 27.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.9 tp -36.19 -48.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.74 62.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -58.89 -46.38 87.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.88 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.2 mt -47.61 -47.99 28.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.985 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -55.1 -48.58 73.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.841 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.3 t90 -49.21 -60.56 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.6 mt -40.74 -53.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.511 HD21 HG22 ' A' ' 21' ' ' THR . 23.3 mt -58.73 -38.78 79.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -62.98 -55.42 25.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -99.48 38.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.9 pttp -77.39 -45.42 25.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.476 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -44.06 -35.89 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.07 -35.27 31.05 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 mt -49.51 123.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -126.09 167.6 15.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.54 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.6 m-85 -132.83 128.43 36.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.69 111.06 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.928 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.88 112.52 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HE3' HG21 ' A' ' 55' ' ' VAL . 22.3 mmtt -89.94 -33.3 16.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.17 129.6 0.26 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 110.835 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.44 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.7 Cg_endo -69.65 122.33 9.04 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.732 2.288 . . . . 0.0 112.371 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 93' ' ' PRO . 37.2 m-85 -37.41 153.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.8 mt -64.33 145.06 56.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -159.16 149.95 15.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.729 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 167.59 24.07 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.673 2.249 . . . . 0.0 112.331 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.438 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 1.3 ptpp? -108.3 27.51 9.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -129.33 148.6 51.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.826 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -105.71 -61.34 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.7 m -99.04 152.27 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.05 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -176.45 -59.67 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.528 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.94 158.67 22.98 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.519 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.9 p -112.68 -46.97 3.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 110.879 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.27 145.29 12.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.529 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 -50.83 0.44 Allowed 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 122.7 2.267 . . . . 0.0 112.32 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.2 p -48.72 -55.75 10.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t -82.84 85.16 7.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -133.17 -47.56 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.846 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -60.67 140.7 57.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.834 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.33 63.7 0.43 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.545 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.2 p -74.64 172.02 12.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 110.864 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 p -73.28 82.08 1.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.48 -144.67 16.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.4 mmt -80.16 128.38 33.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.6 t -75.71 165.74 24.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.64 -40.85 84.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -82.09 -7.03 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.8 -46.37 78.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p -57.94 -16.6 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.5 -57.33 3.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 5.5 tt -54.48 -46.11 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.082 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.549 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.3 mt-10 -63.48 -48.61 76.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 m -57.2 -30.89 64.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 28.6 mt -64.54 -48.64 74.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.697 ' HD2' HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -58.18 -42.07 85.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -39.02 92.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.6 HG22 HD21 ' A' ' 80' ' ' LEU . 48.5 m -64.33 -49.4 71.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.643 HG12 ' CE2' ' A' ' 26' ' ' PHE . 94.5 t -66.69 -39.49 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -53.36 -43.22 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.11 -49.68 69.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 12.5 t80 -45.99 -63.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.643 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.0 m-85 -44.18 -40.4 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.7 m -65.25 -38.3 89.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.603 ' HA ' HG12 ' A' ' 39' ' ' VAL . 31.3 t80 -66.64 -59.6 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -51.49 -37.57 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.58 ' CE1' HD11 ' A' ' 90' ' ' ILE . 17.0 t80 -69.71 -64.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.18 57.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.87 -45.95 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.43 67.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mt -62.71 -33.17 74.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.86 23.43 11.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.65 ' HE2' HG21 ' A' ' 40' ' ' VAL . 10.2 mtmt -94.35 179.11 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -109.54 20.21 18.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.8 p -154.16 159.67 41.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.603 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.3 m -76.58 138.71 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.65 HG21 ' HE2' ' A' ' 36' ' ' LYS . 51.0 t -114.58 137.67 22.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.664 0.745 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.569 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.8 120.82 7.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.611 2.207 . . . . 0.0 112.349 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 58.7 t -73.72 111.96 14.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.738 . . . . 0.0 111.148 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 79.83 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.715 2.277 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -51.43 -45.2 62.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -54.36 -40.25 67.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -74.38 -59.62 2.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.625 ' HE2' ' CE2' ' A' ' 65' ' ' PHE . 92.5 mtp -47.38 -46.19 25.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -43.92 -46.96 8.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -80.77 -39.81 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -127.48 81.64 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -72.28 -30.96 65.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' ALA . 24.0 p -45.01 -50.07 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -36.14 -45.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.515 HG22 HG13 ' A' ' 90' ' ' ILE . 14.4 t -144.7 128.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.49 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 35.0 t -99.64 142.98 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 65' ' ' PHE . 39.6 t -116.56 112.66 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -102.49 162.63 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.6 0.78 64.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.6 mt -75.55 149.35 83.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.603 0.716 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.815 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.3 Cg_endo -69.81 178.47 4.57 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.685 2.257 . . . . 0.0 112.339 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.86 160.21 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.74 19.77 10.97 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -112.94 169.82 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.962 ' CD1' HG21 ' A' ' 56' ' ' VAL . 72.8 t80 -34.31 113.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -159.78 171.06 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.2 t-80 -42.15 141.24 1.42 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.92 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.8 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 0.0 112.378 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.59 -15.11 31.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.07 -7.15 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -91.29 121.25 32.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.82 147.16 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.82 -47.35 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.11 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.5 m -66.77 -57.51 6.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.92 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.9 mt -39.41 -48.32 1.91 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -55.99 -48.23 76.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.8 t90 -49.16 -57.71 6.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -43.1 -52.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.6 HD21 HG22 ' A' ' 21' ' ' THR . 21.6 mt -59.77 -38.28 81.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.23 -55.78 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -97.8 40.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.852 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.59 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 16.7 ptmt -80.05 -53.57 6.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.929 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -36.27 -33.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -83.29 -37.54 12.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 14.4 mt -44.14 125.83 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 t -124.34 162.99 22.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.614 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.9 m-85 -131.77 126.2 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.2 111.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.667 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.23 113.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.185 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.49 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.0 mmtt -93.18 -31.24 14.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.51 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.89 125.71 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 0.0 110.872 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.1 Cg_endo -69.73 119.33 6.29 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -37.83 157.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.97 121.11 9.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -146.78 149.41 36.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.66 0.743 . . . . 0.0 110.815 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -173.69 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.691 2.26 . . . . 0.0 112.372 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -91.78 161.76 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -123.05 157.08 33.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -146.17 170.6 16.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.6 t -93.9 118.66 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.158 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.56 153.29 20.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.34 -162.63 36.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.576 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.4 t -122.93 -61.16 1.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.14 141.05 15.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.457 ' O ' ' C ' ' A' ' 107' ' ' SER . 54.3 Cg_endo -69.73 -20.72 34.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 106' ' ' PRO . 24.9 p -33.9 131.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.832 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.1 t -118.43 -178.98 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.853 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.546 -179.905 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.3 p -168.54 150.16 4.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.35 . . . . 0.0 110.852 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -158.03 174.88 14.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 5' ' ' SER . . . -162.8 76.64 0.17 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.496 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 4' ' ' GLY . 3.3 m -35.65 -62.37 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.822 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.7 p -66.49 88.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.95 -118.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.476 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.01 146.06 31.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.937 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -65.02 171.54 3.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.6 p -73.1 -35.79 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.54 -5.14 59.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.58 -43.67 89.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.174 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' VAL . 4.4 p -61.07 -12.84 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.147 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.9 -57.94 3.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 8.2 tt -50.83 -42.65 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.115 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.7 mt-10 -66.31 -43.23 86.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 m -63.28 -32.94 74.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 27.3 mt -61.41 -45.92 92.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.453 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -59.42 -50.14 75.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -47.78 70.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 HD21 ' A' ' 80' ' ' LEU . 24.3 m -55.25 -49.03 73.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.552 HG12 ' CE2' ' A' ' 26' ' ' PHE . 59.6 t -67.78 -36.1 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.438 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 15.3 mt-10 -57.75 -45.26 86.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -65.95 -47.98 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.406 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.4 t80 -44.87 -59.4 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.552 ' CE2' HG12 ' A' ' 22' ' ' VAL . 20.1 m-85 -46.71 -39.3 11.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.1 m -65.52 -39.9 92.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.79 ' HA ' HG12 ' A' ' 39' ' ' VAL . 12.6 t80 -64.49 -54.12 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.821 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.48 ' CB ' ' CD1' ' A' ' 88' ' ' PHE . 35.5 m -58.13 -43.86 87.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -63.15 -58.66 6.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.38 -27.86 72.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.31 -41.27 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.15 -32.65 69.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.129 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.52 -26.26 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.91 24.1 21.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.521 ' CE ' HG21 ' A' ' 40' ' ' VAL . 15.1 mtmt -96.86 177.21 5.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.6 p -109.24 22.68 15.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.0 p -153.26 165.59 35.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.0 m -84.54 140.46 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.127 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 41' ' ' PRO . 43.6 t -117.82 137.39 24.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.79 114.0 3.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.496 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 82.7 t -71.52 113.6 21.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.649 0.738 . . . . 0.0 111.076 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.427 ' CB ' ' CE ' ' A' ' 46' ' ' LYS . 54.3 Cg_endo -69.74 80.73 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 0.0 112.352 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -52.15 -45.21 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -49.46 -46.55 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' CE ' ' CB ' ' A' ' 43' ' ' PRO . 43.7 mtmt -75.69 -52.83 9.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.619 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 38.5 mtp -51.81 -21.44 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -76.67 -33.27 58.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -34.68 57.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -136.92 109.82 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -97.58 40.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 p -117.61 -41.93 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -48.93 -43.74 39.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.142 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG22 HG13 ' A' ' 90' ' ' ILE . 9.0 t -146.32 124.93 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.466 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 40.0 t -97.76 149.38 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.158 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.873 HG21 ' CD1' ' A' ' 65' ' ' PHE . 98.9 t -118.67 116.56 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.682 ' CD ' HD12 ' A' ' 89' ' ' ILE . 2.2 mp0 -100.74 -179.6 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.33 4.32 73.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.442 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.6 mt -78.11 154.02 79.9 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.67 0.748 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.643 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.8 Cg_endo -69.71 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.715 2.277 . . . . 0.0 112.341 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -87.26 160.16 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.45 29.07 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.643 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.8 p -119.18 167.65 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.529 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.59 126.78 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.063 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.873 ' CD1' HG21 ' A' ' 56' ' ' VAL . 78.4 t80 -35.95 130.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HZ2' ' HE1' ' A' ' 71' ' ' TYR . 8.5 ptpp? -174.44 172.77 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.5 t-80 -47.18 140.99 6.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.558 0.694 . . . . 0.0 110.883 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.987 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.4 Cg_endo -69.73 -7.26 20.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' OE2' ' ND1' ' A' ' 67' ' ' HIS . 5.2 pt-20 -93.09 -17.28 24.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.69 -15.72 53.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.426 ' HE1' ' HZ2' ' A' ' 66' ' ' LYS . 26.1 m-85 -85.05 131.8 34.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.0 OUTLIER -56.44 147.21 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.43 -49.12 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.19 79.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 26.6 m -71.15 -51.54 24.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 68' ' ' PRO . 12.2 mt -45.29 -54.17 7.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.417 ' HE2' HD11 ' A' ' 73' ' ' LEU . 17.9 mttm -49.67 -47.44 50.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.536 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.0 t90 -49.12 -55.87 10.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.9 mt -45.37 -54.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.524 HD21 HG22 ' A' ' 21' ' ' THR . 23.3 mt -59.45 -34.27 72.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.948 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.26 -52.31 55.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -101.92 33.82 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 86' ' ' ILE . 55.8 pttt -76.47 -45.29 31.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.58 -25.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.72 -30.24 9.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 83' ' ' LYS . 20.0 mt -49.57 122.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.8 m -121.82 170.26 9.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 29' ' ' CYS . 6.1 m-85 -128.89 116.13 18.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.682 HD12 ' CD ' ' A' ' 57' ' ' GLN . 9.2 mt -103.83 93.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.166 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.641 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -71.39 114.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.466 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.2 mmtp -93.68 -30.07 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.456 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 128.45 0.27 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.611 0.72 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.453 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 54.1 Cg_endo -69.83 124.82 11.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.383 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.415 ' C ' ' O ' ' A' ' 93' ' ' PRO . 26.5 m-85 -37.24 156.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.4 mt -50.27 156.81 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -118.53 143.38 33.22 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.627 0.727 . . . . 0.0 110.914 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 177.33 5.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.305 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -74.3 -62.38 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -124.8 179.18 5.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -174.98 128.36 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.5 t -135.85 110.75 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.34 170.54 16.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.451 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.33 165.28 24.45 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.464 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.1 p -123.3 -57.97 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.815 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.73 175.7 14.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.482 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 88.14 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.694 2.262 . . . . 0.0 112.347 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.9 t -41.68 117.83 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.3 m -144.17 126.26 15.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.824 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.531 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 p -106.56 112.49 25.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.379 . . . . 0.0 110.826 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 t -145.83 137.92 25.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.04 39.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.47 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.4 t -130.85 170.69 14.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -42.78 144.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.8 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.89 -54.56 0.21 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 14.6 mmt -81.69 137.71 35.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.347 . . . . 0.0 110.828 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 74.8 m -69.84 168.83 14.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 13' ' ' VAL . 7.5 p -61.35 -44.52 98.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.124 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.458 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -80.36 -9.12 59.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 9' ' ' SER . . . -61.85 -46.63 88.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.071 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 10' ' ' VAL . 5.7 p -57.31 -36.37 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -62.2 -68.85 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.9 tt -48.52 -34.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.51 -40.41 64.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -66.05 -38.04 87.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 27.6 mt -59.61 -45.8 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -58.27 -40.67 82.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.842 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -45.74 73.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.479 HG22 HD21 ' A' ' 80' ' ' LEU . 25.7 m -52.15 -49.69 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.089 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.656 HG12 ' CE2' ' A' ' 26' ' ' PHE . 42.3 t -65.92 -39.59 85.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -51.1 -48.31 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -63.97 -48.85 74.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.8 t80 -44.21 -62.69 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' HG12 ' A' ' 22' ' ' VAL . 24.6 m-85 -44.63 -35.14 2.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.0 m -67.59 -39.72 84.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.694 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -62.11 -58.04 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.8 m -54.78 -39.75 68.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -65.78 -64.8 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.78 -24.22 62.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.6 -46.64 63.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.58 -31.03 71.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.99 -34.07 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.36 22.83 11.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.41 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 40' ' ' VAL . 15.0 mtmt -91.55 179.46 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.9 p -107.98 18.98 20.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -152.12 172.72 15.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.694 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.4 m -90.05 140.44 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.18 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 36' ' ' LYS . 42.9 t -116.76 136.31 23.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.654 0.74 . . . . 0.0 111.114 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.78 122.52 9.2 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.604 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 60.2 t -73.12 112.04 14.01 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.659 0.743 . . . . 0.0 111.11 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 80.54 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.761 2.307 . . . . 0.0 112.323 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -48.84 -52.01 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.02 -52.65 14.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -65.86 -57.84 6.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 32.1 mmm -48.25 -33.65 9.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.7 mt -59.97 -32.6 70.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -87.02 -40.32 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -129.18 90.88 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -80.74 -19.89 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p -58.52 -46.72 86.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -40.53 -42.96 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.476 HG22 HG13 ' A' ' 90' ' ' ILE . 5.4 t -146.52 132.03 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 51.1 t -102.91 148.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.918 HG21 ' CD1' ' A' ' 65' ' ' PHE . 12.4 t -121.86 116.9 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -104.73 170.02 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.96 9.6 73.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.7 mt -83.45 150.15 59.49 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.636 0.732 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.664 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.6 Cg_endo -69.78 -171.98 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -83.4 163.69 20.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.37 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.664 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -119.8 157.86 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.166 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.12 123.83 16.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.918 ' CD1' HG21 ' A' ' 56' ' ' VAL . 91.5 t80 -34.62 119.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -167.37 169.89 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.6 t-80 -41.86 140.99 1.36 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.957 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.71 -6.59 18.93 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.657 2.238 . . . . 0.0 112.365 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.66 -21.4 21.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -78.86 -9.65 59.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.44 129.28 39.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.93 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' THR . 4.2 m-20 -57.77 143.46 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 72' ' ' ASP . 9.8 tp -36.32 -48.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -42.69 79.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 72' ' ' ASP . 60.7 m -70.09 -45.77 66.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.0 mt -47.78 -52.75 17.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -51.34 -46.68 62.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.1 t90 -50.05 -56.85 9.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -44.63 -55.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.479 HD21 HG22 ' A' ' 21' ' ' THR . 22.0 mt -57.97 -36.67 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.02 -53.33 55.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -101.38 34.86 2.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 60.7 pttt -77.2 -48.8 16.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -42.87 -27.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.94 -32.26 11.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.1 mt -47.66 121.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 111.154 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -118.03 162.55 18.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.847 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.1 m-85 -131.1 123.33 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.5 110.84 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.22 113.23 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.138 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.462 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 4.9 mmtp -93.17 -32.46 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.567 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -179.12 127.73 0.25 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.428 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.4 Cg_endo -69.87 124.34 10.95 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.669 2.246 . . . . 0.0 112.298 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 0.3 OUTLIER -42.73 166.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.3 mt -82.08 117.13 22.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.955 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.76 125.85 49.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.634 0.73 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -164.63 0.13 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.729 2.286 . . . . 0.0 112.351 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -53.28 168.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -74.49 -61.96 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -70.18 109.05 4.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.84 38.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.096 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.68 -96.49 1.97 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 147.07 57.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.502 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.7 p -145.79 138.95 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.883 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.67 145.16 4.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.508 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 84.8 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.361 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 t 58.27 53.35 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.4 p -99.37 152.15 20.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.844 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 66.25 44.65 2.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -81.28 -42.76 20.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.27 106.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.465 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 t -96.41 150.56 20.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.851 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 t -42.23 160.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.841 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.47 -92.59 0.78 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.466 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.37 156.46 18.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.7 m -98.54 178.59 4.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.853 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p -79.56 -36.07 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.2 -10.73 51.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.68 91.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.13 -26.02 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.178 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.96 -62.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.8 tt -47.36 -36.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.14 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -70.09 -40.67 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -66.43 -38.7 88.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 22' ' ' VAL . 20.0 mt -59.36 -46.33 88.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -64.44 -37.45 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -68.18 -46.45 70.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.588 HG22 HD21 ' A' ' 80' ' ' LEU . 27.7 m -56.69 -45.9 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.087 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.604 HG12 ' CE2' ' A' ' 26' ' ' PHE . 41.0 t -68.18 -31.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.62 -47.38 63.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -45.33 -61.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.604 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.9 m-85 -46.71 -39.98 12.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m -67.46 -40.44 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.47 ' HA ' HG12 ' A' ' 39' ' ' VAL . 9.7 t80 -62.85 -56.53 16.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.0 m -52.61 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.825 ' CE1' HD11 ' A' ' 90' ' ' ILE . 15.1 t80 -66.87 -64.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -23.16 58.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -39.2 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.906 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.17 -27.25 60.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -66.09 -32.66 74.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 25.93 9.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.59 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.6 mtmt -95.56 179.73 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 t -110.93 21.39 16.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.3 p -154.3 163.94 39.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.7 m -79.04 143.04 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.202 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 41' ' ' PRO . 57.5 t -118.92 137.84 25.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.684 0.754 . . . . 0.0 111.09 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.75 120.94 7.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 26' ' ' PHE . 60.6 t -71.61 112.66 14.81 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 80.63 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.716 2.277 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -60.32 -39.61 87.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.9 -38.5 70.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -80.3 -55.02 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.527 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 84.2 mtp -49.41 -35.98 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -85.69 -38.38 18.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.07 91.5 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -81.15 41.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 14.3 p -116.41 -55.86 2.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.795 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 94' ' ' PHE . . . -33.94 -37.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 90' ' ' ILE . 29.7 t -148.02 135.95 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.501 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 46.7 t -109.32 146.07 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 65' ' ' PHE . 15.3 t -117.57 124.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.2 165.27 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.92 62.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.9 mt -85.44 151.2 55.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.536 0.684 . . . . 0.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.616 ' HD2' HG11 ' A' ' 63' ' ' VAL . 54.1 Cg_endo -69.77 -169.07 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 63' ' ' VAL . 7.7 tt0 -87.52 167.5 13.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.21 24.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.616 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.5 p -115.27 159.81 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.63 117.38 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.741 ' CD1' HG21 ' A' ' 56' ' ' VAL . 42.0 t80 -34.21 114.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -159.02 173.76 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 6.9 t-80 -42.92 140.62 1.85 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 110.875 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.769 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.3 Cg_endo -69.78 0.75 5.21 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.643 2.229 . . . . 0.0 112.335 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.42 -17.79 18.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.93 -11.35 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -88.17 121.39 30.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 73' ' ' LEU . 1.8 m-20 -51.45 144.84 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.818 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.518 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.2 tp -36.91 -48.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.89 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -57.18 -48.93 77.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.161 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 68' ' ' PRO . 15.5 mt -43.48 -57.2 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -48.14 -44.0 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.93 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.537 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.8 t90 -53.14 -59.73 4.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.7 mt -41.87 -54.65 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.149 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 21' ' ' THR . 20.8 mt -59.85 -36.86 77.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -63.03 -53.45 53.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -100.84 35.0 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -76.38 -45.54 31.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -42.0 -29.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.8 -35.84 8.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.9 mt -46.01 120.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -120.52 163.13 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.63 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.2 m-85 -129.74 126.65 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.65 111.39 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.825 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -81.97 113.06 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.501 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 22.8 mmtt -91.54 -31.66 15.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.518 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -179.02 132.46 0.28 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.439 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo -69.71 124.66 11.33 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.75 2.3 . . . . 0.0 112.384 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 53' ' ' ALA . 21.5 m-85 -49.07 179.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.9 mt -104.67 113.63 27.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.979 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.65 145.5 0.96 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.67 0.747 . . . . 0.0 110.837 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -172.86 0.62 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.623 2.215 . . . . 0.0 112.366 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -22.83 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.784 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -95.47 162.96 13.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.93 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -170.4 137.36 1.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.9 t -123.73 93.36 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 39.15 74.25 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.437 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.83 -110.81 3.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.478 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.6 p -49.72 108.51 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 0.0 110.849 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.15 -164.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.534 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 172.27 13.01 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.665 2.243 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 t -162.44 131.38 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.848 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.6 t -51.22 126.14 15.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.543 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.4 p -127.46 173.14 10.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.831 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p -86.45 108.77 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.46 -96.01 2.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.496 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.8 m -69.32 119.24 13.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.9 p -79.23 -52.27 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.72 -123.49 2.47 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.461 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.01 51.85 4.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.877 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.416 ' H ' ' HB3' ' A' ' 12' ' ' ALA . 3.9 m -166.31 175.99 7.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 13' ' ' VAL . 6.0 p -60.69 -44.49 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' N ' HG13 ' A' ' 10' ' ' VAL . 1.3 p-10 -80.73 -16.22 54.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.82 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.416 ' HB3' ' H ' ' A' ' 9' ' ' SER . . . -54.59 -35.98 63.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -61.83 -38.89 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -57.96 -69.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 tt -45.84 -32.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.54 -37.74 59.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.449 ' HA ' ' HZ2' ' A' ' 20' ' ' LYS . 55.1 m -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD12 ' CD1' ' A' ' 73' ' ' LEU . 15.7 mt -61.31 -40.96 96.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -63.44 -45.91 88.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HZ2' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -66.13 -44.83 83.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.526 HG22 HD21 ' A' ' 80' ' ' LEU . 98.9 m -53.74 -47.38 70.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.593 HG12 ' CE2' ' A' ' 26' ' ' PHE . 59.5 t -68.73 -36.54 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.93 -47.65 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.2 t80 -45.28 -58.3 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.593 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.5 m-85 -50.13 -40.71 47.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.4 m -65.42 -40.13 92.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.69 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.2 t80 -63.16 -58.48 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.0 m -52.0 -40.65 61.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.733 ' CE1' HD11 ' A' ' 90' ' ' ILE . 17.5 t80 -66.66 -64.72 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -21.89 56.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -41.01 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.2 -27.24 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.83 -31.46 72.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.949 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.6 24.68 10.69 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.514 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.63 ' HE2' HG21 ' A' ' 40' ' ' VAL . 17.6 mtmt -94.66 179.9 5.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 t -109.65 21.3 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.9 p -155.39 174.88 14.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.8 m -88.31 148.35 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.63 HG21 ' HE2' ' A' ' 36' ' ' LYS . 98.6 t -123.12 137.1 27.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.664 0.745 . . . . 0.0 111.153 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.2 Cg_endo -69.74 111.92 2.94 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.405 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 39.6 t -69.96 111.9 10.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.573 0.701 . . . . 0.0 111.111 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 79.97 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.624 2.216 . . . . 0.0 112.355 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -52.05 -48.45 64.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 48' ' ' LEU . 20.6 tt0 -50.34 -43.23 53.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -74.17 -58.37 3.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.405 ' SD ' ' CG1' ' A' ' 42' ' ' VAL . 56.9 mtp -46.59 -35.39 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 45' ' ' GLU . 24.2 mt -54.24 -42.2 69.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.985 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 6.7 ptt85 -84.23 -32.89 24.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.878 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.571 ' OD2' ' CE2' ' A' ' 94' ' ' PHE . 8.3 p-10 -130.62 86.87 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -80.09 -7.39 58.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 53' ' ' ALA . 2.5 p -68.61 -57.26 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.83 -37.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.079 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' SER . 3.4 t -154.33 125.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 56' ' ' VAL . 40.2 t -96.3 165.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.812 HG21 ' CD1' ' A' ' 65' ' ' PHE . 39.4 t -136.2 123.1 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -116.21 166.44 12.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.33 5.49 67.31 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.8 mt -79.68 152.29 74.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.914 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.682 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.2 Cg_endo -69.8 -174.63 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.306 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -83.61 162.69 20.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.1 23.43 2.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -115.93 166.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.491 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.12 128.76 12.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.812 ' CD1' HG21 ' A' ' 56' ' ' VAL . 86.9 t80 -37.87 128.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -174.07 174.49 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.538 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.6 t-80 -50.61 141.87 16.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.569 0.699 . . . . 0.0 110.839 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.681 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.3 Cg_endo -69.7 -1.98 9.34 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 4.3 pt-20 -95.81 -20.09 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -78.12 -17.45 56.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -83.19 145.05 29.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.36 150.09 38.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.649 ' CD1' HD12 ' A' ' 18' ' ' LEU . 7.3 tp -38.77 -51.77 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.28 -56.76 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -55.0 -50.11 69.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.681 HD21 ' O ' ' A' ' 68' ' ' PRO . 19.7 mt -43.19 -57.03 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -47.14 -46.56 23.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 67.4 t90 -51.01 -61.87 1.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mt -40.14 -54.63 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.526 HD21 HG22 ' A' ' 21' ' ' THR . 29.2 mt -58.88 -40.14 83.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.36 -53.76 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -100.97 35.67 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 53.7 pttt -76.79 -45.06 30.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -43.11 -28.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.32 -35.01 9.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.455 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.4 mt -47.61 120.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.356 . . . . 0.0 111.084 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -120.76 164.79 16.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.427 ' CE2' HG22 ' A' ' 56' ' ' VAL . 6.5 m-85 -131.22 122.16 26.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.05 110.48 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.733 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.66 112.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 21.0 mmtt -91.48 -28.79 17.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.49 140.43 0.34 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.86 151.57 68.54 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.672 2.248 . . . . 0.0 112.278 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.571 ' CE2' ' OD2' ' A' ' 50' ' ' ASP . 32.0 m-85 -71.26 118.07 13.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.0 mt -45.9 113.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.961 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.56 153.21 54.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.647 0.737 . . . . 0.0 110.884 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 156.55 63.28 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.399 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -55.33 164.74 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -55.63 165.53 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -169.58 146.98 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.2 t -80.53 125.63 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.173 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.93 101.03 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -172.74 49.98 0.17 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.3 p -171.04 152.82 3.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 110.872 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 99.84 69.45 0.9 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 145.61 57.94 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.644 2.23 . . . . 0.0 112.342 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.8 m -94.33 102.42 14.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.8 t -49.04 113.28 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.533 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -75.05 103.08 5.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 t 60.03 42.17 16.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.63 105.2 0.2 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.409 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.0 p -44.7 144.81 1.02 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.4 p -99.3 41.99 1.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.65 174.97 47.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.89 143.13 26.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.74 0.305 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' ' 12' ' ' ALA . 30.3 m -100.78 165.15 11.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.71 -35.61 25.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -93.29 14.54 17.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.781 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -78.05 -41.72 34.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 13' ' ' VAL . 2.8 p -66.44 -11.39 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.193 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -82.01 -55.47 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 12' ' ' ALA . 11.2 tt -52.49 -36.46 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -72.69 -45.42 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.9 m -59.5 -36.25 75.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 29.8 mt -60.64 -44.8 95.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -58.88 -36.07 74.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -45.79 75.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.665 HG22 HD21 ' A' ' 80' ' ' LEU . 33.0 m -55.83 -50.23 71.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.172 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.511 HG12 ' CE2' ' A' ' 26' ' ' PHE . 39.5 t -66.07 -40.64 87.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -51.9 -49.54 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.59 -47.39 85.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -44.95 -62.11 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.511 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.6 m-85 -45.24 -41.73 8.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 m -62.41 -42.46 99.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.544 ' HA ' HG12 ' A' ' 39' ' ' VAL . 22.9 t80 -63.35 -55.24 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 64.9 m -57.53 -40.41 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CE1' HD11 ' A' ' 90' ' ' ILE . 20.3 t80 -67.14 -62.83 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.53 -23.46 60.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.54 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -72.17 -46.61 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.57 -28.67 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.62 -34.81 77.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 22.85 12.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.534 ' HE2' HG21 ' A' ' 40' ' ' VAL . 19.4 mtmt -93.39 -179.91 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 p -109.34 20.52 18.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.3 p -156.39 159.44 38.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -68.88 155.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG21 ' HE2' ' A' ' 36' ' ' LYS . 70.5 t -130.82 131.75 23.47 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.626 0.726 . . . . 0.0 111.082 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.348 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.68 115.51 15.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.72 0.771 . . . . 0.0 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.92 0.97 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -48.78 -52.85 21.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -45.86 -54.2 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -61.19 2.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.799 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 31.5 mmm -42.25 -39.2 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -49.34 71.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.937 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -80.53 -25.53 38.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.54 87.87 2.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 54' ' ' VAL . 52.2 mt-30 -83.36 -28.31 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 31.0 p -49.84 -56.39 10.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.21 -43.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 51' ' ' GLN . 2.5 t -143.99 122.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.097 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.22 142.01 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.984 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.0 t -111.19 125.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -116.74 162.94 16.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.38 44.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 18.3 mt -92.14 155.96 42.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.668 0.746 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.8 Cg_endo -69.71 -165.59 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' GLY . 10.3 tt0 -88.16 166.73 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.66 33.09 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.654 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -120.28 149.82 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -133.86 123.17 24.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.984 ' CD1' HG21 ' A' ' 56' ' ' VAL . 82.6 t80 -33.98 121.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.452 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.0 ptpt -170.88 166.15 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.531 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.1 t-80 -39.92 141.52 0.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.841 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.954 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.4 Cg_endo -69.71 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.674 2.249 . . . . 0.0 112.356 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -20.54 25.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -81.76 -15.44 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 24.5 m-85 -84.04 123.15 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.7 145.07 7.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -37.99 -49.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.62 76.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.8 m -60.51 -47.84 84.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 68' ' ' PRO . 26.7 mt -47.97 -54.55 12.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -48.59 -43.41 36.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.546 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.6 t90 -56.87 -57.21 13.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.0 mt -44.19 -52.42 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.665 HD21 HG22 ' A' ' 21' ' ' THR . 21.4 mt -60.62 -36.15 77.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.02 -53.09 55.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -101.47 35.31 2.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.856 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 52.3 pttt -75.54 -49.3 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -41.0 -30.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.39 8.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.8 mt -40.47 124.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -121.51 170.2 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -132.47 115.42 15.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.2 mt -101.03 93.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.081 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -72.0 112.91 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -87.82 -31.97 19.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.55 137.34 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.562 0.696 . . . . 0.0 110.886 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 133.73 26.14 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.338 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -51.45 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -93.28 15.1 16.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -82.92 115.82 60.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.712 0.768 . . . . 0.0 110.819 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 166.38 27.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.52 13.55 17.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 100' ' ' HIS . 2.0 pptp? -85.36 -179.0 6.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.487 ' N ' ' HD2' ' A' ' 99' ' ' LYS . 24.0 p80 -175.13 176.13 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 101' ' ' VAL . 10.6 p -161.58 121.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.151 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.76 172.69 12.63 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.87 140.06 15.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.467 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.1 t -80.76 -57.89 3.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.958 0.408 . . . . 0.0 110.865 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.39 147.95 5.27 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 0.87 5.09 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.677 2.251 . . . . 0.0 112.314 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 p -117.66 144.64 45.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.1 p -165.39 163.21 19.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 -179.932 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 t -142.82 142.87 31.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 110.842 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 p -98.54 42.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.84 116.14 5.45 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.43 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 96.7 p -137.7 153.61 49.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.815 0.341 . . . . 0.0 110.889 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.7 t -68.18 135.15 51.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.47 148.96 19.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.526 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.2 tpp -76.24 158.66 31.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 m -151.46 175.46 12.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.68 -39.05 79.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -85.84 -5.08 59.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.576 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -56.98 -50.91 71.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p -61.49 -24.66 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.29 -49.92 65.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 12' ' ' ALA . 3.8 tt -57.19 -33.49 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.413 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 5.1 mt-10 -75.47 -40.82 56.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 m -64.67 -37.71 88.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' VAL . 31.0 mt -64.2 -37.05 86.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.475 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 31.1 mtm105 -66.41 -36.82 83.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -62.79 -48.89 77.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 HD21 ' A' ' 80' ' ' LEU . 28.3 m -56.29 -46.2 79.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.649 HG12 ' CE2' ' A' ' 26' ' ' PHE . 23.4 t -67.01 -35.57 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.428 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 12.7 mt-10 -61.01 -44.66 97.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.72 -46.35 72.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.52 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.9 t80 -46.52 -62.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.649 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.0 m-85 -42.31 -36.45 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.83 -42.98 76.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.583 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -59.59 -49.66 76.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -62.97 -43.79 97.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.625 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.1 t80 -62.37 -58.7 6.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.34 82.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -44.55 86.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.6 71.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.0 mt -64.01 -34.4 77.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.95 11.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.68 ' HE2' HG21 ' A' ' 40' ' ' VAL . 14.3 mtmt -93.25 179.59 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.945 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.87 20.27 18.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.3 p -154.55 164.56 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -77.79 145.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.68 HG21 ' HE2' ' A' ' 36' ' ' LYS . 59.1 t -124.22 132.94 24.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 0.0 111.158 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.7 122.17 8.87 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.626 2.218 . . . . 0.0 112.336 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 79.5 t -68.08 111.54 8.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.707 0.765 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 79.61 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 0.0 112.364 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' MET . 38.3 m-85 -45.23 -73.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.4 tp10 -30.91 -54.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 27.2 mttm -62.09 -43.11 99.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.546 ' N ' ' O ' ' A' ' 44' ' ' TYR . 47.3 mtp -65.78 -58.68 5.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.5 mt -42.45 -35.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.463 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -91.86 -29.34 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.564 ' OD2' ' HB2' ' A' ' 53' ' ' ALA . 25.3 t0 -134.12 75.09 1.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -63.83 -43.76 95.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -40.16 -61.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.564 ' HB2' ' OD2' ' A' ' 50' ' ' ASP . . . -31.43 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' SER . 12.1 t -155.19 119.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 91' ' ' LYS . 21.5 t -98.17 157.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.627 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.9 t -126.68 121.79 59.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -114.28 153.31 29.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.67 15.12 27.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.407 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 17.3 mt -89.64 157.69 46.39 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.648 0.737 . . . . 0.0 110.863 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.647 ' HD2' HG11 ' A' ' 63' ' ' VAL . 52.9 Cg_endo -69.84 -168.01 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 0.0 112.248 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.84 164.86 15.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.2 29.31 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.647 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.1 p -118.66 152.59 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.179 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.97 123.25 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.009 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.627 ' CD1' HG21 ' A' ' 56' ' ' VAL . 86.9 t80 -33.81 126.29 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.83 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' HD3' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -172.49 166.83 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.944 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.4 t-80 -43.01 141.73 1.63 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.676 0.75 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.931 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.76 -7.59 21.45 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.709 2.272 . . . . 0.0 112.325 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HA ' ' CD ' ' A' ' 19' ' ' ARG . 1.5 pp20? -89.23 -16.95 30.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.405 ' CB ' ' HD3' ' A' ' 66' ' ' LYS . 52.0 m-20 -85.62 -13.73 47.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.79 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -85.79 128.5 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.7 m-20 -56.41 141.96 40.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 72' ' ' ASP . 7.5 tp -36.05 -46.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.33 84.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 92.4 m -64.53 -48.13 76.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.931 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.1 mt -45.04 -51.72 9.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -52.99 -46.28 68.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.553 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 56.5 t90 -52.08 -61.81 2.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.993 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.3 mt -39.61 -52.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.595 HD21 HG22 ' A' ' 21' ' ' THR . 19.6 mt -61.22 -37.34 82.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -63.12 -53.84 47.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.78 37.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 44.8 pttt -79.93 -50.04 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.466 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.48 -31.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.083 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -86.9 -37.16 8.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.6 mt -42.47 127.37 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.751 0.31 . . . . 0.0 111.146 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -127.61 166.16 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.56 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.9 m-85 -131.77 121.85 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.48 110.42 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.81 112.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HE3' HG21 ' A' ' 55' ' ' VAL . 24.3 mmtt -91.85 -25.35 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.13 139.41 0.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.655 0.741 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 132.58 23.55 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.695 2.264 . . . . 0.0 112.365 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.573 ' CD2' ' HB3' ' A' ' 46' ' ' LYS . 66.2 m-85 -51.38 131.94 28.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 mt -100.14 123.71 44.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -146.77 148.94 34.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.5 60.57 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -83.78 164.15 19.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -124.98 167.67 14.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -110.53 138.26 47.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.8 t -109.29 95.66 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -120.69 67.99 0.41 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 162.38 150.78 6.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.469 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.7 m -106.63 173.49 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.4 . . . . 0.0 110.913 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 158.82 86.4 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 134.81 28.78 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.9 t -56.12 99.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 t -145.05 147.42 32.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.854 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 m -120.81 153.94 36.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -92.89 111.23 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.67 97.55 1.0 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.9 m -97.86 114.18 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 p -65.94 152.73 43.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 9' ' ' SER . . . 98.09 62.96 0.88 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.552 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 7' ' ' GLY . 3.8 ppp? 32.6 37.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 110.854 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 7' ' ' GLY . 9.8 t -55.08 169.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.6 -39.9 86.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.86 -1.0 55.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.462 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -66.65 -48.84 68.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.057 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -52.21 -28.14 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.62 -60.85 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 12' ' ' ALA . 6.1 tt -49.55 -37.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.409 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.4 mt-10 -72.38 -41.79 65.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 m -64.61 -38.36 90.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' CD1' HD11 ' A' ' 73' ' ' LEU . 26.9 mt -60.92 -35.52 76.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.667 ' NH1' HD11 ' A' ' 76' ' ' LEU . 57.6 mtt-85 -71.88 -41.33 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -58.18 -39.61 79.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.562 HG22 HD21 ' A' ' 80' ' ' LEU . 25.0 m -63.87 -43.97 94.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.763 HG12 ' CE2' ' A' ' 26' ' ' PHE . 47.4 t -70.58 -32.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.223 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 20.0 mt-10 -62.41 -40.15 95.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.73 -46.86 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.565 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 11.1 t80 -47.98 -62.85 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.763 ' CE2' HG12 ' A' ' 22' ' ' VAL . 28.9 m-85 -42.13 -37.73 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.1 m -68.6 -43.51 76.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.556 ' HA ' HG12 ' A' ' 39' ' ' VAL . 28.0 t80 -60.18 -52.55 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -57.83 -43.4 85.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.579 ' CE1' HD11 ' A' ' 90' ' ' ILE . 15.7 t80 -64.06 -61.1 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.952 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.21 -27.37 67.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -42.57 68.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.706 0.288 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 -24.27 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.35 -28.63 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.06 23.47 24.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.572 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.624 ' HE2' HG21 ' A' ' 40' ' ' VAL . 16.5 mtmt -91.92 -179.98 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.889 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 m -109.48 19.11 19.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -150.54 172.13 15.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.196 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -88.58 139.52 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.624 HG21 ' HE2' ' A' ' 36' ' ' LYS . 74.4 t -117.93 133.08 23.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 0.0 111.124 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.4 Cg_endo -69.77 124.7 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.331 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 47' ' ' MET . 90.7 t -72.54 111.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.635 0.731 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 79.9 0.92 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 0.0 112.368 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -52.41 -51.12 60.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -46.0 -51.5 13.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -69.66 -60.5 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.601 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 40.2 mtp -42.2 -39.35 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.943 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.5 mt -53.78 -46.19 70.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -79.39 -31.94 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.32 88.94 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -78.44 -38.38 41.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 53' ' ' ALA . 37.0 p -39.52 -55.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -34.28 -40.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 t -153.06 128.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 56' ' ' VAL . 35.2 t -102.25 165.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.763 HG21 ' CD1' ' A' ' 65' ' ' PHE . 14.5 t -134.48 124.22 44.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -116.02 163.47 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.03 11.98 58.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 13.2 mt -86.29 154.04 56.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.751 ' O ' HG12 ' A' ' 63' ' ' VAL . 54.5 Cg_endo -69.7 172.76 11.99 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.356 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -78.69 147.52 33.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.47 18.83 72.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.3 p -115.41 168.59 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 111.143 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.541 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -146.65 117.85 7.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.763 ' CD1' HG21 ' A' ' 56' ' ' VAL . 68.3 t80 -35.94 122.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' N ' ' OH ' ' A' ' 71' ' ' TYR . 11.2 ptpt -170.8 169.99 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.4 t-80 -42.19 140.82 1.52 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 110.938 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.573 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.2 Cg_endo -69.85 3.34 2.87 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -95.32 -21.7 18.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -83.41 -7.06 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.954 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.419 ' OH ' ' N ' ' A' ' 66' ' ' LYS . 22.9 m-85 -92.72 133.82 35.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.91 154.87 36.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' A' ' 18' ' ' LEU . 6.3 tp -44.59 -47.53 10.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.54 -54.63 44.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.2 m -55.99 -47.1 78.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.667 HD11 ' NH1' ' A' ' 19' ' ' ARG . 22.8 mt -45.29 -59.69 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -46.1 -46.36 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.0 t90 -51.04 -62.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.5 mt -40.21 -51.44 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.562 HD21 HG22 ' A' ' 21' ' ' THR . 28.5 mt -62.12 -36.08 80.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' TRP . 12.0 mm-40 -64.56 -54.07 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -99.65 36.77 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.565 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -76.75 -45.51 28.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.53 -33.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.17 -31.47 28.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.41 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 mt -50.25 118.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.4 m -121.55 156.64 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.56 ' CE1' HG13 ' A' ' 56' ' ' VAL . 7.1 m-85 -121.66 126.56 49.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.71 109.53 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.55 113.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.456 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.3 mmtp -93.84 -26.88 16.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.8 137.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 151.67 68.53 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -72.35 149.29 44.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -120.33 27.52 8.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -85.32 118.49 70.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 0.0 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 106.97 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.751 2.301 . . . . 0.0 112.305 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -95.36 152.27 18.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -115.59 144.08 44.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.509 ' CG ' ' N ' ' A' ' 101' ' ' VAL . 33.4 p-80 -54.6 -49.24 70.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.84 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.509 ' N ' ' CG ' ' A' ' 100' ' ' HIS . 13.4 p -73.49 140.59 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -123.88 -62.08 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.533 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.51 106.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.527 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.1 t -72.92 -57.43 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.937 0.398 . . . . 0.0 110.818 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.64 85.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.528 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 107' ' ' SER . 54.4 Cg_endo -69.58 -176.3 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 106' ' ' PRO . 52.5 p -34.67 136.11 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.7 m -104.26 135.96 44.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.549 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 t -123.44 -47.2 2.0 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.933 0.397 . . . . 0.0 110.856 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m 55.26 44.62 27.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.843 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.59 104.65 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.526 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 t -79.96 165.18 22.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.92 0.391 . . . . 0.0 110.81 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.0 m -126.58 -43.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.861 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.26 111.19 0.25 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.9 ttm 51.16 35.0 12.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.949 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 m -60.93 -177.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 11' ' ' ASP . 7.4 p -66.53 -43.3 90.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.451 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -84.24 -6.49 59.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.513 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -63.08 -45.55 91.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.155 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 13' ' ' VAL . 2.1 p -64.96 -11.37 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.69 -54.87 5.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 12' ' ' ALA . 10.4 tt -52.27 -30.37 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 12' ' ' ALA . 3.4 mt-10 -77.37 -43.48 32.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -61.67 -34.44 75.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 24.0 mt -64.62 -44.45 90.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -61.55 -22.87 65.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -76.26 -56.0 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 m -44.47 -44.81 8.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.799 HG12 ' CE2' ' A' ' 26' ' ' PHE . 21.9 t -71.51 -34.74 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.487 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 14.7 mt-10 -62.75 -39.05 92.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -72.99 -38.05 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.551 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 7.0 t80 -58.41 -60.15 4.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.799 ' CE2' HG12 ' A' ' 22' ' ' VAL . 20.9 m-85 -44.03 -40.8 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.22 -58.0 7.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.7 m -53.24 -40.12 64.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.636 ' CE1' HD11 ' A' ' 90' ' ' ILE . 18.4 t80 -66.72 -63.7 1.01 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.959 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.56 60.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -41.23 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.732 0.301 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.85 67.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.051 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -62.06 -35.3 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.35 25.61 8.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.501 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.737 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.1 mtmt -95.93 179.6 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -111.35 20.51 17.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.9 p -152.5 159.94 43.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.2 m -73.49 141.56 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.737 HG21 ' HE2' ' A' ' 36' ' ' LYS . 98.4 t -120.22 138.91 27.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 0.0 111.178 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.668 ' HD2' HG13 ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.83 122.82 9.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.748 2.299 . . . . 0.0 112.265 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 26' ' ' PHE . 55.2 t -67.98 116.79 42.27 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.628 0.727 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.595 ' CG ' ' CE1' ' A' ' 94' ' ' PHE . 54.0 Cg_endo -69.71 80.03 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.736 2.291 . . . . 0.0 112.349 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.517 ' O ' ' C ' ' A' ' 45' ' ' GLU . 67.9 m-85 -55.69 -72.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.921 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 44' ' ' TYR . 37.0 tt0 -28.79 -56.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -60.74 -48.07 83.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.52 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 74.2 mtp -59.26 -56.92 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.1 mt -43.83 -46.51 7.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -77.81 -31.28 51.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 51.8 m-20 -134.96 95.26 3.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -92.25 51.92 1.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 p -130.27 -38.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -52.97 -35.73 59.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 90' ' ' ILE . 34.5 t -149.29 123.35 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.487 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 33.4 t -95.95 155.06 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.8 t -126.25 121.55 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.114 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -111.68 168.18 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.033 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.98 4.24 78.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.1 mt -78.93 158.11 75.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 0.0 110.925 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.6 Cg_endo -69.81 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.653 2.235 . . . . 0.0 112.3 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -98.3 157.41 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.09 17.53 10.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 64' ' ' ALA . 8.0 p -107.78 168.08 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.577 ' N ' HG22 ' A' ' 63' ' ' VAL . . . -145.94 115.08 7.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.098 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.828 ' CD1' HG21 ' A' ' 56' ' ' VAL . 55.5 t80 -35.01 125.19 0.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.839 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 14.7 ptpt -169.35 172.78 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.0 t-80 -43.84 140.66 2.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.599 0.714 . . . . 0.0 110.818 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.846 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.6 Cg_endo -69.77 2.59 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.1 -16.99 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.04 -11.06 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.521 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.6 m-85 -86.81 116.99 25.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.41 143.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 8.9 tp -39.44 -41.56 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.976 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.63 70.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -58.13 -46.25 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.846 HD21 ' O ' ' A' ' 68' ' ' PRO . 26.7 mt -47.0 -52.5 14.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -50.45 -46.23 56.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.558 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -54.32 -60.95 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.9 mt -41.14 -50.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.7 mt -62.68 -35.6 80.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.1 -55.17 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -98.19 39.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.551 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 19.7 ptmt -78.27 -51.91 9.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.56 -31.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -85.05 -37.51 9.97 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.1 mt -43.18 118.4 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 111.169 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.0 m -118.91 160.17 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.1 m-85 -126.59 125.98 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.11 112.0 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.61 113.31 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.487 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.6 mmtt -93.36 -28.38 16.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.516 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.91 129.5 0.27 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.655 0.74 . . . . 0.0 110.833 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.451 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.3 Cg_endo -69.67 127.26 14.4 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.707 2.271 . . . . 0.0 112.385 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.595 ' CE1' ' CG ' ' A' ' 43' ' ' PRO . 33.0 m-85 -46.57 174.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 95' ' ' LEU . 13.7 mt -91.93 109.0 20.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.992 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.55 143.01 0.98 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.723 0.773 . . . . 0.0 110.851 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -177.34 1.82 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -61.8 149.77 39.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 31.4 mtmm -91.8 -55.0 3.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 99' ' ' LYS . 94.1 m-70 -161.38 148.65 14.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 101' ' ' VAL . 12.7 p -155.72 119.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.18 152.12 28.39 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.441 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.42 95.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.498 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 105' ' ' GLY . 21.0 t -57.31 92.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.931 0.396 . . . . 0.0 110.806 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 104' ' ' SER . . . 35.35 -97.33 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.422 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 104' ' ' SER . 53.7 Cg_endo -69.7 118.49 5.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.74 2.293 . . . . 0.0 112.37 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 m -88.0 -51.65 5.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.0 t -53.76 148.96 9.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.83 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 179.998 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m -62.16 101.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.818 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.5 m -106.92 151.58 25.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.27 48.97 0.79 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.399 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -46.79 132.98 11.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.3 t -167.87 163.43 13.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.42 -105.95 2.67 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.503 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 42.7 mtt -111.75 106.68 15.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.6 m -82.08 -176.22 6.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 11' ' ' ASP . 8.5 p -79.71 -41.82 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.062 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.441 ' N ' HG13 ' A' ' 10' ' ' VAL . 3.3 p30 -83.86 -8.3 59.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.841 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.03 88.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.86 -29.65 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.128 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.25 -59.31 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.82 -34.5 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -40.81 74.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -67.18 -32.14 73.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 15.6 mt -64.27 -46.54 83.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -63.96 -29.08 70.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -67.54 -54.57 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.43 HG22 HD21 ' A' ' 80' ' ' LEU . 6.3 m -51.32 -47.9 62.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.641 HG12 ' CE2' ' A' ' 26' ' ' PHE . 20.0 t -64.72 -37.35 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.04 -43.19 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.36 -44.29 68.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 6.4 t80 -48.92 -61.18 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.675 ' HB3' HG21 ' A' ' 42' ' ' VAL . 19.7 m-85 -44.45 -35.06 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.2 m -68.05 -40.17 82.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 39' ' ' VAL . 4.5 t80 -62.49 -55.04 31.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.68 -35.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -68.03 -58.48 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -26.83 70.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -43.07 77.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.793 0.33 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.91 -27.65 62.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -72.6 -21.1 61.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.16 32.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -90.71 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -98.68 -4.3 34.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.4 p -137.94 166.53 23.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -72.84 129.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.145 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 41' ' ' PRO . 63.0 t -105.67 132.38 20.93 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.585 0.707 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.412 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.1 Cg_endo -69.68 124.46 11.14 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.388 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.675 HG21 ' HB3' ' A' ' 26' ' ' PHE . 81.0 t -64.91 111.17 5.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.693 0.759 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 42' ' ' VAL . 53.5 Cg_endo -69.83 79.18 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.261 . . . . 0.0 112.327 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 47' ' ' MET . 72.7 m-85 -47.3 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 44' ' ' TYR . 9.4 pt-20 -30.04 -42.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 23.7 mttp -73.13 -47.09 47.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' TYR . 70.4 mtp -62.51 -50.98 69.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 11.7 mt -50.4 -37.49 37.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -88.73 -27.63 21.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.629 ' OD2' ' HB2' ' A' ' 53' ' ' ALA . 3.8 t70 -134.11 69.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -59.0 -40.99 86.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 53' ' ' ALA . 3.4 t -48.37 -58.45 4.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.629 ' HB2' ' OD2' ' A' ' 50' ' ' ASP . . . -31.94 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.676 HG22 HG13 ' A' ' 90' ' ' ILE . 59.1 t -138.94 119.74 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.151 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 56' ' ' VAL . 39.2 t -98.94 160.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.841 HG21 ' CD1' ' A' ' 65' ' ' PHE . 18.1 t -129.61 129.1 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.179 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -118.51 163.96 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.3 6.87 62.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB3' HG11 ' A' ' 63' ' ' VAL . 11.6 mt -82.13 157.27 68.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.614 0.721 . . . . 0.0 110.902 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.601 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.3 Cg_endo -69.79 -168.17 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.309 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -90.11 162.37 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 46.61 26.69 2.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.7 p -116.33 163.22 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.91 0.386 . . . . 0.0 111.078 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -145.0 118.77 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.841 ' CD1' HG21 ' A' ' 56' ' ' VAL . 91.5 t80 -34.39 126.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 13.0 ptpt -170.67 165.71 8.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.528 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -38.29 140.82 0.57 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.807 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.0 Cg_endo -69.82 2.23 3.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.668 2.245 . . . . 0.0 112.302 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.22 -20.87 16.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -84.79 -12.61 53.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 20.4 m-85 -84.16 117.04 23.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.4 OUTLIER -45.46 139.12 3.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -35.79 -46.9 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.03 87.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' ASP . 51.8 m -65.49 -45.25 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.807 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.8 mt -46.59 -54.7 8.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -48.94 -50.44 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.547 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 51.8 t90 -50.61 -60.71 2.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.0 mt -39.87 -52.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.43 HD21 HG22 ' A' ' 21' ' ' THR . 17.0 mt -62.95 -40.19 96.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.98 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -55.45 34.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -97.16 37.76 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 58.7 pttt -82.96 -45.64 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -38.43 -27.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.54 -40.07 4.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 85' ' ' GLY . 13.9 mt -34.16 127.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.1 m -127.92 169.6 13.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 56' ' ' VAL . 8.4 m-85 -134.96 127.92 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.23 109.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.133 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.676 HG13 HG22 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -81.75 113.38 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.215 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' HE3' HG21 ' A' ' 55' ' ' VAL . 5.3 mmtp -92.89 -31.74 14.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.618 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.85 127.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.594 0.711 . . . . 0.0 110.859 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.425 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo -69.75 116.76 4.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.727 2.284 . . . . 0.0 112.343 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -35.52 153.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.825 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.3 mt -75.9 143.81 41.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -100.19 101.58 15.06 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.656 0.741 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 119.37 6.32 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.347 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HG2' ' N ' ' A' ' 99' ' ' LYS . 18.2 tttm -169.72 149.89 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' N ' ' HG2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -132.05 -70.61 0.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.99 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -81.36 -67.83 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.4 p -168.32 128.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.25 175.4 29.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.52 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -174.64 66.53 0.1 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.483 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.3 t -52.27 -51.01 60.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.817 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.31 89.85 1.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 166.09 28.72 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.748 2.299 . . . . 0.0 112.328 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -100.16 118.48 36.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.8 m -125.81 102.74 7.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.4 p -91.13 122.13 33.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.92 0.39 . . . . 0.0 110.838 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.7 p -40.38 -46.5 2.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.0 87.33 0.56 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 6' ' ' SER . 13.5 m -63.31 113.78 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.847 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' SER . 5.3 t -35.92 -47.15 0.51 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.64 -129.1 4.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.428 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 66.0 mtt -77.45 117.07 18.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.742 0.306 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -96.06 177.38 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.63 -36.26 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.71 -3.75 58.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.65 92.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p -68.81 -24.12 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.87 -61.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 tt -50.79 -33.55 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.68 -43.9 62.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.6 m -62.96 -33.26 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.1 mt -63.32 -44.84 93.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -62.23 -40.2 95.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -64.55 -46.0 84.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.494 HG22 HD21 ' A' ' 80' ' ' LEU . 28.6 m -57.12 -48.98 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.643 HG12 ' CE2' ' A' ' 26' ' ' PHE . 46.4 t -65.97 -39.01 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.91 -43.69 69.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.1 -49.51 56.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 9.0 t80 -42.72 -61.92 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.643 ' CE2' HG12 ' A' ' 22' ' ' VAL . 25.7 m-85 -45.13 -38.03 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 m -66.82 -47.37 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' HA ' HG12 ' A' ' 39' ' ' VAL . 12.3 t80 -55.6 -52.57 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.3 m -56.49 -46.21 80.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.577 ' CE1' HD11 ' A' ' 90' ' ' ILE . 12.9 t80 -61.95 -62.41 1.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -27.83 64.48 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.519 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -41.81 74.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.24 66.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -64.89 -34.33 78.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.78 6.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.694 ' HE2' HG21 ' A' ' 40' ' ' VAL . 11.4 mtmt -99.86 177.61 5.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.756 0.313 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.9 p -105.84 -0.54 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.4 p -128.78 165.82 20.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.5 146.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.694 HG21 ' HE2' ' A' ' 36' ' ' LYS . 78.3 t -125.31 128.12 24.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.703 0.763 . . . . 0.0 111.157 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 124.33 10.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.254 . . . . 0.0 112.306 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.685 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 73.3 t -71.16 113.1 16.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.682 0.753 . . . . 0.0 111.151 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 80.89 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.245 . . . . 0.0 112.344 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.574 ' O ' ' N ' ' A' ' 47' ' ' MET . 53.1 m-85 -47.85 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' C ' ' O ' ' A' ' 44' ' ' TYR . 35.0 tt0 -29.92 -46.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -70.11 -44.17 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 44' ' ' TYR . 37.2 mmm -63.34 -53.01 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.82 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 12.1 mt -40.29 -35.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 9.7 mtp85 -93.73 -39.83 10.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -122.99 80.11 1.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.0 -28.0 57.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -52.54 -57.65 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.43 -36.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.3 t -152.69 119.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.543 HG21 ' HE3' ' A' ' 91' ' ' LYS . 20.0 t -96.28 153.41 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.794 HG13 ' CE1' ' A' ' 88' ' ' PHE . 11.9 t -125.36 123.58 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -112.15 163.82 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.39 61.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 11.3 mt -81.66 151.01 67.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.971 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.822 ' O ' HG12 ' A' ' 63' ' ' VAL . 54.7 Cg_endo -69.74 -179.95 3.26 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.7 2.266 . . . . 0.0 112.4 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.62 161.24 27.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.83 24.04 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.7 p -115.65 171.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -154.52 119.97 5.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.759 ' CD1' HG21 ' A' ' 56' ' ' VAL . 85.6 t80 -34.75 121.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 8.4 ptpp? -166.6 179.08 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.52 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -51.24 140.74 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.779 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.4 Cg_endo -69.78 2.99 3.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 8.1 pt-20 -98.29 -22.54 16.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -79.12 -15.38 58.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.449 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 20.9 m-85 -83.42 129.55 34.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.9 m-20 -61.67 143.24 56.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -34.78 -45.56 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.096 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' ASP . 87.5 m -60.58 -52.03 66.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 68' ' ' PRO . 24.8 mt -43.04 -56.74 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -46.57 -44.97 18.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.536 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.9 t90 -54.43 -57.9 9.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.7 mt -43.84 -55.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.494 HD21 HG22 ' A' ' 21' ' ' THR . 22.8 mt -59.15 -35.81 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.97 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -64.06 -52.8 57.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -101.74 33.64 2.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.521 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 59.0 pttt -74.87 -44.12 50.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.53 -22.07 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.4 -27.74 10.41 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.469 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mt -53.67 120.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.121 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 p -117.9 165.24 13.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.794 ' CE1' HG13 ' A' ' 56' ' ' VAL . 7.4 m-85 -133.09 122.86 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.43 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.667 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -80.7 113.24 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.543 ' HE3' HG21 ' A' ' 55' ' ' VAL . 32.2 mmtt -93.07 -25.97 17.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.53 140.0 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.673 0.749 . . . . 0.0 110.842 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 145.4 57.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.635 2.224 . . . . 0.0 112.36 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -69.02 141.22 54.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 95' ' ' LEU . 13.2 mt -71.3 108.81 4.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HA ' ' HD2' ' A' ' 97' ' ' PRO . 4.0 mm-40 -144.06 106.03 4.85 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.648 0.737 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 96' ' ' GLU . 53.9 Cg_endo -69.79 101.28 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.721 2.281 . . . . 0.0 112.408 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 99' ' ' LYS . 22.2 ttmt -167.71 151.51 6.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' N ' ' HG2' ' A' ' 98' ' ' LYS . 26.2 mtmt -108.31 108.75 19.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -93.72 137.87 32.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.41 137.01 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 44.5 -151.48 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.52 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.2 161.82 28.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.535 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.9 m -173.95 165.66 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.398 . . . . 0.0 110.853 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.45 148.84 10.54 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.518 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 107' ' ' SER . 54.3 Cg_endo -69.66 -9.42 26.1 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.722 2.281 . . . . 0.0 112.36 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 106' ' ' PRO . 1.6 t -34.8 111.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t -129.17 -49.17 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.835 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.523 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 p -132.84 -49.91 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.2 t -58.94 107.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.11 -133.18 1.47 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.476 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' SER . 39.3 m -148.24 132.76 17.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' SER . 54.6 m -35.23 -57.34 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.5 -45.8 0.41 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.419 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 7.1 mmt -118.51 167.12 11.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -50.21 144.07 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 p -58.15 -30.47 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.075 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.42 -9.68 58.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.61 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -50.18 -44.89 53.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.145 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p -66.72 -22.86 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.22 -44.95 82.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 12' ' ' ALA . 6.7 tt -64.27 -31.64 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -77.0 -34.08 57.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -74.89 -35.26 62.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.3 mt -63.59 -46.27 86.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.53 -38.25 74.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -64.34 -61.35 2.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 m -43.83 -46.92 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.588 HG12 ' CE2' ' A' ' 26' ' ' PHE . 96.4 t -65.13 -36.3 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.502 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 12.3 mt-10 -64.59 -39.24 93.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.87 -51.78 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -40.58 -60.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.588 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.5 m-85 -45.69 -34.69 3.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.886 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m -63.88 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 1.2 t80 -66.37 -64.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.3 m -51.14 -45.12 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.942 ' CE2' HD11 ' A' ' 34' ' ' LEU . 17.7 t80 -59.65 -55.79 30.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' HA2' HD12 ' A' ' 34' ' ' LEU . . . -57.03 -41.17 92.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.43 -38.16 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -18.09 49.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.069 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.942 HD11 ' CE2' ' A' ' 30' ' ' TYR . 30.1 mt -75.18 -26.91 59.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.15 4.33 9.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 153.2 41.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.318 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -88.7 11.61 17.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.3 p -105.87 170.07 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.198 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.5 115.4 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.606 HG13 ' HD2' ' A' ' 41' ' ' PRO . 96.9 t -100.05 137.37 20.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.623 0.725 . . . . 0.0 111.134 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.606 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.8 109.24 2.27 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.707 2.271 . . . . 0.0 112.254 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 30' ' ' TYR . 47.7 t -67.1 111.24 6.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.075 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 53.7 Cg_endo -69.73 79.52 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.293 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -48.9 -48.48 42.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -44.55 -57.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HD3' ' CD2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -69.08 -50.94 43.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.541 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 25.4 mmm -51.12 -24.76 4.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.8 mt -71.21 -32.96 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -87.52 -33.12 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -130.81 88.94 2.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -78.47 -39.86 37.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.2 t -43.56 -58.36 2.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -30.76 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.499 HG22 HG13 ' A' ' 90' ' ' ILE . 12.3 t -148.85 119.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 21.9 t -97.04 149.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.715 HG13 ' CE1' ' A' ' 88' ' ' PHE . 11.2 t -123.16 115.15 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -100.31 -178.02 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.37 -2.23 85.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 65' ' ' PHE . 8.8 mt -77.87 154.09 80.54 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.671 0.748 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.731 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.7 Cg_endo -69.76 -175.42 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.344 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -83.19 164.44 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.84 20.45 1.22 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -113.27 169.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 111.065 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.31 120.85 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.072 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CD1' HG21 ' A' ' 56' ' ' VAL . 61.3 t80 -34.56 123.31 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.536 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.1 ptpt -166.7 175.32 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.946 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.503 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -47.81 140.39 8.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.743 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.0 Cg_endo -69.65 2.08 3.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.674 2.25 . . . . 0.0 112.352 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -98.16 -17.89 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.28 -11.61 49.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.536 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 23.0 m-85 -87.72 112.01 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -40.23 144.5 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tp -39.99 -47.29 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -44.67 95.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.4 m -62.99 -47.98 80.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.743 HD21 ' O ' ' A' ' 68' ' ' PRO . 15.3 mt -46.45 -59.27 3.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -45.18 -42.11 8.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.545 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.4 t90 -56.61 -59.32 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.0 mt -41.65 -55.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.162 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.47 -37.35 77.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -62.5 -54.56 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -98.87 39.85 1.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' GLY . 27.4 pttt -85.86 -37.77 18.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -40.29 -24.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -97.61 -31.8 6.57 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.5 mt -42.25 110.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 111.058 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 m -121.93 138.56 54.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.715 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.7 m-85 -98.01 124.31 42.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.67 110.06 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.676 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.96 113.06 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.152 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 18.8 mmtt -91.08 -32.58 15.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.06 130.13 0.26 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.652 0.739 . . . . 0.0 110.866 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.443 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.76 122.96 9.64 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.669 2.246 . . . . 0.0 112.349 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.584 ' CD2' ' HD3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -37.59 156.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.0 mt -52.78 127.19 22.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.903 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -134.06 83.63 45.09 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.641 0.734 . . . . 0.0 110.89 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -179.26 2.77 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.713 2.275 . . . . 0.0 112.353 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -156.69 151.64 26.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.39 -179.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -175.08 121.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.96 133.73 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.03 156.96 7.38 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.02 135.13 1.79 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.542 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.1 t -47.95 165.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.897 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -124.36 -159.78 10.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.456 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 106.97 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.74 2.293 . . . . 0.0 112.369 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.5 p -119.45 121.54 39.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.7 m -76.77 -61.18 2.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.821 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.492 -179.965 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -130.47 119.78 23.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 t -125.72 124.69 41.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.23 -176.7 33.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.466 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -44.31 116.48 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.866 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.1 p -105.43 134.12 49.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.54 -137.12 12.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.481 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 23.7 mtt -95.59 146.88 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 m -81.16 176.86 9.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.865 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 13' ' ' VAL . 7.6 p -72.45 -38.86 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.14 -9.31 59.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.14 87.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 10' ' ' VAL . 3.9 p -65.35 -28.77 45.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.97 -65.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.951 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 10.1 tt -47.03 -41.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.4 mm-40 -64.54 -45.94 84.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -62.37 -33.06 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.145 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.1 mt -61.06 -48.2 82.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.408 ' CG ' ' HA ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -60.66 -43.47 97.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mtmm -60.88 -52.03 66.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.603 HG22 HD21 ' A' ' 80' ' ' LEU . 95.0 m -51.79 -48.3 63.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.09 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 18' ' ' LEU . 18.9 t -67.12 -36.47 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -54.69 -43.54 72.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.88 -50.99 60.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.569 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.7 t80 -42.71 -64.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.5 m-85 -43.7 -35.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 -36.87 66.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.711 ' HA ' HG12 ' A' ' 39' ' ' VAL . 13.9 t80 -66.79 -46.9 73.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.2 m -64.28 -40.01 95.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.733 ' CD1' HD11 ' A' ' 90' ' ' ILE . 16.2 t80 -69.71 -47.53 62.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.972 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 -28.98 64.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.434 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -47.64 68.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.863 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.08 73.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.0 -36.3 81.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 23.38 9.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.498 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.579 ' HE2' HG21 ' A' ' 40' ' ' VAL . 17.4 mtmt -92.37 178.36 5.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 m -107.42 17.63 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 p -152.82 163.5 39.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.213 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -77.46 146.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.155 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.579 HG21 ' HE2' ' A' ' 36' ' ' LYS . 64.4 t -118.29 133.81 23.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.448 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 96.2 t -70.82 112.06 11.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.577 0.703 . . . . 0.0 111.133 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.2 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -49.49 -49.9 43.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -45.51 -50.66 12.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -71.56 -55.56 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 40.1 mmm -49.84 -19.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.826 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 -35.37 42.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -78.95 -40.11 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.28 99.16 4.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.56 43.42 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 53' ' ' ALA . 12.2 p -118.45 -56.61 2.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.883 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.42 -36.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 52' ' ' SER . 6.2 t -152.48 123.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 56' ' ' VAL . 46.4 t -94.15 161.3 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.801 HG21 ' CD1' ' A' ' 65' ' ' PHE . 14.2 t -134.07 121.76 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.94 166.98 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.35 3.33 69.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.436 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 9.6 mt -76.09 152.68 84.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.685 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.7 Cg_endo -69.75 -172.77 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.626 2.217 . . . . 0.0 112.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.33 160.93 21.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.78 31.7 2.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.685 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -121.79 155.46 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.79 123.17 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 56' ' ' VAL . 78.8 t80 -35.55 119.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 11.8 ptpt -164.65 171.01 14.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.536 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 5.7 t-80 -41.76 140.94 1.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.553 0.692 . . . . 0.0 110.855 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 1.002 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.67 -2.95 10.99 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.385 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HA ' ' CG ' ' A' ' 19' ' ' ARG . 7.5 pt-20 -95.87 -21.83 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -78.13 -14.76 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.0 m-85 -84.77 119.02 24.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' THR . 2.8 m-20 -45.04 142.45 1.88 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 5.9 tp -36.49 -53.87 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.85 72.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 72' ' ' ASP . 65.0 m -64.93 -49.7 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.002 HD21 ' O ' ' A' ' 68' ' ' PRO . 13.7 mt -48.04 -50.49 27.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -51.13 -42.79 60.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.556 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.9 t90 -56.02 -56.11 24.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -46.04 -52.09 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.603 HD21 HG22 ' A' ' 21' ' ' THR . 27.4 mt -60.28 -33.0 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -67.85 -54.37 19.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -99.86 37.39 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.569 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -77.53 -45.23 26.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.47 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.69 -31.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' ILE . . . -83.97 -44.93 6.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLY . 23.9 mt -37.28 119.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 0.0 111.08 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -116.75 166.1 12.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.671 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.7 m-85 -133.92 123.8 25.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.71 111.18 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.733 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.09 113.26 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.498 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.9 mmtt -92.61 -29.59 16.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.433 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.85 139.66 0.36 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.578 0.704 . . . . 0.0 110.877 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 148.73 65.76 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -70.4 118.39 13.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.6 mt -115.29 127.95 55.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.9 142.82 1.33 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.617 0.722 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -173.67 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.637 2.225 . . . . 0.0 112.381 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' LYS . 19.6 pttt -167.57 162.34 14.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 98' ' ' LYS . 33.6 mtpt -37.14 -62.75 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.6 t60 43.07 54.74 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.0 m -95.22 50.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 53.19 -105.38 0.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.551 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -163.58 141.29 7.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.498 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.8 m -138.85 117.24 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.3 120.26 21.14 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.498 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 109.72 2.38 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.668 2.245 . . . . 0.0 112.325 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.3 p -94.03 122.01 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.5 m -104.8 123.58 47.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.517 179.991 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -86.54 151.99 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 110.802 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.3 m -56.31 122.08 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.76 -143.05 5.11 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.56 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 m -101.01 156.35 17.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.3 t -125.66 153.81 43.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.52 -144.83 15.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.436 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -110.68 118.14 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.84 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -72.56 165.44 24.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 13' ' ' VAL . 5.6 p -64.11 -42.19 94.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.091 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -86.22 -12.69 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.431 ' O ' ' CG ' ' A' ' 16' ' ' GLU . . . -61.09 -42.22 98.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.084 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 10' ' ' VAL . 3.2 p -60.01 -33.35 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.75 -66.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.7 tt -49.15 -36.04 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 12' ' ' ALA . 5.2 mm-40 -71.24 -42.64 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 m -65.22 -39.66 93.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.196 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.0 mt -58.24 -45.94 86.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -56.49 -33.36 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' N ' ' HE2' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -70.44 -57.96 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.638 HG22 HD21 ' A' ' 80' ' ' LEU . 9.9 m -40.37 -46.01 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.671 HG12 ' CE2' ' A' ' 26' ' ' PHE . 40.1 t -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 28.1 mt-10 -57.94 -41.91 83.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.45 -42.37 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.467 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 5.9 t80 -50.36 -60.57 2.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.671 ' CE2' HG12 ' A' ' 22' ' ' VAL . 19.0 m-85 -46.87 -37.45 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.0 m -69.56 -42.89 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.737 ' HA ' HG12 ' A' ' 39' ' ' VAL . 5.5 t80 -58.7 -56.79 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -53.73 -47.08 70.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.752 ' CD1' HD11 ' A' ' 90' ' ' ILE . 13.2 t80 -58.83 -68.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.69 -31.23 53.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.489 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.76 -42.23 82.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -28.04 65.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.87 -31.81 72.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.16 24.51 11.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.686 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.9 mtmt -93.86 179.96 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -109.47 20.93 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.7 p -155.42 159.58 39.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -73.28 144.65 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.686 HG21 ' HE2' ' A' ' 36' ' ' LYS . 93.4 t -122.39 138.36 29.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.733 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.631 ' HD2' HG13 ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.75 128.38 15.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 26' ' ' PHE . 69.9 t -72.29 111.87 12.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.612 0.72 . . . . 0.0 111.133 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 80.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.52 ' O ' ' C ' ' A' ' 45' ' ' GLU . 74.0 m-85 -54.96 -72.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.0 tp10 -28.03 -61.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 10.7 mptt -55.07 -49.13 72.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.957 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.561 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 56.9 mtp -57.32 -56.76 17.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 8.6 mt -40.41 -34.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -78.55 -42.33 29.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' MET . 2.4 m-20 -134.16 95.44 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -79.99 42.93 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.4 t -118.76 -57.85 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.58 -38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 90' ' ' ILE . 56.9 t -147.33 119.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.01 146.94 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.74 HG21 ' CD1' ' A' ' 65' ' ' PHE . 23.1 t -115.36 131.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -121.93 166.19 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.0 63.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.8 mt -92.45 158.06 39.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.606 0.717 . . . . 0.0 110.865 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.8 Cg_endo -69.77 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -96.22 164.33 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.93 13.99 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.526 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 64' ' ' ALA . 3.8 p -106.25 175.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.334 . . . . 0.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.731 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -156.55 117.89 3.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.03 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.74 ' CD1' HG21 ' A' ' 56' ' ' VAL . 84.4 t80 -33.67 124.87 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' CD ' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -169.33 179.48 3.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.8 t-80 -51.8 141.48 26.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 110.879 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.724 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.1 Cg_endo -69.8 -6.23 18.13 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.705 2.27 . . . . 0.0 112.362 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -93.23 -18.88 21.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.45 ' HB3' ' CD ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -79.92 -17.25 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.13 133.92 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' LEU . 0.6 OUTLIER -64.91 146.19 55.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.871 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 8.5 tp -37.66 -40.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.18 -53.98 51.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -59.67 -52.76 64.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.4 mt -39.29 -52.31 2.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -52.9 -48.93 66.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.554 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.2 t90 -50.22 -59.83 3.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.2 mt -41.02 -52.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.086 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.638 HD21 HG22 ' A' ' 21' ' ' THR . 20.4 mt -61.09 -37.1 81.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -62.64 -53.12 59.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -100.52 36.67 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' GLY . 56.8 pttt -80.41 -48.72 12.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.455 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.28 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.42 -33.71 7.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 15.1 mt -42.91 122.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.375 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -124.22 163.39 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.2 m-85 -131.48 124.56 30.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.81 110.66 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.67 113.44 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -91.32 -28.69 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.479 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.89 136.53 0.32 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.653 0.739 . . . . 0.0 110.844 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.88 131.79 21.8 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 46' ' ' LYS . 63.6 m-85 -52.36 169.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.841 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.464 ' C ' ' CD ' ' A' ' 96' ' ' GLU . 25.7 mt -109.64 119.86 40.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.877 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' CD ' ' C ' ' A' ' 95' ' ' LEU . 24.1 mp0 -143.2 136.39 13.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.684 0.754 . . . . 0.0 110.858 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -169.23 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.654 2.236 . . . . 0.0 112.354 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 40.6 tptt -116.98 152.31 34.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 11.1 ptmt -81.33 176.47 9.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.899 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 99' ' ' LYS . 9.5 m-70 -174.81 126.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.861 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 102' ' ' GLY . 14.5 p -131.62 155.57 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.167 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -77.76 -151.69 5.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.508 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -129.92 64.17 0.61 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.557 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.1 m -118.14 124.96 49.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.963 0.411 . . . . 0.0 110.768 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 161.41 -158.18 29.91 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.4 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 133.41 25.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.746 2.297 . . . . 0.0 112.336 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.5 m -114.42 145.15 42.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.9 t -97.68 -46.09 6.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.513 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t -107.82 158.7 17.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.976 0.417 . . . . 0.0 110.782 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -141.57 110.89 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.854 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.53 -168.29 12.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.6 p -133.65 177.57 7.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.925 0.393 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.7 t -126.19 155.81 41.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 122.08 172.29 14.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.521 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 9.8 mtt -86.24 155.14 20.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -163.72 174.12 12.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 13' ' ' VAL . 7.7 p -68.26 -47.6 77.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.517 ' N ' HG13 ' A' ' 10' ' ' VAL . 5.0 p-10 -77.7 -17.63 57.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 16' ' ' GLU . . . -49.22 -40.34 33.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 10' ' ' VAL . 8.9 p -69.43 -38.44 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.184 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.51 -64.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.824 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -48.64 -34.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 12' ' ' ALA . 7.3 mm-40 -72.3 -45.26 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -60.78 -35.39 76.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 25.0 mt -62.2 -42.7 99.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -62.07 -41.97 98.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.78 -54.04 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.538 HG22 HD21 ' A' ' 80' ' ' LEU . 87.3 m -44.87 -49.81 10.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.799 HG12 ' CE2' ' A' ' 26' ' ' PHE . 53.4 t -67.8 -40.54 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 14.7 mt-10 -50.76 -47.47 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.47 -51.46 65.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.2 t80 -42.44 -63.92 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.928 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.799 ' CE2' HG12 ' A' ' 22' ' ' VAL . 28.0 m-85 -41.89 -38.89 1.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.2 m -66.78 -44.89 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.611 ' HA ' HG12 ' A' ' 39' ' ' VAL . 14.6 t80 -58.28 -50.9 71.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.2 m -59.3 -43.44 92.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.41 ' CE1' HD11 ' A' ' 90' ' ' ILE . 12.9 t80 -62.1 -63.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.41 -29.28 66.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 -43.13 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.352 . . . . 0.0 110.975 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -33.53 74.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.04 -34.23 75.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 28.35 8.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.663 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.3 mtmt -95.66 179.62 5.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 m -109.23 22.11 16.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.9 p -154.49 175.1 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -88.74 141.53 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.663 HG21 ' HE2' ' A' ' 36' ' ' LYS . 91.9 t -116.7 132.7 23.25 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.657 0.742 . . . . 0.0 111.163 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.0 Cg_endo -69.78 116.72 4.69 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.636 2.224 . . . . 0.0 112.37 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.481 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 46.3 t -67.25 112.28 9.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 79.5 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.709 2.272 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -51.3 -49.19 61.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -49.48 -48.99 47.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -68.34 -60.37 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.692 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 69.7 mtp -45.56 -35.45 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -58.8 -42.2 88.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.974 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -46.32 83.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -134.98 100.02 4.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -84.7 46.22 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.1 p -121.51 -44.61 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.12 -43.7 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.646 HG22 HG13 ' A' ' 90' ' ' ILE . 93.6 t -140.26 128.4 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 56' ' ' VAL . 88.4 t -100.94 158.58 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.084 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.718 HG13 ' CE1' ' A' ' 88' ' ' PHE . 21.6 t -131.76 119.1 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -103.16 178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.78 -0.33 88.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.422 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 59' ' ' LEU . 10.4 mt -77.07 153.84 82.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.723 . . . . 0.0 110.937 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.643 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.0 Cg_endo -69.82 -171.81 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.339 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -84.6 162.51 19.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.64 31.74 1.84 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 60' ' ' PRO . 6.0 p -119.15 161.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.098 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -140.9 119.29 12.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.149 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 48.6 t80 -34.48 131.17 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 11.4 ptpt -175.09 163.14 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.7 t-80 -36.73 141.31 0.39 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.863 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.883 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.77 -4.06 13.28 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.308 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -89.18 -27.03 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.72 -18.64 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-85 -80.97 111.34 17.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -42.69 145.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 11.0 tp -38.85 -46.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.32 82.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 50.2 m -63.16 -45.2 92.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.883 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.7 mt -48.64 -53.05 20.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -49.2 -45.55 44.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.56 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.6 t90 -54.55 -63.77 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -40.05 -50.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.538 HD21 HG22 ' A' ' 21' ' ' THR . 18.0 mt -62.11 -35.65 79.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' TRP . 10.3 mt-10 -65.32 -54.98 21.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -98.21 40.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 18.4 ptmt -82.68 -50.57 8.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 83' ' ' LYS . . . -35.07 -37.95 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.72 13.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.54 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 16.2 mt -37.9 124.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -126.47 169.98 12.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.718 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.6 m-85 -132.54 125.72 31.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.09 112.5 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -84.52 112.46 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.466 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.1 mmtp -91.51 -28.87 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.465 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.57 130.74 0.26 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.757 . . . . 0.0 110.898 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.42 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo -69.71 127.61 14.88 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.742 2.295 . . . . 0.0 112.391 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -45.04 168.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.2 mt -110.62 131.43 55.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -149.81 142.08 15.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.655 0.741 . . . . 0.0 110.868 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -171.89 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.658 2.239 . . . . 0.0 112.322 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -64.79 131.34 46.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -44.24 125.0 4.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -141.53 122.82 14.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.87 107.29 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 0.0 111.119 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.03 91.68 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.86 125.83 0.79 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.8 p -168.66 157.35 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.885 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.72 -74.94 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -1.58 8.66 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.7 p -43.55 -52.42 6.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.8 m -90.7 -62.59 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.551 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.4 t -117.99 -50.01 2.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -101.98 171.64 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.97 -45.88 1.13 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.489 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.7 p -62.99 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.837 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.3 p -144.17 135.99 26.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.57 175.12 40.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.26 158.21 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 110.884 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -112.01 172.21 7.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 11' ' ' ASP . 7.1 p -78.92 -42.05 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.165 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.436 ' N ' HG13 ' A' ' 10' ' ' VAL . 13.1 t70 -79.24 -13.87 59.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.515 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -50.93 -51.41 52.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.84 -19.31 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -71.2 -47.88 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 12' ' ' ALA . 6.1 tt -62.88 -32.76 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -76.39 -39.26 54.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 m -65.91 -35.82 81.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD12 ' CD1' ' A' ' 73' ' ' LEU . 19.4 mt -63.52 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.98 -39.25 81.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -66.01 -52.42 49.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.498 HG22 HD21 ' A' ' 80' ' ' LEU . 27.8 m -52.01 -48.36 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 26' ' ' PHE . 58.8 t -66.5 -38.51 81.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.162 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 13.3 mt-10 -56.75 -41.18 77.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.38 -47.91 62.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.402 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 7.2 t80 -44.59 -63.1 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.576 ' HB3' HG21 ' A' ' 42' ' ' VAL . 21.9 m-85 -43.31 -38.83 2.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.5 m -65.45 -46.02 81.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.556 ' HA ' HG12 ' A' ' 39' ' ' VAL . 10.3 t80 -56.61 -58.28 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 92.9 m -54.06 -40.75 67.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -64.61 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.65 -27.54 58.91 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.531 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -41.66 73.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.03 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.08 -33.99 77.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 25.77 8.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.485 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.673 ' HE2' HG21 ' A' ' 40' ' ' VAL . 12.4 mtmt -96.29 179.24 5.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.93 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.4 7.75 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.5 p -140.31 167.79 21.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -80.35 148.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 ' HE2' ' A' ' 36' ' ' LYS . 87.2 t -127.1 135.51 27.49 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.642 0.734 . . . . 0.0 111.1 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.541 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.79 121.02 7.71 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.74 2.293 . . . . 0.0 112.32 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 26' ' ' PHE . 57.3 t -66.69 112.09 8.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 79.68 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.698 2.265 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' MET . 95.1 m-85 -47.43 -71.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 44' ' ' TYR . 7.7 tp10 -29.42 -59.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -60.13 -40.22 89.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 44' ' ' TYR . 28.0 mmm -64.08 -50.06 69.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 15.5 mt -51.22 -37.2 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -90.29 -26.89 19.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -135.0 77.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -72.52 -40.61 66.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -43.2 -57.28 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -33.02 -39.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.088 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 HG13 ' A' ' 90' ' ' ILE . 13.6 t -148.93 119.92 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.93 152.95 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.886 HG21 ' CD1' ' A' ' 65' ' ' PHE . 31.4 t -121.68 124.56 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -116.52 160.75 20.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.81 10.05 59.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.449 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 59' ' ' LEU . 13.2 mt -85.02 157.83 59.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.4 Cg_endo -69.82 -167.51 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 9.0 tp10 -96.06 156.25 16.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 56.68 18.17 23.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.558 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.569 HG11 ' HD2' ' A' ' 60' ' ' PRO . 9.7 p -109.12 166.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.072 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.528 ' N ' HG22 ' A' ' 63' ' ' VAL . . . -144.37 113.04 6.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.886 ' CD1' HG21 ' A' ' 56' ' ' VAL . 29.1 t80 -34.24 111.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.4 ptpt -156.69 -178.87 7.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.3 t-80 -48.81 141.43 10.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.629 0.728 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.956 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.1 Cg_endo -69.67 -7.31 20.69 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.756 2.304 . . . . 0.0 112.379 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -91.95 -19.92 21.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -81.48 -16.58 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.9 m-85 -84.44 120.13 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.5 OUTLIER -49.66 143.68 6.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.61 ' CD1' HD12 ' A' ' 18' ' ' LEU . 7.9 tp -37.48 -46.06 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.19 80.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 72' ' ' ASP . 61.8 m -67.08 -50.66 60.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.073 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.956 HD21 ' O ' ' A' ' 68' ' ' PRO . 19.5 mt -42.88 -51.82 5.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -52.22 -47.09 65.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.551 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -52.0 -62.25 1.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.5 mt -39.25 -53.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 21' ' ' THR . 20.8 mt -59.61 -39.78 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.66 -54.4 45.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -99.87 38.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.821 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' GLY . 55.4 pttt -80.67 -51.22 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -37.76 -27.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.127 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -90.17 -35.62 7.49 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.54 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.3 mt -43.27 123.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 111.067 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.1 m -121.83 168.75 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 56' ' ' VAL . 9.4 m-85 -136.01 121.34 19.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.07 111.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.64 112.84 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -92.04 -29.77 16.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.466 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.91 134.2 0.29 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.571 0.7 . . . . 0.0 110.846 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 52.9 Cg_endo -69.83 127.58 14.73 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.61 2.206 . . . . 0.0 112.349 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -46.2 126.23 7.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.4 mt -116.99 146.69 42.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -138.07 151.59 70.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.693 0.758 . . . . 0.0 110.864 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 170.95 15.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.767 2.311 . . . . 0.0 112.309 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 99' ' ' LYS . 1.7 ttpm? 63.77 41.09 7.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 100' ' ' HIS . 58.1 mttt 37.98 43.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 99' ' ' LYS . 6.9 p-80 -34.93 129.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.5 t -96.0 84.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.175 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.7 -61.45 4.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 154.93 -139.82 6.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.521 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.2 p -158.41 108.49 2.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.867 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.25 164.72 34.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 158.16 58.0 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.704 2.269 . . . . 0.0 112.312 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -81.22 172.67 13.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.6 t -140.27 173.64 11.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.843 0.354 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.61 -63.29 1.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.0 tt -49.64 -31.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.211 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -76.48 -40.1 51.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 m -67.11 -35.33 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 22' ' ' VAL . 28.3 mt -64.72 -45.24 87.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.927 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -58.08 -34.81 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -67.15 -50.83 59.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.401 HG22 HD21 ' A' ' 80' ' ' LEU . 6.9 m -51.22 -48.2 62.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG12 ' CE2' ' A' ' 26' ' ' PHE . 11.7 t -65.77 -36.12 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.107 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.03 -42.65 94.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.99 -49.61 49.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.574 ' CE1' ' CE ' ' A' ' 83' ' ' LYS . 6.8 t80 -41.93 -64.25 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.563 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.6 m-85 -42.01 -34.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.4 m -72.69 -36.73 67.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.717 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.2 t80 -67.39 -48.68 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.0 m -63.58 -39.81 95.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.691 ' CD1' HD11 ' A' ' 90' ' ' ILE . 13.1 t80 -67.62 -52.57 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.64 -29.02 72.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -44.87 72.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.72 -27.61 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.38 -33.16 75.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.67 20.48 19.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -92.71 179.12 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.1 p -108.53 20.05 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -151.8 164.16 37.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.4 m -80.72 142.07 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.5 HG13 ' HD2' ' A' ' 41' ' ' PRO . 40.2 t -115.63 135.96 22.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.77 117.91 5.37 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.409 HG13 ' SD ' ' A' ' 47' ' ' MET . 92.3 t -73.24 112.07 14.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 80.49 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.686 2.257 . . . . 0.0 112.289 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -53.04 -47.51 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -50.34 -44.83 54.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.947 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -74.32 -59.27 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.566 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 59.3 mtp -45.7 -33.59 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.1 mt -60.46 -48.32 82.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -73.39 -36.29 66.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -128.33 97.93 4.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.797 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -95.13 47.14 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 p -124.52 -41.51 2.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.812 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.89 25.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.064 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 90' ' ' ILE . 25.5 t -149.87 126.0 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 56' ' ' VAL . 46.6 t -98.42 158.4 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.75 HG21 ' CD1' ' A' ' 65' ' ' PHE . 44.5 t -128.13 126.51 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -120.49 165.32 15.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.16 10.82 68.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.6 mt -84.22 155.76 63.41 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.542 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.2 Cg_endo -69.76 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 0.0 112.376 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.57 158.03 15.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.2 17.26 23.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 64' ' ' ALA . 3.4 p -108.61 175.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.136 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.719 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -157.01 120.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.75 ' CD1' HG21 ' A' ' 56' ' ' VAL . 84.6 t80 -34.79 119.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HZ3' ' HE1' ' A' ' 71' ' ' TYR . 11.2 ptpp? -166.56 170.5 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -45.45 141.65 3.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.528 0.68 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.84 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.75 -1.06 7.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 0.0 112.366 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.19 -17.48 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.2 -14.89 57.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.423 ' HE1' ' HZ3' ' A' ' 66' ' ' LYS . 23.6 m-85 -88.33 135.39 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 149.2 47.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.45 HD11 ' CD1' ' A' ' 18' ' ' LEU . 6.8 tp -40.47 -39.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.22 23.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.4 m -59.17 -45.6 90.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.9 mt -46.27 -49.59 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -55.68 -43.79 76.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.542 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 60.1 t90 -53.28 -60.15 3.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.2 mt -41.62 -53.63 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 21' ' ' THR . 23.8 mt -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.99 -53.85 43.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.447 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -100.49 35.13 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.574 ' CE ' ' CE1' ' A' ' 25' ' ' TYR . 21.1 ptmt -74.19 -52.59 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.93 -30.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.066 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -84.96 -37.85 9.79 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 19.4 mt -45.52 124.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 0.0 111.058 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -124.71 168.75 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 56' ' ' VAL . 5.9 m-85 -135.72 129.46 32.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.01 112.0 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.691 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.0 113.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.1 mmtt -91.0 -29.73 17.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.475 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.93 135.29 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.408 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.294 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.865 0.364 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.09 -65.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 tt -50.4 -32.15 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -76.27 -36.91 58.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -70.96 -34.52 71.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.508 HD12 ' CD1' ' A' ' 73' ' ' LEU . 17.1 mt -62.79 -47.45 83.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.949 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -54.99 -41.33 71.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -67.16 -51.58 52.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.607 HG22 HD21 ' A' ' 80' ' ' LEU . 91.6 m -49.03 -48.4 43.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.109 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 26' ' ' PHE . 86.3 t -67.69 -37.02 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.446 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 13.8 mt-10 -56.05 -43.05 77.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -65.68 -49.51 68.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.586 ' CD1' ' HE3' ' A' ' 83' ' ' LYS . 8.7 t80 -44.12 -64.19 0.72 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.538 ' CE2' HG12 ' A' ' 22' ' ' VAL . 26.5 m-85 -42.8 -39.83 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.537 ' HA ' HG12 ' A' ' 39' ' ' VAL . 21.2 t80 -65.28 -56.64 11.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.1 m -54.05 -40.47 67.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.578 ' CD1' HD11 ' A' ' 90' ' ' ILE . 14.8 t80 -65.78 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.19 -25.02 61.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.541 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.13 -42.16 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.68 67.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.091 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -62.69 -34.83 77.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.47 24.03 9.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.545 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.523 ' HE2' HG21 ' A' ' 40' ' ' VAL . 8.7 mtmt -92.35 -179.97 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 t -109.87 19.3 19.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -154.09 161.87 41.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.3 m -74.77 144.35 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.523 HG21 ' HE2' ' A' ' 36' ' ' LYS . 40.5 t -119.46 136.08 24.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.598 0.713 . . . . 0.0 111.135 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.3 Cg_endo -69.71 118.5 5.72 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.662 2.242 . . . . 0.0 112.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.4 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 94.3 t -70.42 111.99 11.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . 53.5 Cg_endo -69.81 79.97 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -55.88 -47.16 77.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -51.27 -46.4 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HD2' ' CB ' ' A' ' 43' ' ' PRO . 44.6 mttt -71.7 -55.56 7.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.469 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 80.1 mtp -50.33 -31.97 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.48 -30.43 71.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -86.03 -38.49 17.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -133.18 94.65 3.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.2 40.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' VAL . 22.1 p -113.36 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -32.95 -35.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 90' ' ' ILE . 19.0 t -148.78 143.32 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.477 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 58.7 t -118.04 139.9 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 65' ' ' PHE . 22.9 t -109.17 125.71 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -120.03 158.85 25.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.12 15.35 45.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.504 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.6 mt -87.12 154.34 54.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.936 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.621 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.9 Cg_endo -69.68 -168.68 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -86.99 164.42 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.79 29.1 0.75 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.437 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.621 HG11 ' HD2' ' A' ' 60' ' ' PRO . 4.0 p -117.84 156.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -139.15 118.26 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 56' ' ' VAL . 83.3 t80 -34.11 117.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.7 ptpt -164.33 174.41 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.524 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -44.86 140.75 3.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.721 . . . . 0.0 110.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.882 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.6 Cg_endo -69.75 2.28 3.66 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -97.18 -22.04 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -81.17 -12.45 59.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.7 m-85 -88.2 117.7 27.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' LEU . 2.0 m-20 -49.02 144.03 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.508 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.2 tp -35.72 -50.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.29 -51.14 63.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -60.98 -46.65 89.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.882 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.1 mt -47.53 -54.96 10.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.938 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -48.56 -47.93 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.2 t90 -48.64 -61.62 1.94 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.2 mt -41.14 -52.42 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.607 HD21 HG22 ' A' ' 21' ' ' THR . 29.4 mt -59.49 -37.82 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.56 -55.27 25.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.73 37.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.586 ' HE3' ' CD1' ' A' ' 25' ' ' TYR . 16.6 ptmt -72.85 -53.92 10.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.17 -33.4 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.055 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.65 -33.28 38.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 25.0 mt -53.19 126.05 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.5 m -123.91 169.06 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.828 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.554 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.1 m-85 -136.42 126.41 26.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.04 109.61 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.17 112.98 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.477 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.4 mmtp -92.05 -31.28 15.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.591 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.72 129.96 0.28 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.875 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.461 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 0.0 112.323 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.789 0.328 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.49 -63.62 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 9.6 tt -51.13 -38.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.7 mm-40 -68.78 -46.03 69.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 m -61.56 -33.44 73.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 19.1 mt -59.25 -47.48 85.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.452 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -58.85 -47.68 84.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -54.53 -52.62 61.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.505 HG22 HD21 ' A' ' 80' ' ' LEU . 24.6 m -51.46 -48.38 62.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.535 HG12 ' CE2' ' A' ' 26' ' ' PHE . 23.7 t -67.72 -37.41 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -56.41 -36.92 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.94 -47.9 27.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.3 t80 -44.34 -63.06 0.96 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.535 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.3 m-85 -41.92 -34.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.1 m -71.83 -38.91 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.746 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.7 t80 -64.8 -47.52 77.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 65.3 m -65.56 -41.75 92.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.744 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.7 t80 -66.7 -47.91 70.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.98 -32.67 63.21 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -42.31 93.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.42 -31.3 70.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -61.71 -36.1 79.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.41 10.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.474 ' HE2' HG21 ' A' ' 40' ' ' VAL . 18.8 mtmt -94.28 179.31 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.0 p -108.65 21.01 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.0 p -155.76 162.27 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.746 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.0 m -76.12 155.41 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.474 HG21 ' HE2' ' A' ' 36' ' ' LYS . 41.5 t -132.87 135.0 25.21 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.663 0.744 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.1 Cg_endo -69.77 118.55 5.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 0.0 112.286 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 81.3 t -67.0 117.81 49.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 111.122 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 80.01 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -50.57 -53.11 32.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 2.6 tp10 -43.16 -56.21 3.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -65.79 -56.1 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 41.0 mmm -50.06 -23.52 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.826 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.24 -30.41 57.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.955 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -84.52 -42.12 15.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.33 94.54 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -81.69 47.63 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.915 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -125.18 -56.07 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.72 -36.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 90' ' ' ILE . 16.1 t -149.69 119.77 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.471 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 19.9 t -95.86 154.85 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.817 HG13 ' CE1' ' A' ' 88' ' ' PHE . 5.0 t -125.69 119.53 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -112.04 158.93 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.41 13.24 42.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.1 mt -85.89 156.97 57.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.667 0.746 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.621 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.4 Cg_endo -69.8 -172.16 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -86.53 158.87 19.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.39 28.7 9.8 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 64' ' ' ALA . 4.2 p -118.69 171.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.635 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -154.66 120.31 5.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 56' ' ' VAL . 82.4 t80 -35.15 121.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -167.31 170.58 11.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.3 t-80 -39.75 141.01 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.65 0.738 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 1.0 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.71 -9.54 26.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -91.19 -16.81 27.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -82.82 -13.88 55.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CD2' HD11 ' A' ' 79' ' ' ILE . 21.9 m-85 -87.39 121.06 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.03 147.67 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 7.0 tp -40.01 -48.8 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.41 -44.73 84.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -63.42 -57.79 9.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.0 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.0 mt -39.44 -47.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -55.05 -46.55 75.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.56 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.5 t90 -54.5 -58.81 6.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.523 HD11 ' CD2' ' A' ' 71' ' ' TYR . 49.4 mt -41.52 -53.76 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 21' ' ' THR . 14.2 mt -61.1 -40.5 93.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -55.61 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -97.93 35.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 51.8 pttt -77.63 -49.77 13.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.82 -26.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -91.24 -39.1 5.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' LYS . 28.4 mt -43.22 122.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 111.149 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -120.49 162.73 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.817 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.3 m-85 -128.25 126.48 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.5 110.35 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.744 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.41 113.17 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 19.5 mmtt -91.45 -28.12 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.474 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 134.5 0.31 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.632 0.73 . . . . 0.0 110.842 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.422 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.2 0 C-N-CA 122.612 2.208 . . . . 0.0 112.392 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.752 0.311 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.47 -65.05 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tt -49.66 -31.01 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -76.6 -40.15 50.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -66.8 -34.44 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.51 HD12 ' CD1' ' A' ' 73' ' ' LEU . 20.6 mt -63.54 -41.39 98.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -64.44 -39.09 93.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -41.6 77.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.511 HG22 HD21 ' A' ' 80' ' ' LEU . 90.0 m -59.78 -49.03 79.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.551 HG12 ' CE2' ' A' ' 26' ' ' PHE . 96.1 t -65.36 -37.34 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.084 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -54.85 -39.14 68.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.92 -52.16 32.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 10.0 t80 -42.34 -62.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.716 ' HB3' HG21 ' A' ' 42' ' ' VAL . 21.4 m-85 -43.78 -40.74 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 m -68.32 -37.83 80.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.75 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -66.47 -47.0 74.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.5 m -64.1 -40.94 97.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.97 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.928 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.9 t80 -66.61 -56.71 9.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.23 -29.84 74.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.464 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -42.25 75.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.745 0.307 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -26.52 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.092 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.5 mt -67.6 -30.9 70.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 23.09 13.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.735 ' HE2' HG21 ' A' ' 40' ' ' VAL . 14.6 mtmt -95.77 178.85 5.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.347 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -107.7 6.06 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.2 p -136.95 160.96 37.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.3 m -79.35 136.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.735 HG21 ' HE2' ' A' ' 36' ' ' LYS . 55.0 t -112.76 137.8 21.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 0.0 111.137 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.584 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.74 125.76 12.53 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.672 2.248 . . . . 0.0 112.383 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 26' ' ' PHE . 61.7 t -71.13 111.93 11.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.619 0.723 . . . . 0.0 111.169 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 80.44 0.89 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.674 2.249 . . . . 0.0 112.326 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -53.02 -53.21 53.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -47.42 -52.03 18.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -65.86 -61.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.551 ' HE1' ' CZ ' ' A' ' 65' ' ' PHE . 79.4 mtp -43.54 -37.95 2.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.5 mt -55.31 -40.26 70.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -82.26 -39.52 22.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -126.16 80.24 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -68.19 -20.63 64.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.2 t -62.25 -57.14 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -31.79 -36.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' SER . 15.0 t -151.53 121.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 91' ' ' LYS . 20.8 t -100.02 157.78 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 65' ' ' PHE . 23.7 t -125.53 123.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -117.36 153.24 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.46 39.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 59' ' ' LEU . 12.3 mt -84.85 155.73 61.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.623 0.725 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.666 ' O ' HG12 ' A' ' 63' ' ' VAL . 52.8 Cg_endo -69.86 178.86 4.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.297 . . . . 0.0 112.311 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.18 154.61 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.08 23.21 51.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.543 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -116.61 164.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.161 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -144.59 117.95 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.746 ' CD1' HG21 ' A' ' 56' ' ' VAL . 64.1 t80 -34.65 120.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -167.11 171.48 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -42.96 141.89 1.57 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.88 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.3 Cg_endo -69.77 -4.88 14.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.319 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.92 -14.27 26.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -85.21 -12.38 52.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.54 128.38 36.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 73' ' ' LEU . 4.5 m-20 -56.63 145.81 27.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.9 tp -36.19 -48.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.74 62.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -58.89 -46.38 87.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.88 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.2 mt -47.61 -47.99 28.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.985 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -55.1 -48.58 73.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.841 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.3 t90 -49.21 -60.56 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.6 mt -40.74 -53.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.511 HD21 HG22 ' A' ' 21' ' ' THR . 23.3 mt -58.73 -38.78 79.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -62.98 -55.42 25.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.465 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.48 38.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.9 pttp -77.39 -45.42 25.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.476 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -44.06 -35.89 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.07 -35.27 31.05 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 mt -49.51 123.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -126.09 167.6 15.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.54 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.6 m-85 -132.83 128.43 36.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.69 111.06 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.928 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.88 112.52 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HE3' HG21 ' A' ' 55' ' ' VAL . 22.3 mmtt -89.94 -33.3 16.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.17 129.6 0.26 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 110.835 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.44 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.201 0 C-N-CA 122.732 2.288 . . . . 0.0 112.371 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.824 0.345 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.5 -57.33 3.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 5.5 tt -54.48 -46.11 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.082 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.549 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.3 mt-10 -63.48 -48.61 76.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 m -57.2 -30.89 64.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 28.6 mt -64.54 -48.64 74.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.697 ' HD2' HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -58.18 -42.07 85.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -39.02 92.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.6 HG22 HD21 ' A' ' 80' ' ' LEU . 48.5 m -64.33 -49.4 71.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.643 HG12 ' CE2' ' A' ' 26' ' ' PHE . 94.5 t -66.69 -39.49 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.481 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -53.36 -43.22 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.11 -49.68 69.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 12.5 t80 -45.99 -63.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.643 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.0 m-85 -44.18 -40.4 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.7 m -65.25 -38.3 89.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.603 ' HA ' HG12 ' A' ' 39' ' ' VAL . 31.3 t80 -66.64 -59.6 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -51.49 -37.57 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.58 ' CE1' HD11 ' A' ' 90' ' ' ILE . 17.0 t80 -69.71 -64.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.18 57.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.87 -45.95 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.43 67.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mt -62.71 -33.17 74.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.86 23.43 11.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.65 ' HE2' HG21 ' A' ' 40' ' ' VAL . 10.2 mtmt -94.35 179.11 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -109.54 20.21 18.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.8 p -154.16 159.67 41.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.603 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.3 m -76.58 138.71 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.65 HG21 ' HE2' ' A' ' 36' ' ' LYS . 51.0 t -114.58 137.67 22.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.664 0.745 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.569 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.8 120.82 7.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.611 2.207 . . . . 0.0 112.349 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 58.7 t -73.72 111.96 14.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.738 . . . . 0.0 111.148 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 79.83 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.715 2.277 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -51.43 -45.2 62.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -54.36 -40.25 67.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -74.38 -59.62 2.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.625 ' HE2' ' CE2' ' A' ' 65' ' ' PHE . 92.5 mtp -47.38 -46.19 25.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -43.92 -46.96 8.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -80.77 -39.81 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -127.48 81.64 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -72.28 -30.96 65.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' ALA . 24.0 p -45.01 -50.07 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -36.14 -45.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.515 HG22 HG13 ' A' ' 90' ' ' ILE . 14.4 t -144.7 128.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.49 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 35.0 t -99.64 142.98 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 65' ' ' PHE . 39.6 t -116.56 112.66 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -102.49 162.63 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.6 0.78 64.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.6 mt -75.55 149.35 83.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.603 0.716 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.815 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.3 Cg_endo -69.81 178.47 4.57 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.685 2.257 . . . . 0.0 112.339 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.86 160.21 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.74 19.77 10.97 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -112.94 169.82 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.962 ' CD1' HG21 ' A' ' 56' ' ' VAL . 72.8 t80 -34.31 113.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -159.78 171.06 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.2 t-80 -42.15 141.24 1.42 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.92 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.8 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 0.0 112.378 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.59 -15.11 31.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -89.07 -7.15 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -91.29 121.25 32.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.82 147.16 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.82 -47.35 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.11 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.5 m -66.77 -57.51 6.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.92 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.9 mt -39.41 -48.32 1.91 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -55.99 -48.23 76.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.8 t90 -49.16 -57.71 6.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -43.1 -52.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.6 HD21 HG22 ' A' ' 21' ' ' THR . 21.6 mt -59.77 -38.28 81.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.23 -55.78 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.43 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -97.8 40.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.852 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.59 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 16.7 ptmt -80.05 -53.57 6.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.929 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -36.27 -33.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -83.29 -37.54 12.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 14.4 mt -44.14 125.83 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 t -124.34 162.99 22.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.614 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.9 m-85 -131.77 126.2 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.2 111.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.667 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.23 113.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.185 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.49 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.0 mmtt -93.18 -31.24 14.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.51 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.89 125.71 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 0.0 110.872 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' VAL . 4.4 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.823 0.344 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.9 -57.94 3.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 8.2 tt -50.83 -42.65 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.115 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.7 mt-10 -66.31 -43.23 86.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 m -63.28 -32.94 74.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 27.3 mt -61.41 -45.92 92.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.453 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -59.42 -50.14 75.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -47.78 70.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 HD21 ' A' ' 80' ' ' LEU . 24.3 m -55.25 -49.03 73.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.552 HG12 ' CE2' ' A' ' 26' ' ' PHE . 59.6 t -67.78 -36.1 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.438 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 15.3 mt-10 -57.75 -45.26 86.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -65.95 -47.98 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.406 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.4 t80 -44.87 -59.4 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.552 ' CE2' HG12 ' A' ' 22' ' ' VAL . 20.1 m-85 -46.71 -39.3 11.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.1 m -65.52 -39.9 92.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.79 ' HA ' HG12 ' A' ' 39' ' ' VAL . 12.6 t80 -64.49 -54.12 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.821 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.48 ' CB ' ' CD1' ' A' ' 88' ' ' PHE . 35.5 m -58.13 -43.86 87.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -63.15 -58.66 6.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.38 -27.86 72.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.31 -41.27 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.15 -32.65 69.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.129 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.52 -26.26 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.91 24.1 21.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.521 ' CE ' HG21 ' A' ' 40' ' ' VAL . 15.1 mtmt -96.86 177.21 5.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.6 p -109.24 22.68 15.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.0 p -153.26 165.59 35.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.0 m -84.54 140.46 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.127 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 41' ' ' PRO . 43.6 t -117.82 137.39 24.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.79 114.0 3.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.496 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 82.7 t -71.52 113.6 21.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.649 0.738 . . . . 0.0 111.076 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.427 ' CB ' ' CE ' ' A' ' 46' ' ' LYS . 54.3 Cg_endo -69.74 80.73 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 0.0 112.352 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -52.15 -45.21 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -49.46 -46.55 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' CE ' ' CB ' ' A' ' 43' ' ' PRO . 43.7 mtmt -75.69 -52.83 9.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.619 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 38.5 mtp -51.81 -21.44 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -76.67 -33.27 58.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -34.68 57.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -136.92 109.82 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -97.58 40.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 p -117.61 -41.93 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -48.93 -43.74 39.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.142 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG22 HG13 ' A' ' 90' ' ' ILE . 9.0 t -146.32 124.93 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.466 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 40.0 t -97.76 149.38 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.158 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.873 HG21 ' CD1' ' A' ' 65' ' ' PHE . 98.9 t -118.67 116.56 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.682 ' CD ' HD12 ' A' ' 89' ' ' ILE . 2.2 mp0 -100.74 -179.6 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.33 4.32 73.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.442 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.6 mt -78.11 154.02 79.9 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.67 0.748 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.643 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.8 Cg_endo -69.71 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.715 2.277 . . . . 0.0 112.341 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -87.26 160.16 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.45 29.07 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.643 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.8 p -119.18 167.65 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.529 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.59 126.78 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.063 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.873 ' CD1' HG21 ' A' ' 56' ' ' VAL . 78.4 t80 -35.95 130.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HZ2' ' HE1' ' A' ' 71' ' ' TYR . 8.5 ptpp? -174.44 172.77 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.5 t-80 -47.18 140.99 6.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.558 0.694 . . . . 0.0 110.883 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.987 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.4 Cg_endo -69.73 -7.26 20.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' OE2' ' ND1' ' A' ' 67' ' ' HIS . 5.2 pt-20 -93.09 -17.28 24.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -81.69 -15.72 53.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.426 ' HE1' ' HZ2' ' A' ' 66' ' ' LYS . 26.1 m-85 -85.05 131.8 34.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.0 OUTLIER -56.44 147.21 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.43 -49.12 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.19 79.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 26.6 m -71.15 -51.54 24.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 68' ' ' PRO . 12.2 mt -45.29 -54.17 7.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.417 ' HE2' HD11 ' A' ' 73' ' ' LEU . 17.9 mttm -49.67 -47.44 50.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.536 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.0 t90 -49.12 -55.87 10.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.9 mt -45.37 -54.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.524 HD21 HG22 ' A' ' 21' ' ' THR . 23.3 mt -59.45 -34.27 72.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.948 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.26 -52.31 55.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.92 33.82 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 86' ' ' ILE . 55.8 pttt -76.47 -45.29 31.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.58 -25.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.72 -30.24 9.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 83' ' ' LYS . 20.0 mt -49.57 122.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.8 m -121.82 170.26 9.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 29' ' ' CYS . 6.1 m-85 -128.89 116.13 18.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.682 HD12 ' CD ' ' A' ' 57' ' ' GLN . 9.2 mt -103.83 93.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.166 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.641 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -71.39 114.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.466 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.2 mmtp -93.68 -30.07 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.456 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 128.45 0.27 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.611 0.72 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.453 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.383 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -62.2 -68.85 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.9 tt -48.52 -34.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.51 -40.41 64.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -66.05 -38.04 87.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 27.6 mt -59.61 -45.8 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -58.27 -40.67 82.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.842 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -45.74 73.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.479 HG22 HD21 ' A' ' 80' ' ' LEU . 25.7 m -52.15 -49.69 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.089 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.656 HG12 ' CE2' ' A' ' 26' ' ' PHE . 42.3 t -65.92 -39.59 85.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -51.1 -48.31 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -63.97 -48.85 74.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.8 t80 -44.21 -62.69 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' HG12 ' A' ' 22' ' ' VAL . 24.6 m-85 -44.63 -35.14 2.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.0 m -67.59 -39.72 84.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.694 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -62.11 -58.04 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.8 m -54.78 -39.75 68.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -65.78 -64.8 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.78 -24.22 62.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.6 -46.64 63.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.58 -31.03 71.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.99 -34.07 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.36 22.83 11.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.41 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 40' ' ' VAL . 15.0 mtmt -91.55 179.46 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.9 p -107.98 18.98 20.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -152.12 172.72 15.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.694 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.4 m -90.05 140.44 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.18 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 36' ' ' LYS . 42.9 t -116.76 136.31 23.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.654 0.74 . . . . 0.0 111.114 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.78 122.52 9.2 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.604 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 60.2 t -73.12 112.04 14.01 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.659 0.743 . . . . 0.0 111.11 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 80.54 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.761 2.307 . . . . 0.0 112.323 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -48.84 -52.01 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.02 -52.65 14.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -65.86 -57.84 6.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 32.1 mmm -48.25 -33.65 9.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.7 mt -59.97 -32.6 70.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -87.02 -40.32 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -129.18 90.88 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -80.74 -19.89 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p -58.52 -46.72 86.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -40.53 -42.96 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.476 HG22 HG13 ' A' ' 90' ' ' ILE . 5.4 t -146.52 132.03 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 51.1 t -102.91 148.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.918 HG21 ' CD1' ' A' ' 65' ' ' PHE . 12.4 t -121.86 116.9 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -104.73 170.02 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.96 9.6 73.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.7 mt -83.45 150.15 59.49 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.636 0.732 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.664 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.6 Cg_endo -69.78 -171.98 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -83.4 163.69 20.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.37 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.664 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -119.8 157.86 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.166 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.12 123.83 16.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.918 ' CD1' HG21 ' A' ' 56' ' ' VAL . 91.5 t80 -34.62 119.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -167.37 169.89 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.6 t-80 -41.86 140.99 1.36 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.957 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.71 -6.59 18.93 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.657 2.238 . . . . 0.0 112.365 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.66 -21.4 21.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -78.86 -9.65 59.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.44 129.28 39.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.93 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' THR . 4.2 m-20 -57.77 143.46 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 72' ' ' ASP . 9.8 tp -36.32 -48.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -42.69 79.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 72' ' ' ASP . 60.7 m -70.09 -45.77 66.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.0 mt -47.78 -52.75 17.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -51.34 -46.68 62.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.1 t90 -50.05 -56.85 9.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -44.63 -55.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.479 HD21 HG22 ' A' ' 21' ' ' THR . 22.0 mt -57.97 -36.67 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.02 -53.33 55.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.38 34.86 2.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 60.7 pttt -77.2 -48.8 16.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -42.87 -27.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.94 -32.26 11.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.1 mt -47.66 121.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 111.154 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -118.03 162.55 18.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.847 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.1 m-85 -131.1 123.33 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.5 110.84 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.22 113.23 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.138 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.462 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 4.9 mmtp -93.17 -32.46 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.567 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -179.12 127.73 0.25 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.428 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.189 0 C-N-CA 122.669 2.246 . . . . 0.0 112.298 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.816 0.341 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.96 -62.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.8 tt -47.36 -36.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.14 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -70.09 -40.67 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -66.43 -38.7 88.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 22' ' ' VAL . 20.0 mt -59.36 -46.33 88.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -64.44 -37.45 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -68.18 -46.45 70.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.588 HG22 HD21 ' A' ' 80' ' ' LEU . 27.7 m -56.69 -45.9 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.087 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.604 HG12 ' CE2' ' A' ' 26' ' ' PHE . 41.0 t -68.18 -31.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.62 -47.38 63.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -45.33 -61.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.604 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.9 m-85 -46.71 -39.98 12.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m -67.46 -40.44 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.47 ' HA ' HG12 ' A' ' 39' ' ' VAL . 9.7 t80 -62.85 -56.53 16.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.0 m -52.61 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.825 ' CE1' HD11 ' A' ' 90' ' ' ILE . 15.1 t80 -66.87 -64.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -23.16 58.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -39.2 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.906 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.17 -27.25 60.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -66.09 -32.66 74.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 25.93 9.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.59 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.6 mtmt -95.56 179.73 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 t -110.93 21.39 16.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.3 p -154.3 163.94 39.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.7 m -79.04 143.04 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.202 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 41' ' ' PRO . 57.5 t -118.92 137.84 25.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.684 0.754 . . . . 0.0 111.09 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.75 120.94 7.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 26' ' ' PHE . 60.6 t -71.61 112.66 14.81 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 80.63 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.716 2.277 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -60.32 -39.61 87.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.9 -38.5 70.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -80.3 -55.02 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.527 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 84.2 mtp -49.41 -35.98 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -85.69 -38.38 18.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.07 91.5 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -81.15 41.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 14.3 p -116.41 -55.86 2.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.795 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -33.94 -37.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 90' ' ' ILE . 29.7 t -148.02 135.95 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.501 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 46.7 t -109.32 146.07 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 65' ' ' PHE . 15.3 t -117.57 124.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.2 165.27 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.92 62.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.9 mt -85.44 151.2 55.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.536 0.684 . . . . 0.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.616 ' HD2' HG11 ' A' ' 63' ' ' VAL . 54.1 Cg_endo -69.77 -169.07 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 63' ' ' VAL . 7.7 tt0 -87.52 167.5 13.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.21 24.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.616 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.5 p -115.27 159.81 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.63 117.38 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.741 ' CD1' HG21 ' A' ' 56' ' ' VAL . 42.0 t80 -34.21 114.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -159.02 173.76 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 6.9 t-80 -42.92 140.62 1.85 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 110.875 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.769 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.3 Cg_endo -69.78 0.75 5.21 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.643 2.229 . . . . 0.0 112.335 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.42 -17.79 18.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.93 -11.35 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -88.17 121.39 30.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 73' ' ' LEU . 1.8 m-20 -51.45 144.84 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.818 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.518 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.2 tp -36.91 -48.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.89 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -57.18 -48.93 77.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.161 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 68' ' ' PRO . 15.5 mt -43.48 -57.2 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -48.14 -44.0 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.93 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.537 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.8 t90 -53.14 -59.73 4.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.7 mt -41.87 -54.65 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.149 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 21' ' ' THR . 20.8 mt -59.85 -36.86 77.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -63.03 -53.45 53.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -100.84 35.0 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -76.38 -45.54 31.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -42.0 -29.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.8 -35.84 8.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.9 mt -46.01 120.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -120.52 163.13 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.63 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.2 m-85 -129.74 126.65 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.65 111.39 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.825 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -81.97 113.06 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.501 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 22.8 mmtt -91.54 -31.66 15.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.518 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -179.02 132.46 0.28 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.439 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo . . . . . 0 N--CA 1.465 -0.206 0 C-N-CA 122.75 2.3 . . . . 0.0 112.384 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.774 0.321 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -57.96 -69.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 tt -45.84 -32.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.54 -37.74 59.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.449 ' HA ' ' HZ2' ' A' ' 20' ' ' LYS . 55.1 m -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD12 ' CD1' ' A' ' 73' ' ' LEU . 15.7 mt -61.31 -40.96 96.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -63.44 -45.91 88.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HZ2' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -66.13 -44.83 83.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.526 HG22 HD21 ' A' ' 80' ' ' LEU . 98.9 m -53.74 -47.38 70.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.593 HG12 ' CE2' ' A' ' 26' ' ' PHE . 59.5 t -68.73 -36.54 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.93 -47.65 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.2 t80 -45.28 -58.3 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.593 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.5 m-85 -50.13 -40.71 47.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.4 m -65.42 -40.13 92.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.69 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.2 t80 -63.16 -58.48 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.0 m -52.0 -40.65 61.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.733 ' CE1' HD11 ' A' ' 90' ' ' ILE . 17.5 t80 -66.66 -64.72 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -21.89 56.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -41.01 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.2 -27.24 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.83 -31.46 72.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.949 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.6 24.68 10.69 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.514 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.63 ' HE2' HG21 ' A' ' 40' ' ' VAL . 17.6 mtmt -94.66 179.9 5.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 t -109.65 21.3 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.9 p -155.39 174.88 14.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.8 m -88.31 148.35 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.63 HG21 ' HE2' ' A' ' 36' ' ' LYS . 98.6 t -123.12 137.1 27.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.664 0.745 . . . . 0.0 111.153 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.2 Cg_endo -69.74 111.92 2.94 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.405 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 39.6 t -69.96 111.9 10.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.573 0.701 . . . . 0.0 111.111 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 79.97 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.624 2.216 . . . . 0.0 112.355 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -52.05 -48.45 64.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 48' ' ' LEU . 20.6 tt0 -50.34 -43.23 53.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -74.17 -58.37 3.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.405 ' SD ' ' CG1' ' A' ' 42' ' ' VAL . 56.9 mtp -46.59 -35.39 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 45' ' ' GLU . 24.2 mt -54.24 -42.2 69.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.985 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 6.7 ptt85 -84.23 -32.89 24.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.878 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.454 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 8.3 p-10 -130.62 86.87 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -80.09 -7.39 58.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 53' ' ' ALA . 2.5 p -68.61 -57.26 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.83 -37.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.079 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' SER . 3.4 t -154.33 125.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 56' ' ' VAL . 40.2 t -96.3 165.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.812 HG21 ' CD1' ' A' ' 65' ' ' PHE . 39.4 t -136.2 123.1 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -116.21 166.44 12.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.33 5.49 67.31 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.8 mt -79.68 152.29 74.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.914 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.682 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.2 Cg_endo -69.8 -174.63 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.306 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -83.61 162.69 20.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.1 23.43 2.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -115.93 166.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.491 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.12 128.76 12.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.812 ' CD1' HG21 ' A' ' 56' ' ' VAL . 86.9 t80 -37.87 128.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -174.07 174.49 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.538 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.6 t-80 -50.61 141.87 16.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.569 0.699 . . . . 0.0 110.839 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.681 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.3 Cg_endo -69.7 -1.98 9.34 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.457 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 4.3 pt-20 -95.81 -20.09 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -78.12 -17.45 56.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -83.19 145.05 29.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.36 150.09 38.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.649 ' CD1' HD12 ' A' ' 18' ' ' LEU . 7.3 tp -38.77 -51.77 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.28 -56.76 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -55.0 -50.11 69.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.681 HD21 ' O ' ' A' ' 68' ' ' PRO . 19.7 mt -43.19 -57.03 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -47.14 -46.56 23.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 67.4 t90 -51.01 -61.87 1.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mt -40.14 -54.63 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.526 HD21 HG22 ' A' ' 21' ' ' THR . 29.2 mt -58.88 -40.14 83.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.36 -53.76 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.486 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -100.97 35.67 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 53.7 pttt -76.79 -45.06 30.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -43.11 -28.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.32 -35.01 9.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.455 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.4 mt -47.61 120.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.356 . . . . 0.0 111.084 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -120.76 164.79 16.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.427 ' CE2' HG22 ' A' ' 56' ' ' VAL . 6.5 m-85 -131.22 122.16 26.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.05 110.48 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.733 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.66 112.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 21.0 mmtt -91.48 -28.79 17.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.49 140.43 0.34 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.672 2.248 . . . . 0.0 112.278 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 13' ' ' VAL . 2.8 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.812 0.339 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -82.01 -55.47 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.2 tt -52.49 -36.46 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -72.69 -45.42 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.9 m -59.5 -36.25 75.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 29.8 mt -60.64 -44.8 95.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -58.88 -36.07 74.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -45.79 75.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.665 HG22 HD21 ' A' ' 80' ' ' LEU . 33.0 m -55.83 -50.23 71.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.172 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.511 HG12 ' CE2' ' A' ' 26' ' ' PHE . 39.5 t -66.07 -40.64 87.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -51.9 -49.54 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.59 -47.39 85.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -44.95 -62.11 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.511 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.6 m-85 -45.24 -41.73 8.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 m -62.41 -42.46 99.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.544 ' HA ' HG12 ' A' ' 39' ' ' VAL . 22.9 t80 -63.35 -55.24 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 64.9 m -57.53 -40.41 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CE1' HD11 ' A' ' 90' ' ' ILE . 20.3 t80 -67.14 -62.83 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.53 -23.46 60.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.54 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -72.17 -46.61 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.57 -28.67 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.62 -34.81 77.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 22.85 12.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.534 ' HE2' HG21 ' A' ' 40' ' ' VAL . 19.4 mtmt -93.39 -179.91 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 p -109.34 20.52 18.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.3 p -156.39 159.44 38.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -68.88 155.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG21 ' HE2' ' A' ' 36' ' ' LYS . 70.5 t -130.82 131.75 23.47 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.626 0.726 . . . . 0.0 111.082 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.348 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.68 115.51 15.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.72 0.771 . . . . 0.0 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.92 0.97 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -48.78 -52.85 21.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -45.86 -54.2 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -61.19 2.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.799 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 31.5 mmm -42.25 -39.2 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -49.34 71.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.937 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -80.53 -25.53 38.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.54 87.87 2.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 54' ' ' VAL . 52.2 mt-30 -83.36 -28.31 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 31.0 p -49.84 -56.39 10.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.21 -43.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 51' ' ' GLN . 2.5 t -143.99 122.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.097 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.22 142.01 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.984 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.0 t -111.19 125.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -116.74 162.94 16.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.38 44.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 18.3 mt -92.14 155.96 42.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.668 0.746 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.8 Cg_endo -69.71 -165.59 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' GLY . 10.3 tt0 -88.16 166.73 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.66 33.09 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.654 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -120.28 149.82 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -133.86 123.17 24.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.984 ' CD1' HG21 ' A' ' 56' ' ' VAL . 82.6 t80 -33.98 121.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.452 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.0 ptpt -170.88 166.15 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.531 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.1 t-80 -39.92 141.52 0.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.841 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.954 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.4 Cg_endo -69.71 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.674 2.249 . . . . 0.0 112.356 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -20.54 25.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -81.76 -15.44 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 24.5 m-85 -84.04 123.15 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.7 145.07 7.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -37.99 -49.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.62 76.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.8 m -60.51 -47.84 84.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 68' ' ' PRO . 26.7 mt -47.97 -54.55 12.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -48.59 -43.41 36.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.546 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.6 t90 -56.87 -57.21 13.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.0 mt -44.19 -52.42 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.665 HD21 HG22 ' A' ' 21' ' ' THR . 21.4 mt -60.62 -36.15 77.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.02 -53.09 55.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.434 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -101.47 35.31 2.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.856 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 52.3 pttt -75.54 -49.3 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -41.0 -30.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.39 8.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.8 mt -40.47 124.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -121.51 170.2 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -132.47 115.42 15.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.2 mt -101.03 93.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.081 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -72.0 112.91 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -87.82 -31.97 19.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.55 137.34 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.562 0.696 . . . . 0.0 110.886 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.338 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.784 0.326 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.29 -49.92 65.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.8 tt -57.19 -33.49 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.413 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 5.1 mt-10 -75.47 -40.82 56.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 m -64.67 -37.71 88.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' VAL . 31.0 mt -64.2 -37.05 86.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.475 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 31.1 mtm105 -66.41 -36.82 83.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -62.79 -48.89 77.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 HD21 ' A' ' 80' ' ' LEU . 28.3 m -56.29 -46.2 79.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.649 HG12 ' CE2' ' A' ' 26' ' ' PHE . 23.4 t -67.01 -35.57 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.428 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 12.7 mt-10 -61.01 -44.66 97.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.72 -46.35 72.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.52 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.9 t80 -46.52 -62.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.649 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.0 m-85 -42.31 -36.45 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.83 -42.98 76.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.583 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -59.59 -49.66 76.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -62.97 -43.79 97.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.625 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.1 t80 -62.37 -58.7 6.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.34 82.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -44.55 86.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.6 71.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.0 mt -64.01 -34.4 77.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.95 11.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.68 ' HE2' HG21 ' A' ' 40' ' ' VAL . 14.3 mtmt -93.25 179.59 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.945 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.87 20.27 18.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.3 p -154.55 164.56 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -77.79 145.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.68 HG21 ' HE2' ' A' ' 36' ' ' LYS . 59.1 t -124.22 132.94 24.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 0.0 111.158 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.7 122.17 8.87 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.626 2.218 . . . . 0.0 112.336 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 79.5 t -68.08 111.54 8.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.707 0.765 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 79.61 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 0.0 112.364 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' MET . 38.3 m-85 -45.23 -73.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.4 tp10 -30.91 -54.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -62.09 -43.11 99.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.546 ' N ' ' O ' ' A' ' 44' ' ' TYR . 47.3 mtp -65.78 -58.68 5.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.5 mt -42.45 -35.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.463 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -91.86 -29.34 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.564 ' OD2' ' HB2' ' A' ' 53' ' ' ALA . 25.3 t0 -134.12 75.09 1.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -63.83 -43.76 95.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -40.16 -61.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.564 ' HB2' ' OD2' ' A' ' 50' ' ' ASP . . . -31.43 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' SER . 12.1 t -155.19 119.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 91' ' ' LYS . 21.5 t -98.17 157.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.627 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.9 t -126.68 121.79 59.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -114.28 153.31 29.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.67 15.12 27.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.407 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 17.3 mt -89.64 157.69 46.39 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.648 0.737 . . . . 0.0 110.863 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.647 ' HD2' HG11 ' A' ' 63' ' ' VAL . 52.9 Cg_endo -69.84 -168.01 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 0.0 112.248 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.84 164.86 15.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.2 29.31 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.647 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.1 p -118.66 152.59 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.179 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.97 123.25 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.009 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.627 ' CD1' HG21 ' A' ' 56' ' ' VAL . 86.9 t80 -33.81 126.29 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.83 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' HD3' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -172.49 166.83 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.944 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.4 t-80 -43.01 141.73 1.63 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.676 0.75 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.931 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.76 -7.59 21.45 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.709 2.272 . . . . 0.0 112.325 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HA ' ' CD ' ' A' ' 19' ' ' ARG . 1.5 pp20? -89.23 -16.95 30.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.405 ' CB ' ' HD3' ' A' ' 66' ' ' LYS . 52.0 m-20 -85.62 -13.73 47.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.79 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -85.79 128.5 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.7 m-20 -56.41 141.96 40.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 72' ' ' ASP . 7.5 tp -36.05 -46.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.33 84.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 92.4 m -64.53 -48.13 76.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.931 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.1 mt -45.04 -51.72 9.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -52.99 -46.28 68.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.553 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 56.5 t90 -52.08 -61.81 2.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.993 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.3 mt -39.61 -52.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.595 HD21 HG22 ' A' ' 21' ' ' THR . 19.6 mt -61.22 -37.34 82.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -63.12 -53.84 47.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.533 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.2 m-80 -99.78 37.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 44.8 pttt -79.93 -50.04 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.466 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.48 -31.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.083 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -86.9 -37.16 8.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.6 mt -42.47 127.37 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.751 0.31 . . . . 0.0 111.146 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -127.61 166.16 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.56 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.9 m-85 -131.77 121.85 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.48 110.42 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.81 112.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HE3' HG21 ' A' ' 55' ' ' VAL . 24.3 mmtt -91.85 -25.35 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.13 139.41 0.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.655 0.741 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.216 0 C-N-CA 122.695 2.264 . . . . 0.0 112.365 -179.987 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.806 0.336 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.62 -60.85 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 6.1 tt -49.55 -37.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.409 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.4 mt-10 -72.38 -41.79 65.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 m -64.61 -38.36 90.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.47 ' CD1' HD11 ' A' ' 73' ' ' LEU . 26.9 mt -60.92 -35.52 76.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.667 ' NH1' HD11 ' A' ' 76' ' ' LEU . 57.6 mtt-85 -71.88 -41.33 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -58.18 -39.61 79.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.562 HG22 HD21 ' A' ' 80' ' ' LEU . 25.0 m -63.87 -43.97 94.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.763 HG12 ' CE2' ' A' ' 26' ' ' PHE . 47.4 t -70.58 -32.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.223 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 20.0 mt-10 -62.41 -40.15 95.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.73 -46.86 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.565 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 11.1 t80 -47.98 -62.85 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.763 ' CE2' HG12 ' A' ' 22' ' ' VAL . 28.9 m-85 -42.13 -37.73 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.1 m -68.6 -43.51 76.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.556 ' HA ' HG12 ' A' ' 39' ' ' VAL . 28.0 t80 -60.18 -52.55 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -57.83 -43.4 85.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.579 ' CE1' HD11 ' A' ' 90' ' ' ILE . 15.7 t80 -64.06 -61.1 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.952 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.21 -27.37 67.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -42.57 68.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.706 0.288 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 -24.27 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.35 -28.63 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.06 23.47 24.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.572 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.624 ' HE2' HG21 ' A' ' 40' ' ' VAL . 16.5 mtmt -91.92 -179.98 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.889 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 m -109.48 19.11 19.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -150.54 172.13 15.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.196 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -88.58 139.52 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.624 HG21 ' HE2' ' A' ' 36' ' ' LYS . 74.4 t -117.93 133.08 23.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 0.0 111.124 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.4 Cg_endo -69.77 124.7 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.331 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 47' ' ' MET . 90.7 t -72.54 111.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.635 0.731 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 79.9 0.92 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 0.0 112.368 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -52.41 -51.12 60.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -46.0 -51.5 13.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -69.66 -60.5 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.601 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 40.2 mtp -42.2 -39.35 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.943 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.5 mt -53.78 -46.19 70.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -79.39 -31.94 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.32 88.94 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -78.44 -38.38 41.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 53' ' ' ALA . 37.0 p -39.52 -55.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -34.28 -40.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 t -153.06 128.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 56' ' ' VAL . 35.2 t -102.25 165.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.763 HG21 ' CD1' ' A' ' 65' ' ' PHE . 14.5 t -134.48 124.22 44.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -116.02 163.47 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.03 11.98 58.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 13.2 mt -86.29 154.04 56.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.751 ' O ' HG12 ' A' ' 63' ' ' VAL . 54.5 Cg_endo -69.7 172.76 11.99 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.356 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -78.69 147.52 33.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.47 18.83 72.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.3 p -115.41 168.59 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 111.143 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.541 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -146.65 117.85 7.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.763 ' CD1' HG21 ' A' ' 56' ' ' VAL . 68.3 t80 -35.94 122.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.419 ' N ' ' OH ' ' A' ' 71' ' ' TYR . 11.2 ptpt -170.8 169.99 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.4 t-80 -42.19 140.82 1.52 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 110.938 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.573 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.2 Cg_endo -69.85 3.34 2.87 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -95.32 -21.7 18.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -83.41 -7.06 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.954 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.419 ' OH ' ' N ' ' A' ' 66' ' ' LYS . 22.9 m-85 -92.72 133.82 35.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.91 154.87 36.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' A' ' 18' ' ' LEU . 6.3 tp -44.59 -47.53 10.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.54 -54.63 44.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.2 m -55.99 -47.1 78.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.667 HD11 ' NH1' ' A' ' 19' ' ' ARG . 22.8 mt -45.29 -59.69 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -46.1 -46.36 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.0 t90 -51.04 -62.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.5 mt -40.21 -51.44 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.562 HD21 HG22 ' A' ' 21' ' ' THR . 28.5 mt -62.12 -36.08 80.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' TRP . 12.0 mm-40 -64.56 -54.07 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.65 36.77 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.565 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -76.75 -45.51 28.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.53 -33.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.17 -31.47 28.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.41 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 mt -50.25 118.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.4 m -121.55 156.64 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.56 ' CE1' HG13 ' A' ' 56' ' ' VAL . 7.1 m-85 -121.66 126.56 49.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.71 109.53 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.55 113.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.456 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.3 mmtp -93.84 -26.88 16.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.8 137.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.216 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 13' ' ' VAL . 2.1 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.79 0.329 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.69 -54.87 5.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 tt -52.27 -30.37 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.37 -43.48 32.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -61.67 -34.44 75.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 24.0 mt -64.62 -44.45 90.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -61.55 -22.87 65.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -76.26 -56.0 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 m -44.47 -44.81 8.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.799 HG12 ' CE2' ' A' ' 26' ' ' PHE . 21.9 t -71.51 -34.74 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.487 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 14.7 mt-10 -62.75 -39.05 92.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -72.99 -38.05 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.551 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 7.0 t80 -58.41 -60.15 4.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.799 ' CE2' HG12 ' A' ' 22' ' ' VAL . 20.9 m-85 -44.03 -40.8 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.22 -58.0 7.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.7 m -53.24 -40.12 64.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.636 ' CE1' HD11 ' A' ' 90' ' ' ILE . 18.4 t80 -66.72 -63.7 1.01 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.959 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.56 60.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -41.23 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.732 0.301 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.85 67.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.051 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -62.06 -35.3 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.35 25.61 8.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.501 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.737 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.1 mtmt -95.93 179.6 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -111.35 20.51 17.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.9 p -152.5 159.94 43.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.2 m -73.49 141.56 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.737 HG21 ' HE2' ' A' ' 36' ' ' LYS . 98.4 t -120.22 138.91 27.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 0.0 111.178 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.668 ' HD2' HG13 ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.83 122.82 9.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.748 2.299 . . . . 0.0 112.265 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 26' ' ' PHE . 55.2 t -67.98 116.79 42.27 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.628 0.727 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 80.03 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.736 2.291 . . . . 0.0 112.349 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.517 ' O ' ' C ' ' A' ' 45' ' ' GLU . 67.9 m-85 -55.69 -72.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.921 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 44' ' ' TYR . 37.0 tt0 -28.79 -56.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -48.07 83.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.52 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 74.2 mtp -59.26 -56.92 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.1 mt -43.83 -46.51 7.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -77.81 -31.28 51.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 51.8 m-20 -134.96 95.26 3.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -92.25 51.92 1.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 p -130.27 -38.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -52.97 -35.73 59.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 90' ' ' ILE . 34.5 t -149.29 123.35 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.487 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 33.4 t -95.95 155.06 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.8 t -126.25 121.55 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.114 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -111.68 168.18 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.033 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.98 4.24 78.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.1 mt -78.93 158.11 75.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 0.0 110.925 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.6 Cg_endo -69.81 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.653 2.235 . . . . 0.0 112.3 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -98.3 157.41 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.09 17.53 10.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 64' ' ' ALA . 8.0 p -107.78 168.08 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.577 ' N ' HG22 ' A' ' 63' ' ' VAL . . . -145.94 115.08 7.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.098 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.828 ' CD1' HG21 ' A' ' 56' ' ' VAL . 55.5 t80 -35.01 125.19 0.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.839 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 14.7 ptpt -169.35 172.78 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.0 t-80 -43.84 140.66 2.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.599 0.714 . . . . 0.0 110.818 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.846 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.6 Cg_endo -69.77 2.59 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.1 -16.99 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.04 -11.06 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.521 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.6 m-85 -86.81 116.99 25.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.41 143.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 8.9 tp -39.44 -41.56 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.976 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.63 70.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -58.13 -46.25 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.846 HD21 ' O ' ' A' ' 68' ' ' PRO . 26.7 mt -47.0 -52.5 14.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -50.45 -46.23 56.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.558 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -54.32 -60.95 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.9 mt -41.14 -50.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.7 mt -62.68 -35.6 80.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.1 -55.17 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.466 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.5 m-80 -98.19 39.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.837 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.551 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 19.7 ptmt -78.27 -51.91 9.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.56 -31.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -85.05 -37.51 9.97 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.1 mt -43.18 118.4 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 111.169 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.0 m -118.91 160.17 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.1 m-85 -126.59 125.98 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.11 112.0 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.61 113.31 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.487 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.6 mmtt -93.36 -28.38 16.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.516 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.91 129.5 0.27 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.655 0.74 . . . . 0.0 110.833 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.451 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.221 0 C-N-CA 122.707 2.271 . . . . 0.0 112.385 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.863 0.363 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.25 -59.31 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.82 -34.5 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -40.81 74.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -67.18 -32.14 73.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 15.6 mt -64.27 -46.54 83.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -63.96 -29.08 70.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -67.54 -54.57 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.43 HG22 HD21 ' A' ' 80' ' ' LEU . 6.3 m -51.32 -47.9 62.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.641 HG12 ' CE2' ' A' ' 26' ' ' PHE . 20.0 t -64.72 -37.35 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.04 -43.19 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.36 -44.29 68.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 6.4 t80 -48.92 -61.18 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.675 ' HB3' HG21 ' A' ' 42' ' ' VAL . 19.7 m-85 -44.45 -35.06 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.2 m -68.05 -40.17 82.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 39' ' ' VAL . 4.5 t80 -62.49 -55.04 31.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.68 -35.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -68.03 -58.48 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -26.83 70.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -43.07 77.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.793 0.33 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.91 -27.65 62.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -72.6 -21.1 61.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.16 32.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -90.71 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -98.68 -4.3 34.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.4 p -137.94 166.53 23.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -72.84 129.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.145 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 41' ' ' PRO . 63.0 t -105.67 132.38 20.93 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.585 0.707 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.412 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.1 Cg_endo -69.68 124.46 11.14 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.388 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.675 HG21 ' HB3' ' A' ' 26' ' ' PHE . 81.0 t -64.91 111.17 5.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.693 0.759 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 42' ' ' VAL . 53.5 Cg_endo -69.83 79.18 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.261 . . . . 0.0 112.327 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 47' ' ' MET . 72.7 m-85 -47.3 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 44' ' ' TYR . 9.4 pt-20 -30.04 -42.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' TYR . 23.7 mttp -73.13 -47.09 47.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' TYR . 70.4 mtp -62.51 -50.98 69.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 11.7 mt -50.4 -37.49 37.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -88.73 -27.63 21.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.629 ' OD2' ' HB2' ' A' ' 53' ' ' ALA . 3.8 t70 -134.11 69.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -59.0 -40.99 86.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 53' ' ' ALA . 3.4 t -48.37 -58.45 4.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.629 ' HB2' ' OD2' ' A' ' 50' ' ' ASP . . . -31.94 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.676 HG22 HG13 ' A' ' 90' ' ' ILE . 59.1 t -138.94 119.74 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.151 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 56' ' ' VAL . 39.2 t -98.94 160.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.841 HG21 ' CD1' ' A' ' 65' ' ' PHE . 18.1 t -129.61 129.1 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.179 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -118.51 163.96 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.3 6.87 62.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB3' HG11 ' A' ' 63' ' ' VAL . 11.6 mt -82.13 157.27 68.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.614 0.721 . . . . 0.0 110.902 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.601 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.3 Cg_endo -69.79 -168.17 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.309 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -90.11 162.37 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 46.61 26.69 2.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.7 p -116.33 163.22 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.91 0.386 . . . . 0.0 111.078 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -145.0 118.77 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.841 ' CD1' HG21 ' A' ' 56' ' ' VAL . 91.5 t80 -34.39 126.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 13.0 ptpt -170.67 165.71 8.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.528 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -38.29 140.82 0.57 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.807 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.0 Cg_endo -69.82 2.23 3.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.668 2.245 . . . . 0.0 112.302 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.22 -20.87 16.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -84.79 -12.61 53.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 20.4 m-85 -84.16 117.04 23.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.4 OUTLIER -45.46 139.12 3.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -35.79 -46.9 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.03 87.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' ASP . 51.8 m -65.49 -45.25 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.807 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.8 mt -46.59 -54.7 8.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -48.94 -50.44 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.547 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 51.8 t90 -50.61 -60.71 2.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.0 mt -39.87 -52.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.43 HD21 HG22 ' A' ' 21' ' ' THR . 17.0 mt -62.95 -40.19 96.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.98 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -55.45 34.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -97.16 37.76 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 58.7 pttt -82.96 -45.64 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -38.43 -27.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.54 -40.07 4.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 85' ' ' GLY . 13.9 mt -34.16 127.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.1 m -127.92 169.6 13.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 56' ' ' VAL . 8.4 m-85 -134.96 127.92 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.23 109.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.133 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.676 HG13 HG22 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -81.75 113.38 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.215 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.499 ' HE3' HG21 ' A' ' 55' ' ' VAL . 5.3 mmtp -92.89 -31.74 14.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.618 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.85 127.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.594 0.711 . . . . 0.0 110.859 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.425 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo . . . . . 0 C--N 1.342 0.206 0 C-N-CA 122.727 2.284 . . . . 0.0 112.343 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.87 -61.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 tt -50.79 -33.55 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.68 -43.9 62.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.6 m -62.96 -33.26 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.1 mt -63.32 -44.84 93.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -62.23 -40.2 95.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -64.55 -46.0 84.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.494 HG22 HD21 ' A' ' 80' ' ' LEU . 28.6 m -57.12 -48.98 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.643 HG12 ' CE2' ' A' ' 26' ' ' PHE . 46.4 t -65.97 -39.01 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.91 -43.69 69.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.1 -49.51 56.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 9.0 t80 -42.72 -61.92 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.643 ' CE2' HG12 ' A' ' 22' ' ' VAL . 25.7 m-85 -45.13 -38.03 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 m -66.82 -47.37 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.407 ' HA ' HG12 ' A' ' 39' ' ' VAL . 12.3 t80 -55.6 -52.57 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.3 m -56.49 -46.21 80.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.577 ' CE1' HD11 ' A' ' 90' ' ' ILE . 12.9 t80 -61.95 -62.41 1.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -27.83 64.48 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.519 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -41.81 74.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.24 66.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -64.89 -34.33 78.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.78 6.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.694 ' HE2' HG21 ' A' ' 40' ' ' VAL . 11.4 mtmt -99.86 177.61 5.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.756 0.313 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.9 p -105.84 -0.54 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.4 p -128.78 165.82 20.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.5 146.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.694 HG21 ' HE2' ' A' ' 36' ' ' LYS . 78.3 t -125.31 128.12 24.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.703 0.763 . . . . 0.0 111.157 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 124.33 10.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.254 . . . . 0.0 112.306 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.685 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 73.3 t -71.16 113.1 16.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.682 0.753 . . . . 0.0 111.151 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 80.89 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.245 . . . . 0.0 112.344 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.574 ' O ' ' N ' ' A' ' 47' ' ' MET . 53.1 m-85 -47.85 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.498 ' C ' ' O ' ' A' ' 44' ' ' TYR . 35.0 tt0 -29.92 -46.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -70.11 -44.17 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 44' ' ' TYR . 37.2 mmm -63.34 -53.01 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.82 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 12.1 mt -40.29 -35.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 9.7 mtp85 -93.73 -39.83 10.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -122.99 80.11 1.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.0 -28.0 57.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -52.54 -57.65 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.43 -36.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.3 t -152.69 119.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.543 HG21 ' HE3' ' A' ' 91' ' ' LYS . 20.0 t -96.28 153.41 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.794 HG13 ' CE1' ' A' ' 88' ' ' PHE . 11.9 t -125.36 123.58 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -112.15 163.82 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.39 61.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 11.3 mt -81.66 151.01 67.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.971 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.822 ' O ' HG12 ' A' ' 63' ' ' VAL . 54.7 Cg_endo -69.74 -179.95 3.26 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.7 2.266 . . . . 0.0 112.4 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.62 161.24 27.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.83 24.04 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.7 p -115.65 171.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -154.52 119.97 5.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.759 ' CD1' HG21 ' A' ' 56' ' ' VAL . 85.6 t80 -34.75 121.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 8.4 ptpp? -166.6 179.08 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.52 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -51.24 140.74 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.779 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.4 Cg_endo -69.78 2.99 3.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 8.1 pt-20 -98.29 -22.54 16.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -79.12 -15.38 58.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.449 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 20.9 m-85 -83.42 129.55 34.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.9 m-20 -61.67 143.24 56.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -34.78 -45.56 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.096 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' ASP . 87.5 m -60.58 -52.03 66.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 68' ' ' PRO . 24.8 mt -43.04 -56.74 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -46.57 -44.97 18.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.536 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.9 t90 -54.43 -57.9 9.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.7 mt -43.84 -55.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.494 HD21 HG22 ' A' ' 21' ' ' THR . 22.8 mt -59.15 -35.81 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.97 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -64.06 -52.8 57.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.74 33.64 2.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.521 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 59.0 pttt -74.87 -44.12 50.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.53 -22.07 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.4 -27.74 10.41 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.469 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mt -53.67 120.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.121 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 p -117.9 165.24 13.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.794 ' CE1' HG13 ' A' ' 56' ' ' VAL . 7.4 m-85 -133.09 122.86 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.43 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.667 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -80.7 113.24 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.543 ' HE3' HG21 ' A' ' 55' ' ' VAL . 32.2 mmtt -93.07 -25.97 17.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.53 140.0 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.673 0.749 . . . . 0.0 110.842 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.342 0.201 0 C-N-CA 122.635 2.224 . . . . 0.0 112.36 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.793 0.33 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.22 -44.95 82.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 tt -64.27 -31.64 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -77.0 -34.08 57.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -74.89 -35.26 62.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.3 mt -63.59 -46.27 86.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.53 -38.25 74.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -64.34 -61.35 2.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 m -43.83 -46.92 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.588 HG12 ' CE2' ' A' ' 26' ' ' PHE . 96.4 t -65.13 -36.3 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.502 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 12.3 mt-10 -64.59 -39.24 93.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.87 -51.78 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -40.58 -60.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.588 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.5 m-85 -45.69 -34.69 3.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.886 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m -63.88 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 1.2 t80 -66.37 -64.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.3 m -51.14 -45.12 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.942 ' CE2' HD11 ' A' ' 34' ' ' LEU . 17.7 t80 -59.65 -55.79 30.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.501 ' HA2' HD12 ' A' ' 34' ' ' LEU . . . -57.03 -41.17 92.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.43 -38.16 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -18.09 49.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.069 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.942 HD11 ' CE2' ' A' ' 30' ' ' TYR . 30.1 mt -75.18 -26.91 59.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.15 4.33 9.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 153.2 41.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.318 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -88.7 11.61 17.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.3 p -105.87 170.07 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.198 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.5 115.4 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.606 HG13 ' HD2' ' A' ' 41' ' ' PRO . 96.9 t -100.05 137.37 20.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.623 0.725 . . . . 0.0 111.134 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.606 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.8 109.24 2.27 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.707 2.271 . . . . 0.0 112.254 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 30' ' ' TYR . 47.7 t -67.1 111.24 6.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.075 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 53.7 Cg_endo -69.73 79.52 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.293 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -48.9 -48.48 42.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -44.55 -57.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.541 ' CG ' ' N ' ' A' ' 47' ' ' MET . 0.0 OUTLIER -69.08 -50.94 43.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.541 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 25.4 mmm -51.12 -24.76 4.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.8 mt -71.21 -32.96 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -87.52 -33.12 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -130.81 88.94 2.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -78.47 -39.86 37.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.2 t -43.56 -58.36 2.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -30.76 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG22 HG13 ' A' ' 90' ' ' ILE . 12.3 t -148.85 119.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 21.9 t -97.04 149.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.715 HG13 ' CE1' ' A' ' 88' ' ' PHE . 11.2 t -123.16 115.15 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -100.31 -178.02 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.37 -2.23 85.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 65' ' ' PHE . 8.8 mt -77.87 154.09 80.54 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.671 0.748 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.731 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.7 Cg_endo -69.76 -175.42 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.344 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -83.19 164.44 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.84 20.45 1.22 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -113.27 169.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 111.065 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.31 120.85 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.072 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CD1' HG21 ' A' ' 56' ' ' VAL . 61.3 t80 -34.56 123.31 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.536 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.1 ptpt -166.7 175.32 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.946 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.503 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -47.81 140.39 8.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.743 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.0 Cg_endo -69.65 2.08 3.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.674 2.25 . . . . 0.0 112.352 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -98.16 -17.89 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.28 -11.61 49.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.536 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 23.0 m-85 -87.72 112.01 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -40.23 144.5 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tp -39.99 -47.29 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -44.67 95.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.4 m -62.99 -47.98 80.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.743 HD21 ' O ' ' A' ' 68' ' ' PRO . 15.3 mt -46.45 -59.27 3.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -45.18 -42.11 8.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.545 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.4 t90 -56.61 -59.32 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.0 mt -41.65 -55.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.162 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.47 -37.35 77.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -62.5 -54.56 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.565 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.1 m-80 -98.87 39.85 1.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' GLY . 27.4 pttt -85.86 -37.77 18.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -40.29 -24.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -97.61 -31.8 6.57 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.5 mt -42.25 110.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 111.058 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 m -121.93 138.56 54.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.715 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.7 m-85 -98.01 124.31 42.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.67 110.06 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.676 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.96 113.06 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.152 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 18.8 mmtt -91.08 -32.58 15.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.06 130.13 0.26 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.652 0.739 . . . . 0.0 110.866 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.443 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.231 0 C-N-CA 122.669 2.246 . . . . 0.0 112.349 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.853 0.358 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.97 -65.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.951 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 10.1 tt -47.03 -41.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.4 mm-40 -64.54 -45.94 84.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -62.37 -33.06 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.145 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.1 mt -61.06 -48.2 82.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.408 ' CG ' ' HA ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -60.66 -43.47 97.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mtmm -60.88 -52.03 66.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.603 HG22 HD21 ' A' ' 80' ' ' LEU . 95.0 m -51.79 -48.3 63.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.09 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 18' ' ' LEU . 18.9 t -67.12 -36.47 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -54.69 -43.54 72.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.88 -50.99 60.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.569 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.7 t80 -42.71 -64.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.5 m-85 -43.7 -35.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 -36.87 66.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.711 ' HA ' HG12 ' A' ' 39' ' ' VAL . 13.9 t80 -66.79 -46.9 73.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.2 m -64.28 -40.01 95.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.733 ' CD1' HD11 ' A' ' 90' ' ' ILE . 16.2 t80 -69.71 -47.53 62.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.972 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 -28.98 64.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.434 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -47.64 68.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.863 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.08 73.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.0 -36.3 81.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 23.38 9.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.498 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.579 ' HE2' HG21 ' A' ' 40' ' ' VAL . 17.4 mtmt -92.37 178.36 5.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 m -107.42 17.63 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 p -152.82 163.5 39.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.213 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -77.46 146.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.155 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.579 HG21 ' HE2' ' A' ' 36' ' ' LYS . 64.4 t -118.29 133.81 23.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.448 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 96.2 t -70.82 112.06 11.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.577 0.703 . . . . 0.0 111.133 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.2 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -49.49 -49.9 43.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -45.51 -50.66 12.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -71.56 -55.56 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 40.1 mmm -49.84 -19.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.826 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 -35.37 42.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -78.95 -40.11 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.28 99.16 4.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.56 43.42 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 53' ' ' ALA . 12.2 p -118.45 -56.61 2.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.883 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.42 -36.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 52' ' ' SER . 6.2 t -152.48 123.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 56' ' ' VAL . 46.4 t -94.15 161.3 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.801 HG21 ' CD1' ' A' ' 65' ' ' PHE . 14.2 t -134.07 121.76 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.94 166.98 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.35 3.33 69.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.436 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 9.6 mt -76.09 152.68 84.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.685 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.7 Cg_endo -69.75 -172.77 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.626 2.217 . . . . 0.0 112.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.33 160.93 21.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.78 31.7 2.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.685 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -121.79 155.46 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.79 123.17 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 56' ' ' VAL . 78.8 t80 -35.55 119.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 11.8 ptpt -164.65 171.01 14.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.536 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 5.7 t-80 -41.76 140.94 1.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.553 0.692 . . . . 0.0 110.855 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 1.002 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.67 -2.95 10.99 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.385 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HA ' ' CG ' ' A' ' 19' ' ' ARG . 7.5 pt-20 -95.87 -21.83 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -78.13 -14.76 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.0 m-85 -84.77 119.02 24.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' THR . 2.8 m-20 -45.04 142.45 1.88 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 5.9 tp -36.49 -53.87 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.85 72.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 72' ' ' ASP . 65.0 m -64.93 -49.7 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.002 HD21 ' O ' ' A' ' 68' ' ' PRO . 13.7 mt -48.04 -50.49 27.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -51.13 -42.79 60.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.556 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.9 t90 -56.02 -56.11 24.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -46.04 -52.09 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.603 HD21 HG22 ' A' ' 21' ' ' THR . 27.4 mt -60.28 -33.0 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -67.85 -54.37 19.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.45 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.5 m-80 -99.86 37.39 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.569 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -77.53 -45.23 26.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.47 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.69 -31.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' ILE . . . -83.97 -44.93 6.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLY . 23.9 mt -37.28 119.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 0.0 111.08 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -116.75 166.1 12.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.671 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.7 m-85 -133.92 123.8 25.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.71 111.18 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.733 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.09 113.26 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.498 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.9 mmtt -92.61 -29.59 16.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.433 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.85 139.66 0.36 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.578 0.704 . . . . 0.0 110.877 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.465 -0.171 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.836 0.35 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.75 -66.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.7 tt -49.15 -36.04 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.24 -42.64 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 m -65.22 -39.66 93.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.196 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.0 mt -58.24 -45.94 86.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -56.49 -33.36 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' N ' ' HE2' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -70.44 -57.96 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.638 HG22 HD21 ' A' ' 80' ' ' LEU . 9.9 m -40.37 -46.01 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.671 HG12 ' CE2' ' A' ' 26' ' ' PHE . 40.1 t -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 28.1 mt-10 -57.94 -41.91 83.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.45 -42.37 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.467 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 5.9 t80 -50.36 -60.57 2.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.671 ' CE2' HG12 ' A' ' 22' ' ' VAL . 19.0 m-85 -46.87 -37.45 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.0 m -69.56 -42.89 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.737 ' HA ' HG12 ' A' ' 39' ' ' VAL . 5.5 t80 -58.7 -56.79 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -53.73 -47.08 70.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.752 ' CD1' HD11 ' A' ' 90' ' ' ILE . 13.2 t80 -58.83 -68.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.69 -31.23 53.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.489 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.76 -42.23 82.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -28.04 65.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.87 -31.81 72.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.16 24.51 11.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.686 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.9 mtmt -93.86 179.96 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -109.47 20.93 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.7 p -155.42 159.58 39.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -73.28 144.65 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.686 HG21 ' HE2' ' A' ' 36' ' ' LYS . 93.4 t -122.39 138.36 29.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.733 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.631 ' HD2' HG13 ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.75 128.38 15.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 26' ' ' PHE . 69.9 t -72.29 111.87 12.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.612 0.72 . . . . 0.0 111.133 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 80.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.52 ' O ' ' C ' ' A' ' 45' ' ' GLU . 74.0 m-85 -54.96 -72.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.0 tp10 -28.03 -61.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -55.07 -49.13 72.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.957 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.561 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 56.9 mtp -57.32 -56.76 17.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 8.6 mt -40.41 -34.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -78.55 -42.33 29.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' MET . 2.4 m-20 -134.16 95.44 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -79.99 42.93 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.4 t -118.76 -57.85 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.58 -38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 90' ' ' ILE . 56.9 t -147.33 119.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.01 146.94 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.74 HG21 ' CD1' ' A' ' 65' ' ' PHE . 23.1 t -115.36 131.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -121.93 166.19 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.0 63.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.8 mt -92.45 158.06 39.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.606 0.717 . . . . 0.0 110.865 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.8 Cg_endo -69.77 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -96.22 164.33 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.93 13.99 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.526 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 64' ' ' ALA . 3.8 p -106.25 175.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.334 . . . . 0.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.731 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -156.55 117.89 3.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.03 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.74 ' CD1' HG21 ' A' ' 56' ' ' VAL . 84.4 t80 -33.67 124.87 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' CD ' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -169.33 179.48 3.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.8 t-80 -51.8 141.48 26.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 110.879 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.724 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.1 Cg_endo -69.8 -6.23 18.13 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.705 2.27 . . . . 0.0 112.362 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -93.23 -18.88 21.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.45 ' HB3' ' CD ' ' A' ' 66' ' ' LYS . 34.4 t-20 -79.92 -17.25 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.13 133.92 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' LEU . 0.6 OUTLIER -64.91 146.19 55.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.871 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 8.5 tp -37.66 -40.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.18 -53.98 51.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -59.67 -52.76 64.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.4 mt -39.29 -52.31 2.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -52.9 -48.93 66.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.554 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.2 t90 -50.22 -59.83 3.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.2 mt -41.02 -52.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.086 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.638 HD21 HG22 ' A' ' 21' ' ' THR . 20.4 mt -61.09 -37.1 81.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -62.64 -53.12 59.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.511 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -100.52 36.67 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' GLY . 56.8 pttt -80.41 -48.72 12.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.455 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.28 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.42 -33.71 7.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 15.1 mt -42.91 122.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.375 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -124.22 163.39 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.552 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.2 m-85 -131.48 124.56 30.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.81 110.66 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.67 113.44 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -91.32 -28.69 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.479 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.89 136.53 0.32 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.653 0.739 . . . . 0.0 110.844 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.342 0.204 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 -179.967 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.843 0.354 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.51 -64.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.824 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -48.64 -34.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -72.3 -45.26 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -60.78 -35.39 76.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 25.0 mt -62.2 -42.7 99.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -62.07 -41.97 98.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.78 -54.04 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.538 HG22 HD21 ' A' ' 80' ' ' LEU . 87.3 m -44.87 -49.81 10.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.799 HG12 ' CE2' ' A' ' 26' ' ' PHE . 53.4 t -67.8 -40.54 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 14.7 mt-10 -50.76 -47.47 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.47 -51.46 65.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.2 t80 -42.44 -63.92 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.928 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.799 ' CE2' HG12 ' A' ' 22' ' ' VAL . 28.0 m-85 -41.89 -38.89 1.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.2 m -66.78 -44.89 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.611 ' HA ' HG12 ' A' ' 39' ' ' VAL . 14.6 t80 -58.28 -50.9 71.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.2 m -59.3 -43.44 92.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.41 ' CE1' HD11 ' A' ' 90' ' ' ILE . 12.9 t80 -62.1 -63.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.41 -29.28 66.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 -43.13 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.352 . . . . 0.0 110.975 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -33.53 74.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.04 -34.23 75.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 28.35 8.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.663 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.3 mtmt -95.66 179.62 5.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 m -109.23 22.11 16.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.9 p -154.49 175.1 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -88.74 141.53 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.663 HG21 ' HE2' ' A' ' 36' ' ' LYS . 91.9 t -116.7 132.7 23.25 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.657 0.742 . . . . 0.0 111.163 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.0 Cg_endo -69.78 116.72 4.69 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.636 2.224 . . . . 0.0 112.37 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.481 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 46.3 t -67.25 112.28 9.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 79.5 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.709 2.272 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -51.3 -49.19 61.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -49.48 -48.99 47.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -68.34 -60.37 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.692 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 69.7 mtp -45.56 -35.45 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -58.8 -42.2 88.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.974 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -46.32 83.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -134.98 100.02 4.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -84.7 46.22 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.1 p -121.51 -44.61 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.12 -43.7 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.646 HG22 HG13 ' A' ' 90' ' ' ILE . 93.6 t -140.26 128.4 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 56' ' ' VAL . 88.4 t -100.94 158.58 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.084 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.718 HG13 ' CE1' ' A' ' 88' ' ' PHE . 21.6 t -131.76 119.1 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -103.16 178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.78 -0.33 88.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.422 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 59' ' ' LEU . 10.4 mt -77.07 153.84 82.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.723 . . . . 0.0 110.937 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.643 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.0 Cg_endo -69.82 -171.81 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.339 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -84.6 162.51 19.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.64 31.74 1.84 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 60' ' ' PRO . 6.0 p -119.15 161.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.098 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -140.9 119.29 12.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.149 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 48.6 t80 -34.48 131.17 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 11.4 ptpt -175.09 163.14 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.7 t-80 -36.73 141.31 0.39 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.863 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.883 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.77 -4.06 13.28 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.308 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -89.18 -27.03 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.72 -18.64 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-85 -80.97 111.34 17.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -42.69 145.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 11.0 tp -38.85 -46.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.32 82.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 50.2 m -63.16 -45.2 92.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.883 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.7 mt -48.64 -53.05 20.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -49.2 -45.55 44.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.56 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.6 t90 -54.55 -63.77 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -40.05 -50.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.538 HD21 HG22 ' A' ' 21' ' ' THR . 18.0 mt -62.11 -35.65 79.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' TRP . 10.3 mt-10 -65.32 -54.98 21.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.467 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -98.21 40.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 18.4 ptmt -82.68 -50.57 8.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 83' ' ' LYS . . . -35.07 -37.95 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.72 13.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.54 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 16.2 mt -37.9 124.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -126.47 169.98 12.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.718 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.6 m-85 -132.54 125.72 31.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.09 112.5 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -84.52 112.46 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.466 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.1 mmtp -91.51 -28.87 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.465 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.57 130.74 0.26 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.757 . . . . 0.0 110.898 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.42 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.742 2.295 . . . . 0.0 112.391 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.82 0.343 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -71.2 -47.88 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.1 tt -62.88 -32.76 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -76.39 -39.26 54.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 m -65.91 -35.82 81.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.61 HD12 ' CD1' ' A' ' 73' ' ' LEU . 19.4 mt -63.52 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.98 -39.25 81.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -66.01 -52.42 49.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.498 HG22 HD21 ' A' ' 80' ' ' LEU . 27.8 m -52.01 -48.36 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 26' ' ' PHE . 58.8 t -66.5 -38.51 81.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.162 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 13.3 mt-10 -56.75 -41.18 77.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.38 -47.91 62.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.402 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 7.2 t80 -44.59 -63.1 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.576 ' HB3' HG21 ' A' ' 42' ' ' VAL . 21.9 m-85 -43.31 -38.83 2.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.5 m -65.45 -46.02 81.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.556 ' HA ' HG12 ' A' ' 39' ' ' VAL . 10.3 t80 -56.61 -58.28 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 92.9 m -54.06 -40.75 67.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -64.61 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.65 -27.54 58.91 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.531 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -41.66 73.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.03 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.08 -33.99 77.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 25.77 8.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.485 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.673 ' HE2' HG21 ' A' ' 40' ' ' VAL . 12.4 mtmt -96.29 179.24 5.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.93 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.4 7.75 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.5 p -140.31 167.79 21.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -80.35 148.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 ' HE2' ' A' ' 36' ' ' LYS . 87.2 t -127.1 135.51 27.49 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.642 0.734 . . . . 0.0 111.1 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.541 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.79 121.02 7.71 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.74 2.293 . . . . 0.0 112.32 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 26' ' ' PHE . 57.3 t -66.69 112.09 8.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 79.68 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.698 2.265 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' MET . 95.1 m-85 -47.43 -71.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 44' ' ' TYR . 7.7 tp10 -29.42 -59.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -60.13 -40.22 89.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 44' ' ' TYR . 28.0 mmm -64.08 -50.06 69.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 15.5 mt -51.22 -37.2 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -90.29 -26.89 19.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -135.0 77.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -72.52 -40.61 66.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -43.2 -57.28 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -33.02 -39.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.088 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 HG13 ' A' ' 90' ' ' ILE . 13.6 t -148.93 119.92 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.93 152.95 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.886 HG21 ' CD1' ' A' ' 65' ' ' PHE . 31.4 t -121.68 124.56 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -116.52 160.75 20.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.81 10.05 59.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.449 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 59' ' ' LEU . 13.2 mt -85.02 157.83 59.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.4 Cg_endo -69.82 -167.51 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 9.0 tp10 -96.06 156.25 16.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 56.68 18.17 23.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.558 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.569 HG11 ' HD2' ' A' ' 60' ' ' PRO . 9.7 p -109.12 166.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.072 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.528 ' N ' HG22 ' A' ' 63' ' ' VAL . . . -144.37 113.04 6.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.886 ' CD1' HG21 ' A' ' 56' ' ' VAL . 29.1 t80 -34.24 111.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.4 ptpt -156.69 -178.87 7.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.3 t-80 -48.81 141.43 10.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.629 0.728 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.956 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.1 Cg_endo -69.67 -7.31 20.69 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.756 2.304 . . . . 0.0 112.379 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -91.95 -19.92 21.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -81.48 -16.58 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.9 m-85 -84.44 120.13 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.5 OUTLIER -49.66 143.68 6.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.61 ' CD1' HD12 ' A' ' 18' ' ' LEU . 7.9 tp -37.48 -46.06 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.19 80.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 72' ' ' ASP . 61.8 m -67.08 -50.66 60.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.073 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.956 HD21 ' O ' ' A' ' 68' ' ' PRO . 19.5 mt -42.88 -51.82 5.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -52.22 -47.09 65.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.551 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -52.0 -62.25 1.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.5 mt -39.25 -53.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 21' ' ' THR . 20.8 mt -59.61 -39.78 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.66 -54.4 45.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.467 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.87 38.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.821 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' GLY . 55.4 pttt -80.67 -51.22 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -37.76 -27.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.127 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -90.17 -35.62 7.49 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.54 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.3 mt -43.27 123.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 111.067 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.1 m -121.83 168.75 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 56' ' ' VAL . 9.4 m-85 -136.01 121.34 19.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.07 111.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.64 112.84 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -92.04 -29.77 16.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.466 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.91 134.2 0.29 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.571 0.7 . . . . 0.0 110.846 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 52.9 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 122.61 2.206 . . . . 0.0 112.349 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t -88.95 153.09 21.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.916 0.388 . . . . 0.0 110.804 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -108.14 -59.37 1.86 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.53 52.02 0.66 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.4 m -45.69 121.07 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.934 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 m -109.93 108.42 18.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.41 -139.35 1.48 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 30.6 ttp -123.37 153.7 39.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -53.51 149.62 7.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.682 ' O ' HG12 ' A' ' 13' ' ' VAL . 5.4 p -73.5 -34.84 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.141 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.85 -16.43 59.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -54.52 -46.23 73.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 10' ' ' VAL . 2.5 p -54.07 -17.51 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.177 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -78.61 -63.29 1.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 12' ' ' ALA . 8.0 tt -49.64 -31.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.211 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -76.48 -40.1 51.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 m -67.11 -35.33 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 22' ' ' VAL . 28.3 mt -64.72 -45.24 87.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.927 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -58.08 -34.81 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -67.15 -50.83 59.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.401 HG22 HD21 ' A' ' 80' ' ' LEU . 6.9 m -51.22 -48.2 62.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.563 HG12 ' CE2' ' A' ' 26' ' ' PHE . 11.7 t -65.77 -36.12 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.107 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.03 -42.65 94.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.99 -49.61 49.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.574 ' CE1' ' CE ' ' A' ' 83' ' ' LYS . 6.8 t80 -41.93 -64.25 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.563 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.6 m-85 -42.01 -34.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.4 m -72.69 -36.73 67.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.717 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.2 t80 -67.39 -48.68 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.0 m -63.58 -39.81 95.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.691 ' CD1' HD11 ' A' ' 90' ' ' ILE . 13.1 t80 -67.62 -52.57 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.64 -29.02 72.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -44.87 72.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.72 -27.61 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.38 -33.16 75.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.67 20.48 19.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -92.71 179.12 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.1 p -108.53 20.05 19.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -151.8 164.16 37.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.4 m -80.72 142.07 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.5 HG13 ' HD2' ' A' ' 41' ' ' PRO . 40.2 t -115.63 135.96 22.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.77 117.91 5.37 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.409 HG13 ' SD ' ' A' ' 47' ' ' MET . 92.3 t -73.24 112.07 14.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 80.49 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.686 2.257 . . . . 0.0 112.289 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -53.04 -47.51 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -50.34 -44.83 54.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.947 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -74.32 -59.27 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.566 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 59.3 mtp -45.7 -33.59 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.1 mt -60.46 -48.32 82.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -73.39 -36.29 66.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -128.33 97.93 4.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.797 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -95.13 47.14 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 p -124.52 -41.51 2.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.812 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.89 25.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.064 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 90' ' ' ILE . 25.5 t -149.87 126.0 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 56' ' ' VAL . 46.6 t -98.42 158.4 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.75 HG21 ' CD1' ' A' ' 65' ' ' PHE . 44.5 t -128.13 126.51 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -120.49 165.32 15.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.16 10.82 68.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.6 mt -84.22 155.76 63.41 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.542 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 54.2 Cg_endo -69.76 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 0.0 112.376 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.57 158.03 15.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.2 17.26 23.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 64' ' ' ALA . 3.4 p -108.61 175.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.136 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.719 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -157.01 120.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.75 ' CD1' HG21 ' A' ' 56' ' ' VAL . 84.6 t80 -34.79 119.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HZ3' ' HE1' ' A' ' 71' ' ' TYR . 11.2 ptpp? -166.56 170.5 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -45.45 141.65 3.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.528 0.68 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.84 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.75 -1.06 7.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 0.0 112.366 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.19 -17.48 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.2 -14.89 57.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.423 ' HE1' ' HZ3' ' A' ' 66' ' ' LYS . 23.6 m-85 -88.33 135.39 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 149.2 47.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.45 HD11 ' CD1' ' A' ' 18' ' ' LEU . 6.8 tp -40.47 -39.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.22 23.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.4 m -59.17 -45.6 90.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.9 mt -46.27 -49.59 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -55.68 -43.79 76.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.542 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 60.1 t90 -53.28 -60.15 3.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.2 mt -41.62 -53.63 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 21' ' ' THR . 23.8 mt -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.99 -53.85 43.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.447 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -100.49 35.13 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.574 ' CE ' ' CE1' ' A' ' 25' ' ' TYR . 21.1 ptmt -74.19 -52.59 11.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.93 -30.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.066 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -84.96 -37.85 9.79 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 19.4 mt -45.52 124.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 0.0 111.058 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -124.71 168.75 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 56' ' ' VAL . 5.9 m-85 -135.72 129.46 32.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.01 112.0 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.691 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.0 113.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.1 mmtt -91.0 -29.73 17.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.475 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.93 135.29 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.6 Cg_endo -69.86 129.75 18.04 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.294 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -48.82 160.09 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.8 mt -86.17 117.68 25.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -165.02 142.54 5.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.676 0.751 . . . . 0.0 110.881 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 137.27 35.06 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.716 2.277 . . . . 0.0 112.403 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -65.48 169.78 5.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -108.64 139.48 43.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -70.14 150.4 46.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.71 128.81 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.114 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.75 -96.79 1.14 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.42 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.44 125.16 5.16 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.56 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.8 t -92.76 157.94 16.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 110.849 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.35 68.39 0.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.447 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 118.69 5.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.411 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.6 m -135.94 170.8 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 85.6 p -113.47 154.99 26.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.859 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.477 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -43.35 -58.24 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.937 0.399 . . . . 0.0 110.885 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 t -95.29 152.5 18.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.955 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.64 -161.32 31.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.2 m -78.51 127.19 31.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.972 0.415 . . . . 0.0 110.844 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 m -108.3 168.1 9.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.61 -46.15 2.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 8.8 ttt -103.73 169.93 8.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.37 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 m -101.82 163.83 12.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 13' ' ' VAL . 8.7 p -70.95 -40.09 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 10' ' ' VAL . 2.2 m-20 -80.94 -11.28 59.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.03 -43.02 86.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.09 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.2 p -58.53 -30.66 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.175 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.09 -65.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 tt -50.4 -32.15 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -76.27 -36.91 58.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -70.96 -34.52 71.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.508 HD12 ' CD1' ' A' ' 73' ' ' LEU . 17.1 mt -62.79 -47.45 83.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.949 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -54.99 -41.33 71.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -67.16 -51.58 52.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.607 HG22 HD21 ' A' ' 80' ' ' LEU . 91.6 m -49.03 -48.4 43.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.109 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 26' ' ' PHE . 86.3 t -67.69 -37.02 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.446 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 13.8 mt-10 -56.05 -43.05 77.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -65.68 -49.51 68.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.586 ' CD1' ' HE3' ' A' ' 83' ' ' LYS . 8.7 t80 -44.12 -64.19 0.72 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.538 ' CE2' HG12 ' A' ' 22' ' ' VAL . 26.5 m-85 -42.8 -39.83 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.537 ' HA ' HG12 ' A' ' 39' ' ' VAL . 21.2 t80 -65.28 -56.64 11.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.1 m -54.05 -40.47 67.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.578 ' CD1' HD11 ' A' ' 90' ' ' ILE . 14.8 t80 -65.78 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.19 -25.02 61.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.541 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.13 -42.16 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.68 67.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.091 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -62.69 -34.83 77.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.47 24.03 9.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.545 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.523 ' HE2' HG21 ' A' ' 40' ' ' VAL . 8.7 mtmt -92.35 -179.97 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 t -109.87 19.3 19.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -154.09 161.87 41.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.3 m -74.77 144.35 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.523 HG21 ' HE2' ' A' ' 36' ' ' LYS . 40.5 t -119.46 136.08 24.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.598 0.713 . . . . 0.0 111.135 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.3 Cg_endo -69.71 118.5 5.72 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.662 2.242 . . . . 0.0 112.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.4 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 94.3 t -70.42 111.99 11.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.598 0.713 . . . . 0.0 111.173 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . 53.5 Cg_endo -69.81 79.97 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -55.88 -47.16 77.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -51.27 -46.4 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HD2' ' CB ' ' A' ' 43' ' ' PRO . 44.6 mttt -71.7 -55.56 7.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.469 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 80.1 mtp -50.33 -31.97 15.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.48 -30.43 71.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -86.03 -38.49 17.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -133.18 94.65 3.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.2 40.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' VAL . 22.1 p -113.36 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -32.95 -35.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 90' ' ' ILE . 19.0 t -148.78 143.32 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.477 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 58.7 t -118.04 139.9 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 65' ' ' PHE . 22.9 t -109.17 125.71 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -120.03 158.85 25.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.12 15.35 45.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.504 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.6 mt -87.12 154.34 54.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.61 0.719 . . . . 0.0 110.936 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.621 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.9 Cg_endo -69.68 -168.68 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -86.99 164.42 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.79 29.1 0.75 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.437 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.621 HG11 ' HD2' ' A' ' 60' ' ' PRO . 4.0 p -117.84 156.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -139.15 118.26 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 56' ' ' VAL . 83.3 t80 -34.11 117.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.7 ptpt -164.33 174.41 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.524 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -44.86 140.75 3.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.721 . . . . 0.0 110.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.882 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.6 Cg_endo -69.75 2.28 3.66 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -97.18 -22.04 16.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -81.17 -12.45 59.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.7 m-85 -88.2 117.7 27.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' LEU . 2.0 m-20 -49.02 144.03 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.508 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.2 tp -35.72 -50.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.29 -51.14 63.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -60.98 -46.65 89.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.118 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.882 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.1 mt -47.53 -54.96 10.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.938 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -48.56 -47.93 39.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.2 t90 -48.64 -61.62 1.94 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.2 mt -41.14 -52.42 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.607 HD21 HG22 ' A' ' 21' ' ' THR . 29.4 mt -59.49 -37.82 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.56 -55.27 25.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.73 37.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.586 ' HE3' ' CD1' ' A' ' 25' ' ' TYR . 16.6 ptmt -72.85 -53.92 10.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.17 -33.4 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.055 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.65 -33.28 38.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 25.0 mt -53.19 126.05 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.5 m -123.91 169.06 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.828 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.554 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.1 m-85 -136.42 126.41 26.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.04 109.61 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.17 112.98 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.477 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.4 mmtp -92.05 -31.28 15.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.591 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.72 129.96 0.28 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.875 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.461 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.74 119.44 6.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 0.0 112.323 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' PRO . 32.0 m-85 -35.02 148.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 94' ' ' PHE . 15.3 mt -36.17 136.91 0.28 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.467 ' CG ' ' HD2' ' A' ' 97' ' ' PRO . 30.0 tt0 -102.48 139.94 20.67 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.579 0.705 . . . . 0.0 110.919 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 96' ' ' GLU . 54.1 Cg_endo -69.72 165.55 30.53 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.79 2.327 . . . . 0.0 112.327 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -45.24 -44.75 11.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -110.67 105.53 14.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.957 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.652 ' NE2' HG22 ' A' ' 101' ' ' VAL . 1.1 p80 -48.74 -41.68 32.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.652 HG22 ' NE2' ' A' ' 100' ' ' HIS . 29.5 m -130.56 90.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.52 141.85 22.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.05 148.68 23.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.0 p -130.22 -46.88 1.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.001 0.429 . . . . 0.0 110.898 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 121.49 84.32 0.75 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.464 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 2.83 3.18 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.648 2.232 . . . . 0.0 112.389 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.7 t -110.74 112.17 23.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.808 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.0 m -112.54 128.91 56.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.505 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p -91.75 108.79 20.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.88 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -72.36 96.82 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.91 -136.61 9.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -106.46 -46.09 4.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 0.0 110.862 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.5 t -47.46 97.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.849 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.92 -42.34 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 4.4 ttt -119.87 108.61 14.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.1 p -76.56 152.64 35.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.86 -38.23 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -86.58 7.84 24.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.98 -42.46 76.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.1 p -63.02 -29.21 46.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.129 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.49 -63.62 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 9.6 tt -51.13 -38.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.7 mm-40 -68.78 -46.03 69.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 m -61.56 -33.44 73.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 19.1 mt -59.25 -47.48 85.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.452 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -58.85 -47.68 84.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -54.53 -52.62 61.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.505 HG22 HD21 ' A' ' 80' ' ' LEU . 24.6 m -51.46 -48.38 62.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.535 HG12 ' CE2' ' A' ' 26' ' ' PHE . 23.7 t -67.72 -37.41 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -56.41 -36.92 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.94 -47.9 27.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.3 t80 -44.34 -63.06 0.96 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.535 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.3 m-85 -41.92 -34.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.1 m -71.83 -38.91 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.746 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.7 t80 -64.8 -47.52 77.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 65.3 m -65.56 -41.75 92.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.744 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.7 t80 -66.7 -47.91 70.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.98 -32.67 63.21 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -42.31 93.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.42 -31.3 70.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -61.71 -36.1 79.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.41 10.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.474 ' HE2' HG21 ' A' ' 40' ' ' VAL . 18.8 mtmt -94.28 179.31 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.0 p -108.65 21.01 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.0 p -155.76 162.27 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.746 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.0 m -76.12 155.41 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.474 HG21 ' HE2' ' A' ' 36' ' ' LYS . 41.5 t -132.87 135.0 25.21 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.663 0.744 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.1 Cg_endo -69.77 118.55 5.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 0.0 112.286 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 81.3 t -67.0 117.81 49.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 111.122 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 80.01 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -50.57 -53.11 32.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 2.6 tp10 -43.16 -56.21 3.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 10.3 mptt -65.79 -56.1 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 41.0 mmm -50.06 -23.52 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.826 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.24 -30.41 57.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.955 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -84.52 -42.12 15.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.33 94.54 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -81.69 47.63 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.915 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -125.18 -56.07 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.72 -36.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 90' ' ' ILE . 16.1 t -149.69 119.77 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.471 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 19.9 t -95.86 154.85 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.817 HG13 ' CE1' ' A' ' 88' ' ' PHE . 5.0 t -125.69 119.53 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -112.04 158.93 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.41 13.24 42.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.1 mt -85.89 156.97 57.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.667 0.746 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.621 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.4 Cg_endo -69.8 -172.16 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -86.53 158.87 19.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.39 28.7 9.8 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 64' ' ' ALA . 4.2 p -118.69 171.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.635 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -154.66 120.31 5.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 56' ' ' VAL . 82.4 t80 -35.15 121.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -167.31 170.58 11.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.3 t-80 -39.75 141.01 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.65 0.738 . . . . 0.0 110.879 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 1.0 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.71 -9.54 26.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -91.19 -16.81 27.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -82.82 -13.88 55.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CD2' HD11 ' A' ' 79' ' ' ILE . 21.9 m-85 -87.39 121.06 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.03 147.67 2.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 7.0 tp -40.01 -48.8 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.41 -44.73 84.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -63.42 -57.79 9.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.0 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.0 mt -39.44 -47.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -55.05 -46.55 75.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.56 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.5 t90 -54.5 -58.81 6.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.523 HD11 ' CD2' ' A' ' 71' ' ' TYR . 49.4 mt -41.52 -53.76 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 21' ' ' THR . 14.2 mt -61.1 -40.5 93.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -55.61 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -97.93 35.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 51.8 pttt -77.63 -49.77 13.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.82 -26.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -91.24 -39.1 5.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' LYS . 28.4 mt -43.22 122.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 111.149 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -120.49 162.73 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.817 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.3 m-85 -128.25 126.48 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.5 110.35 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.744 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.41 113.17 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 19.5 mmtt -91.45 -28.12 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.474 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 134.5 0.31 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.632 0.73 . . . . 0.0 110.842 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.422 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.8 128.9 16.65 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.612 2.208 . . . . 0.0 112.392 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.557 ' CE2' ' HB3' ' A' ' 46' ' ' LYS . 72.6 m-85 -50.79 149.4 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.09 120.54 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -106.08 125.89 31.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 0.0 110.931 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 176.63 6.52 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.734 2.289 . . . . 0.0 112.314 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -66.04 154.62 39.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -86.93 152.09 22.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.884 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -138.69 148.91 44.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.2 m -62.93 139.38 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.84 -159.08 18.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.515 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.59 62.29 1.4 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.442 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 t -121.12 128.13 52.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.82 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -75.45 -159.65 8.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.428 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 134.91 29.09 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.687 2.258 . . . . 0.0 112.351 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.7 p -136.66 174.97 10.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.1 t -172.05 108.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.51 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -126.84 101.21 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.845 0.355 . . . . 0.0 110.866 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -143.57 128.03 17.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.899 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.56 -166.52 12.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 m -125.79 146.18 49.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 110.778 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -124.79 97.29 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.11 -179.42 39.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.517 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 148.87 37.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.801 0.334 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.6 m -149.44 175.96 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 11' ' ' ASP . 7.1 p -74.34 -43.02 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.106 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' N ' HG13 ' A' ' 10' ' ' VAL . 14.4 m-20 -81.72 -10.86 59.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.42 73.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.096 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 10' ' ' VAL . 2.7 p -52.78 -21.73 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.47 -65.05 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tt -49.66 -31.01 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -76.6 -40.15 50.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -66.8 -34.44 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.51 HD12 ' CD1' ' A' ' 73' ' ' LEU . 20.6 mt -63.54 -41.39 98.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -64.44 -39.09 93.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -41.6 77.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.511 HG22 HD21 ' A' ' 80' ' ' LEU . 90.0 m -59.78 -49.03 79.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.085 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.551 HG12 ' CE2' ' A' ' 26' ' ' PHE . 96.1 t -65.36 -37.34 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.084 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -54.85 -39.14 68.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.92 -52.16 32.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 10.0 t80 -42.34 -62.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.716 ' HB3' HG21 ' A' ' 42' ' ' VAL . 21.4 m-85 -43.78 -40.74 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 m -68.32 -37.83 80.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.75 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -66.47 -47.0 74.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.5 m -64.1 -40.94 97.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.97 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.928 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.9 t80 -66.61 -56.71 9.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.23 -29.84 74.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.464 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -42.25 75.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.745 0.307 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -26.52 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.092 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.5 mt -67.6 -30.9 70.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 23.09 13.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.735 ' HE2' HG21 ' A' ' 40' ' ' VAL . 14.6 mtmt -95.77 178.85 5.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.347 . . . . 0.0 110.864 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.9 t -107.7 6.06 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.2 p -136.95 160.96 37.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.3 m -79.35 136.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.735 HG21 ' HE2' ' A' ' 36' ' ' LYS . 55.0 t -112.76 137.8 21.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 0.0 111.137 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.584 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.74 125.76 12.53 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.672 2.248 . . . . 0.0 112.383 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 26' ' ' PHE . 61.7 t -71.13 111.93 11.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.619 0.723 . . . . 0.0 111.169 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 80.44 0.89 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.674 2.249 . . . . 0.0 112.326 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -53.02 -53.21 53.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -47.42 -52.03 18.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -65.86 -61.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.551 ' HE1' ' CZ ' ' A' ' 65' ' ' PHE . 79.4 mtp -43.54 -37.95 2.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.5 mt -55.31 -40.26 70.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -82.26 -39.52 22.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -126.16 80.24 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -68.19 -20.63 64.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 54' ' ' VAL . 2.2 t -62.25 -57.14 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -31.79 -36.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 52' ' ' SER . 15.0 t -151.53 121.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 91' ' ' LYS . 20.8 t -100.02 157.78 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 65' ' ' PHE . 23.7 t -125.53 123.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -117.36 153.24 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.46 39.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.529 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 59' ' ' LEU . 12.3 mt -84.85 155.73 61.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.623 0.725 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.666 ' O ' HG12 ' A' ' 63' ' ' VAL . 52.8 Cg_endo -69.86 178.86 4.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.297 . . . . 0.0 112.311 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.18 154.61 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.08 23.21 51.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.543 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -116.61 164.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.161 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -144.59 117.95 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.746 ' CD1' HG21 ' A' ' 56' ' ' VAL . 64.1 t80 -34.65 120.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -167.11 171.48 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.8 t-80 -42.96 141.89 1.57 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.88 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.3 Cg_endo -69.77 -4.88 14.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.319 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.92 -14.27 26.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -85.21 -12.38 52.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.54 128.38 36.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 73' ' ' LEU . 4.5 m-20 -56.63 145.81 27.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.9 tp -36.19 -48.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.74 62.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -58.89 -46.38 87.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.88 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.2 mt -47.61 -47.99 28.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.985 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -55.1 -48.58 73.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.841 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.3 t90 -49.21 -60.56 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.6 mt -40.74 -53.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.511 HD21 HG22 ' A' ' 21' ' ' THR . 23.3 mt -58.73 -38.78 79.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -62.98 -55.42 25.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.465 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.48 38.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.9 pttp -77.39 -45.42 25.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.476 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -44.06 -35.89 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.07 -35.27 31.05 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 mt -49.51 123.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -126.09 167.6 15.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.54 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.6 m-85 -132.83 128.43 36.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.69 111.06 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.928 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.88 112.52 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HE3' HG21 ' A' ' 55' ' ' VAL . 22.3 mmtt -89.94 -33.3 16.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.17 129.6 0.26 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 110.835 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.44 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.7 Cg_endo -69.65 122.33 9.04 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.732 2.288 . . . . 0.0 112.371 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 93' ' ' PRO . 37.2 m-85 -37.41 153.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.8 mt -64.33 145.06 56.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -159.16 149.95 15.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.729 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 167.59 24.07 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.673 2.249 . . . . 0.0 112.331 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.438 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 1.3 ptpp? -108.3 27.51 9.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -129.33 148.6 51.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.826 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -105.71 -61.34 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.7 m -99.04 152.27 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.05 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -176.45 -59.67 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.528 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.94 158.67 22.98 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.519 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.9 p -112.68 -46.97 3.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 110.879 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 106.27 145.29 12.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.529 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 -50.83 0.44 Allowed 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 122.7 2.267 . . . . 0.0 112.32 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.2 p -48.72 -55.75 10.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t -82.84 85.16 7.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -133.17 -47.56 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.846 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -60.67 140.7 57.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.834 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.33 63.7 0.43 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.545 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.2 p -74.64 172.02 12.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 110.864 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 p -73.28 82.08 1.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.48 -144.67 16.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.4 mmt -80.16 128.38 33.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.6 t -75.71 165.74 24.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.64 -40.85 84.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -82.09 -7.03 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.8 -46.37 78.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p -57.94 -16.6 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.5 -57.33 3.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 5.5 tt -54.48 -46.11 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.082 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.549 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.3 mt-10 -63.48 -48.61 76.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 m -57.2 -30.89 64.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 28.6 mt -64.54 -48.64 74.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.697 ' HD2' HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -58.18 -42.07 85.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -39.02 92.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.6 HG22 HD21 ' A' ' 80' ' ' LEU . 48.5 m -64.33 -49.4 71.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.643 HG12 ' CE2' ' A' ' 26' ' ' PHE . 94.5 t -66.69 -39.49 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 18.5 mt-10 -53.36 -43.22 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.11 -49.68 69.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 12.5 t80 -45.99 -63.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.874 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.643 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.0 m-85 -44.18 -40.4 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.7 m -65.25 -38.3 89.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.603 ' HA ' HG12 ' A' ' 39' ' ' VAL . 31.3 t80 -66.64 -59.6 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -51.49 -37.57 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.58 ' CE1' HD11 ' A' ' 90' ' ' ILE . 17.0 t80 -69.71 -64.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.16 -18.18 57.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.87 -45.95 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.43 67.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mt -62.71 -33.17 74.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.86 23.43 11.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.65 ' HE2' HG21 ' A' ' 40' ' ' VAL . 10.2 mtmt -94.35 179.11 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -109.54 20.21 18.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.8 p -154.16 159.67 41.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.603 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.3 m -76.58 138.71 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.65 HG21 ' HE2' ' A' ' 36' ' ' LYS . 51.0 t -114.58 137.67 22.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.664 0.745 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.569 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.8 120.82 7.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.611 2.207 . . . . 0.0 112.349 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 58.7 t -73.72 111.96 14.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.738 . . . . 0.0 111.148 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 79.83 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.715 2.277 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -51.43 -45.2 62.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -54.36 -40.25 67.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -74.38 -59.62 2.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.625 ' HE2' ' CE2' ' A' ' 65' ' ' PHE . 92.5 mtp -47.38 -46.19 25.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -43.92 -46.96 8.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -80.77 -39.81 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -127.48 81.64 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -72.28 -30.96 65.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' ALA . 24.0 p -45.01 -50.07 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -36.14 -45.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.515 HG22 HG13 ' A' ' 90' ' ' ILE . 14.4 t -144.7 128.43 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.49 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 35.0 t -99.64 142.98 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 65' ' ' PHE . 39.6 t -116.56 112.66 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -102.49 162.63 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.6 0.78 64.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.6 mt -75.55 149.35 83.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.603 0.716 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.815 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.3 Cg_endo -69.81 178.47 4.57 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.685 2.257 . . . . 0.0 112.339 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.86 160.21 27.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.74 19.77 10.97 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -112.94 169.82 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.962 ' CD1' HG21 ' A' ' 56' ' ' VAL . 72.8 t80 -34.31 113.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -159.78 171.06 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.2 t-80 -42.15 141.24 1.42 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.92 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.8 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 0.0 112.378 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -90.59 -15.11 31.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -89.07 -7.15 56.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -91.29 121.25 32.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.82 147.16 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.82 -47.35 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.11 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.5 m -66.77 -57.51 6.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.92 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.9 mt -39.41 -48.32 1.91 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -55.99 -48.23 76.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.8 t90 -49.16 -57.71 6.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -43.1 -52.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.6 HD21 HG22 ' A' ' 21' ' ' THR . 21.6 mt -59.77 -38.28 81.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.23 -55.78 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.43 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -97.8 40.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.852 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.59 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 16.7 ptmt -80.05 -53.57 6.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.929 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -36.27 -33.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -83.29 -37.54 12.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' LYS . 14.4 mt -44.14 125.83 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 t -124.34 162.99 22.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.614 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.9 m-85 -131.77 126.2 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.2 111.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.667 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.23 113.07 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.185 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.49 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.0 mmtt -93.18 -31.24 14.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.51 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.89 125.71 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 0.0 110.872 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.1 Cg_endo -69.73 119.33 6.29 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -37.83 157.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.97 121.11 9.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -146.78 149.41 36.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.66 0.743 . . . . 0.0 110.815 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -173.69 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.691 2.26 . . . . 0.0 112.372 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -91.78 161.76 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -123.05 157.08 33.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -146.17 170.6 16.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.6 t -93.9 118.66 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.158 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.56 153.29 20.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.34 -162.63 36.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.576 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.4 t -122.93 -61.16 1.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.14 141.05 15.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.457 ' O ' ' C ' ' A' ' 107' ' ' SER . 54.3 Cg_endo -69.73 -20.72 34.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 106' ' ' PRO . 24.9 p -33.9 131.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.832 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.1 t -118.43 -178.98 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.853 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.546 -179.905 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.3 p -168.54 150.16 4.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.35 . . . . 0.0 110.852 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -158.03 174.88 14.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.856 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 5' ' ' SER . . . -162.8 76.64 0.17 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.496 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 4' ' ' GLY . 3.3 m -35.65 -62.37 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.822 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.7 p -66.49 88.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.95 -118.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.476 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.01 146.06 31.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.937 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -65.02 171.54 3.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.6 p -73.1 -35.79 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.54 -5.14 59.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.58 -43.67 89.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.174 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' VAL . 4.4 p -61.07 -12.84 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.147 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.9 -57.94 3.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 8.2 tt -50.83 -42.65 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.115 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.7 mt-10 -66.31 -43.23 86.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 m -63.28 -32.94 74.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 27.3 mt -61.41 -45.92 92.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.453 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -59.42 -50.14 75.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -47.78 70.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 HD21 ' A' ' 80' ' ' LEU . 24.3 m -55.25 -49.03 73.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.552 HG12 ' CE2' ' A' ' 26' ' ' PHE . 59.6 t -67.78 -36.1 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.438 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 15.3 mt-10 -57.75 -45.26 86.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -65.95 -47.98 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.406 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.4 t80 -44.87 -59.4 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.552 ' CE2' HG12 ' A' ' 22' ' ' VAL . 20.1 m-85 -46.71 -39.3 11.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.1 m -65.52 -39.9 92.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.79 ' HA ' HG12 ' A' ' 39' ' ' VAL . 12.6 t80 -64.49 -54.12 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.821 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.48 ' CB ' ' CD1' ' A' ' 88' ' ' PHE . 35.5 m -58.13 -43.86 87.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -63.15 -58.66 6.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.38 -27.86 72.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.31 -41.27 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.15 -32.65 69.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.129 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.52 -26.26 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.91 24.1 21.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.521 ' CE ' HG21 ' A' ' 40' ' ' VAL . 15.1 mtmt -96.86 177.21 5.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.6 p -109.24 22.68 15.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 110.872 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.0 p -153.26 165.59 35.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.14 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.0 m -84.54 140.46 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.127 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 41' ' ' PRO . 43.6 t -117.82 137.39 24.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.79 114.0 3.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.496 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 82.7 t -71.52 113.6 21.07 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.649 0.738 . . . . 0.0 111.076 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.427 ' CB ' ' CE ' ' A' ' 46' ' ' LYS . 54.3 Cg_endo -69.74 80.73 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 0.0 112.352 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -52.15 -45.21 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -49.46 -46.55 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' CE ' ' CB ' ' A' ' 43' ' ' PRO . 43.7 mtmt -75.69 -52.83 9.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.619 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 38.5 mtp -51.81 -21.44 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -76.67 -33.27 58.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -34.68 57.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.51 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -136.92 109.82 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -97.58 40.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 p -117.61 -41.93 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -48.93 -43.74 39.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.142 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG22 HG13 ' A' ' 90' ' ' ILE . 9.0 t -146.32 124.93 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.466 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 40.0 t -97.76 149.38 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.158 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.873 HG21 ' CD1' ' A' ' 65' ' ' PHE . 98.9 t -118.67 116.56 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.682 ' CD ' HD12 ' A' ' 89' ' ' ILE . 2.2 mp0 -100.74 -179.6 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.33 4.32 73.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.442 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.6 mt -78.11 154.02 79.9 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.67 0.748 . . . . 0.0 110.854 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.643 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.8 Cg_endo -69.71 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.715 2.277 . . . . 0.0 112.341 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -87.26 160.16 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.45 29.07 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.643 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.8 p -119.18 167.65 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.529 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.59 126.78 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.063 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.873 ' CD1' HG21 ' A' ' 56' ' ' VAL . 78.4 t80 -35.95 130.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HZ2' ' HE1' ' A' ' 71' ' ' TYR . 8.5 ptpp? -174.44 172.77 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.5 t-80 -47.18 140.99 6.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.558 0.694 . . . . 0.0 110.883 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.987 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.4 Cg_endo -69.73 -7.26 20.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' OE2' ' ND1' ' A' ' 67' ' ' HIS . 5.2 pt-20 -93.09 -17.28 24.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -81.69 -15.72 53.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.426 ' HE1' ' HZ2' ' A' ' 66' ' ' LYS . 26.1 m-85 -85.05 131.8 34.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.0 OUTLIER -56.44 147.21 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.1 tp -40.43 -49.12 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.19 79.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 26.6 m -71.15 -51.54 24.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 68' ' ' PRO . 12.2 mt -45.29 -54.17 7.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.417 ' HE2' HD11 ' A' ' 73' ' ' LEU . 17.9 mttm -49.67 -47.44 50.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.536 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.0 t90 -49.12 -55.87 10.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.9 mt -45.37 -54.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.524 HD21 HG22 ' A' ' 21' ' ' THR . 23.3 mt -59.45 -34.27 72.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.948 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.26 -52.31 55.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.92 33.82 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 86' ' ' ILE . 55.8 pttt -76.47 -45.29 31.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -40.58 -25.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.72 -30.24 9.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 83' ' ' LYS . 20.0 mt -49.57 122.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.126 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.8 m -121.82 170.26 9.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 29' ' ' CYS . 6.1 m-85 -128.89 116.13 18.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.682 HD12 ' CD ' ' A' ' 57' ' ' GLN . 9.2 mt -103.83 93.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.166 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.641 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -71.39 114.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.466 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.2 mmtp -93.68 -30.07 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.943 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.456 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.55 128.45 0.27 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.611 0.72 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.453 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 54.1 Cg_endo -69.83 124.82 11.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.383 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.415 ' C ' ' O ' ' A' ' 93' ' ' PRO . 26.5 m-85 -37.24 156.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.4 mt -50.27 156.81 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -118.53 143.38 33.22 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.627 0.727 . . . . 0.0 110.914 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 177.33 5.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.305 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -74.3 -62.38 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -124.8 179.18 5.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -174.98 128.36 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.5 t -135.85 110.75 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.34 170.54 16.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.451 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.33 165.28 24.45 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.464 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.1 p -123.3 -57.97 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.815 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.73 175.7 14.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.482 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 88.14 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.694 2.262 . . . . 0.0 112.347 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.9 t -41.68 117.83 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.3 m -144.17 126.26 15.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.824 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.531 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 p -106.56 112.49 25.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.379 . . . . 0.0 110.826 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 t -145.83 137.92 25.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.04 39.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.47 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.4 t -130.85 170.69 14.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -42.78 144.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.8 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.89 -54.56 0.21 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 14.6 mmt -81.69 137.71 35.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.347 . . . . 0.0 110.828 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 74.8 m -69.84 168.83 14.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 13' ' ' VAL . 7.5 p -61.35 -44.52 98.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.124 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.458 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -80.36 -9.12 59.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 9' ' ' SER . . . -61.85 -46.63 88.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.071 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 10' ' ' VAL . 5.7 p -57.31 -36.37 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -62.2 -68.85 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.9 tt -48.52 -34.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.51 -40.41 64.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -66.05 -38.04 87.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 27.6 mt -59.61 -45.8 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -58.27 -40.67 82.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.842 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -45.74 73.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.479 HG22 HD21 ' A' ' 80' ' ' LEU . 25.7 m -52.15 -49.69 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.089 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.656 HG12 ' CE2' ' A' ' 26' ' ' PHE . 42.3 t -65.92 -39.59 85.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -51.1 -48.31 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -63.97 -48.85 74.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.8 t80 -44.21 -62.69 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' HG12 ' A' ' 22' ' ' VAL . 24.6 m-85 -44.63 -35.14 2.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.0 m -67.59 -39.72 84.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.694 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -62.11 -58.04 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.8 m -54.78 -39.75 68.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -65.78 -64.8 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.78 -24.22 62.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.6 -46.64 63.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.58 -31.03 71.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.99 -34.07 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.36 22.83 11.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.41 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 40' ' ' VAL . 15.0 mtmt -91.55 179.46 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.9 p -107.98 18.98 20.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -152.12 172.72 15.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.694 HG12 ' HA ' ' A' ' 28' ' ' PHE . 2.4 m -90.05 140.44 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.18 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 36' ' ' LYS . 42.9 t -116.76 136.31 23.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.654 0.74 . . . . 0.0 111.114 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.78 122.52 9.2 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.386 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.604 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 60.2 t -73.12 112.04 14.01 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.659 0.743 . . . . 0.0 111.11 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 80.54 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.761 2.307 . . . . 0.0 112.323 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -48.84 -52.01 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.02 -52.65 14.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -65.86 -57.84 6.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 32.1 mmm -48.25 -33.65 9.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.7 mt -59.97 -32.6 70.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -87.02 -40.32 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -129.18 90.88 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -80.74 -19.89 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p -58.52 -46.72 86.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -40.53 -42.96 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.476 HG22 HG13 ' A' ' 90' ' ' ILE . 5.4 t -146.52 132.03 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 51.1 t -102.91 148.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.918 HG21 ' CD1' ' A' ' 65' ' ' PHE . 12.4 t -121.86 116.9 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -104.73 170.02 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.96 9.6 73.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.7 mt -83.45 150.15 59.49 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.636 0.732 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.664 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.6 Cg_endo -69.78 -171.98 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -83.4 163.69 20.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.37 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.664 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -119.8 157.86 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 111.166 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.12 123.83 16.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.918 ' CD1' HG21 ' A' ' 56' ' ' VAL . 91.5 t80 -34.62 119.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -167.37 169.89 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.6 t-80 -41.86 140.99 1.36 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 0.0 110.848 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.957 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.71 -6.59 18.93 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.657 2.238 . . . . 0.0 112.365 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.66 -21.4 21.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -78.86 -9.65 59.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.44 129.28 39.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.93 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' THR . 4.2 m-20 -57.77 143.46 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 72' ' ' ASP . 9.8 tp -36.32 -48.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -42.69 79.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 72' ' ' ASP . 60.7 m -70.09 -45.77 66.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.0 mt -47.78 -52.75 17.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -51.34 -46.68 62.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 65.1 t90 -50.05 -56.85 9.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -44.63 -55.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.479 HD21 HG22 ' A' ' 21' ' ' THR . 22.0 mt -57.97 -36.67 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.02 -53.33 55.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.38 34.86 2.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 60.7 pttt -77.2 -48.8 16.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -42.87 -27.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.94 -32.26 11.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.1 mt -47.66 121.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 111.154 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -118.03 162.55 18.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.847 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.1 m-85 -131.1 123.33 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.5 110.84 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.22 113.23 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.138 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.462 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 4.9 mmtp -93.17 -32.46 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.567 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -179.12 127.73 0.25 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.428 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.4 Cg_endo -69.87 124.34 10.95 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.669 2.246 . . . . 0.0 112.298 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 0.3 OUTLIER -42.73 166.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.3 mt -82.08 117.13 22.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.955 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.76 125.85 49.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.634 0.73 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -164.63 0.13 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.729 2.286 . . . . 0.0 112.351 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -53.28 168.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -74.49 -61.96 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -70.18 109.05 4.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.84 38.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.096 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.68 -96.49 1.97 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 147.07 57.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.502 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.7 p -145.79 138.95 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.883 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.67 145.16 4.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.508 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 84.8 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.361 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 t 58.27 53.35 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.4 p -99.37 152.15 20.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.844 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 66.25 44.65 2.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 p -81.28 -42.76 20.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.27 106.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.465 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 t -96.41 150.56 20.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.851 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 t -42.23 160.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.841 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.47 -92.59 0.78 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.466 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.37 156.46 18.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.331 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.7 m -98.54 178.59 4.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.853 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p -79.56 -36.07 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.2 -10.73 51.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.68 91.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.13 -26.02 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.178 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.96 -62.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.8 tt -47.36 -36.22 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.14 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -70.09 -40.67 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -66.43 -38.7 88.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 22' ' ' VAL . 20.0 mt -59.36 -46.33 88.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -64.44 -37.45 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -68.18 -46.45 70.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.588 HG22 HD21 ' A' ' 80' ' ' LEU . 27.7 m -56.69 -45.9 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.087 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.604 HG12 ' CE2' ' A' ' 26' ' ' PHE . 41.0 t -68.18 -31.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.62 -47.38 63.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -45.33 -61.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.604 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.9 m-85 -46.71 -39.98 12.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m -67.46 -40.44 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.47 ' HA ' HG12 ' A' ' 39' ' ' VAL . 9.7 t80 -62.85 -56.53 16.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.0 m -52.61 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.825 ' CE1' HD11 ' A' ' 90' ' ' ILE . 15.1 t80 -66.87 -64.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.93 -23.16 58.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -39.2 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.906 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.17 -27.25 60.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 mt -66.09 -32.66 74.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 25.93 9.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.59 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.6 mtmt -95.56 179.73 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 t -110.93 21.39 16.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.3 p -154.3 163.94 39.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.7 m -79.04 143.04 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.202 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 41' ' ' PRO . 57.5 t -118.92 137.84 25.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.684 0.754 . . . . 0.0 111.09 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.75 120.94 7.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 26' ' ' PHE . 60.6 t -71.61 112.66 14.81 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 80.63 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.716 2.277 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -60.32 -39.61 87.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.9 -38.5 70.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -80.3 -55.02 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.95 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.527 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 84.2 mtp -49.41 -35.98 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.24 -33.66 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -85.69 -38.38 18.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.07 91.5 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -81.15 41.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 14.3 p -116.41 -55.86 2.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.795 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 94' ' ' PHE . . . -33.94 -37.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 90' ' ' ILE . 29.7 t -148.02 135.95 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.501 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 46.7 t -109.32 146.07 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 65' ' ' PHE . 15.3 t -117.57 124.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.2 165.27 12.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.92 62.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.9 mt -85.44 151.2 55.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.536 0.684 . . . . 0.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.616 ' HD2' HG11 ' A' ' 63' ' ' VAL . 54.1 Cg_endo -69.77 -169.07 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 63' ' ' VAL . 7.7 tt0 -87.52 167.5 13.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.21 24.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.616 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.5 p -115.27 159.81 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -141.63 117.38 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.741 ' CD1' HG21 ' A' ' 56' ' ' VAL . 42.0 t80 -34.21 114.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -159.02 173.76 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 6.9 t-80 -42.92 140.62 1.85 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 110.875 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.769 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.3 Cg_endo -69.78 0.75 5.21 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.643 2.229 . . . . 0.0 112.335 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.42 -17.79 18.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.93 -11.35 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -88.17 121.39 30.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 73' ' ' LEU . 1.8 m-20 -51.45 144.84 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.818 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.518 ' CD1' HD12 ' A' ' 18' ' ' LEU . 6.2 tp -36.91 -48.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.89 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -57.18 -48.93 77.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.161 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 68' ' ' PRO . 15.5 mt -43.48 -57.2 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -48.14 -44.0 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.93 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.537 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.8 t90 -53.14 -59.73 4.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.7 mt -41.87 -54.65 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.149 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 21' ' ' THR . 20.8 mt -59.85 -36.86 77.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -63.03 -53.45 53.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -100.84 35.0 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -76.38 -45.54 31.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -42.0 -29.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.8 -35.84 8.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.9 mt -46.01 120.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p -120.52 163.13 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.63 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.2 m-85 -129.74 126.65 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.65 111.39 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.825 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -81.97 113.06 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.501 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 22.8 mmtt -91.54 -31.66 15.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.518 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -179.02 132.46 0.28 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.439 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo -69.71 124.66 11.33 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.75 2.3 . . . . 0.0 112.384 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 53' ' ' ALA . 21.5 m-85 -49.07 179.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.9 mt -104.67 113.63 27.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.979 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.65 145.5 0.96 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.67 0.747 . . . . 0.0 110.837 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -172.86 0.62 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.623 2.215 . . . . 0.0 112.366 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -22.83 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.784 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -95.47 162.96 13.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.93 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -170.4 137.36 1.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.9 t -123.73 93.36 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 39.15 74.25 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.437 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.83 -110.81 3.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.478 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.6 p -49.72 108.51 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 0.0 110.849 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.15 -164.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.534 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 172.27 13.01 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.665 2.243 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 t -162.44 131.38 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.848 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.6 t -51.22 126.14 15.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.543 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.4 p -127.46 173.14 10.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.831 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p -86.45 108.77 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.46 -96.01 2.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.496 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.8 m -69.32 119.24 13.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.9 p -79.23 -52.27 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.72 -123.49 2.47 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.461 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.01 51.85 4.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.877 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.416 ' H ' ' HB3' ' A' ' 12' ' ' ALA . 3.9 m -166.31 175.99 7.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 13' ' ' VAL . 6.0 p -60.69 -44.49 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' N ' HG13 ' A' ' 10' ' ' VAL . 1.3 p-10 -80.73 -16.22 54.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.82 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.416 ' HB3' ' H ' ' A' ' 9' ' ' SER . . . -54.59 -35.98 63.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -61.83 -38.89 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -57.96 -69.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 tt -45.84 -32.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.54 -37.74 59.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.449 ' HA ' ' HZ2' ' A' ' 20' ' ' LYS . 55.1 m -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD12 ' CD1' ' A' ' 73' ' ' LEU . 15.7 mt -61.31 -40.96 96.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -63.44 -45.91 88.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HZ2' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -66.13 -44.83 83.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.526 HG22 HD21 ' A' ' 80' ' ' LEU . 98.9 m -53.74 -47.38 70.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.593 HG12 ' CE2' ' A' ' 26' ' ' PHE . 59.5 t -68.73 -36.54 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.93 -47.65 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 8.2 t80 -45.28 -58.3 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.593 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.5 m-85 -50.13 -40.71 47.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.4 m -65.42 -40.13 92.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.69 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.2 t80 -63.16 -58.48 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.0 m -52.0 -40.65 61.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.733 ' CE1' HD11 ' A' ' 90' ' ' ILE . 17.5 t80 -66.66 -64.72 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 -21.89 56.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -41.01 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.2 -27.24 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.83 -31.46 72.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.949 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.6 24.68 10.69 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.514 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.63 ' HE2' HG21 ' A' ' 40' ' ' VAL . 17.6 mtmt -94.66 179.9 5.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 t -109.65 21.3 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.9 p -155.39 174.88 14.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 28' ' ' PHE . 1.8 m -88.31 148.35 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.63 HG21 ' HE2' ' A' ' 36' ' ' LYS . 98.6 t -123.12 137.1 27.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.664 0.745 . . . . 0.0 111.153 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.2 Cg_endo -69.74 111.92 2.94 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.405 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 39.6 t -69.96 111.9 10.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.573 0.701 . . . . 0.0 111.111 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 79.97 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.624 2.216 . . . . 0.0 112.355 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -52.05 -48.45 64.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 48' ' ' LEU . 20.6 tt0 -50.34 -43.23 53.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -74.17 -58.37 3.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.405 ' SD ' ' CG1' ' A' ' 42' ' ' VAL . 56.9 mtp -46.59 -35.39 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 45' ' ' GLU . 24.2 mt -54.24 -42.2 69.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.985 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 6.7 ptt85 -84.23 -32.89 24.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.878 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.571 ' OD2' ' CE2' ' A' ' 94' ' ' PHE . 8.3 p-10 -130.62 86.87 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -80.09 -7.39 58.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 53' ' ' ALA . 2.5 p -68.61 -57.26 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.83 -37.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.079 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' SER . 3.4 t -154.33 125.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 56' ' ' VAL . 40.2 t -96.3 165.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.812 HG21 ' CD1' ' A' ' 65' ' ' PHE . 39.4 t -136.2 123.1 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -116.21 166.44 12.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.33 5.49 67.31 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.8 mt -79.68 152.29 74.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.914 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.682 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.2 Cg_endo -69.8 -174.63 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.306 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -83.61 162.69 20.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.1 23.43 2.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -115.93 166.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.491 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.12 128.76 12.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.812 ' CD1' HG21 ' A' ' 56' ' ' VAL . 86.9 t80 -37.87 128.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -174.07 174.49 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.538 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 1.6 t-80 -50.61 141.87 16.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.569 0.699 . . . . 0.0 110.839 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.681 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.3 Cg_endo -69.7 -1.98 9.34 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 4.3 pt-20 -95.81 -20.09 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -78.12 -17.45 56.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -83.19 145.05 29.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.36 150.09 38.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.649 ' CD1' HD12 ' A' ' 18' ' ' LEU . 7.3 tp -38.77 -51.77 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.28 -56.76 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -55.0 -50.11 69.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.681 HD21 ' O ' ' A' ' 68' ' ' PRO . 19.7 mt -43.19 -57.03 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -47.14 -46.56 23.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 67.4 t90 -51.01 -61.87 1.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mt -40.14 -54.63 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.526 HD21 HG22 ' A' ' 21' ' ' THR . 29.2 mt -58.88 -40.14 83.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.36 -53.76 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.486 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -100.97 35.67 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 53.7 pttt -76.79 -45.06 30.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -43.11 -28.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.32 -35.01 9.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.455 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.4 mt -47.61 120.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.356 . . . . 0.0 111.084 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -120.76 164.79 16.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.427 ' CE2' HG22 ' A' ' 56' ' ' VAL . 6.5 m-85 -131.22 122.16 26.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.05 110.48 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.733 HD11 ' CE1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.66 112.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 21.0 mmtt -91.48 -28.79 17.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.49 140.43 0.34 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.86 151.57 68.54 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.672 2.248 . . . . 0.0 112.278 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.571 ' CE2' ' OD2' ' A' ' 50' ' ' ASP . 32.0 m-85 -71.26 118.07 13.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.0 mt -45.9 113.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.961 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.56 153.21 54.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.647 0.737 . . . . 0.0 110.884 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 156.55 63.28 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.399 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -55.33 164.74 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -55.63 165.53 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -169.58 146.98 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.2 t -80.53 125.63 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.173 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.93 101.03 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -172.74 49.98 0.17 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.3 p -171.04 152.82 3.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 110.872 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 99.84 69.45 0.9 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 145.61 57.94 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.644 2.23 . . . . 0.0 112.342 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.8 m -94.33 102.42 14.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.8 t -49.04 113.28 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.533 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -75.05 103.08 5.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 t 60.03 42.17 16.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.63 105.2 0.2 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.409 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.0 p -44.7 144.81 1.02 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.4 p -99.3 41.99 1.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.65 174.97 47.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.89 143.13 26.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.74 0.305 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' ' 12' ' ' ALA . 30.3 m -100.78 165.15 11.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.71 -35.61 25.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -93.29 14.54 17.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.781 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -78.05 -41.72 34.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 13' ' ' VAL . 2.8 p -66.44 -11.39 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.193 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -82.01 -55.47 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 12' ' ' ALA . 11.2 tt -52.49 -36.46 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -72.69 -45.42 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.9 m -59.5 -36.25 75.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 29.8 mt -60.64 -44.8 95.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -58.88 -36.07 74.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -45.79 75.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.665 HG22 HD21 ' A' ' 80' ' ' LEU . 33.0 m -55.83 -50.23 71.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.172 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.511 HG12 ' CE2' ' A' ' 26' ' ' PHE . 39.5 t -66.07 -40.64 87.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -51.9 -49.54 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.59 -47.39 85.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -44.95 -62.11 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.511 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.6 m-85 -45.24 -41.73 8.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 m -62.41 -42.46 99.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.544 ' HA ' HG12 ' A' ' 39' ' ' VAL . 22.9 t80 -63.35 -55.24 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 64.9 m -57.53 -40.41 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CE1' HD11 ' A' ' 90' ' ' ILE . 20.3 t80 -67.14 -62.83 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.53 -23.46 60.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.54 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -72.17 -46.61 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.57 -28.67 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.62 -34.81 77.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 22.85 12.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.534 ' HE2' HG21 ' A' ' 40' ' ' VAL . 19.4 mtmt -93.39 -179.91 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 p -109.34 20.52 18.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.3 p -156.39 159.44 38.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -68.88 155.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG21 ' HE2' ' A' ' 36' ' ' LYS . 70.5 t -130.82 131.75 23.47 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.626 0.726 . . . . 0.0 111.082 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 109.47 2.32 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.657 2.238 . . . . 0.0 112.348 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.68 115.51 15.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.72 0.771 . . . . 0.0 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.92 0.97 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -48.78 -52.85 21.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -45.86 -54.2 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -61.19 2.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.799 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 31.5 mmm -42.25 -39.2 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -49.34 71.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.937 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -80.53 -25.53 38.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.54 87.87 2.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 54' ' ' VAL . 52.2 mt-30 -83.36 -28.31 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 31.0 p -49.84 -56.39 10.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.21 -43.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 51' ' ' GLN . 2.5 t -143.99 122.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.097 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.22 142.01 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.984 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.0 t -111.19 125.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -116.74 162.94 16.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.38 44.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 18.3 mt -92.14 155.96 42.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.668 0.746 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.8 Cg_endo -69.71 -165.59 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' GLY . 10.3 tt0 -88.16 166.73 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.66 33.09 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.654 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -120.28 149.82 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -133.86 123.17 24.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.984 ' CD1' HG21 ' A' ' 56' ' ' VAL . 82.6 t80 -33.98 121.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.452 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.0 ptpt -170.88 166.15 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.531 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.1 t-80 -39.92 141.52 0.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.841 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.954 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.4 Cg_endo -69.71 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.674 2.249 . . . . 0.0 112.356 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -20.54 25.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -81.76 -15.44 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 24.5 m-85 -84.04 123.15 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.7 145.07 7.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -37.99 -49.05 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.62 76.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.8 m -60.51 -47.84 84.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 68' ' ' PRO . 26.7 mt -47.97 -54.55 12.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -48.59 -43.41 36.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.546 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.6 t90 -56.87 -57.21 13.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.0 mt -44.19 -52.42 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.665 HD21 HG22 ' A' ' 21' ' ' THR . 21.4 mt -60.62 -36.15 77.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.02 -53.09 55.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.434 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.6 m-80 -101.47 35.31 2.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.856 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 52.3 pttt -75.54 -49.3 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -41.0 -30.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.39 8.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.8 mt -40.47 124.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -121.51 170.2 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -132.47 115.42 15.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.2 mt -101.03 93.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.081 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -72.0 112.91 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -87.82 -31.97 19.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.55 137.34 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.562 0.696 . . . . 0.0 110.886 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 133.73 26.14 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.338 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -51.45 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -93.28 15.1 16.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -82.92 115.82 60.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.712 0.768 . . . . 0.0 110.819 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 166.38 27.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.52 13.55 17.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 100' ' ' HIS . 2.0 pptp? -85.36 -179.0 6.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.487 ' N ' ' HD2' ' A' ' 99' ' ' LYS . 24.0 p80 -175.13 176.13 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 101' ' ' VAL . 10.6 p -161.58 121.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.151 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.76 172.69 12.63 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.87 140.06 15.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.467 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.1 t -80.76 -57.89 3.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.958 0.408 . . . . 0.0 110.865 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.39 147.95 5.27 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 0.87 5.09 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.677 2.251 . . . . 0.0 112.314 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 p -117.66 144.64 45.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.1 p -165.39 163.21 19.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 -179.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 t -142.82 142.87 31.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 110.842 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 p -98.54 42.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.84 116.14 5.45 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.43 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 96.7 p -137.7 153.61 49.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.815 0.341 . . . . 0.0 110.889 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.7 t -68.18 135.15 51.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.47 148.96 19.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.526 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.2 tpp -76.24 158.66 31.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.5 m -151.46 175.46 12.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.68 -39.05 79.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -85.84 -5.08 59.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.576 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -56.98 -50.91 71.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p -61.49 -24.66 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.29 -49.92 65.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 12' ' ' ALA . 3.8 tt -57.19 -33.49 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.413 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 5.1 mt-10 -75.47 -40.82 56.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 m -64.67 -37.71 88.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' VAL . 31.0 mt -64.2 -37.05 86.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.475 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 31.1 mtm105 -66.41 -36.82 83.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -62.79 -48.89 77.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 HD21 ' A' ' 80' ' ' LEU . 28.3 m -56.29 -46.2 79.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.649 HG12 ' CE2' ' A' ' 26' ' ' PHE . 23.4 t -67.01 -35.57 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.428 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 12.7 mt-10 -61.01 -44.66 97.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.72 -46.35 72.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.52 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 6.9 t80 -46.52 -62.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.649 ' CE2' HG12 ' A' ' 22' ' ' VAL . 22.0 m-85 -42.31 -36.45 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.83 -42.98 76.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.583 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -59.59 -49.66 76.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -62.97 -43.79 97.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.625 ' CE1' HD11 ' A' ' 90' ' ' ILE . 14.1 t80 -62.37 -58.7 6.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.34 82.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -44.55 86.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.6 71.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.0 mt -64.01 -34.4 77.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.95 11.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.68 ' HE2' HG21 ' A' ' 40' ' ' VAL . 14.3 mtmt -93.25 179.59 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.945 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.87 20.27 18.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.3 p -154.55 164.56 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -77.79 145.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.68 HG21 ' HE2' ' A' ' 36' ' ' LYS . 59.1 t -124.22 132.94 24.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.597 0.713 . . . . 0.0 111.158 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.7 122.17 8.87 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.626 2.218 . . . . 0.0 112.336 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 79.5 t -68.08 111.54 8.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.707 0.765 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 79.61 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 0.0 112.364 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' MET . 38.3 m-85 -45.23 -73.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.4 tp10 -30.91 -54.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 27.2 mttm -62.09 -43.11 99.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.546 ' N ' ' O ' ' A' ' 44' ' ' TYR . 47.3 mtp -65.78 -58.68 5.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.5 mt -42.45 -35.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.463 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -91.86 -29.34 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.564 ' OD2' ' HB2' ' A' ' 53' ' ' ALA . 25.3 t0 -134.12 75.09 1.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -63.83 -43.76 95.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -40.16 -61.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.564 ' HB2' ' OD2' ' A' ' 50' ' ' ASP . . . -31.43 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' SER . 12.1 t -155.19 119.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 91' ' ' LYS . 21.5 t -98.17 157.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.627 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.9 t -126.68 121.79 59.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -114.28 153.31 29.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.67 15.12 27.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.407 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 17.3 mt -89.64 157.69 46.39 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.648 0.737 . . . . 0.0 110.863 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.647 ' HD2' HG11 ' A' ' 63' ' ' VAL . 52.9 Cg_endo -69.84 -168.01 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 0.0 112.248 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.84 164.86 15.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.2 29.31 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.647 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.1 p -118.66 152.59 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.179 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.97 123.25 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.009 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.627 ' CD1' HG21 ' A' ' 56' ' ' VAL . 86.9 t80 -33.81 126.29 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.83 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' HD3' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -172.49 166.83 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.944 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.532 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.4 t-80 -43.01 141.73 1.63 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.676 0.75 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.931 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.76 -7.59 21.45 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.709 2.272 . . . . 0.0 112.325 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HA ' ' CD ' ' A' ' 19' ' ' ARG . 1.5 pp20? -89.23 -16.95 30.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.405 ' CB ' ' HD3' ' A' ' 66' ' ' LYS . 52.0 m-20 -85.62 -13.73 47.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.79 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -85.79 128.5 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.7 m-20 -56.41 141.96 40.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 72' ' ' ASP . 7.5 tp -36.05 -46.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.33 84.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 72' ' ' ASP . 92.4 m -64.53 -48.13 76.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.931 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.1 mt -45.04 -51.72 9.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -52.99 -46.28 68.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.553 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 56.5 t90 -52.08 -61.81 2.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.993 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.3 mt -39.61 -52.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.595 HD21 HG22 ' A' ' 21' ' ' THR . 19.6 mt -61.22 -37.34 82.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -63.12 -53.84 47.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.533 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.2 m-80 -99.78 37.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 44.8 pttt -79.93 -50.04 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.466 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.48 -31.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.083 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -86.9 -37.16 8.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.6 mt -42.47 127.37 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.751 0.31 . . . . 0.0 111.146 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -127.61 166.16 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.56 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.9 m-85 -131.77 121.85 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.48 110.42 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.81 112.88 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HE3' HG21 ' A' ' 55' ' ' VAL . 24.3 mmtt -91.85 -25.35 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.13 139.41 0.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.655 0.741 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 132.58 23.55 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.695 2.264 . . . . 0.0 112.365 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.573 ' CD2' ' HB3' ' A' ' 46' ' ' LYS . 66.2 m-85 -51.38 131.94 28.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 mt -100.14 123.71 44.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -146.77 148.94 34.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.5 60.57 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -83.78 164.15 19.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -124.98 167.67 14.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.415 ' O ' ' CD2' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -110.53 138.26 47.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.8 t -109.29 95.66 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -120.69 67.99 0.41 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 162.38 150.78 6.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.469 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.7 m -106.63 173.49 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.4 . . . . 0.0 110.913 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 158.82 86.4 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 134.81 28.78 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.9 t -56.12 99.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 t -145.05 147.42 32.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.854 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 m -120.81 153.94 36.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -92.89 111.23 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.67 97.55 1.0 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.9 m -97.86 114.18 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 p -65.94 152.73 43.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 9' ' ' SER . . . 98.09 62.96 0.88 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.552 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 7' ' ' GLY . 3.8 ppp? 32.6 37.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 110.854 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 7' ' ' GLY . 9.8 t -55.08 169.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.6 -39.9 86.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.86 -1.0 55.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.462 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -66.65 -48.84 68.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.057 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -52.21 -28.14 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.62 -60.85 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 12' ' ' ALA . 6.1 tt -49.55 -37.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.409 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 7.4 mt-10 -72.38 -41.79 65.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 m -64.61 -38.36 90.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' CD1' HD11 ' A' ' 73' ' ' LEU . 26.9 mt -60.92 -35.52 76.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.667 ' NH1' HD11 ' A' ' 76' ' ' LEU . 57.6 mtt-85 -71.88 -41.33 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -58.18 -39.61 79.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.562 HG22 HD21 ' A' ' 80' ' ' LEU . 25.0 m -63.87 -43.97 94.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.763 HG12 ' CE2' ' A' ' 26' ' ' PHE . 47.4 t -70.58 -32.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.223 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 20.0 mt-10 -62.41 -40.15 95.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.73 -46.86 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.565 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 11.1 t80 -47.98 -62.85 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.763 ' CE2' HG12 ' A' ' 22' ' ' VAL . 28.9 m-85 -42.13 -37.73 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.1 m -68.6 -43.51 76.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.556 ' HA ' HG12 ' A' ' 39' ' ' VAL . 28.0 t80 -60.18 -52.55 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -57.83 -43.4 85.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.579 ' CE1' HD11 ' A' ' 90' ' ' ILE . 15.7 t80 -64.06 -61.1 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.952 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.21 -27.37 67.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -42.57 68.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.706 0.288 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 -24.27 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.35 -28.63 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.06 23.47 24.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.572 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.624 ' HE2' HG21 ' A' ' 40' ' ' VAL . 16.5 mtmt -91.92 -179.98 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.889 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 m -109.48 19.11 19.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -150.54 172.13 15.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.196 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -88.58 139.52 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.624 HG21 ' HE2' ' A' ' 36' ' ' LYS . 74.4 t -117.93 133.08 23.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 0.0 111.124 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.4 Cg_endo -69.77 124.7 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.721 2.281 . . . . 0.0 112.331 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 47' ' ' MET . 90.7 t -72.54 111.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.635 0.731 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 79.9 0.92 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 0.0 112.368 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -52.41 -51.12 60.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -46.0 -51.5 13.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -69.66 -60.5 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.601 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 40.2 mtp -42.2 -39.35 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.943 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.5 mt -53.78 -46.19 70.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -79.39 -31.94 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.32 88.94 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -78.44 -38.38 41.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 53' ' ' ALA . 37.0 p -39.52 -55.6 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -34.28 -40.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 t -153.06 128.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 56' ' ' VAL . 35.2 t -102.25 165.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.763 HG21 ' CD1' ' A' ' 65' ' ' PHE . 14.5 t -134.48 124.22 44.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -116.02 163.47 15.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.03 11.98 58.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 13.2 mt -86.29 154.04 56.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.751 ' O ' HG12 ' A' ' 63' ' ' VAL . 54.5 Cg_endo -69.7 172.76 11.99 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.356 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -78.69 147.52 33.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.47 18.83 72.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.3 p -115.41 168.59 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 111.143 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.541 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -146.65 117.85 7.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.763 ' CD1' HG21 ' A' ' 56' ' ' VAL . 68.3 t80 -35.94 122.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' N ' ' OH ' ' A' ' 71' ' ' TYR . 11.2 ptpt -170.8 169.99 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.4 t-80 -42.19 140.82 1.52 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 110.938 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.573 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.2 Cg_endo -69.85 3.34 2.87 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -95.32 -21.7 18.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -83.41 -7.06 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.954 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.419 ' OH ' ' N ' ' A' ' 66' ' ' LYS . 22.9 m-85 -92.72 133.82 35.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.91 154.87 36.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' A' ' 18' ' ' LEU . 6.3 tp -44.59 -47.53 10.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.54 -54.63 44.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.2 m -55.99 -47.1 78.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.667 HD11 ' NH1' ' A' ' 19' ' ' ARG . 22.8 mt -45.29 -59.69 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -46.1 -46.36 16.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.552 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.0 t90 -51.04 -62.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.5 mt -40.21 -51.44 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.562 HD21 HG22 ' A' ' 21' ' ' THR . 28.5 mt -62.12 -36.08 80.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' TRP . 12.0 mm-40 -64.56 -54.07 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.65 36.77 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.565 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -76.75 -45.51 28.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.53 -33.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.17 -31.47 28.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.41 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 mt -50.25 118.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.4 m -121.55 156.64 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.56 ' CE1' HG13 ' A' ' 56' ' ' VAL . 7.1 m-85 -121.66 126.56 49.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.71 109.53 28.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -82.55 113.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.456 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.3 mmtp -93.84 -26.88 16.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.8 137.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 151.67 68.53 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -72.35 149.29 44.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -120.33 27.52 8.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -85.32 118.49 70.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 0.0 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 106.97 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.751 2.301 . . . . 0.0 112.305 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -95.36 152.27 18.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -115.59 144.08 44.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.509 ' CG ' ' N ' ' A' ' 101' ' ' VAL . 33.4 p-80 -54.6 -49.24 70.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.84 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.509 ' N ' ' CG ' ' A' ' 100' ' ' HIS . 13.4 p -73.49 140.59 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -123.88 -62.08 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.533 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.51 106.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.527 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.1 t -72.92 -57.43 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.937 0.398 . . . . 0.0 110.818 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.64 85.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.528 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 107' ' ' SER . 54.4 Cg_endo -69.58 -176.3 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 106' ' ' PRO . 52.5 p -34.67 136.11 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.7 m -104.26 135.96 44.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.549 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 t -123.44 -47.2 2.0 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.933 0.397 . . . . 0.0 110.856 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m 55.26 44.62 27.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.843 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.59 104.65 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.526 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 t -79.96 165.18 22.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.92 0.391 . . . . 0.0 110.81 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.0 m -126.58 -43.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.861 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.26 111.19 0.25 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.9 ttm 51.16 35.0 12.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.949 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 m -60.93 -177.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 11' ' ' ASP . 7.4 p -66.53 -43.3 90.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.451 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -84.24 -6.49 59.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.513 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -63.08 -45.55 91.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.155 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 13' ' ' VAL . 2.1 p -64.96 -11.37 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.69 -54.87 5.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 12' ' ' ALA . 10.4 tt -52.27 -30.37 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 12' ' ' ALA . 3.4 mt-10 -77.37 -43.48 32.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -61.67 -34.44 75.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 24.0 mt -64.62 -44.45 90.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -61.55 -22.87 65.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -76.26 -56.0 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 m -44.47 -44.81 8.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.799 HG12 ' CE2' ' A' ' 26' ' ' PHE . 21.9 t -71.51 -34.74 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.487 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 14.7 mt-10 -62.75 -39.05 92.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -72.99 -38.05 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.551 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 7.0 t80 -58.41 -60.15 4.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.799 ' CE2' HG12 ' A' ' 22' ' ' VAL . 20.9 m-85 -44.03 -40.8 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.22 -58.0 7.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.7 m -53.24 -40.12 64.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.636 ' CE1' HD11 ' A' ' 90' ' ' ILE . 18.4 t80 -66.72 -63.7 1.01 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.959 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.56 60.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -41.23 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.732 0.301 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.85 67.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.051 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.0 mt -62.06 -35.3 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.35 25.61 8.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.501 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.737 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.1 mtmt -95.93 179.6 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -111.35 20.51 17.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.9 p -152.5 159.94 43.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.2 m -73.49 141.56 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.737 HG21 ' HE2' ' A' ' 36' ' ' LYS . 98.4 t -120.22 138.91 27.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 0.0 111.178 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.668 ' HD2' HG13 ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.83 122.82 9.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.748 2.299 . . . . 0.0 112.265 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 26' ' ' PHE . 55.2 t -67.98 116.79 42.27 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.628 0.727 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.595 ' CG ' ' CE1' ' A' ' 94' ' ' PHE . 54.0 Cg_endo -69.71 80.03 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.736 2.291 . . . . 0.0 112.349 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.517 ' O ' ' C ' ' A' ' 45' ' ' GLU . 67.9 m-85 -55.69 -72.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.921 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 44' ' ' TYR . 37.0 tt0 -28.79 -56.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -60.74 -48.07 83.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.52 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 74.2 mtp -59.26 -56.92 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 9.1 mt -43.83 -46.51 7.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -77.81 -31.28 51.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 51.8 m-20 -134.96 95.26 3.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -92.25 51.92 1.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 p -130.27 -38.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -52.97 -35.73 59.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 90' ' ' ILE . 34.5 t -149.29 123.35 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.487 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 33.4 t -95.95 155.06 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 65' ' ' PHE . 19.8 t -126.25 121.55 59.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.114 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -111.68 168.18 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.033 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.98 4.24 78.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.1 mt -78.93 158.11 75.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 0.0 110.925 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.6 Cg_endo -69.81 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.653 2.235 . . . . 0.0 112.3 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -98.3 157.41 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.09 17.53 10.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 64' ' ' ALA . 8.0 p -107.78 168.08 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.577 ' N ' HG22 ' A' ' 63' ' ' VAL . . . -145.94 115.08 7.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.098 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.828 ' CD1' HG21 ' A' ' 56' ' ' VAL . 55.5 t80 -35.01 125.19 0.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.839 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 14.7 ptpt -169.35 172.78 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 8.0 t-80 -43.84 140.66 2.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.599 0.714 . . . . 0.0 110.818 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.846 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.6 Cg_endo -69.77 2.59 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.1 -16.99 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.04 -11.06 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.521 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 22.6 m-85 -86.81 116.99 25.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.41 143.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 8.9 tp -39.44 -41.56 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.976 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.63 70.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -58.13 -46.25 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.846 HD21 ' O ' ' A' ' 68' ' ' PRO . 26.7 mt -47.0 -52.5 14.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -50.45 -46.23 56.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.558 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -54.32 -60.95 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.9 mt -41.14 -50.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.7 mt -62.68 -35.6 80.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.1 -55.17 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.466 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.5 m-80 -98.19 39.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.837 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.551 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 19.7 ptmt -78.27 -51.91 9.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -36.56 -31.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -85.05 -37.51 9.97 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' LYS . 18.1 mt -43.18 118.4 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 111.169 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.0 m -118.91 160.17 22.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 56' ' ' VAL . 6.1 m-85 -126.59 125.98 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.11 112.0 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -81.61 113.31 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.487 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 24.6 mmtt -93.36 -28.38 16.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.516 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.91 129.5 0.27 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.655 0.74 . . . . 0.0 110.833 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.451 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 53.3 Cg_endo -69.67 127.26 14.4 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.707 2.271 . . . . 0.0 112.385 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.595 ' CE1' ' CG ' ' A' ' 43' ' ' PRO . 33.0 m-85 -46.57 174.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 95' ' ' LEU . 13.7 mt -91.93 109.0 20.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.992 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.55 143.01 0.98 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.723 0.773 . . . . 0.0 110.851 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -177.34 1.82 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -61.8 149.77 39.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 31.4 mtmm -91.8 -55.0 3.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 99' ' ' LYS . 94.1 m-70 -161.38 148.65 14.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 101' ' ' VAL . 12.7 p -155.72 119.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.18 152.12 28.39 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.441 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.42 95.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.498 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 105' ' ' GLY . 21.0 t -57.31 92.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.931 0.396 . . . . 0.0 110.806 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 104' ' ' SER . . . 35.35 -97.33 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.422 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 104' ' ' SER . 53.7 Cg_endo -69.7 118.49 5.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.74 2.293 . . . . 0.0 112.37 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 m -88.0 -51.65 5.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.0 t -53.76 148.96 9.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.83 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 179.998 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m -62.16 101.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.818 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.5 m -106.92 151.58 25.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.27 48.97 0.79 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.399 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -46.79 132.98 11.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.3 t -167.87 163.43 13.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.42 -105.95 2.67 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.503 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 42.7 mtt -111.75 106.68 15.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.6 m -82.08 -176.22 6.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 11' ' ' ASP . 8.5 p -79.71 -41.82 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.062 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.441 ' N ' HG13 ' A' ' 10' ' ' VAL . 3.3 p30 -83.86 -8.3 59.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.841 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.03 88.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.86 -29.65 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.128 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.25 -59.31 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.82 -34.5 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -40.81 74.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m -67.18 -32.14 73.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 15.6 mt -64.27 -46.54 83.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -63.96 -29.08 70.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -67.54 -54.57 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.43 HG22 HD21 ' A' ' 80' ' ' LEU . 6.3 m -51.32 -47.9 62.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.641 HG12 ' CE2' ' A' ' 26' ' ' PHE . 20.0 t -64.72 -37.35 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.04 -43.19 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.36 -44.29 68.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 6.4 t80 -48.92 -61.18 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.675 ' HB3' HG21 ' A' ' 42' ' ' VAL . 19.7 m-85 -44.45 -35.06 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.2 m -68.05 -40.17 82.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 39' ' ' VAL . 4.5 t80 -62.49 -55.04 31.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.68 -35.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -68.03 -58.48 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -26.83 70.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -43.07 77.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.793 0.33 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.91 -27.65 62.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -72.6 -21.1 61.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.16 32.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -90.71 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -98.68 -4.3 34.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.4 p -137.94 166.53 23.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -72.84 129.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.145 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 41' ' ' PRO . 63.0 t -105.67 132.38 20.93 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.585 0.707 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.412 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.1 Cg_endo -69.68 124.46 11.14 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.388 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.675 HG21 ' HB3' ' A' ' 26' ' ' PHE . 81.0 t -64.91 111.17 5.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.693 0.759 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 42' ' ' VAL . 53.5 Cg_endo -69.83 79.18 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.261 . . . . 0.0 112.327 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 47' ' ' MET . 72.7 m-85 -47.3 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 44' ' ' TYR . 9.4 pt-20 -30.04 -42.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 23.7 mttp -73.13 -47.09 47.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' TYR . 70.4 mtp -62.51 -50.98 69.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 11.7 mt -50.4 -37.49 37.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -88.73 -27.63 21.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.629 ' OD2' ' HB2' ' A' ' 53' ' ' ALA . 3.8 t70 -134.11 69.6 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -59.0 -40.99 86.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 53' ' ' ALA . 3.4 t -48.37 -58.45 4.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.629 ' HB2' ' OD2' ' A' ' 50' ' ' ASP . . . -31.94 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.676 HG22 HG13 ' A' ' 90' ' ' ILE . 59.1 t -138.94 119.74 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.151 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 56' ' ' VAL . 39.2 t -98.94 160.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.841 HG21 ' CD1' ' A' ' 65' ' ' PHE . 18.1 t -129.61 129.1 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.179 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -118.51 163.96 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.3 6.87 62.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB3' HG11 ' A' ' 63' ' ' VAL . 11.6 mt -82.13 157.27 68.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.614 0.721 . . . . 0.0 110.902 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.601 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.3 Cg_endo -69.79 -168.17 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.309 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -90.11 162.37 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 46.61 26.69 2.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.7 p -116.33 163.22 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.91 0.386 . . . . 0.0 111.078 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -145.0 118.77 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.841 ' CD1' HG21 ' A' ' 56' ' ' VAL . 91.5 t80 -34.39 126.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 13.0 ptpt -170.67 165.71 8.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.528 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -38.29 140.82 0.57 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.807 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.0 Cg_endo -69.82 2.23 3.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.668 2.245 . . . . 0.0 112.302 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.22 -20.87 16.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -84.79 -12.61 53.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 20.4 m-85 -84.16 117.04 23.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.4 OUTLIER -45.46 139.12 3.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -35.79 -46.9 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.03 87.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' ASP . 51.8 m -65.49 -45.25 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.807 HD21 ' O ' ' A' ' 68' ' ' PRO . 14.8 mt -46.59 -54.7 8.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -48.94 -50.44 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.547 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 51.8 t90 -50.61 -60.71 2.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.0 mt -39.87 -52.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.091 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.43 HD21 HG22 ' A' ' 21' ' ' THR . 17.0 mt -62.95 -40.19 96.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.98 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -55.45 34.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -97.16 37.76 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 58.7 pttt -82.96 -45.64 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -38.43 -27.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.54 -40.07 4.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 85' ' ' GLY . 13.9 mt -34.16 127.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.1 m -127.92 169.6 13.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 56' ' ' VAL . 8.4 m-85 -134.96 127.92 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.23 109.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.133 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.676 HG13 HG22 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -81.75 113.38 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.215 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' HE3' HG21 ' A' ' 55' ' ' VAL . 5.3 mmtp -92.89 -31.74 14.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.618 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.85 127.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.594 0.711 . . . . 0.0 110.859 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.425 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo -69.75 116.76 4.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.727 2.284 . . . . 0.0 112.343 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -35.52 153.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.825 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.3 mt -75.9 143.81 41.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -100.19 101.58 15.06 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.656 0.741 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 119.37 6.32 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.347 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HG2' ' N ' ' A' ' 99' ' ' LYS . 18.2 tttm -169.72 149.89 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' N ' ' HG2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -132.05 -70.61 0.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.99 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -81.36 -67.83 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.4 p -168.32 128.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.25 175.4 29.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.52 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -174.64 66.53 0.1 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.483 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.3 t -52.27 -51.01 60.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.817 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.31 89.85 1.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 166.09 28.72 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.748 2.299 . . . . 0.0 112.328 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -100.16 118.48 36.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.8 m -125.81 102.74 7.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.4 p -91.13 122.13 33.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.92 0.39 . . . . 0.0 110.838 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.7 p -40.38 -46.5 2.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.0 87.33 0.56 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 6' ' ' SER . 13.5 m -63.31 113.78 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.847 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' SER . 5.3 t -35.92 -47.15 0.51 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.64 -129.1 4.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.428 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 66.0 mtt -77.45 117.07 18.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.742 0.306 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -96.06 177.38 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.63 -36.26 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.71 -3.75 58.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.65 92.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p -68.81 -24.12 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.87 -61.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 tt -50.79 -33.55 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.68 -43.9 62.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.6 m -62.96 -33.26 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.1 mt -63.32 -44.84 93.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -62.23 -40.2 95.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -64.55 -46.0 84.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.494 HG22 HD21 ' A' ' 80' ' ' LEU . 28.6 m -57.12 -48.98 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.643 HG12 ' CE2' ' A' ' 26' ' ' PHE . 46.4 t -65.97 -39.01 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.91 -43.69 69.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.1 -49.51 56.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 83' ' ' LYS . 9.0 t80 -42.72 -61.92 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.643 ' CE2' HG12 ' A' ' 22' ' ' VAL . 25.7 m-85 -45.13 -38.03 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 m -66.82 -47.37 72.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' HA ' HG12 ' A' ' 39' ' ' VAL . 12.3 t80 -55.6 -52.57 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.3 m -56.49 -46.21 80.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.577 ' CE1' HD11 ' A' ' 90' ' ' ILE . 12.9 t80 -61.95 -62.41 1.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.66 -27.83 64.48 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.519 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -41.81 74.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.23 -29.24 66.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt -64.89 -34.33 78.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.78 6.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.694 ' HE2' HG21 ' A' ' 40' ' ' VAL . 11.4 mtmt -99.86 177.61 5.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.756 0.313 . . . . 0.0 110.945 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.9 p -105.84 -0.54 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.4 p -128.78 165.82 20.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.5 146.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.694 HG21 ' HE2' ' A' ' 36' ' ' LYS . 78.3 t -125.31 128.12 24.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.703 0.763 . . . . 0.0 111.157 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 124.33 10.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.254 . . . . 0.0 112.306 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.685 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 73.3 t -71.16 113.1 16.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.682 0.753 . . . . 0.0 111.151 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 80.89 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.245 . . . . 0.0 112.344 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.574 ' O ' ' N ' ' A' ' 47' ' ' MET . 53.1 m-85 -47.85 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' C ' ' O ' ' A' ' 44' ' ' TYR . 35.0 tt0 -29.92 -46.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -70.11 -44.17 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.574 ' N ' ' O ' ' A' ' 44' ' ' TYR . 37.2 mmm -63.34 -53.01 59.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.82 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 12.1 mt -40.29 -35.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 9.7 mtp85 -93.73 -39.83 10.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -122.99 80.11 1.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.0 -28.0 57.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -52.54 -57.65 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.43 -36.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.3 t -152.69 119.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.543 HG21 ' HE3' ' A' ' 91' ' ' LYS . 20.0 t -96.28 153.41 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.127 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.794 HG13 ' CE1' ' A' ' 88' ' ' PHE . 11.9 t -125.36 123.58 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -112.15 163.82 13.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.39 61.16 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 11.3 mt -81.66 151.01 67.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.971 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.822 ' O ' HG12 ' A' ' 63' ' ' VAL . 54.7 Cg_endo -69.74 -179.95 3.26 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.7 2.266 . . . . 0.0 112.4 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.62 161.24 27.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.83 24.04 5.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.7 p -115.65 171.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -154.52 119.97 5.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.759 ' CD1' HG21 ' A' ' 56' ' ' VAL . 85.6 t80 -34.75 121.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 8.4 ptpp? -166.6 179.08 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.52 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.9 t-80 -51.24 140.74 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.779 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.4 Cg_endo -69.78 2.99 3.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' OE1' ' CE1' ' A' ' 67' ' ' HIS . 8.1 pt-20 -98.29 -22.54 16.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -79.12 -15.38 58.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.449 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 20.9 m-85 -83.42 129.55 34.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.9 m-20 -61.67 143.24 56.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 6.5 tp -34.78 -45.56 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.096 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' ASP . 87.5 m -60.58 -52.03 66.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 68' ' ' PRO . 24.8 mt -43.04 -56.74 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -46.57 -44.97 18.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.536 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 62.9 t90 -54.43 -57.9 9.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.7 mt -43.84 -55.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.494 HD21 HG22 ' A' ' 21' ' ' THR . 22.8 mt -59.15 -35.81 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.97 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -64.06 -52.8 57.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -101.74 33.64 2.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.521 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 59.0 pttt -74.87 -44.12 50.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.53 -22.07 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.4 -27.74 10.41 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.469 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mt -53.67 120.06 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.121 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 p -117.9 165.24 13.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.794 ' CE1' HG13 ' A' ' 56' ' ' VAL . 7.4 m-85 -133.09 122.86 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.43 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.667 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -80.7 113.24 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.543 ' HE3' HG21 ' A' ' 55' ' ' VAL . 32.2 mmtt -93.07 -25.97 17.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.53 140.0 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.673 0.749 . . . . 0.0 110.842 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 145.4 57.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.635 2.224 . . . . 0.0 112.36 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -69.02 141.22 54.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 95' ' ' LEU . 13.2 mt -71.3 108.81 4.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HA ' ' HD2' ' A' ' 97' ' ' PRO . 4.0 mm-40 -144.06 106.03 4.85 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.648 0.737 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 96' ' ' GLU . 53.9 Cg_endo -69.79 101.28 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.721 2.281 . . . . 0.0 112.408 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 99' ' ' LYS . 22.2 ttmt -167.71 151.51 6.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' N ' ' HG2' ' A' ' 98' ' ' LYS . 26.2 mtmt -108.31 108.75 19.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -93.72 137.87 32.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.41 137.01 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 44.5 -151.48 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.52 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.2 161.82 28.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.535 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.9 m -173.95 165.66 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.398 . . . . 0.0 110.853 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.45 148.84 10.54 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.518 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 107' ' ' SER . 54.3 Cg_endo -69.66 -9.42 26.1 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.722 2.281 . . . . 0.0 112.36 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 106' ' ' PRO . 1.6 t -34.8 111.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t -129.17 -49.17 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.835 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.523 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 p -132.84 -49.91 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.2 t -58.94 107.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.11 -133.18 1.47 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.476 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' SER . 39.3 m -148.24 132.76 17.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' SER . 54.6 m -35.23 -57.34 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.5 -45.8 0.41 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.419 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 7.1 mmt -118.51 167.12 11.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -50.21 144.07 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 p -58.15 -30.47 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.075 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.42 -9.68 58.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.61 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -50.18 -44.89 53.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.145 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p -66.72 -22.86 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.22 -44.95 82.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 12' ' ' ALA . 6.7 tt -64.27 -31.64 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -77.0 -34.08 57.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -74.89 -35.26 62.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.3 mt -63.59 -46.27 86.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.53 -38.25 74.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -64.34 -61.35 2.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 m -43.83 -46.92 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.588 HG12 ' CE2' ' A' ' 26' ' ' PHE . 96.4 t -65.13 -36.3 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.502 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 12.3 mt-10 -64.59 -39.24 93.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.885 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.87 -51.78 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -40.58 -60.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.588 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.5 m-85 -45.69 -34.69 3.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.886 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m -63.88 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 1.2 t80 -66.37 -64.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.3 m -51.14 -45.12 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.942 ' CE2' HD11 ' A' ' 34' ' ' LEU . 17.7 t80 -59.65 -55.79 30.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' HA2' HD12 ' A' ' 34' ' ' LEU . . . -57.03 -41.17 92.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.43 -38.16 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -18.09 49.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.069 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.942 HD11 ' CE2' ' A' ' 30' ' ' TYR . 30.1 mt -75.18 -26.91 59.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.15 4.33 9.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 153.2 41.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.318 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -88.7 11.61 17.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.3 p -105.87 170.07 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.198 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.5 115.4 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.606 HG13 ' HD2' ' A' ' 41' ' ' PRO . 96.9 t -100.05 137.37 20.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.623 0.725 . . . . 0.0 111.134 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.606 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.8 109.24 2.27 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.707 2.271 . . . . 0.0 112.254 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 30' ' ' TYR . 47.7 t -67.1 111.24 6.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.075 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 53.7 Cg_endo -69.73 79.52 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.293 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -48.9 -48.48 42.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -44.55 -57.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HD3' ' CD2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -69.08 -50.94 43.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.541 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 25.4 mmm -51.12 -24.76 4.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.8 mt -71.21 -32.96 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -87.52 -33.12 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -130.81 88.94 2.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -78.47 -39.86 37.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.2 t -43.56 -58.36 2.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -30.76 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.499 HG22 HG13 ' A' ' 90' ' ' ILE . 12.3 t -148.85 119.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HE3' ' A' ' 91' ' ' LYS . 21.9 t -97.04 149.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.715 HG13 ' CE1' ' A' ' 88' ' ' PHE . 11.2 t -123.16 115.15 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -100.31 -178.02 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.37 -2.23 85.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.44 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 65' ' ' PHE . 8.8 mt -77.87 154.09 80.54 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.671 0.748 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.731 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.7 Cg_endo -69.76 -175.42 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.344 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -83.19 164.44 20.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.84 20.45 1.22 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 60' ' ' PRO . 3.2 p -113.27 169.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 111.065 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -150.31 120.85 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.072 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CD1' HG21 ' A' ' 56' ' ' VAL . 61.3 t80 -34.56 123.31 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.536 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.1 ptpt -166.7 175.32 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.946 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.503 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 7.5 t-80 -47.81 140.39 8.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.542 0.687 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.743 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.0 Cg_endo -69.65 2.08 3.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.674 2.25 . . . . 0.0 112.352 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -98.16 -17.89 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.28 -11.61 49.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.536 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 23.0 m-85 -87.72 112.01 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -40.23 144.5 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tp -39.99 -47.29 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -44.67 95.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.4 m -62.99 -47.98 80.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.743 HD21 ' O ' ' A' ' 68' ' ' PRO . 15.3 mt -46.45 -59.27 3.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -45.18 -42.11 8.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.545 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 61.4 t90 -56.61 -59.32 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.0 mt -41.65 -55.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.162 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.47 -37.35 77.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -62.5 -54.56 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.565 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.1 m-80 -98.87 39.85 1.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' GLY . 27.4 pttt -85.86 -37.77 18.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -40.29 -24.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.073 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -97.61 -31.8 6.57 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.5 mt -42.25 110.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 111.058 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 m -121.93 138.56 54.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.715 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.7 m-85 -98.01 124.31 42.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.67 110.06 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.676 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.96 113.06 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.152 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 18.8 mmtt -91.08 -32.58 15.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.478 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.06 130.13 0.26 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.652 0.739 . . . . 0.0 110.866 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.443 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.76 122.96 9.64 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.669 2.246 . . . . 0.0 112.349 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.584 ' CD2' ' HD3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -37.59 156.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.0 mt -52.78 127.19 22.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.903 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -134.06 83.63 45.09 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.641 0.734 . . . . 0.0 110.89 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -179.26 2.77 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.713 2.275 . . . . 0.0 112.353 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -156.69 151.64 26.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.39 -179.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -175.08 121.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.96 133.73 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.03 156.96 7.38 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.02 135.13 1.79 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.542 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.1 t -47.95 165.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.897 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -124.36 -159.78 10.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.456 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 106.97 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.74 2.293 . . . . 0.0 112.369 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.5 p -119.45 121.54 39.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.7 m -76.77 -61.18 2.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.821 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.492 -179.965 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -130.47 119.78 23.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 t -125.72 124.69 41.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.23 -176.7 33.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.466 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -44.31 116.48 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.866 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.1 p -105.43 134.12 49.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.54 -137.12 12.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.481 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 23.7 mtt -95.59 146.88 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 m -81.16 176.86 9.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.865 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 13' ' ' VAL . 7.6 p -72.45 -38.86 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.14 -9.31 59.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.14 87.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 10' ' ' VAL . 3.9 p -65.35 -28.77 45.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.97 -65.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.951 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 10.1 tt -47.03 -41.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 4.4 mm-40 -64.54 -45.94 84.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -62.37 -33.06 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.145 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.1 mt -61.06 -48.2 82.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.408 ' CG ' ' HA ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -60.66 -43.47 97.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 mtmm -60.88 -52.03 66.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.603 HG22 HD21 ' A' ' 80' ' ' LEU . 95.0 m -51.79 -48.3 63.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.09 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 18' ' ' LEU . 18.9 t -67.12 -36.47 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -54.69 -43.54 72.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.88 -50.99 60.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.569 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 8.7 t80 -42.71 -64.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' HG12 ' A' ' 22' ' ' VAL . 21.5 m-85 -43.7 -35.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 -36.87 66.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.711 ' HA ' HG12 ' A' ' 39' ' ' VAL . 13.9 t80 -66.79 -46.9 73.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.2 m -64.28 -40.01 95.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.733 ' CD1' HD11 ' A' ' 90' ' ' ILE . 16.2 t80 -69.71 -47.53 62.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.972 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 -28.98 64.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.434 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -47.64 68.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.863 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.08 73.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.0 -36.3 81.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 23.38 9.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.498 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.579 ' HE2' HG21 ' A' ' 40' ' ' VAL . 17.4 mtmt -92.37 178.36 5.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 m -107.42 17.63 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 p -152.82 163.5 39.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.213 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -77.46 146.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.155 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.579 HG21 ' HE2' ' A' ' 36' ' ' LYS . 64.4 t -118.29 133.81 23.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.631 0.729 . . . . 0.0 111.126 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.448 HG11 ' HZ ' ' A' ' 65' ' ' PHE . 96.2 t -70.82 112.06 11.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.577 0.703 . . . . 0.0 111.133 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.2 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -49.49 -49.9 43.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -45.51 -50.66 12.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -71.56 -55.56 7.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 40.1 mmm -49.84 -19.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.826 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 -35.37 42.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -78.95 -40.11 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.28 99.16 4.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.56 43.42 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 53' ' ' ALA . 12.2 p -118.45 -56.61 2.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.883 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -33.42 -36.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 52' ' ' SER . 6.2 t -152.48 123.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 56' ' ' VAL . 46.4 t -94.15 161.3 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.801 HG21 ' CD1' ' A' ' 65' ' ' PHE . 14.2 t -134.07 121.76 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.94 166.98 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.35 3.33 69.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.436 ' HB3' ' CG1' ' A' ' 63' ' ' VAL . 9.6 mt -76.09 152.68 84.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.685 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.7 Cg_endo -69.75 -172.77 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.626 2.217 . . . . 0.0 112.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -83.33 160.93 21.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 44.78 31.7 2.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.685 HG11 ' HD2' ' A' ' 60' ' ' PRO . 3.2 p -121.79 155.46 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -137.79 123.17 19.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 56' ' ' VAL . 78.8 t80 -35.55 119.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 11.8 ptpt -164.65 171.01 14.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.536 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 5.7 t-80 -41.76 140.94 1.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.553 0.692 . . . . 0.0 110.855 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 1.002 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.67 -2.95 10.99 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.385 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HA ' ' CG ' ' A' ' 19' ' ' ARG . 7.5 pt-20 -95.87 -21.83 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -78.13 -14.76 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.0 m-85 -84.77 119.02 24.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' THR . 2.8 m-20 -45.04 142.45 1.88 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 5.9 tp -36.49 -53.87 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.85 72.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 72' ' ' ASP . 65.0 m -64.93 -49.7 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.002 HD21 ' O ' ' A' ' 68' ' ' PRO . 13.7 mt -48.04 -50.49 27.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -51.13 -42.79 60.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.556 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 69.9 t90 -56.02 -56.11 24.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -46.04 -52.09 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.603 HD21 HG22 ' A' ' 21' ' ' THR . 27.4 mt -60.28 -33.0 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -67.85 -54.37 19.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.45 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.5 m-80 -99.86 37.39 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.569 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 15.5 pttp -77.53 -45.23 26.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.47 ' N ' ' HG3' ' A' ' 83' ' ' LYS . . . -42.69 -31.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' ILE . . . -83.97 -44.93 6.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLY . 23.9 mt -37.28 119.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 0.0 111.08 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -116.75 166.1 12.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.671 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.7 m-85 -133.92 123.8 25.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.71 111.18 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.733 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -82.09 113.26 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.498 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 23.9 mmtt -92.61 -29.59 16.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.433 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -178.85 139.66 0.36 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.578 0.704 . . . . 0.0 110.877 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 148.73 65.76 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -70.4 118.39 13.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.6 mt -115.29 127.95 55.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.9 142.82 1.33 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.617 0.722 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -173.67 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.637 2.225 . . . . 0.0 112.381 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' LYS . 19.6 pttt -167.57 162.34 14.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 98' ' ' LYS . 33.6 mtpt -37.14 -62.75 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.6 t60 43.07 54.74 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.0 m -95.22 50.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 53.19 -105.38 0.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.551 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -163.58 141.29 7.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.498 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.8 m -138.85 117.24 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.3 120.26 21.14 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.498 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 109.72 2.38 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.668 2.245 . . . . 0.0 112.325 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.3 p -94.03 122.01 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.5 m -104.8 123.58 47.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.517 179.991 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -86.54 151.99 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 110.802 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.3 m -56.31 122.08 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.76 -143.05 5.11 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.56 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 m -101.01 156.35 17.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.3 t -125.66 153.81 43.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.52 -144.83 15.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.436 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -110.68 118.14 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.84 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -72.56 165.44 24.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 13' ' ' VAL . 5.6 p -64.11 -42.19 94.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.091 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -86.22 -12.69 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.431 ' O ' ' CG ' ' A' ' 16' ' ' GLU . . . -61.09 -42.22 98.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.084 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 10' ' ' VAL . 3.2 p -60.01 -33.35 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.75 -66.48 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.7 tt -49.15 -36.04 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.124 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 12' ' ' ALA . 5.2 mm-40 -71.24 -42.64 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 m -65.22 -39.66 93.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.196 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 23.0 mt -58.24 -45.94 86.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -56.49 -33.36 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' N ' ' HE2' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -70.44 -57.96 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.638 HG22 HD21 ' A' ' 80' ' ' LEU . 9.9 m -40.37 -46.01 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.671 HG12 ' CE2' ' A' ' 26' ' ' PHE . 40.1 t -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG3' ' CG ' ' A' ' 68' ' ' PRO . 28.1 mt-10 -57.94 -41.91 83.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.45 -42.37 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.467 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 5.9 t80 -50.36 -60.57 2.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.671 ' CE2' HG12 ' A' ' 22' ' ' VAL . 19.0 m-85 -46.87 -37.45 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.0 m -69.56 -42.89 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.737 ' HA ' HG12 ' A' ' 39' ' ' VAL . 5.5 t80 -58.7 -56.79 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -53.73 -47.08 70.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.752 ' CD1' HD11 ' A' ' 90' ' ' ILE . 13.2 t80 -58.83 -68.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.69 -31.23 53.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.489 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.76 -42.23 82.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -28.04 65.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.87 -31.81 72.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.16 24.51 11.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.686 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.9 mtmt -93.86 179.96 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 m -109.47 20.93 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.7 p -155.42 159.58 39.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -73.28 144.65 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.686 HG21 ' HE2' ' A' ' 36' ' ' LYS . 93.4 t -122.39 138.36 29.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.733 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.631 ' HD2' HG13 ' A' ' 40' ' ' VAL . 52.9 Cg_endo -69.75 128.38 15.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 26' ' ' PHE . 69.9 t -72.29 111.87 12.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.612 0.72 . . . . 0.0 111.133 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 80.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.52 ' O ' ' C ' ' A' ' 45' ' ' GLU . 74.0 m-85 -54.96 -72.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 44' ' ' TYR . 4.0 tp10 -28.03 -61.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 10.7 mptt -55.07 -49.13 72.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.957 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.561 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 56.9 mtp -57.32 -56.76 17.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 8.6 mt -40.41 -34.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -78.55 -42.33 29.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' MET . 2.4 m-20 -134.16 95.44 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -79.99 42.93 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.4 t -118.76 -57.85 2.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -32.58 -38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 90' ' ' ILE . 56.9 t -147.33 119.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.8 t -98.01 146.94 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.74 HG21 ' CD1' ' A' ' 65' ' ' PHE . 23.1 t -115.36 131.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -121.93 166.19 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.16 18.0 63.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 59' ' ' LEU . 11.8 mt -92.45 158.06 39.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.606 0.717 . . . . 0.0 110.865 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD3' ' CZ3' ' A' ' 78' ' ' TRP . 53.8 Cg_endo -69.77 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -96.22 164.33 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.93 13.99 2.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.526 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 64' ' ' ALA . 3.8 p -106.25 175.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.334 . . . . 0.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.731 ' H ' HG22 ' A' ' 63' ' ' VAL . . . -156.55 117.89 3.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.03 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.74 ' CD1' HG21 ' A' ' 56' ' ' VAL . 84.4 t80 -33.67 124.87 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' CD ' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -169.33 179.48 3.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.8 t-80 -51.8 141.48 26.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 110.879 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.724 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.1 Cg_endo -69.8 -6.23 18.13 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.705 2.27 . . . . 0.0 112.362 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -93.23 -18.88 21.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.45 ' HB3' ' CD ' ' A' ' 66' ' ' LYS . 34.4 t-20 -79.92 -17.25 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.13 133.92 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' LEU . 0.6 OUTLIER -64.91 146.19 55.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.871 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.547 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 8.5 tp -37.66 -40.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.18 -53.98 51.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -59.67 -52.76 64.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 68' ' ' PRO . 16.4 mt -39.29 -52.31 2.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -52.9 -48.93 66.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.554 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 52.2 t90 -50.22 -59.83 3.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.2 mt -41.02 -52.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.086 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.638 HD21 HG22 ' A' ' 21' ' ' THR . 20.4 mt -61.09 -37.1 81.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -62.64 -53.12 59.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.511 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.3 m-80 -100.52 36.67 1.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' GLY . 56.8 pttt -80.41 -48.72 12.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.455 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -38.28 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -93.42 -33.71 7.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 15.1 mt -42.91 122.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.375 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -124.22 163.39 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' CE2' HG22 ' A' ' 56' ' ' VAL . 7.2 m-85 -131.48 124.56 30.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.81 110.66 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -83.67 113.44 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -91.32 -28.69 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.479 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.89 136.53 0.32 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.653 0.739 . . . . 0.0 110.844 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.88 131.79 21.8 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 46' ' ' LYS . 63.6 m-85 -52.36 169.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.841 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.464 ' C ' ' CD ' ' A' ' 96' ' ' GLU . 25.7 mt -109.64 119.86 40.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.877 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' CD ' ' C ' ' A' ' 95' ' ' LEU . 24.1 mp0 -143.2 136.39 13.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.684 0.754 . . . . 0.0 110.858 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -169.23 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.654 2.236 . . . . 0.0 112.354 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 40.6 tptt -116.98 152.31 34.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 100' ' ' HIS . 11.1 ptmt -81.33 176.47 9.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.899 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 99' ' ' LYS . 9.5 m-70 -174.81 126.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.861 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 102' ' ' GLY . 14.5 p -131.62 155.57 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.167 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -77.76 -151.69 5.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.508 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -129.92 64.17 0.61 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.557 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.1 m -118.14 124.96 49.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.963 0.411 . . . . 0.0 110.768 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 161.41 -158.18 29.91 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.4 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 133.41 25.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.746 2.297 . . . . 0.0 112.336 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.5 m -114.42 145.15 42.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.9 t -97.68 -46.09 6.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.513 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t -107.82 158.7 17.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.976 0.417 . . . . 0.0 110.782 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -141.57 110.89 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.854 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.53 -168.29 12.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.6 p -133.65 177.57 7.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.925 0.393 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.7 t -126.19 155.81 41.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 122.08 172.29 14.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.521 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 9.8 mtt -86.24 155.14 20.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -163.72 174.12 12.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 13' ' ' VAL . 7.7 p -68.26 -47.6 77.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.517 ' N ' HG13 ' A' ' 10' ' ' VAL . 5.0 p-10 -77.7 -17.63 57.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 16' ' ' GLU . . . -49.22 -40.34 33.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 10' ' ' VAL . 8.9 p -69.43 -38.44 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.184 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.51 -64.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.824 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -48.64 -34.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 12' ' ' ALA . 7.3 mm-40 -72.3 -45.26 60.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -60.78 -35.39 76.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 73' ' ' LEU . 25.0 mt -62.2 -42.7 99.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -62.07 -41.97 98.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.78 -54.04 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.538 HG22 HD21 ' A' ' 80' ' ' LEU . 87.3 m -44.87 -49.81 10.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.799 HG12 ' CE2' ' A' ' 26' ' ' PHE . 53.4 t -67.8 -40.54 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 14.7 mt-10 -50.76 -47.47 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.47 -51.46 65.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.2 t80 -42.44 -63.92 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.928 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.799 ' CE2' HG12 ' A' ' 22' ' ' VAL . 28.0 m-85 -41.89 -38.89 1.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.907 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.2 m -66.78 -44.89 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.611 ' HA ' HG12 ' A' ' 39' ' ' VAL . 14.6 t80 -58.28 -50.9 71.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.2 m -59.3 -43.44 92.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.41 ' CE1' HD11 ' A' ' 90' ' ' ILE . 12.9 t80 -62.1 -63.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.41 -29.28 66.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 -43.13 82.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.352 . . . . 0.0 110.975 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.95 -33.53 74.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.04 -34.23 75.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 28.35 8.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.663 ' HE2' HG21 ' A' ' 40' ' ' VAL . 13.3 mtmt -95.66 179.62 5.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 m -109.23 22.11 16.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.806 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.9 p -154.49 175.1 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -88.74 141.53 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.663 HG21 ' HE2' ' A' ' 36' ' ' LYS . 91.9 t -116.7 132.7 23.25 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.657 0.742 . . . . 0.0 111.163 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.0 Cg_endo -69.78 116.72 4.69 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.636 2.224 . . . . 0.0 112.37 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.481 ' CG1' ' SD ' ' A' ' 47' ' ' MET . 46.3 t -67.25 112.28 9.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 79.5 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.709 2.272 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -51.3 -49.19 61.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -49.48 -48.99 47.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -68.34 -60.37 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.692 ' CE ' ' CE2' ' A' ' 65' ' ' PHE . 69.7 mtp -45.56 -35.45 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -58.8 -42.2 88.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.974 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -46.32 83.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -134.98 100.02 4.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -84.7 46.22 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.1 p -121.51 -44.61 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.12 -43.7 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.646 HG22 HG13 ' A' ' 90' ' ' ILE . 93.6 t -140.26 128.4 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 56' ' ' VAL . 88.4 t -100.94 158.58 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.084 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.718 HG13 ' CE1' ' A' ' 88' ' ' PHE . 21.6 t -131.76 119.1 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -103.16 178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.78 -0.33 88.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.422 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 59' ' ' LEU . 10.4 mt -77.07 153.84 82.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.723 . . . . 0.0 110.937 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.643 ' O ' HG12 ' A' ' 63' ' ' VAL . 53.0 Cg_endo -69.82 -171.81 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.339 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -84.6 162.51 19.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.64 31.74 1.84 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 60' ' ' PRO . 6.0 p -119.15 161.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.098 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 65' ' ' PHE . . . -140.9 119.29 12.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.149 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' ' CE ' ' A' ' 47' ' ' MET . 48.6 t80 -34.48 131.17 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 11.4 ptpt -175.09 163.14 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 4.7 t-80 -36.73 141.31 0.39 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.863 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.883 ' O ' HD21 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.77 -4.06 13.28 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.308 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -89.18 -27.03 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -76.72 -18.64 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-85 -80.97 111.34 17.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -42.69 145.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 11.0 tp -38.85 -46.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.32 82.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 50.2 m -63.16 -45.2 92.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.883 HD21 ' O ' ' A' ' 68' ' ' PRO . 18.7 mt -48.64 -53.05 20.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -49.2 -45.55 44.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.56 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 66.6 t90 -54.55 -63.77 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -40.05 -50.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.538 HD21 HG22 ' A' ' 21' ' ' THR . 18.0 mt -62.11 -35.65 79.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' TRP . 10.3 mt-10 -65.32 -54.98 21.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.467 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -98.21 40.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 25' ' ' TYR . 18.4 ptmt -82.68 -50.57 8.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 83' ' ' LYS . . . -35.07 -37.95 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.72 13.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.54 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 83' ' ' LYS . 16.2 mt -37.9 124.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -126.47 169.98 12.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.718 ' CE1' HG13 ' A' ' 56' ' ' VAL . 5.6 m-85 -132.54 125.72 31.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.09 112.5 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -84.52 112.46 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.466 ' HE3' ' CG2' ' A' ' 55' ' ' VAL . 5.1 mmtp -91.51 -28.87 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.465 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.57 130.74 0.26 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.757 . . . . 0.0 110.898 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.42 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 54.4 Cg_endo -69.71 127.61 14.88 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.742 2.295 . . . . 0.0 112.391 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -45.04 168.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.2 mt -110.62 131.43 55.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -149.81 142.08 15.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.655 0.741 . . . . 0.0 110.868 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -171.89 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.658 2.239 . . . . 0.0 112.322 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -64.79 131.34 46.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -44.24 125.0 4.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -141.53 122.82 14.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.87 107.29 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 0.0 111.119 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.03 91.68 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.86 125.83 0.79 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.8 p -168.66 157.35 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.885 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.72 -74.94 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -1.58 8.66 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.7 p -43.55 -52.42 6.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.8 m -90.7 -62.59 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.551 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.4 t -117.99 -50.01 2.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -101.98 171.64 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.97 -45.88 1.13 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.489 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.7 p -62.99 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.837 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.3 p -144.17 135.99 26.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.57 175.12 40.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.26 158.21 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 110.884 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -112.01 172.21 7.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 11' ' ' ASP . 7.1 p -78.92 -42.05 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.165 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.436 ' N ' HG13 ' A' ' 10' ' ' VAL . 13.1 t70 -79.24 -13.87 59.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.515 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -50.93 -51.41 52.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.84 -19.31 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -71.2 -47.88 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 12' ' ' ALA . 6.1 tt -62.88 -32.76 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -76.39 -39.26 54.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 m -65.91 -35.82 81.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD12 ' CD1' ' A' ' 73' ' ' LEU . 19.4 mt -63.52 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.98 -39.25 81.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -66.01 -52.42 49.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.498 HG22 HD21 ' A' ' 80' ' ' LEU . 27.8 m -52.01 -48.36 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 26' ' ' PHE . 58.8 t -66.5 -38.51 81.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.162 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' CG ' ' HG3' ' A' ' 68' ' ' PRO . 13.3 mt-10 -56.75 -41.18 77.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.38 -47.91 62.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.402 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 7.2 t80 -44.59 -63.1 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.576 ' HB3' HG21 ' A' ' 42' ' ' VAL . 21.9 m-85 -43.31 -38.83 2.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.5 m -65.45 -46.02 81.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.556 ' HA ' HG12 ' A' ' 39' ' ' VAL . 10.3 t80 -56.61 -58.28 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 92.9 m -54.06 -40.75 67.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -64.61 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.65 -27.54 58.91 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.531 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -41.66 73.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.03 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.08 -33.99 77.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.85 25.77 8.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.485 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.673 ' HE2' HG21 ' A' ' 40' ' ' VAL . 12.4 mtmt -96.29 179.24 5.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.93 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.4 7.75 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.5 p -140.31 167.79 21.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -80.35 148.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 ' HE2' ' A' ' 36' ' ' LYS . 87.2 t -127.1 135.51 27.49 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.642 0.734 . . . . 0.0 111.1 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.541 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.2 Cg_endo -69.79 121.02 7.71 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.74 2.293 . . . . 0.0 112.32 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 26' ' ' PHE . 57.3 t -66.69 112.09 8.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 79.68 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.698 2.265 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' MET . 95.1 m-85 -47.43 -71.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 44' ' ' TYR . 7.7 tp10 -29.42 -59.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -60.13 -40.22 89.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.57 ' N ' ' O ' ' A' ' 44' ' ' TYR . 28.0 mmm -64.08 -50.06 69.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 15.5 mt -51.22 -37.2 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -90.29 -26.89 19.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -135.0 77.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -72.52 -40.61 66.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -43.2 -57.28 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -33.02 -39.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.088 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 HG13 ' A' ' 90' ' ' ILE . 13.6 t -148.93 119.92 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.93 152.95 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.886 HG21 ' CD1' ' A' ' 65' ' ' PHE . 31.4 t -121.68 124.56 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -116.52 160.75 20.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.81 10.05 59.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.449 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 59' ' ' LEU . 13.2 mt -85.02 157.83 59.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' HG11 ' A' ' 63' ' ' VAL . 53.4 Cg_endo -69.82 -167.51 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 9.0 tp10 -96.06 156.25 16.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 56.68 18.17 23.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.558 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.569 HG11 ' HD2' ' A' ' 60' ' ' PRO . 9.7 p -109.12 166.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.072 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.528 ' N ' HG22 ' A' ' 63' ' ' VAL . . . -144.37 113.04 6.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.886 ' CD1' HG21 ' A' ' 56' ' ' VAL . 29.1 t80 -34.24 111.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 71' ' ' TYR . 12.4 ptpt -156.69 -178.87 7.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 3.3 t-80 -48.81 141.43 10.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.629 0.728 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.956 ' O ' HD21 ' A' ' 76' ' ' LEU . 54.1 Cg_endo -69.67 -7.31 20.69 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.756 2.304 . . . . 0.0 112.379 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -91.95 -19.92 21.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -81.48 -16.58 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 66' ' ' LYS . 25.9 m-85 -84.44 120.13 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.5 OUTLIER -49.66 143.68 6.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.61 ' CD1' HD12 ' A' ' 18' ' ' LEU . 7.9 tp -37.48 -46.06 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.19 80.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 72' ' ' ASP . 61.8 m -67.08 -50.66 60.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.073 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.956 HD21 ' O ' ' A' ' 68' ' ' PRO . 19.5 mt -42.88 -51.82 5.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -52.22 -47.09 65.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.551 ' CZ3' ' HD3' ' A' ' 60' ' ' PRO . 59.9 t90 -52.0 -62.25 1.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.5 mt -39.25 -53.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 21' ' ' THR . 20.8 mt -59.61 -39.78 85.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.66 -54.4 45.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.467 HD22 ' N ' ' A' ' 82' ' ' ASN . 1.4 m-80 -99.87 38.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.821 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' GLY . 55.4 pttt -80.67 -51.22 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' N ' ' CG ' ' A' ' 83' ' ' LYS . . . -37.76 -27.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.127 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 83' ' ' LYS . . . -90.17 -35.62 7.49 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.54 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LYS . 21.3 mt -43.27 123.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 111.067 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.1 m -121.83 168.75 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 56' ' ' VAL . 9.4 m-85 -136.01 121.34 19.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.07 111.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -83.64 112.84 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -92.04 -29.77 16.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.466 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -178.91 134.2 0.29 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.571 0.7 . . . . 0.0 110.846 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' C ' ' HD3' ' A' ' 92' ' ' ARG . 52.9 Cg_endo -69.83 127.58 14.73 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.61 2.206 . . . . 0.0 112.349 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -46.2 126.23 7.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.4 mt -116.99 146.69 42.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -138.07 151.59 70.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.693 0.758 . . . . 0.0 110.864 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 170.95 15.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.767 2.311 . . . . 0.0 112.309 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 99' ' ' LYS . 1.7 ttpm? 63.77 41.09 7.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 100' ' ' HIS . 58.1 mttt 37.98 43.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 99' ' ' LYS . 6.9 p-80 -34.93 129.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.5 t -96.0 84.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.175 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.7 -61.45 4.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 154.93 -139.82 6.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.521 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.2 p -158.41 108.49 2.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.867 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.25 164.72 34.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 158.16 58.0 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.704 2.269 . . . . 0.0 112.312 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -81.22 172.67 13.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.6 t -140.27 173.64 11.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 179.995 . . . . . . . . 0 0 . 1 stop_ save_